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Abstract 
The majority of reports of imported malaria in Europe come from the UK, France, 
Germany and Italy. Most of those affected are of African origin visiting friends and 
relatives (VFRs). There is little understanding of the factors that enhance and 
constrain effective malaria prevention practices in this group. Two studies were 
undertaken to investigate this. 
An epidemiological analysis of 13813 reports made in the UK between 2001 and 
2008 showed that 58% lived in London, where 83% of infections were caused by 
Plasmodiumfalciparum. The rate per 100000 offalciparum infections in the capital 
in 2008 in those categorised as of "Black African" ethnicity was 131.0 (CI: 120.0-
142.1), compared to 0.3 (CI: 0.2-0.5) amongst the "White British". 
To investigate factors influencing the behaviours of VFRs, semi-structured 
interviews were undertaken with African VFRs resident in the UK visiting Nigeria 
and Ghana (n = 20), malaria patients (n= 6), practice nurses (n= 10), GPs (n = 10), 
community pharmacists (n= 7) and hospital consultants (n= 3). 
Factors influencing the use of mosquito avoidance methods included knowledge 
about the local environment, a perceived inevitability of contracting malaria, and a 
desire to use methods common amongst host families. Chemoprophylaxis use was 
influenced by perceptions of susceptibility, by previous experiences of malaria, 
perceptions of the seriousness of malaria, and peer pressure. Relevant structural 
factors included the cost of chemoprophylaxis and difficulties in accessing health 
advice. 
This research showed that in managing malaria, VFRs choose pragmatically 
between two parallel social and environmental contexts and the structural constraints 
associated with each. A novel conceptual framework shows the complex manner in 
which these interact, and may be appropriate in different countries and also in future 
research investigating other travel-related diseases in migrants. Practical 
recommendations for research priorities within the UK imported malaria context are 
made. 
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1.1 Estimates of global migration. the definition of imported malaria and 
its incidence in the UK 
It is estimated that in 2010, 3.1 % of the global population lived outside their country of 
birth, representing nearly 214 million people (United Nations, 2009 p.14 7). Europe is 
host to about one third of this number (United Nations, 2009). It has been noted that 
whilst the health concerns of many migrants will be similar to the indigenous 
population, they may be more at risk of certain infectious diseases which are endemic in 
their country of origin, but not in the host nation (Health Protection Agency, 2011 b). 
Malaria is an example of a disease that can still have an impact in countries from which 
it has been eliminated. "Imported malaria" has been described as "an infection that was 
acquired in an endemic area by an individual (either a tourist or indigenous native) but 
diagnosed in a non-endemic country after development of the clinical disease" 
(Muentener et aI., 1999 p.561). In the UK, there was an average of 1965 laboratory 
confirmed reports of imported malaria infections between 1987 and 2006 (Smith et aI., 
2008). The number of reports made is likely to be an under-estimate of the true 
incidence. A capture-recapture study comparing reports made to the UK's Malaria 
Reference Laboratory (MRL), where national epidemiological surveillance is 
conducted, with Hospital Episode Statistics (HES), which provide details of hospital 
admissions, concluded that between July 2003 and December 2004, only 56% of all 
cases, 66% of falciparum cases and 62% of cases in London were reported to the MRL 
(Cathcart et aI., 2009). 
1.2 Imported malaria in the UK since the Second World War 
Bradley states that there are three factors which detennine the incidence of imported 
malaria: levels of endemicity in malarious countries; the amount of migration into the 
non-malarious country, and the use of chemoprophylaxis and other preventative 
measures by those visiting countries where malaria can be contracted (Bradley, 1989). 
His synopsis of malaria infection in the UK after 1945, and more recent trends in 
malaria epidemiology, described by Smith and colleagues, demonstrate the relevance of 
these three factors (Bradley, 1989, Smith et aI., 2008). After an increase in the number 
of cases of imported malaria when troops returned after the end of the Second World 
War, the number of reports made each year remained below 500 until 1973, with 
increases only seen as a result of involvement in other foreign conflicts, such as the 
Korean war (Bradley, 1989). From the early 1970s, the number of reports, 
predominately caused by P. vivax, began to increase, and vivax cases constituted the 
17 
highest proportion of the reports of imported malaria in the UK, contributing over 1000 
cases each year until 1982. This increase was thought to be caused by people arriving to 
settle in the UK from Asian countries, and their subsequent trips back to these countries 
to visit friends and relatives, coupled with high rates of viva x malaria in Asian countries 
following eradication failures (Bradley, 1989). The incidence of cases caused by P. 
vivax then declined to just under 1000 cases a year, but continued to be the main 
species of malaria causing imported infections in the UK until 1988, including a brief 
resurgence in incidence to over 1000 cases in 1986 and 1987 (Bradley, 1989). After 
1988, a decrease in vivax infections began, and this has been sustained (Smith et aI., 
2008). Whilst cases of P. vivax contributed 3954 (40%) to the total number of reports of 
imported malaria reports in the UK between 1987 and 1991, they only accounted for 
1244 (14%) of this total between 2002 and 2006 (Smith et aI., 2008). Successful control 
efforts in urbanised areas of countries within Asia where most travellers stay have been 
identified as a likely cause of this decline (Smith et aI., 2008). 
From 1988 onwards, cases of falciparum malaria diagnosed in the UK, but acquired in 
particular in West Africa began to increase (Bradley, 1989). Falciparum malaria is the 
most serious form of malaria, not only because of the severity of symptoms it causes, 
but also because of the high levels of mortality which can be attributed to it. Between 
1987 and 1991 there were cumulatively 5120 reports of imported malaria, of which 
51 % were caused by P. Jalciparnm. Between 2002-2006, the cumulative incidence of 
reports offalciparum malaria had risen to 6753 (76%), of the total number ofreports 
(Smith et aI., 2008). Reasons for the increase are thought to be the result of immigration 
from, as well as subsequent travel to visit friends and relatives in highly malaria-
endemic countries of Africa (Bradley, 1989, Smith et aI., 2008), exacerbated by 
chloroquine resistance in these countries (Bradley, 1989). Another factor contributing 
to this picture of increasing disease incidence has been described as the failure by those 
visiting friends and relatives to take chemoprophylaxis, with only 7% of those visiting 
friends and relatives (VFRs) reported to have used this protection against malaria 
between 1999 to 2006 (Smith et aI., 2008). Between 1996 and 2007 there were 183 
deaths caused by infections with P. Jalciparum in the UK, a case fatality rate of 7.4 
(95% confidence interval (el): 6.3 to 8.5) per 1000 (Smith et aI., 2008). 
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1.3 Current epidemiology of imported malaria in the UK 
Those people resident in the UK who visit friends and relatives in African countries 
currently constitute the largest proportion of travellers who return with the disease 
(Smith et aI., 2008). Similarly, in a review of 14 studies of imported malaria in 
Australia, the USA and Europe carried out between 1984 and 2007, which included 
eight studies from Europe, between 21.1 % and 68.3% of all cases were in YFRs (Pavli 
and Maltezou, 2010). No other reason for travel accounted for such a high proportion of 
reports, and between 57% and 94.5% of all imported malaria reports in the studies 
included in the review were acquired in Africa (Pavli and Maltezou, 2010). Recent data 
from TropNetEurop a European-wide sentinel surveillance system, demonstrated that 
in 2009, Nigeria, Ghana, Cameroon and Benin were the area where most falciparum 
infections were acquired (TropNetEurop, 2010). The UK-based epidemiological study 
carried out by Smith and colleagues and referred to above, found that half of all 
falciparum cases between 1987 and 2006 were in those visiting Nigeria or Ghana 
(Smith et aI., 2008). These data suggest that just as globally most of the burden of 
malaria disease lies in Sub-Saharan Africa (Tatem et aI., 2010), so the current 
epidemiology of imported malaria in European countries mirrors this distribution in 
incidence. 
There is some evidence of a recent reduction in the burden of imported malaria caused 
by P. Jalciparum from West Africa, with a study showing an annual 9.8% (CI: 6.5-13%) 
decrease in reports between 1993 and 2008 made to the MRL amongst YFR travellers 
to four West African countries (Nigeria, Ghana, Sierra Leone and the Gambia) (Behrens 
et aI., 2008). The authors noted that this decline occurred despite published evidence of 
the low use of malaria chemoprophylaxis amongst YFRs visiting Sub-Saharan Africa 
during at least part of this time period (1999 to 2006) (Smith et aI., 2008). Behrens and 
colleagues concluded that a simultaneous reduction of 7.9% in reports of patients who 
were treated for malaria in the UK, but who were normally resident in West Africa, led 
to the most likely explanation for the findings being that declining transmission in West 
African countries linked to increased urbanisation, and successful control methods in 
West African countries, such as greater use of insecticide-treated bednets may have 
accounted for this decrease (Behrens et aI., 2008). However, the authors acknowledged 
that 29% of malaria reports made to the MRL during the time period in which the study 
was conducted did not have the reason for travel completed, and 12% of reports did not 
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include the country visited. These limitations need to be borne in mind when 
interpreting the findings. Nevertheless, a similar study analysing national surveillance 
data from the Netherlands also reported a declining incidence of imported malaria 
between 2000 and 2007 (Van Rijckevorsel et aI., 2010). As in the UK, the majority of 
travellers were VFRs visiting Nigeria and Ghana. These authors explained that there 
was no evidence of a decrease in malaria incidence within these African countries 
which might explain the findings, and speculated that the reduction may be caused by 
travellers putting more effort into mosquito control methods and staying in better 
quality housing in urban areas. 
More recent data from the MRL show an increase in the total number of reports of 
malaria, from 1370 in 2008, to 1495 in 2009 and to 1761 in 2010 (Health Protection 
Agency, 2010, Health Protection Agency, 2011a), although more data and a detailed 
analysis of these, including a comparison of incidence with changes in the volume of 
VFR travellers will be required to determine more long-term trends. 
As stated above, in the UK, about half of all reports of malaria cases were acquired in 
Nigeria or in Ghana (Smith et aI., 2008). A recent analysis of technical and operational 
factors which might affect the likelihood of achieving malaria elimination in malaria-
endemic countries has indicated that with respect to both Nigeria and Ghana, the 
intensity of transmission and the amount of malaria which is imported into these 
countries are likely to be their main barriers to malaria elimination. Operational factors 
such as government stability, adequate infrastructures and health systems, political 
commitment to eliminating malaria, and the size and poor access to medical services for 
the population at risk will also contribute (Tatem et aI., 2010). Previous attempts to 
eradicate malaria were judged to have failed partly for these operational reasons and 
partly because of vector resistance to insecticides and parasite resistance to chloroquine 
(Bruce-Chwatt, 1987). As Bradley points out, "history has shown the importance of 
unexpected and relatively unpredictable events in determining the amount of imported 
malaria" (Bradley, 1989 p.9). This, he claims makes it difficult to determine future 
patterns (Bradley, 1989). As a result of these uncertainties, and the difficulties 
associated with eliminating malaria in malaria-endemic countries visited by many 
VFRs, it likely that malaria will remain a public health problem in the UK for several 
years to come. 
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1.4 Study rationale 
There are several reasons which make it worthwhile to understand the factors that 
contribute to the incidence of malaria in the West African community in London. 
Firstly, malaria is a commonly reported travel-related illness. For example, between 
1997 and 2006, malaria was one of the most commonly reported diagnoses in travellers 
with systemic febrile illnesses who presented to clinics in non-malaria endemic 
countries that are part of a world-wide sentinel surveillance system (Wilson et aI., 
2007). However, this disease is almost entirely preventable. For this reason alone, 
reducing the incidence of malaria infections will make a significant impact on the 
prevention of travel-related illness, and as such is a worthwhile Public Health challenge. 
Understanding the factors that contribute to this incidence is central to the development 
of appropriate interventions to achieve this. 
Secondly, it is recognised that one focus of research into imported malaria in the UK 
should be on West African communities visiting friends and relatives, as they bear a 
disproportionate burden of these infections (Muentener et aI., 1999, Smith et aI., 2008, 
Zuckerman, 2008). Despite this, few data are available on why many members of the 
African Diaspora do not protect themselves against malaria when travelling to a 
malarious country (Neave et aI., 2010). 
Thirdly, the topic of imported malaria raises fundamental questions about the control of 
infectious diseases in an early 21 5t century dominated by increased migration and travel. 
On the one hand, Angell and Cetron point out that the means exist to prevent most 
travel-related illnesses such as malaria, but structural barriers, such as poor access to 
pre-travel health advice and prevention tools may be the barrier to achieving this 
(Angell and Cetron 2005). On the other hand, it may be that national boundaries are no 
longer sufficient to achieve the control of diseases. As Lee claims, "spatial or 
geographical boundaries, in particular the territorial borders of states, are becoming 
relatively less important as a consequence of globalisation" (Lee, 2002 p.6), whilst 
Gushulak makes the point that "many of the health threats, risks, and challenges related 
to health outcomes due to migration result from factors and influences present outside 
the jurisdiction and hence the direct influence, of the migrant-receiving nations" 
(Gushulak, 2010 p.4). While these views are not necessarily contradictory, they do 
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represent different ways of approaching the problem of disease control in the 21 st 
century. However, whichever view point is adopted, little progress will be made 
without a better understanding of the factors that influence the health behaviours of 
migrants in general. This is true of malaria as it is of any other imported disease. In this 
thesis, I am concerned with addressing this gap in understanding the contextual factors 
that influence the health behaviours of migrants resident in a non-endemic country who 
acquire malaria when visiting friends and relatives living in a malaria endemic country. 
1.5 Aims and objectives of the study 
The aim of this research is to understand the factors that contribute to the burden of 
imported malaria among Nigerians and Ghanaians living in London. The objectives are: 
• To investigate the epidemiology of imported malaria in the UK between 2001 
and 2008 
• To explore the perceptions and experiences of malaria among London residents 
visiting friends and relatives in Nigeria and Ghana 
• To describe the perceptions and experiences of health professionals providing 
pre-travel advice and post travel treatment for malaria in London 
• To explain the factors the enhance and constrain the uptake and effective use of 
malaria prevention and treatment among London residents visiting friends and 
relatives in Nigeria and Ghana 
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Chapter two: Malaria: the vector, parasite and 
environmental factors affecting transmission; 
symptoms and loss of immunity; prevention, diagnosis 
and treatment. 
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The first section of this chapter gives details of the malaria vector and parasite, and 
explains the environmental factors which facilitate transmission. This is followed by a 
discussion of how immunity to malaria is acquired, then lost upon leaving a malarious 
country and describes those genetic factors which may affect susceptibility to malaria. 
The second section provides details of the UK's recommendations on malaria 
prevention, diagnosis and treatment. Comparative details of diagnosis and treatment 
recommendations in Nigeria and Ghana are also given. The chapter concludes by 
describing how National Health Service (NHS) pre-travel health services with respect to 
malaria prevention are organised in the UK. 
2.1 Malaria transmission 
2.1.1 The malaria vector 
Although there are about 70 speCIes of mosquito that can transmit malaria, 
approximately 40 of these are considered to be vectors that are of medical 
importance because of their ability to transmit malaria (Service, 1996 p.39). In Sub-
Saharan Africa, the three species of malaria-transmitting mosquito vectors 
considered particularly important are Anopheles Arabiensis, Anopheles Funestus, 
and Anopheles Gambiae (Service, 1996 p.41). All three species bite humans both 
indoors and outdoors from dusk to dawn. Therefore, individuals should take 
particular care to protect themselves from mosquito bites during these times. The 
resting position of mosquitoes is also relevant for malaria control, as it impacts on 
the effectiveness of household spraying (Service, 1996 p.38). With respect to 
Anopheles Arabiensis, Anopheles Funestus, and Anopheles Gambiae, although all 
three species rest mostly indoors, they do not do this exclusively. 
The larval stages of the anopheles mosquito require water for their development. 
These can be temporary collections of water such as the small puddles found in tin 
cans, car tyres, axils of plants and tree holes, as well as more permanent bodies such 
as swamps, marshes, and ponds. However larger bodies of water where predators of 
mosquito larvae, such as fish, may be present are generally not preferred (Service, 
1996 p.37). Some anopheles species prefer to live in either sunlit areas, for example, 
Anopheles Arabiensis and Anopheles Gambiae, whilst others, such as Anopheles 
Funestus prefer the shade (Service, 1996 p.42-44). 
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2.1.2 The malaria parasite 
Four species of malaria parasite (P. Ja/ciparnm. P. vi vax. P. ova/e and P. malariae) 
commonly cause malaria in humans, although cases of infections with P. knowlesi 
have been reported (Singh et aI., 2004). Infections caused by P.Jalciparnm, most 
commonly acquired in Sub-Saharan Africa, are responsible for the majority of global 
malaria-related illness and death (Snow et aI., 2005). 
The parasites which cause malaria in humans live for part of their life-cycle in the 
human host (the intermediate host), and part of their life in the mosquito (definitive 
host). When a human is bitten by a mosquito that has been infected with the malaria 
parasite, sporozoites are injected from the insect into the human body and those that 
are not killed by the immune system migrate to the liver within about half an hour. 
There are two stages to the life cycle of the plasmodium parasite that take place within 
the human body. The first is termed exo-erythrocytic schizogony, and is a period of 
asexual multiplication of the parasite. During this stage, on entering the liver, 
sporozoites become schizonts. Within each schizont, thousands of merozoites are 
formed. For P. Ja/ciparnm infections, this stage of the life cycle lasts between five to 
seven days. In the case of P. vivax and P. ova/e, liver schizonts can remain dormant for 
a period of months or years, causing re-activation of disease at a later date. (Health 
Protection Agency, 2007b) 
The second stage of the life cycle of the parasite within the human host is called 
erythrocytic schizogony, and occurs when merozoites leave the liver and enter the 
blood, invading red blood cells. Within these red blood cells they form trophozoites, 
which initially resemble rings with the edges thicker than the centre. These 
trophozoites divide asexually to form schizonts. New merozoites are then formed from 
these schizonts. Upon rupture of the red blood cell, merozoites are released and invade 
more red blood cells. Fever and other clinical symptoms of malaria occur with the 
release of new merozoites and invasion of more red blood cells, with the cycle of 
invasion of red blood cells by each generation of merozoites occurring on average 48 
hours for infections with P .ja/ciparum. However. there may be no regularity to the 
timing in which the cycle occurs. (Health Protection Agency, 2007b). 
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Instead of continuing the pattern of asexual replication, some trophozoites form 
gametocytes, the sexual stage of the parasite ' s life cycle. These are picked up by the 
mosquito when she bites an infected human. The life cycle of the parasite is completed 
within the mosquito, with sporozoites entering another human host when the mosquito 
bites, so repeating the cycle. 
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Figure 2.1.1 the life cycle of the malaria parasite within the human host, and the stages at which 
chemoprophylaxis can act. 
(Source: Guidelines for malaria prevention in travellers from the United Kingdom (Health Protection 
Agency, 2007b). Reproduced with permission of Professor Peter Chiodini) 
2.1.3 Environmental factors affecting malaria transmission 
In many areas of West Africa, the temperature and rainfall levels mean that malaria 
may be transmitted throughout the year (MARA, 2004). However transmission rates 
may vary within countries in Sub-Saharan Africa (Snow et aI., 2005), A range of 
factors have been proposed to explain how the local environment may affect the 
transmission of malaria. These include how land use provides opportunities for 
mosquitoes to breed, the density of the local population, local initiatives, such as 
vector control methods, individual and household factors , such as socio-economic 
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status, which may, for example impact on the material used for housing, larval and 
adult mosquito factors and climatic features (Robert et aI., 2003). 
As already described, increased urbanisation in West African countries including 
Nigeria and Ghana may be affecting the transmission of malaria (Behrens et aI., 2008). 
Whilst in 1950, 10.2% (3 746 000) of the population of Nigeria were estimated to live 
in urban areas, by the year 2000 this was thought to have risen to approximately 42.5% 
(53000000), and by 2010 to nearly 49.8% (79 000 000). Comparative estimates for 
urban populations in Ghana were 15.4% (769999) in 1950, 44% (8 500000) in 2000 
and 51.4% (12524000) in 2010 (United Nations, 2010). One method of measuring the 
risk of infection which demonstrates the decreased risk in urban areas is the 
entomological inoculation rate (EIR). This is an estimate of the number of infective 
bites per person per year (Robert et aI., 2003). A review of 39 studies measuring this 
rate in urban, urban periphery and rural areas in Africa found a mean EIR of 7.1 in city 
centres, 45.8 in peri-urban areas (defined as areas adjoining market gardens, rice fields 
or those close to lakes) and 167.7 in rural areas (Robert et aI., 2003). 
As well as differing in urban versus rural areas, entomological inoculation rates also 
differ between areas within cities, being dependent on local environmental factors such 
as levels of neighbourhood vegetation, infrastructure and household wealth (Robert et 
aI., 2003). Robert points out that poverty impacts on malaria transmission through a 
lack of access to health services, poor vector control measures, and because poorer 
people may live close to breeding ground for mosquitoes (Robert et aI., 2003). 
Although details of the country visited by VFRs are collected by the MRL, the area 
visited within these countries is not. This does not appear to be a variable collected in 
other European surveillance systems. As such, there is no clear evidence of whether 
VFRs visit urban or rural areas, or a mixture of both. Schlagenhauf and colleagues, in a 
review of imported malaria in five European countries, contend that VFRs are more 
likely to go to more rural areas, with simple non-air conditioned rooms, and where 
transmission rates are higher (Schlagenhauf et aI., 2003). On the other hand, Bouchaud 
and other French colleagues, consider that Africans were more likely to take trips to 
urban areas compared to indigenous Europeans, based on a study in which it was 
found that of 252 African patients, 32% stayed in urban areas, compared to 13.5% of 
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99 European patients (Bouchaud et aI., 2005). The difference in these perceptions 
could be due to the particular populations with whom the authors interacted, but 
demonstrate the paucity of information about these issues. 
2.2 The symptoms of malaria. the development and loss of immunity 
In malaria-endemic countries, two groups are at most risk of malaria. One of these is 
pregnant women, particularly those expecting their first child, who are susceptible to 
severe anaemia as a consequence of malaria infection (World Health Organisation, 
2011a). Spontaneous abortion may also be a consequence, whilst babies born to 
malaria-infected women may suffer from the effects of low birth weight, as malaria 
may interfere with growth within the womb (World Health Organisation, 2011a). 
The other group most at risk in malarious countries is young children. Passive 
immunity, that is, immunity passed from mother to child, is one reason why children in 
the first few months of life do not acquire malaria (Doolan et aI., 2009). Whilst Doolan 
states that this immunity is thought to be passed in utero (Doolan et aI., 2009), he also 
quotes one study which suggests that maternal antibodies may be transmitted through 
breast milk (Kassim et aI., 2000). 
Following the loss of passive immunity, children are at risk of developing clinical 
disease. Symptoms include headache, fatigue, abdominal discomfort and muscle and 
joint aches, usually followed by fever, chills, perspiration and anorexia. More serious 
life-threatening symptoms may occur. Severe malaria, almost always caused by 
infections with P. falciparom, has been defined by the World Health Organisation as 
"acute falciparum malaria with signs of severity, and/or evidence of vital organ 
malfunction" (World Health Organisation, 2010). 
Through sustained exposure to the plasmodium parasite, active immunity is gradually 
acquired. This is dependent on repeated exposure to different strains of the same 
plasmodium i.e. it is strain-specific (Macdonald, 1950) and to the intensity and 
duration of exposure to malaria (Struik and Riley, 2004). There are three types of 
immunity, which are described by Doolan as follows: 
Hi) antidisease immunity, conferring protection against clinical disease, which 
affects the risk and extent of morbidity associated with a given parasite density 
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ii) antiparasite immunity. conferring protection against parasitaemia. which affects 
the density o.f parasites 
iii) premunition. providing protection against new infections by maintaining a /ow-
grade and general~y asymptomatic parasitaemia" (Doolan et aI., 2009 p.14) 
After acquiring a degree of immunity to malaria, provided there is repeated exposure 
to the plasmodium parasite, subsequent infections are likely to be mild or 
asymptomatic (Bloland and Williams, 2003 p.30, Struik and Riley, 2004). This 
protection develops in children from between the ages of two to five years in areas 
where malaria is transmitted throughout the year, such as Nigeria and Ghana. It is 
estimated that for full clinical immunity to be acquired, about five infections each year 
for a period of ten to 15 years are required (Doolan et aI., 2009). 
Those born in a malarious country but who are no longer exposed to infection, for 
example migrants who leave a malarious area, gradually lose the partial immunity they 
gained as a result of continuous exposure to malaria parasites. As a consequence of 
this, the World Health Organisation (WHO) recommends that chemoprophylaxis is 
taken by any individual travelling to a malarious country in the season during which 
malaria can be transmitted there, and who has lived outside a malarious area for more 
than six months (World Health Organisation, 2005a p.134, World Health Organisation, 
2005b p134». Despite these guidelines, the time period after which immunity against 
malaria is reduced after leaving a malarious country and the subsequent effect on the 
clinical course of a malaria infection acquired upon re-entry to a malarious country 
have been subjects of some debate. For example, in a comparison of 99 European and 
252 African malaria-infected patients, Bouchaud and colleagues found that those 
patients born in Sub-Saharan African countries, all of who had been resident in France 
for more than four years, had fewer parasite densities, less frequent and severe 
symptoms, and more rapid clearance of both fever and parasite than patients born in 
Europe but who visited these countries. From this they concluded that immunity to 
falciparum malaria persists even after several years of non-exposure (Bouchaud et aI., 
2005). Other researchers have reported contradictory results. Bunn and colleagues 
studied 260 patients who had acquired malaria in highly malaria-endemic areas of Sub-
Saharan Africa and who, upon return to the UK, had been admitted to the Hospital for 
Tropical Diseases between 1996 and 2003 (Bunn et aI., 2004). They found no 
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significant difference between levels of mean parasitaemia at admission in patients not 
currently resident in a malarious country, compared to patients who were African 
visitors to the UK and so who were regularly exposed to malaria, with nearly a third of 
the latter group requiring parenteral treatment. Neither of these two studies however 
specifically reported on the ethnicity of their patients who had either been born or 
resident in African countries, and this could have impacted on their exposure to 
malaria-carrying mosquitoes during the time they were resident in malaria endemic 
countries. 
Jennings and colleagues, in another study undertaken at the Hospital for Tropical 
Diseases (HTD) of 99 patients with falciparum malaria treated between 2000 and 
2002, some who lived in Sub-Saharan Africa, and others who were resident in the UK, 
did compare patients by ethnicity and found that neither this, current residence in a 
malarious country nor previous exposure to malaria made any difference to the 
numbers of patients who acquired severe malaria compared to those who acquired 
uncomplicated malaria (Jennings et aI., 2006). However, they acknowledged that these 
patients may not have been a representative sample of the wider population, 
constituting a group whose symptoms were severe enough to warrant them seeking 
medical treatment. Indeed, this is also true of the studies carried out by Bunn and 
Bouchaud (Bunn et aI., 2004, Bouchaud et aI., 2005), and there may be a cohort of 
patients of African ethnicity living in malaria-free countries who, if infected, 
experience symptoms which are sufficiently mild not to require hospital treatment. 
Jennings and colleagues also surmised that those patients taking part in the study who 
were normally resident in a malarious area and able to afford a trip to Europe may live 
in areas where there is relatively little exposure to malaria and that this may have 
accounted for the severity of their symptoms (Jennings et aI., 2006). 
More recently, Phillips and colleagues in a study of 676 patients treated in another 
London hospital found that those of white ethnicity were 8.2 times more likely than 
patients classified as being of Black African ethnicity to suffer severe malaria and that 
those who suffered previous malaria infections were also less likely to experience 
these severe symptoms (Phillips et aI., 2009). The authors noted that the differences in 
their fmdings compared to those reported by Jennings and colleagues (Jennings et aI., 
2006) depended to some extent on the way in which the WHO definition of "severe 
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malaria" was interpreted in each study. However, they considered that even a few 
episodes of malaria may offer some protection against severe infections. One 
limitation to the study acknowledged by the authors was that there was no indication of 
the length of time that had passed since the previous infections reported by 
participants. Another, not noted by the authors, but of relevance, was that there was no 
information about whether the previously reported infections had been laboratory-
confirmed to guarantee these were true malaria cases. 
One explanation for the protection against severe malaria that has been reported in 
some studies is that the immunological mechanisms that protect against severe malaria 
remain after non-exposure to parasites, but inflammatory responses to relatively low 
parasite numbers cause clinical symptoms in those who have not been re-infected with 
malaria for a long period (Struik and Riley, 2004). Thus VFRs who have been bought 
up in a malarious country and then migrated to a non-endemic area will be 
symptomatic upon being re-infected, but severe symptoms and death will be less likely 
than for those who did not acquire semi-immunity at an early age. Support for this 
theory comes from case fatality rates of imported malaria reported in the UK between 
1987 and 2006, which were significantly lower amongst people travelling to visit 
friends and relatives (0.25%) compared to people travelling for other purposes (1.9%) 
(Smith et al., 2008). 
Mascarello and colleagues have emphasised that the duration of non-exposure may 
also have an effect on immunity (Mascarello et aI., 2009). In their Italian study, two 
VFR patient cohorts were compared. Those patients who lived outside a malarious 
country for an average of eight years (range 1-19.7 years) had a higher parasitaemia 
rate and lower platelet count compared to those who had lived outside a malarious area 
for an average of jive years (range I-II years). 
These studies suggest that despite the duration of non-exposure to malaria of six 
months recommended by the WHO as the time after which malaria chemoprophylaxis 
should be taken, there is no clear evidence to support this. The findings also 
demonstrate the lack of consensus amongst experts about this issue, and summarise the 
on-going debate about the extent to which ethnicity can be used as an indicator to 
predict outcomes of infection. 
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2.2.1 Genetic factors affecting susceptibility to malaria 
Two host factors known to affect susceptibility to malaria in some people of African 
descent are the genetic abnormalities sickle-cell anaemia and Glucose-6-phosphate 
dehydrogenase (G6PD) deficiency. 
Sickle cell trait and disease affects the plasticity of red blood cells, causing them to 
block small blood vessels and disrupt the flow of oxygen. The greatest prevalence of 
sickle-cell disease is found in those with origins in Sub-Saharan Africa, India, Saudi 
Arabia and the Mediterranean (World Health Organisation, 2006). It is estimated that 
up to 2% of children in Sub-Saharan African countries are born with sickle-cell 
disease. 
Individuals with sickle cell trait are carriers of the disorder and are thought to have 
some protection against malaria. However, it is recommended that they take 
chemoprophylaxis when travelling to a malarious country (Health Protection Agency, 
2007b) . Those with sickle-cell disease are more likely to suffer from severe symptoms 
if they become infected with malaria and for these individuals, the Health Protection 
Agency recommends rigorous adherence to chemoprophylaxis and bite avoidance 
(Health Protection Agency, 2007b). 
G6PD deficiency refers to the lack of an enzyme which protects the red blood cell 
against oxidative damage. This deficiency is thought to provide some protection 
against malaria. Differences in the methods used to measure prevalence affects the 
estimates of people thought to be affected by this condition (Nkhoma, 2009). 
However, controlling for these, the estimated prevalence ofG6PD was 8.5% (CI: 7.9% 
to 9.1 %) in studies carried out in Sub-Saharan Africa, compared to 5.2% (CI: 4.7% to 
5.8%) in countries in the Americas (Nkhoma, 2009). Despite the protection that G6PD 
gives, all G6PD-deficient travellers are advised to take chemoprophylaxis when 
travelling to a malaria endemic country and to avoid taking primaquine, as it can cause 
haemolysis (Health Protection Agency, 2007b) 
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2.3 Recommendations for the prevention, diagnosis and treatment of 
imported malaria in the UK. 
The World Health Organisation has specified four measures it considers important for 
the control of imported malaria (World Health Organisation, 201Ib). To make these 
easier to recall, they are commonly termed ABCD; A: be Aware of the risk, the 
incubation period and the main symptoms; B: avoid being Bitten by mosquitoes, 
especially between dusk and dawn; C: Take antimalarial drugs (Chemoprophylaxis) to 
suppress infection where appropriate; D: immediately seek Diagnosis and treatment if 
a fever develops one week or more after entering an area where there is a malaria risk, 
and up to three months after departure (World Health Organisation, 20 lib). 
2.3.1 The prevention of imported malaria 
The UK's Health Protection Agency's (HPA) "Guidelines for malaria prevention in 
travellers from the United Kingdom" endorses these WHO guidelines, and provides 
useful guidance on the first three of these components (Health Protection Agency, 
2007b), which are summarised below. 
Travellers should be aware of how malaria is transmitted when they are travelling to a 
malaria-endemic country and the level of risk when visiting an urban compared to a 
rural area. They should also know the incubation period for falciparum malaria 
(between seven to 14 days). 
Methods of vector control recommended by the HP A include insect repellents which 
are used on the skin, and insecticides, which are sprayed within a room to kill 
mosquitoes. Repellents applied should contain up to 50% DEET. These are also 
considered suitable for pregnant women in all trimesters and for children older than 
two months of age. Covering of bare skin between dusk and dawn is also 
recommended to avoid being bitten by malaria-carrying mosquitoes. 
The use of mosquito nets is recommended for rooms where there is not adequate 
screening of windows. It is advised that these should be treated with permethrin before 
use, and be re-impregnated every six to twelve months. Care should be taken to avoid 
tears or gaps in nets through which mosquitoes can penetrate. Permethrin-impregnated 
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nets can also be purchased, which maintain their protection for between three to five 
years. 
The use of air conditioning in bedrooms is considered effective against mosquito bites 
as the temperature within the room is reduced sufficiently to deter mosquitoes. For the 
same reason, electric fans are also recommended. 
The use of appropriate chemoprophylaxis is the third recommendation made by the 
WHO and endorsed by the HP A. The length of time before which malaria 
chemoprophylaxis should be taken and the duration of time after travel during which it 
should be continued are dependent on the mode of action of each type of 
chemoprophylaxis. These are shown in figure 2.1.1. Causal chemoprophylaxis acts 
against liver schizonts before they enter the blood stream. As these schizonts take up to 
seven days to develop in the liver, causal chemoprophylaxis should be continued for 
seven days after leaving a malarious country to ensure that all schizonts have been 
eradicated. Suppressive chemoprophylaxis acts against the blood stages of the parasite 
and for this reason need to be taken for several weeks after leaving a malarious area to 
ensure that all parasites are eliminated. 
For visits to Sub-Saharan Africa, three chemoprophylactic drugs are considered 
appropriate. These are Atovaquone plus proguanil (AP), mefloquine and the antibiotic 
doxycycline. Atovaquone plus proguanil has both causal and suppressive actions. It 
should be taken for one to two days before arriving in a malaria-endemic area, daily 
during the period spent in the malarious country, and for a week after leaving. 
Mefloquine is a suppressive chemoprophylactic. It should be taken for two to three 
weeks before travel, weekly thereafter, and continued for four weeks after leaving a 
malarious area. Doxycycline is a suppressive chemoprophylactic. It should be taken for 
one to two days before travel, and continued for four weeks upon return. The efficacy 
of each of these three chemoprophylactic drugs is approximately 90% (Bradley and 
Bannister, 2003). Table 2.3.1 provides details of each regimen including the retail cost 
in 2009. 
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Table 2.3.1 Retail costs* and regimen of chemoprophylactic drugs suitable for adults going to a 
malarious area in Sub-Saharan Africa drugs (British National Formulary, 2009 pp.404-411) 
Cost for 
Name of Dosage Start and length of Retail traveller for drug administration price* a 14 day 
visit 
One 2-3 weeks before £29.06 
Mefloquine tablet entering a malarious for eight £32.69 
area, and four weeks tablets 
weekly 
after leaving 
Atavaquone One 1-2 tablets before £50.42 
entering a malarious 
plus proguanil tablet 
area, and for one week for 12 £96.60 (AP) daily 
after leaving tablets 
One 1-2 days before entering £3.52 for 
Doxycycline tablet malarious area, and four 28100mg £5.53 
daily weeks after leaving tablets 
.. 
• PrIces are taken from the Bntlsh NatIOnal Formulary (British National Formulary. 2009) and the profit margm suggested by 
the National Phannacy Association added to these to approximate a retail price. (personal communication: National Phannacy 
Association) 
2.3.2 The diagnosis of imported malaria 
The UK's malaria prevention guidelines give details ofthe recommended method of 
malaria diagnosis in the UK (Health Protection Agency, 2007b). Where there is 
clinical suspicion of an infection with P. falciparum, a blood sample should be taken, 
treated with an anti-coagulant, and sent to the laboratory for analysis within an hour of 
the patient's presentation. The need for urgency is partly to enable swift 
commencement of treatment if malaria is confmned, and also because laboratory 
identification of malaria parasites in blood becomes more difficult over time, because 
of contamination by the anti-coagulant used. The UK malaria guidelines emphasise 
that malaria diagnosis cannot reliably be made on the basis of clinical symptoms, and 
microscopy is the mainstay of laboratory confirmation, which can be used to identify 
both the species of parasite and the level of paras it aemi a (Health Protection Agency, 
2007b). Three negative tests carried out over three consecutive days are required to 
exclude malaria (Health Protection Agency, 2007b). 
Only one study has quantified delays in malaria diagnosis in the UK, and this has 
focused on mis-diagnoses, rather than delays in ensuring the timely despatch of blood 
samples (Ladhani et aI., 2003). This study described the epidemiology and treatment 
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of 211 children diagnosed with malaria and seen at a London hospital between 1996 
and 2001. The majority, (93%) were of African ethnicity, and 75% were born in the 
UK. Ninety eight children had just visited Nigeria and 18 presented at the hospital 
whilst visiting the UK from Nigeria where they lived. Comparable figures for Ghana 
were 40 and six. A further 27 children lived in, or had just visited other African 
countries, including nine from Uganda. Twelve were from the Indian Sub-Continent. 
All those travelling to malaria-endemic countries were visiting friends or relatives. Of 
the 114 who had seen their General Practitioner (GP) before attending the Accident 
and Emergency (A&E) Department, an initial diagnosis of malaria was not made for 
60 (53%) of children. Although the length of time between the initial presentation and 
malaria being subsequently diagnosed was just one day in 41 cases, it was between 
two to five days in 13 cases, and between seven and fourteen days in six cases. 
Diagnoses other than malaria made by GPs included upper respiratory tract infection 
(n=lO); pneumonia (n=6); gastroenteritis (n=4); infected bites (n=2); appendicitis 
(n=1) and diagnosis not known (n=4). Upon presentation at the hospital, 104 (89%) 
were correctly diagnosed with malaria, either immediately, or after being admitted for 
further investigations. Three were sent home with a diagnosis of tonsillitis and one 
with gastroenteritis. All returned to the A&E Department when their symptoms did not 
improve. A further 68 family members of the child presenting were also diagnosed 
with imported malaria by the hospital at the same time, although they were not the 
family member who originally attended. The authors noted that delays in diagnosis 
were more common in those who initially presented at their GP surgery for treatment, 
compared to those who presented directly to A&E, and surmised that mis-diagnoses 
may have occurred because malaria was mistakenly assumed to be caused by other 
common childhood illnesses. 
2.3.3 The treatment of imported malaria 
The UK's malaria treatment guidelines are available for clinicians working in the UK 
(Lalloo et aI., 2007). An overview of these with respect to infections with P. 
falciparum is given below. 
The recommended treatment of uncomplicated fa1ciparum malaria in adults in the UK 
is by use of oral therapies. These include either: 
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• quinine for five to seven days together with doxycylcine taken either at the same 
time or subsequently for seven days 
• atovaquone Proguanil (AP) for three days 
• artemether lumefantrine for three days 
Sulfadoxine Pyrimethamine (SP) is not recommended for adults because of possible 
parasite resistance. 
For adults with severe malaria, drugs should be administered parenterally, until 
patients are well enough to swallow, when the regimen should be continued for a total 
of seven days. As with uncomplicated malaria, oral doxycylcine should also be 
administered when swallowing is possible. Artesunate is an alternative, again given 
intravenously at first. Doxycylcine should be given simultaneously. 
For children with uncomplicated falciparum malaria, the same drugs as for adults are 
recommended, but in lower doses. Treatment with SP, given with quinine, is also an 
option. Children with severe malaria in the UK should be treated only with intravenous 
quinine. 
The guidelines recommend that all patients infected with P .jalciparnm should be 
admitted to hospital, as their condition can deteriorate rapidly. This is considered 
particularly important for children, the elderly and pregnant women who are more at 
risk of developing severe disease. Malaria specialists must be involved in the care of 
patients infected with P. Jalciparnm. Although not included in the guidelines, the 
isolation of patients may be used until the possibility of the patient being infected with 
other infectious pathogens is excluded (personal communication Professor Chris 
Whitty). 
Despite the national guidelines recommending that all patients with falciparum malaria 
should be treated as in-patients, these are not consistently followed, with one London 
hospital serving a large African community routinely treating patients with 
uncomplicated falciparum malaria as out-patients. This is because of the experience of 
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clinicians working at this hospital of this being a safe and effective method of treating 
these patients (personal communication Dr J Klein, Guys and St Thomas Hospital). 
Although treatment options for imported malaria are not the main topic of this thesis, 
the choice of different treatment policies within London provides evidence of the 
ambiguity about the potential seriousness of imported falciparum malaria. 
2.4 Diagnosis and treatment of malaria in Nigeria and Ghana 
2.4.1 Diagnosis 
In many African countries, including Nigeria and Ghana, malaria is commonly 
diagnosed on the basis of clinical symptoms (Bloland and Williams, 2003 p.58). This 
means that a diagnosis is made without the parasite being identified in a laboratory. 
The advantages of diagnoses based on clinical symptoms are clear for countries where 
there is limited access to specialist equipment and trained laboratory technicians who 
are able to use these methods of diagnosis (Bloland and Williams, 2003 p.58). Whilst 
rapid diagnostic tests are an alternative method, requiring minimal staff training, a 
deterrent to their use may be the prohibitive costs of the testing kits (Bloland and 
Williams, 2003 p.64). 
One disadvantage of a diagnosis based on clinical symptoms is that mis-diagnoses may 
occur, meaning the true cause of the illness will not be identified (Bloland and 
Williams, 2003 p.58, Bell et aI., 2006). As the symptoms of malaria are similar to 
many other diseases, this can also lead to delayed treatment of the real cause (Bloland 
and Williams, 2003 p.58). In addition, a delay in seeking appropriate treatment risks 
the likelihood of uncomplicated infection deteriorating into severe malaria (Dada and 
Omokhodion, 2007). In recognition of these issues, and because the inappropriate use 
of drugs can lead to drug resistance, in 2010, the WHO up-dated their malaria 
treatment guidelines (World Health Organisation, 2010). As part of this, they stated 
that wherever possible, all malaria must be parasitiologically confirmed before 
treatment is started. These guidelines are intended to ensure that there is more targeted, 
and so effective, use of Artemisinin Combination Therapies (ACTs), the current 
treatment regimen for falciparum malaria in Nigeria and Ghana, and that illnesses 
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which are found not to be malaria can be treated appropriately (World Health 
Organisation, 2010). 
2.4.2 Treatment 
2.4.2a Parasite resistance 
Resistance to anti-malarial drugs arises when some parasites mutate to prevent the 
action of the drug being effective. Parasite resistance to chloroquine was first identified 
in 1960 in Columbia and Thailand, and spread to other areas of the world, including 
Africa (Bruce-Chwatt, 1987). A global monitoring report carried out by the WHO in 
2005 found that in Nigeria between 1998 and 2003, the median clinical failure of 
chloroquine in 11 studies was 25.8% (range 2%-53.7%). For Ghana, during the same 
time period, median failure rates were 23.2% (range 9%-31.3%) (World Health 
Organisation, 2005c). This report also showed that there was some parasite resistance 
to SP. In Nigeria, median clinical resistance to this drug in seven studies carried out 
between 2001 and 2003 was 9.3% (range 5.7% to 43.5%), whilst in Ghana it was 3% 
(range 0%-5.2%) (World Health Organisation, 2005c). 
The resistance of P. Jalciparum to chloroquine and to SP meant that there was a 
change in the recommended regimen for treatment in both Nigeria and Ghana to 
ACTs. This occurred in Ghana in 2004 and was implemented in 2005 (Republic of 
Ghana, 2009). In Nigeria the change was made in 2005 (Federal Republic of Nigeria, 
2005). 
Current recommended drug regunens for adults with uncomplicated falciparum 
malaria in countries in Sub-Saharan Africa are: 
• artemether plus lumefantrine 
• artesunate plus amodiaquine 
• Artesunate plus mefloquine 
• artesunate plus SP 
• dihydroartemisinin plus piperaquine (World Health Organisation, 20 I 0). 
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For adults with severe malaria, a parenteral dose of artesunate should be given, 
followed by a full course of anti-malarial treatment (World Health Organisation, 
2010). 
2.4.2b Treatment options and sub-optimal drugs 
In Nigeria and Ghana, malaria symptoms are most commonly initially treated in the 
home (McCombie, 2002, Williams and Jones, 2004, Adongo et aI., 2005). A recent 
study carried out in urban Nigeria found that this method was used to treat symptoms 
of malaria in 70% (801108) of children and 70.3% (128/176) of adults (Adedotun et 
aI., 2010). 
Home treatment of malaria may initially take the form of sponging the patient with 
tepid water, watching to see if more serious symptoms develop, and the alleviation of 
symptoms by analgesics and by the administration of herbal medicines (Williams and 
Jones, 2004). Anti-malarial drugs taken may be those left over from treatment of 
previous malaria episodes, or purchased from a variety of outlets (Goodman et aI., 
2007). In Nigeria and Ghana, these may be sourced from the formal health sector, or 
bought from patent medicine vendors and pharmacies (Ahorlu et aI., 1997, Onwujekwe 
et aI., 2005b, Buabeng et aI., 2007). Foster states clearly the benefits of the informal 
health sector: it is convenient and economical (Foster, 1995). In a more recent review 
of the practices of informal medicine vendors for the treatment of fever and malaria 
throughout Sub-Saharan Africa including Nigeria and Ghana, these findings were 
echoed, and specifically it was noted that in comparison to the formal health sector, the 
service offered is faster, opening times are longer, and staff are friendly and 
approachable (Goodman et aI., 2007). However, this method of treatment may involve 
the use of inappropriate medicines being given, insufficient dosages of anti-malarials 
(Afolabi et aI., 2004) and non-completion of the prescribed course, either because of 
the decision to save some tablets to treat future episodes, or because these may be 
given to friends and family members (McCombie, 2002). 
Drugs purchased from a range of informal vendors as well as from the formal health 
service may be sub-optimal in quality. The problem of sub-optimal drugs are well 
recognised, not only in Africa, but throughout the world (Amin and Kokwaro, 2007). 
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The drug dispensed may contain none of the active ingredient, alternatively too much, 
or too little. Those which contain too much of the active ingredient may cause toxicity 
within the body. On the other hand, too little of the active ingredient means that 
symptoms may not be relieved in the patient. 
Sub-optimal drugs may be the result of illegal counterfeiting, poor manufacturing, or a 
failure to maintain their storage at an appropriate temperature and humidity (Amin and 
Kokwaro, 2007). 
A range of studies have tested the quality of drugs that are used for the treatment of 
malaria in Sub-Saharan African countries, including Nigeria and Ghana. For example, 
three studies investigating the proportion of sub-standard chloroquine tablets found 
that this ranged from 4% (2/54) (Onwujekwe et aI., 2009) to 31 % (10/32) (Shakoor et 
aI., 1997), and to 87% (71182) (Taylor et aI., 2001). For SP, comparative proportions 
were lh (50%) (Bate et aI., 2008), to 39% (33/113) (Onwujekwe et aI., 2009). 
One study suggests that the numbers of sub-quality drugs that are sold in retail outlets 
may be decreasing. This was a study carried out in Lagos (in 2007, 2008 and 2010) 
and Accra (in 2007 and again in 2010). The proportion of "older monotherapies" 
(excluding chloroquine), artemisinin monotherapies and ACTs that failed tests fell 
over this time period (Bate and Hess, 2010). However, use of the most sophisticated 
techniques (spectrometry) to measure drug quality showed that around one third of 
some drugs tested in 2010 were sub-optimal, suggesting that this is still a problem, in 
these geographical areas at least. Further research is needed to corroborate these 
findings and detect trends. 
2.5 Pre-travel health services in the UK with respect to imported malaria 
The topics included in this section are the accessibility of pre-travel health advice; the 
length of time before travel within which health advice should be sought; the choice of 
clinic available to the traveller and the cost of chemoprophylaxis. 
2.5.1 Access to pre-travel health advice 
The Association of British Travel Agents (ABTA) recommends that before a contract 
is made between a client (i.e. a traveller) and any ABT A- approved company, they 
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must "inform their clients of health requirements that are compulsory for the journeys 
to be undertaken" and "advise clients travelling abroad to check recommended practice 
with their GP, practice nurse or travel health clinic" (Association of British Travel 
Agents, 2008 p.3). 
Two studies have investigated the giving of pre-travel health advice to travellers by 
travel agents. One was a study undertaken before the 2008 ABT A advice was given 
(Grabowski and Behrens, 1996), the second study was conducted after this (Bazaz et 
aI., 2010). The first used face-to-face interviews with 202 travel agents throughout the 
UK, of which 38/202 (19%) were located in London. Notes were made clandestinely 
by researchers about whether travel health advice was offered for people pretending to 
be planning a trip to popular holiday destinations in either Kenya or India, both 
malarious areas. Sixty one percent of travel agents did not volunteer any advice until 
prompted. However, of those working in the London area, 47% did issue advice, more 
than those than in other areas of the UK. Amongst those who did offer pre-travel 
health advice, about 20% gave what was described by the authors as "some malaria 
advice". After being prompted about risks to their health when travelling, the 
proportion who offered advice rose to 71%, with 63% mentioning a risk of malaria. 
However, nearly 1 0% did not give any travel advice at all, even when prompted 
(Grabowski and Behrens, 1996). 
The second study, carried out after the ABT A guidance was issued, measured the 
availability and access of pre-travel advice about malaria offered on the internet by 
travel operators and airline websites (Bazaz et aI., 2010). Of 29 websites on which on-
line trips could be purchased to four malarious areas (Lagos, Banjul, Islamabad and 
Chiang Mai), only eight (28%) provided information about malaria on their own 
website, and only five (17%) of these provided country-specific information, described 
the most malarious areas within the country and provided details of appropriate 
chemoprophylaxis. For those agents who did not make advice available on their own 
website, eight (28%) did not have any links to other websites offering travel health 
advice. An average of 2.4 mouse clicks was required to access malaria-specific 
information for all 29 websites. It was also possible to purchase a ticket on all 29 
websites without fmding any malaria-specific advice, if the quickest method to do so 
was used. The authors concluded that the travel industry and Public Health institutions 
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need to work together to ensure that accurate pre-travel health advice is provided to 
travellers. They also commented that as many VFRs may use the internet to purchase 
tickets to travel to a malarious country, these websites offer a valuable opportunity to 
offer pre-travel health advice to this group. 
The results of both these studies suggest that the provision of pre-travel health advice 
by travel agents is sub-optimal. It is not clear why this might be so. Possible reasons 
could be concerns about customers' unwillingness to take a trip once they are aware of 
health risks. Alternatively, travel agents themselves could be unaware of the possible 
health needs of their customers when visiting a malarious country. In the study by 
Grabowksi and Behrens, both trips planned were to popular holiday destinations, 
rather than areas typically visited by VFRs (Grabowski and Behrens, 1996), and this 
limits the extent to which the results may be extrapolated to this group. 
For face-to-face pre-travel advice in the UK, travellers may use either a privately-
funded travel clinic which charge for the use of their services, or the NHS, through 
which free travel health advice can be accessed. Since 2004, the UK's Department of 
Health (DH) has given GP practices the option not to provide travel health services, 
although this incurs a loss of 2% of their budget (Department of Health, 2004). In 
cases where GPs choose to opt-out of these services, the local Primary Care 
Organisation must however ensure the provision of such services for patients at 
another GP practice (Department of Health, 2004). One other factor relevant to the 
provision of NHS pre-travel health advices is that this is not included as one of the 
performance indicators introduced by the Government in 2004, entitled Quality and 
Outcomes Framework indicators, and for which General Practitioners receive financial 
rewards for good performance (The Health And Social Care Information Centre, 
2011). 
2.5.2 Length of time within which pre-travel advice should be obtained 
There is no consistency to the advice given to travellers about the length of time before 
travel before which health advice should be sought by travellers. For example, the 
World Health Organisation recommends between four and six weeks (World Health 
Organisation, 2005a), whilst the UK's National Travel Health Network and Centre 
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advise at least SIX weeks (National Travel Health Network and Centre, 2011). 
Chiodini, a senior member of the UK's Royal College of Nursing's Travel Health 
Forum recommends that ideally, travellers should attend for pre-travel advice ideally at 
least eight weeks in advance (Chiodini, 2005). In the study by Bazaz and colleagues 
described above, 16 of 29 websites recommended that pre-travel advice should be 
sought from a doctor or travel clinic at least four weeks before travelling (Bazaz et al., 
2010). 
2.5.3 Operation of pre-travel health clinics 
With respect to the optimal operation of a travel health clinic, Chiodini recommends 
the following: 
• posters and other sources of information, such as the GP's practice website are 
used to emphasise the need to attend in good time for pre-travel health advice; 
• travel clinics should be held at times that suit the work and school schedules of its 
patients, in order to avoid missed appointments. Late night clinics, held particularly 
on Fridays, and Saturday morning clinics are suggested 
• first consultations for one or two travellers who attend the clinic together should be 
30 minutes, or 45 minutes if larger groups of people travelling together seek advice 
on the same occasion 
• follow-up appointments should be scheduled for five to ten minutes (Chiodini, 
2005). 
Little research has been carried out to evaluate the standard of pre-travel health advice 
provided by NHS-funded primary care. One study compared the standard of pre-travel 
advice given in 1996 and again in 2006 in clinics in the county of Bedfordshire, as 
measured by a self-administered questionnaire completed by GPs and by practice 
nurses (Chiodini, 2009). Indicators to measure this focused on knowledge and 
prescribing of chemoprophylaxis, the provision of information about mosquito 
avoidance methods, advice given about the risk of malaria after returning home, and 
the use of a protocol. Results from the more recent 2006 questionnaire indicated that 
nurses' knowledge was greater than that of GPs, and that few practices used a protocol 
when giving advice. The provision of information in more deprived areas of the study 
area, in which larger Asian and African communities lived, was poorer than in more 
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affluent areas. The study author noted that those who may be in most need of 
appropriate pre-travel health advice, could be those who in fact do not receive this 
(Chiodini, 2009). 
Another study was carried out in South Cheshire Health Authority, in the North West 
of England (Hoveyda et aI., 2004). This was a postal questionnaire study, sent to all 91 
GP practices in the area. Of the 86% who identified themselves as the lead advisor of 
travel advice, 97% were practice nurses, with the remaining 3% GPs. A total of 38 
different sources of information were used by respondents, which, the authors 
considered, may lead to inconsistent advice being offered. Despite 70% having access 
to the internet, the most popular source of information used by 72% of those giving 
pre-travel health advice was a wall immunisation chart. Thirty six percent of 
respondents used this as their main source of information. The authors noted that this 
information source may not offer comprehensive information on travel-associated 
health risks. Fourteen percent used Travax. (This is an interactive website, maintained 
by Health Protection Scotland, which is available to travel health care providers 
throughout the UK. For those working outside Scotland, there is annual charge of £ 1 00 
for each practice which uses the service, or alternatively Primary Care Trusts (PCTs) 
may purchase a yearly licence for £1000 (Travax, 2011 ». 
The median amount of time that respondents spent on a pre-travel health consultation 
measured in the study by Hoveyda and colleagues was 11 minutes (range five to 30 
minutes), and the most commonly reported duration was 15 minutes. Although the 
majority of the respondents claimed to cover the full range of travel health risks that 
might be faced by the traveller during the consultation, including mosquito avoidance 
methods, the authors questioned whether 15 minutes was enough time for pre-travel 
health advice to be given (Hoveyda et aI., 2004). 
2.5.4 Financing of malaria chemoprophylaxis 
In 1995, the DH issued regulations that malaria chemoprophylaxis, previously 
available on NHS prescriptions (termed FPI0s) must be paid for on a private (ie 
unsubsidised) prescription (Department of Health, 1995). Table 2.3.1 gave the cost of 
chemoprophylaxis issued on a private prescription for a trip by one adult to a 
malarious country in Sub-Saharan Africa for 14 days in 2009. In addition to these 
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costs, both GPs and community phannacists may charge the patient for issuing and/or 
dispensing the private prescription respectively. Charges for this vary, both by 
individual GP and by community phannacy (British National Fonnulary, 2009). 
Concerns were raised after the 1995 policy change that the cost of private prescriptions 
may lead travellers to purchase ineffective over-the-counter drugs such as chloroquine 
instead of mefloquine (Evans, 1996). One commentator postulated that this may 
particularly affect the practices of travellers on low budgets (Hollyoak, 1995). 
Clinicians working in what they described as a "poor area" in the West Midlands, in 
which 9% of the community belonged to ethnic minority groups, claimed that one 
reason for a fall in the number of malaria prescriptions written in the area before and 
after the policy change, and an increase in local malaria notifications after the change 
could be due to an unwillingness of patients to purchase unsubsidised malaria 
chemoprophylaxis. Other reasons considered by the study authors that this might be 
the result of economic deprivation and unawareness of the availability of anti-malarial 
drugs (Badrinath et aI., 1998). The authors also noted that an alternative explanation 
for the decrease in one of the anti-malarials prescribed, namely mefloquine, may have 
been adverse publicity about the possible side effects of this drug which were raised in 
the British media in 1995 (Badrinath et aI., 1998). 
More recently, a letter to the British Medical Journal by a locum GP working in 
London described her personal experience of patients deciding not to purchase 
chemoprophylaxis for their whole family once the cost was known, but choosing 
instead to prioritise their children. Others asked for a cheaper regimen (Hossain, 2008). 
However, no large scale surveys have taken place to evaluate any change in anti-
malarial up-take following the DH's policy change. 
The Lambeth, Southwark and Lewisham (LSL) Health Authority decided not to 
implement the 1995 DH regulations. This followed advice from the Public Health 
Department's Director of Public Health, that because of concerns that, given the 
already high burden of disease caused by imported malaria in the area, increasing the 
cost of prescriptions may provide a further barrier to the use of chemoprophylaxis 
(personal communication Dr Rachel Heathcock, South East London Health Protection 
Unit). Malaria chemoprophylaxis continued to be available for the cost of an NHS 
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prescription for all residents in these peTs (organisations which replaced Health 
Authorities and which are largely co-tenninous with London boroughs) throughout the 
period that the research for this thesis was undertaken. This cost ranged from £6.40 
from April 2004 to £7.20 in April 2009. Residents in LSL exempt from prescription 
charges receive chemoprophylaxis for no cost. 
These concerns by health care professionals about the possible outcomes of private 
prescribing of anti-malarial drugs, together with the decision by LSL Health Authority 
to refuse to implement the 1995 DH regulations demonstrate the somewhat contentious 
issue of the cost of malaria chemoprophylaxis and its impact on malaria infections. 
2.6 Summary 
In this chapter, a range of factors have been identified which are relevant to the 
transmission of malaria and to the natural history of the disease. A debate about the 
time required for immunity to malaria to be lost after leaving malaria has been 
summarised. The ways in which malaria is treated in the UK and in Nigeria and Ghana 
have been described, and of particular note are the differences between these countries. 
In one, the UK, regulatory frameworks constrain access to drugs and the provision of 
care, whilst in Nigeria and Ghana the infonnal health centre is used extensively and 
there is little reliance on fonnal medical services. 
Policies in the UK relevant to malaria prevention have also been discussed. It was 
shown that there is no consistency to the time before travel during which pre-travel 
health advice should be sought, and that individual GPs practices may choose to opt-
out of providing these services, albeit with some financial penalties. Although little 
research has been undertaken with respect to the operation of pre-travel health 
services, the limited data suggest that the typical duration of a consultation may be 15 
minutes. The somewhat controversial nature of the policy surrounding the cost of 
chemoprophylaxis is another key issue described in this chapter. 
A review of the academic literature about knowledge, attitudes and practices with 
respect to malaria prevention, diagnosis and treatment will form the focus of the next 
chapter. Also included is a discussion about what is meant by the term "VFR". 
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Chapter three: the definition of VFR; malaria 
knowledge, perception of risk and preventive and 
treatment seeking behaviours in VFRs and in Nigeria 
and Ghana. 
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This chapter begins by describing a recent debate about what is meant by the term 
"VFR" and what should be encompassed within this term. The second part of the 
chapter describes the primary research that has been undertaken to explore the 
knowledge, attitudes and practices ofVFRs of African descent living in non-malarious 
countries with respect to malaria. Some will have been born in malarious countries 
and spent part of their lives there before emigrating. Thus, they will have been exposed 
not only to the personal risk of acquiring malaria, but also to local knowledge and 
practices of malaria prevention and treatment. Others may have been born in non-
malarious countries, and exposed to these issues when visiting friends and relatives in 
malarious countries. In view of this, this chapter also includes research carried out to 
investigate knowledge and behaviours relating to malaria in Nigeria and Ghana, the 
two countries described by Smith and colleagues in the most recent epidemiological 
analysis of imported malaria in the UK as being those where most cases in the UK are 
acquired (Smith et aI., 2008). 
3.1 Definition of visiting friends and relatives 
In the academic literature, a variety of terms has been used to describe those most at 
risk of imported malaria. These include "immigrant", "migrant", (Scolari et aI., 2002) 
"non-national" (Schlagenhauf et aI., 2003) and "ethnic minority" (Phillips-Howard et 
aI., 1990a). Visiting friends and relatives (VFR) is also a term now commonly used in 
the literature (Semaille et aI., 1999, Angell and Cetron, 2005), as well as in national 
and international policy documents (Health Protection Agency, 2007a, European 
Centre for Disease Prevention and Control, 2009). 
There has recently been some disagreement about what is encompassed within the 
definition ofa "VFR", and the characteristics of those to be included in the term 
(Arguin, 2010, Barnett et aI., 2010, Matteelli et aI., 2010). Barnett and colleagues 
argue that although there were three implicit components to the term traditionally used 
to defme VFR, that is: i) ethnicity being different to the majority of the popUlation; (ii) 
the purpose of travel being to visit friends and relatives; and (iii) in the country being 
visited there should be a higher prevalence of specific infectious diseases such as 
malaria, there was no standard defmition (Barnett et aI., 20 I 0). They recommend a 
new defmition ofVFR to be used by clinicians, health professionals and researchers. 
This new definition, the authors assert, should include two components. 
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The first component put forward by Barnett and colleagues is that the purpose of travel 
should be to visit friends and relatives, thus assuming a proximity to the local 
population with respect to amongst other factors, "type of accommodation, mode of 
travel at the destination, exposure to food and water, intimate exposures, and access to 
social support systems including healthcare" (Barnett et aI., 2010 p.165) A focus on 
purpose of travel, rather than ethnicity or immigration status they claim, will 
circumvent potential stereotyping and bias that may be associated with these terms. 
Importantly, they also state that "both race and ethnicity are inter-dependent variables 
within the broader concepts of socio-economics, genetics and biology, behaviour and 
environmental assessment" (Barnett et aI., 20 I 0 p.166). Therefore ethnicity should not 
be considered as a distinct level of analysis. The use of the new definition, the authors 
argue, will enable inclusion of all those for whom a travel-related health risk exists 
when they visit friends and relatives, for example the wife or child of an immigrant, 
who may not be defmed as a VFR in the traditional definition, which included 
ethnicity. 
The second component of the new definition proposed by Barnett and colleagues is 
that there should be an "epidemiologic gradient of health risk between the two 
locations, supported by an assessment ofheaIth determinants" (Barnett et aI., 2010 
p.165). This, they say, need not infer that travel will be from a rich to a poor area, but 
rather that the health risk differs between the usual area of residence and that being 
visited. An example is given ofa traveller from the West Coast to the East Coast of the 
USA who should be warned of the risk of contracting Lyme disease when seeking pre-
travel advice (Barnett et aI., 2010). 
Against this proposal of a new definition, Arguin argues firstly, that although no 
standard defmition exists, there is a common agreement amongst researchers about 
what is meant by VFR (Arguin, 2010). He claims that the use of the term "VFR" is a 
"surrogate marker for an interaction among a complex set of behaviours that may be 
difficult to identify individually" (Arguin, 2010 p. 148), and that the inclusion of 
ethnicity in this is paramount. To justify his claim, he points firstly to the fact that 14 
of 16 articles in the peer-reviewed literature who defined VFRs used what he termed 
the "classic" definition, that is, one which included ethnicity. He also cites commonly 
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used definitions ofVFR that have referred to ethnicity. These are the WHO's 
"immigrants travelling to their place of origin" (World Health Organisation, 2005a) 
and the use of this tenn in a chapter of the "Yellow Book: CDC Health Infonnation for 
International Travel", including the following: 
A traveler categorized as a VFR is an immigrant. ethnically and racially distinct 
from the majority population of the country ofresidence (a higher-income country). 
who returns to his or her homeland (lower-income country) to visitfriends or 
relatives. Included in the VFR category are family members such as the spouse or 
children. who were born in the country of residence (Centre for Diseases Control 
and Prevention, 2009). 
Furthennore, Arguin argues that cultural beliefs impact on risk, and the importance of 
this factor is lost if ethnicity is not included within the definition of VFR (Arguin, 
2010). Evidence for this, he claims, comes from two studies. In one, an examination of 
data held in the GeoSentinel international surveillance system between 1997 and 2004, 
those termed "immigrant VFRs" which included those people who were born abroad, 
had higher rates of malaria and typhoid and were less likely to seek pre-travel advice 
than those who were termed "traveller VFRs", that is, those who were visiting friends 
and relatives, but were second generation migrants (Leder, Tong et al. 2006). In the 
other, a cross-sectional study of USA-based travellers to India, whilst VFRs were less 
likely to access pre-travel advice than non-VFRs, ethnicity was a stronger predictor of 
this than reason for travel. Hence, it was argued that: 
"our findings support those of the GeoSentinel study in highlighting the importance 
of a clear VFR definition that highlights not only the reason for travel but also for 
ethnicity or country of birth and travel destination" (Baggett et aI., 2009 p.117). 
Matteelli and his colleagues, all of whom were authors of the original paper arguing 
for the change in definition, in reply to Arguin, stress the "increasingly mobile and 
culturally ethnically and racially intertwined world in which we live" (Matteelli et aI., 
2010 p.430) . They re-emphasise the necessity for examining health beliefs at an 
individual level, rather than basing this on assumptions of immigration status or 
ethnicity, which, they claim may not accurately predict health-related behaviours and 
beliefs (Matteelli et aI., 2010). They also state that socio-economic status may be a 
better predictor of health during travel than ethnicity, although they do not explore this 
in any detail (Matteelli et aI., 2010). 
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In the latest edition ofthe "Yellow Book: CDC Health Infonnation for International 
Travel" Keystone supports the more traditional definition, noting that the proposed 
new definition by may be "too broad and not take into consideration cultural, 
economic. and attitudinal issues" (Centre for Diseases Control and Prevention, 2011). 
In the introduction to this thesis, it was noted that little progress will be made in 
improving migrant health behaviours without a better understanding of the factors that 
influence the health behaviours of migrants in general. The disagreement about what 
should be included in the term "VFR" described in this section highlights the question 
about the extent to which ethnicity can also be included as a separate level of analysis, 
and its interaction with other detenninants of health. 
Throughout this thesis, the tenn "VFR" has been used. In this chapter it is the tenn 
chosen by study authors themselves, for example by Pistone and colleagues in a 
publication discussing risk perception, knowledge and behaviours amongst travellers 
of African ethnicity, and by Smith and colleagues in an epidemiological review of risk 
factors imported malaria (Pistone et aI., 2007, Smith et aI., 2008). It is also the tenn 
used by the MRL to categorise one reason for travel of malaria patients. The issue of 
what the term "VFR" should include will be discussed in the final chapter of this 
thesis. 
3.2 Knowledge about transmission of malaria 
3.2.1 Knowledge amongst VFRs 
Few studies have investigated the accuracy of the knowledge held by VFRs about how 
malaria is transmitted. Of those which have, Pistone and colleagues assessed this as 
part of a study investigating the knowledge, attitudes and practices towards malaria of 
two groups, described as VFRs, before travelling to their countries of origin in Sub-
Saharan Africa (Pistone et aI., 2007). One group was composed of individuals who had 
attended a pre-travel health clinic (n=122); members of the second group (n=69) were 
recruited after purchasing air travel tickets, but had not, and did not intend to seek pre-
travel health advice. The most popular countries being visited by the VFRs were in 
West Africa and also the Democratic Republic of Congo. 
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The majority (1411191) (74%) of study participants knew that malaria was transmitted 
by mosquitoes, with the other most commonly mentioned transmission routes being 
thought to be through water (12/191) (6%), caused by poor personal hygiene ( 121 191 ) 
(6%), or exposure to the sun (7/191) (4%). No statistically significant difference was 
found between the knowledge held by each group, although the authors noted that one 
of the limitations to the study was that the sample size may have been insufficiently 
large enough to detect such differences if they existed. 
Another study investigated the travel health practices amongst Nigerians living in 
Houston, Texas. The study methodology chosen was focus group discussions and 
semi-structured interviews with Nigerian travellers who had either visited Nigeria in 
the previous year, who intended to do so in the coming year, or who had fallen sick 
whilst visiting Nigeria (Leonard and VanLandingham, 2001). Semi-structured 
interviews with physicians and pharmacists were also carried out. As in the French 
study (Pistone et aI., 2007), most Nigerian travellers knew how malaria was 
transmitted, although the exact number was not specified, nor the total number of 
respondents (Leonard and VanLandingham, 2001). 
A third study investigated knowledge about how malaria is transmitted, interviewing 
292 immigrants from West African countries including amongst others, Nigeria and 
Ghana. Respondents lived in the Netherlands, and were recruited through churches and 
societies serving the West African community, as well as at a large multi-cultural 
festival which attracted migrants (Schilthuis et aI., 2007). Each completed a 
questionnaire with the assistance of an interviewer. Nearly 50% had a primary reason 
of visiting friends and relatives for the most recent trip home they had made. In this 
study, knowledge about malaria transmission was categorised by the authors into 
"correct"' or incorrect knowledge". Only 811292 (28%) of participants named 
mosquitoes as being the sole route of malaria transmission. However, despite a wide 
range of other factors being cited by participants, 95% of respondents included 
mosquitoes. As in the study by Pistone, other beliefs, considered by the authors to be 
"incorrect knowledge" were broadly related to a perceived link between malaria and 
contaminated water, but also considered connected to the air, to stress, or to "taking 
too much anti-malarial medicines for prevention". These were mentioned by 256 
participants as being possible routes to malaria transmission (Schilthuis et aI., 2007). 
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3.2.2 Knowledge about malaria transmission in Nigeria and Ghana 
Studies conducted in Nigeria and Ghana, carried out in both urban and rural 
environments, have shown that in common with the majority of respondents in the 
studies undertaken in Europe and the USA, most people were aware that malaria was 
caused by the bite ofa mosquito (see table 3.2.1). 
Table 3.2.1 Proportion of respondents who knew that malaria was caused by a bite of a mosquito in 
studies carried out in urban and rural areas of Nigeria and Ghana (2000-2010) 
Study Region/Country Proportion who knew 
malaria was caused 
by mosquito bite 
(Onwujekwe et aI., Five rural areas of 1796/1908 (94%) 
2000) South Eastern Nigeria 
(Adedotun et aI., 2010) Urban areas of South 179/192 (93.2%) 
Western Nigeria 
(Chirdan et aI., 2008) North-Central Nigeria 104/150 (69.3%) 
(Akpan,2007) Southern Nigeria 581/612 (91.5%) 
(Dike et aI., 2006) Rural area of South 655/1197 (55%) 
Eastern Nigeria 
(Adongo et aI., 2005) North-Eastern Ghana 119/150 (79%) 
(De La Cruz et aI., Central Ghana 94/537 (92.9%) 
2006) 
(De La Cruz et aI., Eastern Ghana 498/514 (97.3%) 
2006) 
(Buabeng et aI., 2007). Central Ghana 500/500 (100%) 
Other reasons for malaria transmission identified in these studies included the 
environment, food and water, and stress, suggesting that there are some common 
beliefs about alternative reasons for malaria transmission amongst VFRs. Other 
reasons identified in the studies carried out in Africa included witchcraft (Onwujekwe 
et aI., 2000) and poor personal hygiene (Asenso-Okyere, 1994). 
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3.3 Mosquito avoidance measures 
3.3.1 Concerns about mosquito bites and planned prevention measures amongst 
VFRs 
Two studies have investigated VFRs' concerns about being bitten by mosquitoes when 
visiting a malarious country. Pistone and colleagues, in the French study described 
above, found that the perceived unavoidability of mosquito bites was mentioned by 
25% (22/89) of those who were concerned about malaria (Pistone et aI., 2007). In the 
Houston study, which compared travellers' attitudes towards malaria compared to 
typhoid and hepatitis A, many respondents explained that they felt less confident in 
their ability to control the local environment, compared to their confidence in avoiding 
food and water-borne diseases such as typhoid (Leonard and VanLandingham, 2001). 
Only Pistone and colleagues investigated in any detail the use of mosquito avoidance 
measures, with 51 % (97/191) of respondents planning to use either repellents, long 
clothes or bednets (Pistone et aI., 2007). More respondents in the travel clinic group 
planned to use these compared to those who only visited a travel agency, but in a 
second interview conducted after travel with 106 of the original respondents, only 16% 
(17/106) had protected themselves in some way, including 8% (9/106) who slept in air-
conditioned rooms, 7% (7/106) who used skin repellents, or 4% (4/106) who used 
mosquito coils (Pistone et aI., 2007). 
3.3.2 Measures taken to avoid mosquito bites in Nigeria and Ghana 
In contrast to the paucity of infonnation about mosquito bite prevention measures used 
by members of the African Diaspora when visiting malarious countries, several studies 
have reported on a range of methods used for protection against mosquito bites 
amongst residents of Nigeria and Ghana. Aside from mosquito nets, which are 
discussed in the next section, a variety of measures were reported as being used to 
prevent the nuisance of mosquitoes, the most common being insecticides (see table 
3.3.1). 
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Table 3.3.1 Measures taken to avoid mosquito bites in studies carried out in Nigeria and Ghana 
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3.3.3 Use of bednets amongst VFRs 
In studies carried out among VFRs from the African Diaspora, only one has researched 
the use of bed nets (Pistone et aI., 2007). The results of this study showed a marked 
discrepancy between the intention to use bed nets (711122) (58%) of the travel clinic 
group and (22/69) (32%) of the travel agent group and actual usage as reported on 
return to France (17/106) (16%), all of whom were in the travel clinic group) (Pistone 
et aI., 2007). 
3.3.4 Ownership and use of mosquito nets in Nigeria and Ghana 
The benefits of nets treated with insecticide in reducing malaria-associated morbidity 
and mortality were recognised during the 1990s (Phillips, 2001). Since then, several 
studies have investigated the ownership and use of nets in a variety of locations 
including Nigeria and Ghana. These have typically reported that although households 
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may be aware of the availability of nets, they may not be purchased or used. For 
example, in rural areas of South Eastern Nigeria, Onwujewke and colleagues found 
that although 90% (1708/1908) recognised that mosquito nets were a means of 
preventing malaria, only 19.5% had actually purchased them (Onwujekwe et aI., 
2000). In a rural Ghanaian based study, only 34% (359/1057) owned a mosquito net 
(Ahorlu et aI., 1997), whilst in another Ghanaian study carried out in another rural-
based community, 10% (86/900) had slept under a mosquito net the previous night (De 
La Cruz et aI., 2006). 
In Nigeria and Ghana, research investigating the reasons why bednets are not used has 
been carried out in both rural and urban areas. Whilst inadequate detailed knowledge 
of vector biology and control amongst respondents was thought to be the major factor 
for the low use of nets in a study carried out in Ghana (Kudom and Mensah, 2010), 
more have described how accurate knowledge, both about malaria transmission and the 
potential consequences of malaria, do not necessarily increase usage. Instead, the 
initial purchase or the replacement of torn nets may be considered unaffordable 
(Ahorlu et aI., 1997, Onwujekwe et aI., 2000). Alternatively access to nets may be 
difficult in rural areas (Onwujekwe et aI., 2000). However, bed net use was low 
(35/192: 18%) even in an urban community where just over half of the study 
respondents had attended some, or completed the whole of their secondary education, 
and only 4.2% were unemployed (Adedotun et aI., 2010). The inconvenience of 
sleeping in a stuffy and constrained atmosphere (Ahorlu et aI., 1997, Agyepong and 
Manderson, 1999), inability to sleep if a mosquito entered a net (Ahorlu et aI., 1997); 
fear of toxicity from the chemicals used to treat the net (Akpan, 2007); lack of a place 
to hang the net (Ordinioha, 2007); or forgetting to put it up (Ordinioha, 2007) have 
been cited as other reasons for nets not being used. 
Some studies which have compared the use of mosquito nets for adults and children 
have reported a prioritisation of mosquito nets for the latter. For example they were 
used for 47% (16/34) of children, but only 18% (6/34) for all household members in an 
urban area of Ghana (Agyepong and Manderson, 1999). The prioritisation of nets for 
children was also found in a urban Nigerian-based study where, of 35 families who 
used nets, 32 had children under 10 years of age (Adedotun et aI., 2010). However, a 
review of 16 studies carried out throughout Sub-Saharan Africa which investigated the 
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relationship between net ownership and their use, and included studies carried out in 
Nigeria, concluded that nets were not necessarily prioritised for children (Korenromp 
et aI., 2003). 
Policies to promote the use of bednets have been implemented in both Nigeria and 
Ghana. In Ghana, since 2002, insecticide treated nets (ITNs) have been subsidised for 
children under the age of five and for pregnant women living in poorer communities 
(Ghana Statistical Service, 2009). In Nigeria, a more recent policy adopted in 2008 
was to distribute ITNs to women via a variety of outlets, for example to pregnant 
women who attend antenatal classes, and for children who complete a vaccination 
course for diphtheria, pertussis and tetanus (National Population Division and ICF 
Macro, 2009). 
Nationwide data have been collected on the ownership and use of nets, as part of wider 
surveys covering a wide range of demographic and health issues in both countries 
(Ghana Statistical Service, 2009). In Ghana, the most recent report which included data 
collected in 2008, surveyed more than 12 000 households in 2008. In Nigeria, just over 
34 000 were surveyed in the same year. 
Tables 3.3.2 and 3.3.3 give details about net ownership from these surveys. In both 
countries, they have revealed a geographical variation in net ownership, and shown 
that those in higher socio-economic groups may be less likely to own a net. In Ghana 
these proportions were 40.6% in richer people, compared to 56.4% in those oflower 
socio-economic status, and in Nigeria, 18.5% compared to 15.5% in the more wealthy. 
The reasons why this might be so were not explored. 
However, both countries reported an increase in the ownership of nets compared to 
2003, the period when the previous survey was carried out. In Nigeria, the proportion 
who owned any type of net was 12% in 2003, increasing to 17% in 2008. Ownership 
of ITNs increased from only 2% to 8% during this time period, despite the policy 
described above of offering subsidised distribution of ITNs to targeted groups. In 
Ghana, more people owned a net than in Nigeria in 2003 (18%) substantially 
increasing to 45% in 2008. Ownership of ITNs increased from 3% to 33% in the same 
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time period in this country. Despite the increase, net ownership and use was still not 
taken up by the majority of the population in Ghana by the time of the 2008 survey. 
Table 3.3.2 Ownenhip of bed nets in Nigeria and Ghana 2008 
Nigeria Ghana 
% households which owned a net 17 45 
% households owned> 1 net 8 19 
% households who owned an 8.6% rural 37.5% rural 
ITN: urban vs. rural 7.6% urban 27.2% urban 
% households who owned any net 18.5% rural 53% rural 
urban vs. rural 14.1% urban 37.2% urban 
Table 3.3.3 Use of bed nets in Nigeria and Ghana 
Nigeria Ghana 
% households which used a net for 14.2 «1 year) 51 % «1 year) 
children <5 years 9.4% (4 years of 31.6% (4 years 
age) of age) 
% households 
12.6% rural 45.2 rural 
used a net for children 
10.5% urban 34.8% urban 
urban vs. rural 
% households who used an ITN for 59.3% «I year) 64.3% «I year) 
children < 5 if owned 39.3% (4 years of 46.5% (4 years 
age) of age) 
% households who used ITN for children 
51.1% rural 56.2% rural 
if owned 
47.8% urban 49.9% urban 
urban vs. rural 
These studies about the ownership and use of bednets in Nigeria and Ghana show that 
knowledge about how malaria is transmitted is not a major determinant of their use, 
but rather that a range of factors relating to geographical area, their cost, and the 
practical difficulties associated with sleeping comfortably under them are taken into 
consideration. Reasons why those of higher socio-economic status may be less likely 
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to use them are unclear. The introduction of policies to increase their ownership and 
use has only been partly successful, and appear to have been more so in Ghana, 
compared to Nigeria. 
3.4 The uptake of pre-travel health advice and chemoprophylaxis amongst 
VFRs 
3.4.1 Pre-travel health advice 
Only two studies carried out, one in the USA, the other in Italy, have estimated the up-
take of pre-travel health advice amongst VFRs. In the first, researchers found that only 
a "minority" of respondents would access pre-travel advice, but did not provide details 
of the number who planned to do so (Leonard and Vanlandingham, 2001). The second 
study was carried out in an Italian clinic set up to provide health services to illegal 
immigrants (Scolari et aI., 2002). Just over three quarters of respondents were from 
Sub-Saharan Africa, with half from Senegal and 63 (13%) from Nigeria. A further 106 
patients were from Asia, with 68 (13.4%) from Pakistan. Four patients (0.8%) were 
from other regions of the world. 
It was not known how many of the 504 study participants were themselves 
undocumented migrants, although only 36% had a regular permit to stay in Italy. It is 
possible that their immigration status may have impacted on their ability to access pre-
travel health advice and the extent to which the fmdings from this study can be 
extrapolated to the general population is unclear. Taking this limitation into account, of 
1701504 (34%) participants who had travelled to a malarious country at least once, 
only 30 (17.6%) had sought pre-travel advice. A longer period oftime resident in Italy 
was the only variable where there was an association with accessing pre-travel health 
advice. 
3.4.2 Chemoprophylaxis 
The use of chemoprophylaxis before travel to a malarious country is another topic that 
has been investigated. In one study, 2011292 (69%) of respondents reported that they 
used chemoprophylaxis on the last trip (Schilthuis et at., 2007). However, the authors 
noted that there was some confusion about the meaning of the term, and they estimated 
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that in fact, only one third of the group may have used chemoprophylaxis on previous 
trips (Schilthuis et aI., 2007). 
In the second study, ofVFRs in France, 171/191 (94%) reported that they planned to 
use chemoprophylaxis (Pistone et aI., 2007). Not surprisingly, a statistically significant 
higher proportion (119/122) (97%) of those attending the travel clinic reported 
intending to take chemoprophylaxis than those attending the travel agent (60/69) 
(87%) (p<0.05), although the number who intended to do so in the latter group was 
also high (Pistone et aI., 2007). It is possible that these results reflect a desire to give a 
response which was socially acceptable to the interviewers. 
3.4.3 Factors influencing the uptake of pre-travel advice & chemoprophylaxis 
Several studies have investigated those factors which might influence the decision to 
use pre-travel advice and chemoprophylaxis among VFRs. These can be divided into 
those relating to perceptions of risk, severity of illness, personal susceptibility, 
concerns about the drugs available, as well as structural factors such as the cost of 
chemoprophylaxis and the availability of pre-travel health advice (Leonard and 
VanLandingham, 2001, Scolari et aI., 2002, Morgan and Figueroa-Munoz, 2005, 
Pistone et aI., 2007, Schilthuis et aI., 2007). 
3.5 Perceptions of risk of acquiring malaria amongst VFRs 
These can be categorised into perceptions of potential compared to personal risk, the 
priority given to malaria as a health concern, beliefs about personal susceptibility, 
belief that protection has been given via vaccination; concerns about 
chemoprophylactic drugs and other barriers to the use of chemoprophylaxis. Each will 
be considered in tum. 
3.5.1 Potential compared to personal risk 
In three studies carried out to examine perceptions of the risk of malaria when 
travelling to a malarious country, researchers divided participants' knowledge about 
risk into two distinct categories; the awareness amongst study participants that there 
was a potential risk of acquiring imported malaria when travelling to a malarious 
country, and perceptions of "personal rislC', that is, the extent to which individuals 
believed their particular circumstances placed them at risk or protected them from 
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imported malaria (Scolari et aI., 2002, Pistone et aI., 2007, Schilthuis et aI., 2007). In 
the French study, although 87% of respondents knew it was possible to get malaria in 
the country they were visiting, only 49% considered themselves at personal risk. 
While there was no statistically significant difference between those attending the pre-
travel clinic and the travel agent with respect to knowledge of the possibility of 
contracting malaria, 33% of those who visited a travel agency believed themselves to 
be at risk of malaria compared to only 7% of those who visited a travel clinic (p<0.05). 
Clearly, the low perception of risk amongst the latter group could be attributed to the 
precautions they had taken by attending the clinic to access chemoprophylaxis and 
receive pre-travel advice (Pistone et aI., 2007). 
In the study of knowledge, attitudes and practices amongst 504 migrants who attended 
a Public Health Clinic in Italy, 351 (70%) recognised that malaria existed in their 
country of origin (Scolari et aI., 2002). For those participants who originated from 
countries in Sub-Saharan Africa, this increased to 73%. However, of the 1401170 
(82%) who had not sought pre-travel advice on a previous trip to a malarious country, 
73 (52%) had not done so because they believed they were not at personal risk. These 
data were not stratified by area of origin and included some respondents who 
originated from areas other than Sub-Saharan Africa. 
In the study of Dutch VFRs, the perceived risk of catching malaria by participants was 
assessed by the study authors as either "high" or "not high" (Schilthuis et aI., 2007). 
Overall, 159/292 (54%) of the participants considered the potential risk to be high. To 
measure personal risk, participants were asked how dangerous the risk was for 
themselves, compared to specific risk groups, (the definition of these groups was not 
provided). Forty six percent categorised the risk to themselves as "very dangerous", 
but 20% considered it as hnot very dangerous" and 23% believed there was "no 
danger". The authors conceded that the sample chosen for this study was not random. 
Nearly two thirds were Ghanaian, who must produce up-to-date evidence of 
vaccination against yellow fever upon arrival in Ghana, so necessitating attendance at a 
travel clinic at least once every ten years. This required attendance, it was surmised, 
might make them more aware of a personal risk, presumably because they would 
receive pre-travel advice during pre-travel consultations. 
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3.5.2 Malaria as a priority health concern of VFRs 
Perceptions of the comparative risk of acquiring malaria compared to other concerns of 
VFR travellers when visiting their country of origin have been investigated by two 
researchers (Leonard and Vanlandingham, 2001, Pistone et aI., 2007). In the latter 
study, malaria was the most commonly reported health concern, cited by 89/191 (47%) 
of respondents. Others were food and water-borne diseases (49/191) (26%); Acquired 
Immune Deficiency Syndrome (AIDS) (13/191) (7%); and meningitis (10/191) (5%). 
In the study by Leonard and Landlingham, contaminated water and malaria were the 
most common health care concerns voiced by VFR respondents, with particular 
concerns about the latter. The predominance of malaria as a healthcare concern of 
VFRs was also noted by the physicians who were interviewed as part of the study. The 
focus on malaria was interpreted by the authors as partly due to a lack of knowledge 
and experience of other diseases, such as typhoid and hepatitis A (Leonard and 
Vanlandingham, 200 I), but could also have been an example of response bias, that is, 
the desire of the respondent to share the interests of the researchers. 
The Houston study found that worries about the high likelihood of acquiring malaria, 
rather than concerns about the potential severity of the illness were more commonly 
voiced (Leonard and Vanlandingham, 2001). Many participants in this study 
described it as being "a potentially undesirable consequence of travel" and it was 
explained as being a disease that is endemic in Nigeria, and experienced as an easily 
treated, mild, flu-like illness. 
A further study corroborated the findings of the Houston study with respect to malaria 
being perceived as a non-serious illness. This was a focus group study carried out in 
London with 44 members of the African community which focused on reasons for the 
use of chemoprophylaxis amongst members of the African community in London. The 
majority of participants came from Uganda (16); Nigeria (15); Kenya (4); Zambia (2) 
and Sierra Leone (2) (Morgan and Figueroa-Munoz, 2005). Six were born in the UK, 
the rest were from Africa. 
The experience of malaria presenting itself as a mild illness was illustrated by the 
quotation below: 
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... "before I went to Africa. I grew up thinking, malaria, oh, it's such a serious 
disease. And then when I was in Africa working everybody had malaria every now 
and then, a few times a year.' ... it was seen as part of everyday life ... it seemed that 
everybody who had malaria was walking around with a 'flu sort of thing. It just 
seemed like 'flu to me, that sort of problem. And I think, I don't know, in a way that 
kind of makes you think it's not a big problem" (Morgan and Figueroa-Munoz, 2005 
p.362) 
There are two possible explanations for the perception of the respondent. Firstly, as 
noted in chapter one, it is widely acknowledged that many febrile illness in sub-
Saharan Amca are misdiagnosed as malaria (Bell et aI., 2006) and 'malaria' has 
become a word to describe all mild febrile illness many of which would never progress 
to severe disease (Bloland and Williams, 2003 p.30). Thus, the illness perceived as 
being malaria by the respondent cited above may have actually been symptoms of 
other diseases or conditions. 
Secondly, as noted in section 2.2, once semi-immunity to malaria has been acquired, it 
may be subsequently experienced as a mild or asymptomatic illness. Witnessing semi-
immune adults with mild symptoms of malaria may be the reason why the study 
participant cited in this quotation perceived malaria in this way, without recognising 
that symptoms may be more severe in those who lose exposure to the parasite. 
Only one respondent in the London and Houston studies respectively described the 
severity of symptoms of malaria they had personally experienced when visiting as a 
VFR (Leonard and VanLandingham, 2001, Morgan and Figueroa-Munoz, 2005). Both 
reported that they had experienced malaria as a debilitating illness. In the London 
study, the majority of participants commented more commonly on their perceptions of 
their personal semi-immunity (Morgan and Figueroa-Munoz, 2005). Few recognised a 
loss of immunity over time, or considered how this might increase their risk of 
suffering more serious symptoms when visiting mends and relatives abroad (Morgan 
and Figueroa-Munoz, 2005). Thus, as well as viewing mends and relatives 
experiencing malaria as a mild illness, many appeared to believe that this was a likely 
outcome for themselves. 
In the study by Schilthuis and colleagues on the other hand, only 4/90 (4.4%) who did 
not intend to take chemoprophylaxis did not do so because they believed that they 
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were immune (Schilthuis et aI., 2007). However, another explanation for not taking 
chemoprophylaxis, "I come from West Africa so I don't need vaccinations" cited by 
8/90 (8.8%) respondents could imply a belief in immunity, but the choice ofa 
questionnaire design which only allowed for classification into short answers, did not 
allow for a detailed examination of the rationale for some of the beliefs voiced. 
3.5.3 Personal susceptibility to malaria 
Whilst some participants in Morgan and Figueroa-Munoz's London study believed 
they were immune from malaria, others believed that they were not personally 
susceptible because they were confident that they had never contracted malaria, despite 
being bought up in malarious countries in West Africa (Morgan and Figueroa-Munoz, 
2005). Whilst this might be the case, alternative explanations may be related to the 
mis-diagnosis of previous malaria infections, or recall bias have accounted for the 
results. 
In the London focus group study there was reported to be considerable discussion 
about why some people seemed to be more susceptible to malaria than others, despite 
being equally exposed, with biological factors, implicating an individual's blood, or 
more specifically sickle-cell trait andlor G6PD deficiency being understood as being 
implicated (Morgan and Figueroa-Munoz, 2005). 
Not all participants believed that they were protected from malaria, either by immunity 
or non-susceptibility, as some feIt malaria to be a serious illness. For those visiting 
mainly urban areas, travel to a more rural area was a factor that some participants 
recognised increased their personal risk, and the few who were Human 
Immunodeficiency Virus (HIV) positive also reported themselves as being diligent in 
their use of anti-malarials, irrespective of the location visited (Morgan and Figueroa-
Munoz, 2005). This suggests that some individuals are aware to some extent of the 
personal and environmental factors which may increase their personal risk. 
3.5.4 Perceptions of having been vaccinated against malaria 
In Morgan and Figueroa-Munoz's focus group study, a few respondents believed that 
they had been vaccinated against malaria, and were reported to be "adamant" that this 
was the case, with one participant aHirming his belief that this was the reason he never 
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contracted malaria when in a malarious country (Morgan and Figueroa-Munoz, 2005). 
Belief in having been vaccinated against malaria was also found amongst respondents 
in the Dutch study, where it was cited by 9/90 (10%) as a reason for not needing 
malaria chemoprophylaxis (Schilthuis et aI., 2007), and by 221102 (22%) in the study 
by Pistone and colleagues (Pistone et aI., 2007). It was presumed by the French 
researchers that some might mistake yellow fever vaccination for a malaria vaccination 
(Pistone et aI., 2(07). 
3.5.5 Concerns about chemoprophylactic drugs 
Fear of the side effects of chemoprophylactic drugs was cited in two studies as being a 
barrier to their use (Leonard and Vanlandingham, 2001, Morgan and Figueroa-
Munoz, 2005). In the latter study, this was reported by 10/90 (11 %) as a reason "not to 
be vaccinated" the proxy term used by the researchers for not taking 
chemoprophylactic drugs (Schilthuis et aI., 2007). Other concerns about 
chemoprophylactic drugs mentioned in the London based study were doubts about 
their efficacy, either as a result of "getting used to them" or worries about mosquito 
resistance to the drugs, whilst some respondents felt that they were only effective 
against "a more serious type" of malaria (Morgan and Figueroa-Munoz, 2005). In this 
study, those of higher socio-economic status were found more likely to have accessed 
information about, and to be aware of different types of chemoprophylaxis (Morgan 
and Figueroa-Munoz, 2005). 
3.5.6 Other barriers to the use of chemoprophylaxis 
A number of other barriers have been identified which may deter some VFRs from 
accessing chemoprophylaxis, and illustrate the wide range of factors which may 
influence this, (although some of these beliefs were held by few respondents). Many of 
these were described in the Dutch study (Schilthuis et aI., 2007). For some reasons 
cited, such as "~I never take preventive measures" given by 14/90 (15.6%) it was 
difficult to determine the underlying rationale for this claim. Others, such as "I do not 
get sick easily" (7/90) (7.8%) or "I come from West Africa, so I don't need 
vaccinations" (8/90) (8%) could perhaps be connected to perceptions of personal 
susceptibility or immunity. "My room is fully insect free" (1/90) (1.1 %) was related to 
the concept of the risk of acquiring malaria, whilst "I can avoid unhygienic food and 
water" (1/90) (1.1 %) could be related to misconceptions about the way in which 
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malaria is transmitted, as described in section 3.3.1. "I only take tablets" (3) (3.3%) 
was perhaps linked to personal preferences for prevention and a misconception that an 
injection is needed. Beliefs connected to fatality "I do not believe in taking anything 
because I cannot die now" and religious belief "God protects me all the time" were 
each cited by one (1 %) of participants. Other justifications included "It is only 
necessary for special groups such as children" and "I use traditional methods" cited by 
three (3%) and one (1%) respectively. 
3.6 Structural factors impacting on the use of chemoprophylaxis. 
In this section concerns about the expertise of clinicians, the cost of chemoprophylaxis, 
and access to these drugs and to pre-travel health clinics are discussed. 
3.6.1 Distrust of doctors 
In the study by Morgan and Figueroa-Mw1oz, distrust of doctors was the result of 
different drugs being prescribed on separate occasions by the same GP without 
explanation (Morgan and Figueroa-Mw1oz, 2005). In the study by Leonard and 
Vanlandingham, the focus of the distrust was more connected with concerns about the 
lack of experience of some clinicians, particularly those not of Nigerian origin. For 
example, many respondents claimed the majority of physicians "read about malaria in 
a book" but had no practical familiarity, and no interest in travel health. Several 
Nigerian physicians in this study reported that they were called upon to offer pre-travel 
advice not only to friends and relatives, but to non-Nigerian colleagues because of 
their expertise (Leonard and VanLandingham, 200 I ). 
3.6.2 Cost of chemoprophylaxis 
In three studies cost was mentioned as a deterrent to obtaining pre-travel health advice. 
These were carried out in countries with differing healthcare systems: the UK 
(Morgan and Figueroa-Munoz, 2005), the Netherlands (Schilthuis et aI., 2007), and the 
United States (Leonard and Vanlandingham, 2001). In the Dutch study, in which the 
authors explained that the majority of citizens are covered by health insurance, cost 
was the second most commonly reported reason for not accessing pre-travel health 
services, mentioned by 15/90 (17%). However, as observed earlier, II % of all 
respondents did not have health insurance and having to pay for the full cost of a 
consultation and chemoprophylaxis prescribed may have made this a deterrent. 
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In Houston, a health insurance system also operates. Cost was the most commonly 
reported reason why VFRs might not access pre-travel health (Leonard and 
VanLandingham, 2001). One respondent, who was a physician, estimated that about 
half of all travellers reject pre-travel health advice because of the cost. The study 
authors noted that many travellers are uninsured or have insurance plans which do not 
cover visits or immunisations they might need for overseas travel. Whilst there was 
some evidence of respondents being unable to afford the cost of mefloquine, the drug 
most commonly prescribed, other reasons for not purchasing it were the competing 
priorities of other costs associated with travel, and the availability of much cheaper 
drugs in Nigeria. One respondent who chose to purchase drugs upon arrival in Africa 
based her decision partly on cost and partly because of her belief that she was not 
travelling to a highly malaria-prevalent area. 
Physicians interviewed for the Houston study reported that many patients complained 
about the high cost of chemoprophylaxis (Leonard and VanLandingham, 2001). Some 
prioritised chemoprophylaxis for their children, whilst others bought only a proportion 
of that needed, with the aim of purchasing the remainder in Nigeria. To manage the 
unaffordability of mefloquine, some physicians prescribed chloroquine, or advised 
patients to purchase SP upon arrival in Nigeria and to take it if symptoms of malaria 
developed. These are drugs which, as described in section 2.4.2a, are associated with 
malaria parasite resistance. 
In one area of London, as noted in section 2.5.4, those who access pre-travel health 
advice from their GP receive it for no charge. However, in the London study, for those 
who attended a private clinic, or who were not residents of this area, and who therefore 
must pay for malaria chemoprophylaxis on a private prescription, the associated costs 
were voiced as being a concern (Morgan and Figueroa-Munoz, 2005). Even in areas 
where malaria was subsidised, not all GPs implemented the policy of offering malaria 
chemoprophylaxis on an NHS prescription, with one husband asked to pay for a 
private prescription whilst his wife obtained subsidised chemoprophylaxis from 
another nurse within the same practice. As in the Houston based study, some 
respondents used other ways to overcome the cost, for example by purchasing drugs 
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illegally before travel, though mindful they may not be effective (Morgan and 
Figueroa-Munoz, 2005). 
3.6.3 Access to clinics and chemoprophylaxis 
This issue has been mentioned only briefly in the academic literature. Not being able to 
access pre-travel advice at short notice was a barrier to its use for some participants in 
two studies (Morgan and Figueroa-Munoz, 2005, Schilthuis et aI., 2007). By contrast 
the Houston study found that access to drugs rather than to pre-travel health services 
was the more significant problem (Leonard and VanLandingham, 2001). 
3.7 Adherence to and appropriateness of chemoprophylaxis 
Two studies of VFRs have reported on adherence to chemoprophylaxis by their study 
participants. In the study by Pistone and colleagues, the responses to a range of 
questions made the researchers conclude that the use of travel clinics has a positive 
benefit on uptake and adherence to chemoprophylaxis (Pistone et aI., 2007). For 
example, the reported use of chemoprophylaxis was statistically significantly greater 
amongst those who had visited a travel clinic compared to a travel agent before travel 
(55/64; 86%), compared to 25/42: (60%). However, whilst more in the travel clinic 
group used chemoprophylaxis, only 29% (31/106) used this appropriately (correct 
drug, dosage and adherence), suggesting that the advice given may not be followed 
accurately. In the Italian study, length of time resident in Italy was the only variable 
associated with taking the correct dosage (Scolari et aI., 2002). 
Several factors have been reported as contributing to non-adherence to 
chemoprophylaxis among VFRs. These include those which were categorised by the 
authors ofthe French study as "insufficient malaria risk perception" "negligence" and 
not having the drug available after returning to France, often because of leaving the 
drugs for family and friends in the countries they visited (Pistone et aI., 2007). This 
third reason was also cited by Morgan and Figueroa-Munoz as being common amongst 
VFRs in the London-based focus group study. It was a popular practice undertaken to 
help friends and family in African countries overcome the expense of buying drugs for 
treatment and avoid the risk of purchasing fake drugs (Morgan and Figueroa-Munoz, 
2005). 
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Participants in the London focus group study also reported difficulties in managing 
complex drug regimes, stopping the course once they felt they had not been bitten by 
mosquitoes, adverse side effects, such as itching when taking chloroquine, (a reaction 
to taking chloroquine thought to affect up to 50% of Africans (Aghahowa et aI., 2010), 
and difficulty in swallowing the drugs (Morgan and Figueroa-Munoz, 2005). 
3.8 Diagnosis and treatment of malaria 
3.8.1 Uncomplicated malaria in VFRs 
The few data that exist on the diagnosis of malaria among VFRs suggest that they are 
likely to self-diagnose, without initial recourse to a health care professional (Leonard 
and Vanlandingham, 2001, Morgan and Figueroa-Munoz, 2005). It was recognised by 
some participants in the Houston study that such actions could lead to a delay in 
accurate diagnosis and appropriate treatment (Leonard and Vanlandingham, 2001). 
3.8.1 a Fever as a synonym for uncomplicated malaria amongst VFRs 
In the London focus groups, several participants asked whether the words "fever" and 
"malaria" were the same (Morgan and Figueroa-Munoz, 2005). This uncertainty may 
have resulted from policies implemented with respect to malaria treatment in many 
countries in Sub-Saharan Africa. These policies, put forward by the Integrated 
Management of Childhood illnesses (ACMI), recommended that any history of fever 
in children in an area with a high incidence of malaria should be treated for malaria 
(Bloland and Williams, 2003 p. 59). As explained in section 2.4.1, the recommended 
policy now put forward by the WHO is that all suspected cases of malaria should be 
parasitiologically confirmed before treatment commences wherever this is possible 
(World Health Organisation, 2010). However, it is possible that VFRs' uncertainty 
about these two words is a result oftheir awareness of the traditional way of 
diagnosing malaria based on clinical symptoms. 
One reason that VFRs might self-diagnose rather than relying on health professionals 
was their lack of trust in the ability of health professionals in a non-endemic country to 
be able to diagnose malaria (Leonard and VanLandingham, 2001). The Leonard and 
Vanlandingham study also found that VFR participants as well as pharmacists and 
clinicians of Nigerian origin were aware of the necessity of a speedy and accurate 
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diagnosis but there were beliefs that clinicians in the USA were unfamiliar with the 
condition, and ill equipped to diagnose it. Anecdotes were described of patients being 
initially diagnosed with allergies or conditions such as influenza with which doctors 
were more familiar, including an example of a pharmacist who returned to Houston 
with malaria and who was given a range of tests for other diseases which delayed her 
treatment, despite her assertions that her illness was caused by malaria. Other VFR 
respondent in this study cited anecdotes of patients who nearly died whilst under the 
care of non-Nigerian healthcare providers, and compared this with their belief that no 
one in Nigeria could die from malaria. Some reported that they had taken the trouble to 
find and pay for treatment from a Nigerian physician whom, it was felt would be more 
knowledgeable, sympathetic and aware that malaria could be treated effectively and 
quickly (Leonard and Vanlandingham, 2001). 
A further concern amongst respondents in the Houston study was the embarrassment 
and stigma of being put into isolation upon admission to hospital because of 
unwarranted fears that they were infectious or suspected of being infected with HIV. 
The Houston study found that some of the participants cited the cost of treatment, both 
for drugs and for an appointment from US based healthcare providers as a reason for 
not seeking treatment for malaria in that country, particularly when this was compared 
to the much lower cost of treatment in Nigeria. 
With respect to treatment options upon return to a non-malarious country, chloroquine 
was named as a drug purchased over the counter from community pharmacists in the 
UK to treat perceived malaria symptoms. (Morgan and Figueroa-Munoz, 2005). In the 
Houston study, chloroquine, SP and Halofantrine were also mentioned (Leonard and 
VanLandingham, 200 I). The latter is a drug similar to quinine and mefloquine in 
chemical composition, but which rarely can cause cardiac failure (Centre for Diseases 
Control and Prevention, 2001). Some travellers bought these medications back to the 
USA be used in the event of developing malaria symptoms in order to avoid potential 
problems with treatment seeking in that country, whilst others chose to take SP on 
their arrival in Nigeria and again upon return to protect them against symptoms should 
they contract the disease. As explained in section 2.4.2a, chloroquine and SP are 
associated with parasite resistance and may not be effective treatments for malaria. 
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3.8.2 Diagnosis and treatment for malaria in Nigeria and Ghana 
VFRs in the Houston study compared their difficulties in seeking treatment for malaria 
in that city to the ease with which malaria is treated in Nigeria and Ghana, where, as 
described in section 2.4.1, diagnosis carried out by the individual or by a doctor based 
on clinical symptoms is the norm, and easy availability of drugs allows swift treatment 
of a commonly experienced illness. However, although home treatment may be the 
usual practice, in an urban study in South-Western Nigeria, higher levels of education 
were associated with the use of clinics to care for sick children who did not respond to 
home treatment, suggesting that there may be an economic factor influencing decision 
making (Adedotun et aI., 20lO). In another study carried out in the same country, the 
use of primary care in preference to home treatment was also associated with being in 
a higher socio-economic group (Onwujekwe, 2005). The potential link between socio-
economic status and treatment options for malaria has not been explored in the 
literature carried out with the African Diaspora. 
3.8.3 Diagnosis and treatment of severe malaria in VFRs and in Nigeria and 
Ghana 
Very few data have been published on VFRs' knowledge, attitudes and behaviours 
concerning severe malaria. Participants in the London focus group questioned whether 
there were two "types" of malaria, one a mild one, the other "a very serious killer" 
which they referred to as "cerebral malaria" (Morgan and Figueroa-Munoz, 2005). 
They were unable to explain any more about it, other than for several to say that 
relatives had died from it (Morgan and Figueroa-Munoz, 2005). More detailed research 
on perceptions of VFRs surrounding severe malaria has not been carried out in Europe, 
nor in the USA. In Nigeria and Ghana, however, it has also been reported that where 
patients present with convulsions, supernatural forces may be held responsible by 
some people, and traditional healers considered more appropriate for patient 
management (McCombie, 2002, Williams and Jones, 2004, Adongo et aI., 2005, 
Onwujekwe et aI., 2005a). 
3.9 Risk and risk assessment 
One of the themes to arise from the research already carried out is about perceptions of 
risk. Whilst the majority of participants in the European literature review recognised 
72 
there was a potential risk of acquiring malaria when visiting a malarious country, 
fewer considered themselves to be at personal risk. Amongst the variety of factors 
contributing to the personal assessments of risk, some were related to individual 
susceptibility, whilst others were connected to beliefs about sustained immunity, and 
perceptions that malaria would result in only mild, easily treated symptoms. This topic 
deserves further exploration. 
A difference between experts and lay people in the understanding of what constitutes a 
risk has been noted (Kunreuther, 2002, Slovic, 2002). Commonly, experts arc 
considered to hold specialist objective knowledge, whilst lay people are considered 
unscientific, inferior and SUbjective with respect to risk (Lupton, 1999). It has been 
noted however, that expert knowledge is not in itself uncontested, and scientists 
themselves disagree (Douglas and Wildavsky, 1982 pp.49-66, Kasperson et aI., 1988). 
With respect to imported malaria, disagreements between experts have already been 
identified in this thesis. One example is what constitutes a VFR, as described in section 
3.1. The amount of time over which semi-immunity to malaria is lost upon leaving a 
malarious country, included in section 2.2, is another. 
To understand how lay and expert people assess risk, in the discipline of cognitive 
psychology, psychometric tests may be used to assess how people respond to hazards 
(Lupton, 1999). For example, experts and lay people have been asked to rate a list of 
events and technologies for the perceived risk associated with each one. A majority of 
lay people identified nuclear power as the most risky, compared to experts, who 
considered motor vehicles to be so (Slovic, 2002). Siovic claims that experts judge risk 
according to the probability of an event happening, and the likely mortality associated 
with this. Key factors affecting the lay person's perception of risk are the perceived 
dread associated with a risk and the degree of uncertainty with which it will occur 
(Slovic, 2002). Slovic claims that although lay perceptions of risk are more complex 
than assessments of mortality and morbidity as typically assessed by experts, they are 
both quantifiable and predictable. This theory depends on the premise made by 
cognitive psychologists that assessment of risk is made by individuals rationally 
(Lupton, 1999). This has been disputed. CaIman makes the point that if decision 
making about risk were purely based on "rational" evidence. about 25% of people in 
the UK would not continue to smoke (CaIman, 2002). Similarly, since nearly all 
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imported malaria cases and certainly all deaths are preventable with the use of 
chemoprophylaxis, it could be supposed that if individual travellers were acting in the 
way which would be most beneficial to them, up-take of chemoprophylaxis would he 
high and imported-malaria associated morbidity and mortality could be avoided. 
Clearly, so called "rationality" using a cognitive process of cause and effect is not the 
sole premise on which decisions are made. Evidence for this with respect to imported 
malaria comes from the range of answers provided by respondents about what factors 
were relevant to the decision to use personal protection against malaria, for example 
perceptions of personal susceptibility described above, but also the cost of 
chemoprophylaxis, and trusting in protection from God. People then, do not make 
decisions about risk in a vacuum, but take into account a wide range of contextual 
factors (Lupton, 1993). 
Douglas and Wildavsky claim that risk is a cultural construct (Douglas and Wildavsky, 
1982). In line with other risk theorists described above (Kasperson et aI., 1988, Slovic, 
2002), they recognise that knowledge is an important factor with respect to risk. They 
also acknowledge the importance of personal subjectivity. For example, a recent bad 
experience is more likely to make people perceive that a similar event may happen to 
them again. However they assert that: 
"between private, subjective perception and public physical science there lies 
culture, a middle area of shared beliefr; and values" (Doug/as and Wildmwky, 19H2 
p.194) 
It is only when there is broad social agreement about what constitutes a risk that it is 
kept out of contention. People operate in a world where many risks are uncertain, and 
in which they cannot know everything. Faced with this dilemma, decisions are not 
made in isolation to contextual factors in the way proposed by cognitive psychologists. 
Instead, people edit these, choosing to concentrate on some, but not on others. As they 
are social creatures, people are largely influenced by their sociality: 
"humans act less as individuals and more as social beings who have internalised 
social pressures and delegated their decision-making processes to institutions. They 
manage as well as they do, without knowing the risks they face, by/ollowing .'Weia/ 
rules on what to ignore. Institutions are their problem-simp/~fying devices" (Douglas 
and Wildavsky, 1982 p.80) 
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The social environment however "imposes constraints upon choice and sets boundaries 
on the range of feasible alternatives" (Douglas and Wildavsky, 1982), p77). However. 
they stress that as social change occurs, values and perceptions change too. Therefore. 
they stress the dynamic and fluid environment in which a culture operates and which 
influence perceptions of risk. 
The relevance of Douglas and Wildavsky's theory can be seen from some of the 
findings from studies carried out to explore the knowledge, attitudes and practices of 
VFRs and described in this chapter. Firstly it takes into account the importance of 
factors relevant at the individual level, for example, the participant in Morgan and 
Figueroa's focus group study who was anxious to avoid contracting malaria because of 
her HIV status. Secondly, the importance of knowledge in assessing risk is recognised, 
as seen for example by studies which measured knowledge about malaria transmission 
or knowledge of the potential risk of acquiring imported malaria. Thirdly, it takes into 
account the relevance of societal factors which also affect how decision making is 
undertaken. One example of this is firstly the extract from Morgan and Figueroa-
Munoz's focus group study where a respondent thought malaria was a serious illness 
until she travelled to a malarious country and saw many people who appeared to have 
malaria but experienced mild symptoms (Morgan and Figueroa-Munoz, 2005), whilst 
another is from the study by Leonard and VanLandingham, where study participants 
noted that in Nigeria, treatment for malaria was perceived as being given quickly and 
efficiently and compared this to the way in which it was treated in Houston (Leonard 
and VanLandingham, 2001). The relevance of Douglas' and Wildavsky's theory to the 
assessment of risk by participants in the research to be presented in this thesis will be 
discussed in the final chapter. 
3.10 Summary 
This chapter began by describing a debate about what is meant by the term "VFR" and 
the relevance of the concept of "ethnicity" to this. 
Following this, the results of a review carried out to explore the research that that has 
been undertaken to examine the knowledge, attitudes and practices of VFRs about 
imported malaria was shown. Relevant studies undertaken in Nigerian and Ghana were 
also described. The results show that there is a paucity of research carried out with 
75 
respect to imported malaria, and of those studies which have been carried out, not all 
were exclusively with VFRs. Furthermore, the particular circumstances of some 
respondents, for instance those who were illegal immigrants, in at least one study may 
have influenced their decision making. The methodology chosen for all but two of the 
studies used a survey design, with small sample sizes, thus limiting the opportunity f(lr 
study participants to voice their own opinions and the extrapolation of the results to a 
larger population. 
Some of the issues identified in chapter one (the ABeD of malaria control) were 
chosen as topics to investigate by the researchers whose work is discussed in this 
chapter. The results showed that knowledge of how malaria is transmitted was high, as 
it was in studies carried out in Nigeria and Ghana, and that among travellers, there is a 
good awareness that a malarious country is being visited. 
Unlike in Nigeria and Ghana, little research has been carried out with respect to 
knowledge, attitudes and beliefs about mosquito avoidance measures. In Nigeria and 
Ghana, it was shown that despite policies encouraging the use of bednets, there are 
several reasons why they are not popular. With respect to the use of chemoprophylaxis. 
a range of factors were identified which may impact on the decision to use them. As 
well as some related to the circumstances of the individual respondent, beliefs about 
the likely consequences of such infections were identified, as were structural factors. 
including the cost of chemoprophylaxis, beliefs about the competence of clinicians and 
access to healthcare. 
Only one study carried out in the UK referred to the diagnosis and treatment of malaria 
(Morgan and Figueroa-Munoz, 2005). These issues were not the main focus of this 
research, and were only referred to briefly. The other was carried out in the USA 
(Leonard and VanLandingham, 2001). As such, the structural context differed to the 
UK, and this may have impacted on the generalizability of the findings of this 
research. There is much that is not known about the knowledge attitudes and practices 
of VFRs living in the UK vis a vis malaria diagnosis and treatment, for example, the 
rationale behind the preference of some for self-diagnosis and treatment of suspected 
malaria, when this can be offered free of charge in the UK. Furthermore, neither the 
perceptions of providers of pre-travel health advice, nor clinicians who treat cases of 
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imported malaria in VFRs have been explored. As they have direct contact with VFRs 
who seek pre-travel health advice and treatment, it is likely that they would have useful 
information to impart both about what they believe to be the reasons which explain the 
relatively high incidence of malaria in the Nigerian and Ghanaian community in 
London, and also about structural factors which impact on the uptake and eflicicncy of 
diagnostic and treatment services. 
Morgan and Figueroa- Munoz made the point that their findings "reflect an 
intermeshing of ideas and practices that are widespread in the general UK population 
with the particular beliefs and circumstances associated with their ethnic origin" 
(Morgan and Figueroa-Munoz, 2005 p.368), suggesting that both contexts are taken 
into consideration by VFRs with respect to malaria control. The results from this 
chapter, not only from their own study, but also that carried out by Leonard and 
VanLandingham in particular, (Leonard and VanLandingham, 2001) demonstrate the 
potential validity of this statement. 
The topic of risk and risk assessment was also explored in this chapter, and a theory 
identified which emphasises the importance of knowledge, personal factors and the 
social environment in decision making about risk. Some evidence of how this might be 
relevant to imported malaria was described. 
The next chapter begins by setting out a conceptual framework which draws on 
findings of this chapter, and proposes the factors which may be relevant in 
understanding the reasons for the burden of imported malaria in the Nigerian and 
Ghanaian communities living in London. It then describes the methods which will be 
used to explore this in this thesis. 
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Chapter four: a conceptual framework; the mixed 
methodology approach; methods of the quantitative 
and qualitative study. 
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This chapter begins by critiquing psychological and sociological models of service 
uptake, as well as a model of societal and individual determinants of medical care 
utilisation. It proposes a more suitable conceptual framework to explain the reasons for 
the burden of imported malaria in the Nigerian and Ghanaian communities in London. 
Quantitative and qualitative research methodologies and their underlying 
epistemologies are then discussed, and a rationale given for using mixed methodologies 
in this thesis. The methods used to understand the burden of imported malaria in the 
Nigerian and Ghanaian communities and their strengths and limitations are descrihed. 
4.1 Models of service uptake 
As noted in section 1.4, malaria is largely a preventable disease. Prevention for the 
individual traveller depends on taking measures to avoid bites from mosquitoes which 
may be infected with Plasmodium species, and using appropriate chemoprophylaxis. 
Two common theories seek to explain those factors which detennine health behaviours. 
One is based on psychological factors, whilst another is based on sociological factors. 
Another model focuses specifically on those factors which determine the use of medical 
services. In this section I critique each of these theories, and then present a novel 
conceptual framework which I believe begins to explain more accurately the context 
within which decision making is made about imported malaria amongst Nigerian and 
Ghanaian VFRS. 
There are several psychological models of service uptake. These typically relate to 
factors which impact on primary prevention of disease. Amongst the most well-known 
are the "Health belief model" and the "The theory of reasoned action" (Ajzen.l and M, 
1980, Becker, 1974). These models purport to explain the decision making process that 
individuals undertake when considering changing their behaviour, for example when 
deciding whether to stop smoking, or reducing their intake of alcohol. There is a 
presupposition that individuals will act in their own self-interest, and that behaviour 
change is possible. Health promotion campaigns using these psychological theories to 
underpin their work aim to change behaviours by increasing the individuals' awareness 
of the risks associated with them, with an expectation that once these are known, the 
individual will wish to adapt his or her behaviours to avoid these. In chapter three of 
this thesis, questions asked of migrants in previous research included whether they were 
aware of the potential serious consequences of malaria for themselves when travelling 
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to a malarious country. The need to measure this awareness appeared to be based on the 
assumption that travellers to malarious countries will not protect themselves against 
malaria if they are not aware of the risk. One major criticism of psychological models is 
that they do not take into account the contextual factors which may affect decision 
making (Nutbeam, 2004). With respect to the prevention of imported malaria. these may 
include access to pre-travel health advice health services and to prompt diagnosis and 
treatment. Without access to these services, even if an individual is aware of the risk of 
acquiring imported malaria, he or she will be constrained in his or her ability to do so. 
Sociological models of service uptake, in contrast to psychological models, focus on the 
structural factors which might impact on service uptake. As explained by Krieger. 
"these explicitly address economic and political determinants of health and di.\·('cl.\'('. 
including structural barriers to people leading health lives" (Krieger. 200 I p.670). 
In sections 2.5.3 and 2.5.4 of this thesis, examples of the perceived importance of 
structural factors with respect to the prevention of imported malaria have already been 
shown. One was the concern voiced by clinicians that removing the subsidy for 
chemoprophylaxis has been claimed to present a barrier to it usc (Hollyoak. 1995. 
Evans, 1996, Badrinath et aI., 1998, Hossain, 2008). Another example is the provision 
of pre-travel health advice, where, as noted by Chiodini, the provision of information 
was poorer in areas that had relatively larger migrant populations (Chiodini, 2009). 
However, social production of disease theories have been criticised on the basis that 
they do not take into consideration the range of other factors which form part of the 
context in which decision making is made (Krieger, 2001). With respect to imported 
malaria, some of these other factors have already been identified in chapter two and 
three, alongside structural barriers. They include biological factors, for example loss of 
immunity, environmental factors, such as the local prevalence of anopheles mosquitoes 
which may impact on the perception of risk of acquiring malaria, and cultural factors. 
including a wish to follow local customs used by friends and family in Nigeria or Ghana 
to treat malaria. Thus, although structural barriers to service uptake are likely to be 
important, they may not fully explain the range of factors which impact on the burden 
of malaria. 
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Furthennore, although structural barriers to service uptake are relevant. those based on a 
social production of disease model to explain behaviours typically focus on those that 
are valid within one geographical context. Yet, for members of the African diaspora, 
who are exposed to two different ways of managing malaria, each with particular 
structural constraints, both these contexts (in Nigeria and Ghana and in the UK) are 
likely to be of importance. 
A model which focuses specifically on those factors which influence the utilisation of 
health services is that proposed by Andersen and Newman (Anderson and Newman. 
2005). They explain the uptake of medical care as a function of three interacting factors. 
These are societal detenninants, health services systems and individual detenninants. 
Societal detenninants are sub-divided in this model into "technology" and nonns". 
According to the model, societal detenninants affect individual behaviours both directly 
and through health system services. Advances in technology specifically are said to 
affect the utilisation of services, for example improved surgical techniques make 
hospital stays shorter than previously. With respect to "nonns", the authors point to a 
growing homogeneity within society about what are considered suitable locations for 
healthcare. "Health systems services" are divided in the model into "resources" and 
"organisation". These refer to the quantity of services available and the way in which 
these are controlled. The third factor, individual detenninants are divided into a range of 
predisposing, enabling and illness level components. In the first are included a) 
demographic factors; b) social structure (including a range of elements such as race and 
education c) beliefs, such as knowledge about disease, attitudes about health services 
and an individual's own values about the importance of health. Enabling factors are 
divided into family and community components. Examples of the fonner are the 
financial resources available to the family, whilst community services refer to the 
amount of health care available in the community and their cost at the family level. 
Illness level refers to the perceptions of the individual about his or her level of illness 
and the clinician's evaluation of these. 
In the context of imported malaria, this model takes into account more of the factors 
which affect decision making about imported malaria, in comparison to the 
psychological and sociological models described above and many are relevant in the 
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context of imported malaria. For example, the amount of pre-travel health services 
available within a community could reasonably be thought to have an impact on their 
use, whilst financial resources in different families may make them more or less able to 
purchase chemoprophylaxis in those areas where this is not subsidised. In section 2.2.1, 
the genetic factor sickle-cell disorder, which is more common in certain races including 
those born in African countries was shown to either offer protection against malaria (for 
those with sickle-cell trait) or make them more likely to suffer serious symptoms (f()r 
those with sickle-cell disease). Race is included in the model under the "social 
structure" component of enabling factors affecting individual determinants of health care 
utilisation. 
There are however several reasons why this is model is not suitable to explain the 
burden of imported malaria in the Nigerian and Ghanaian communities living in 
London. The model only considers those factors which impact on the uptake of medical 
services, yet there are other influences which impact on the burden of this disease. One 
example is environmental determinants. Specifically, it was noted in section 2.1.3 that 
there are lower entomological inoculation rates in urban compared to rural areas of 
Africa, meaning that there will be less exposure to malaria parasite vectors for those 
VFRs who stay in urban areas. This gradual urbanisation has been directly linked to the 
decreased risk of cases of imported malaria reported between 1993 and 2008 (Behrens 
et aI., 2008), although this claim needs validation. A model which aims to consider the 
factors which impact on the burden of imported malaria, rather than solely on medical 
care utilisation is more relevant to the aims of this thesis. 
Another example of factors which may impact on the burden of imported malaria but do 
not necessarily determine the uptake of medical services is related to environmental 
determinants, and this is the the mosquito prevention measures that may be provided in 
host families in malarious countries and which protect YFRs against infected mosquito 
bites. These may include structures such as door and window nets in host 
accommodation, or the provision of insecticides and insect repellents which can be 
purchased in a range of retail outlets. 
Of course, it is also possible that these environmental determinants do impact on the 
utilisation of medical care services. Part of the decision making process about whether 
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to access pre-travel health advice may be influenced in part by perceptions of the 
number of mosquitoes expected to be seen in the vicinity or about knowledge about 
protection measures available. This strengthens the assertion that environmental 
determinants should be included in a model. 
The inclusion of improvements in technology is considered to be a positive influence in 
the medical care utilisation model, yet not all technologies are beneficial in the context 
of imported malaria. For example those which enable the mass production of sub-
standard drugs for malaria treatment that are exported to African countries and may be 
used by VFRs has a negative, rather than a positive impact on the burden of malaria. 
The enabling family and community factors in the medical care utilisation model focus 
on issues such as income and the urban-rural nature of the community. No attention is 
given to the perceptions of how the attitudes of other family members in malarious 
countries to the seriousness of disease may impact on an individual's decision to usc 
services. 
The model considers that efficacy of treatment by clinicians impacts on the decision to 
use medical services but does not take into consideration that this belief may be 
dependent on personal characteristics of individual clinicians. Leonard and 
VanLandingham (Leonard and VanLandingham, 2001) found that African VFRs were 
distrustful of non-African doctors in particular, and would seek out those with from the 
same ethnicity. 
Most importantly however, the model is limited to discussing the factors which affect 
the utilisation of health services in one country, for example the USA. One of the aims 
of the thesis is to explore the factors that enhance and constrain the uptake and effective 
use of malaria prevention and treatment among London residents visiting friends and 
relatives in Nigeria and Ghana. The results of the literature review in chapter three 
showed that for members of an African diaspora, decision-making is influenced 
simultaneously by two different contexts: the range of factors relevant in malaria-
endemic countries and how malaria is managed in the UK context. Thus, within this 
thesis it will be important to explore in detail how these contexts interact in order to 
understand the reasons that impact on the burden of imported malaria. Whilst changes 
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over time are considered to some extent within the model of medical care utilisation, it 
does not consider in detail how an individual's perceptions may change over time as he 
or she experiences the advantages and disadvantages of each context, nor the 
environmental factors associated with urbanisation discussed above. 
In this thesis, an alternative model is proposed specifically to explain the factors 
impacting on the burden of imported malaria in African VFRs. It describes in detail 
what factors are taken into consideration by the individual when deciding whether and 
how to protect him or herself against malaria, and how this decision making interacts 
with structural barriers in each context which are considered by the individual. An 
outline of the conceptual framework, drawing on the evidence presented in chapters two 
and three is shown in figure 4.1. The rectangular boxes at the top and bottom of the 
model describe the social, structural and physical environments which provide the 
context in which decision making is made by VFRs. The arrows leading from these 
rectangular boxes represent that both these contexts are taken into account 
simultaneously by VFRs when making decisions. The oval shape contains the factors 
which may be considered by the individual VFR within these social, structural and 
physical contexts. 
The relevance of the conceptual framework within the context of the thesis will be 
discussed again in the final chapter. 
84 
Social, structural and physical 
environment: UK 
Knowledge 
Biological factors 
Logistical/Visit specific factors 
Perceptions of risk 
Economic factors 
Social, structural and physical 
environment: Nigeria/Ghana 
Ob erved 
burden f 
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Figure 4.1.1 Conceptual framework proposing the context within which decisions lire mllde by 
VFRs of Nigerian and Ghanaian descent about malllria control 
4.2 Quantitative and qualitative research methodologies 
The epidemiological analysis carried out by Smith and colleagues identified those 
communities most at risk of imported malaria in the UK for the 20 year period 1987 to 
2006, and described what was known about risk factor in these groups. It is worth 
stating the value of epidemiology, which measures hea lth and di ease indicators at a 
population level and may also describe which groups to target for a particular 
intervention, a point made by Smith and colleagues with respect to imported malaria in 
their 2008 paper (Smith et aI., 2008). However, the identification of risk fa ctors per se 
does not explain the underlying factors which may impact on ri k. For example, mith 
and colleagues found that amongst those travellers who were born in Africa only 28 .7% 
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(CI: 28% to 30%) took chemoprophylaxis (Smith et aI., 2008), but the epidemiological 
design of the research study did not enable an understanding of why this might be so. 
It is being increasingly recognised that a focus on individual risk factors is not sufficient 
to explain the reasons for health and disease (Pearce, 1996, McMichael, 1999, Krieger, 
2001), and Porter notes that since the 1990s there has been a "paradigm shin" amongst 
many theorists and practitioners in Public Health (Porter, 2006). One reason for this has 
been proposed by Baum, namely: "the questions asked by public health researchers 
have become more complex, more embedded in social. political and economic factors" 
(Baum, 1995 p.459), whilst Creswell and Garrett explain that "research processes 
continuously evolve and change in response to the complex, interconnected global 
communities and their needs in the world" (Creswell and Garrett, 2008 p.321). This 
means that additional research tools may be needed to describe and understand these 
issues (Baum, 1995). 
To explore the reasons for the burden of imported malaria in Europe and in the USA, 
qualitative, as well as quantitative research methodologies have already been employed 
in different studies (Scolari et aI., 2002, Morgan and Figueroa-Munoz, 2005, Leder et 
aI., 2006, Pistone et aI., 2007, Schilthuis et aI., 2007, Smith et aI., 2008). The 
advantages of epidemiologically focused research with respect to imported malaria have 
already been identified in this thesis. The benefits associated with qualitative research 
methodologies with respect to understanding the context within which decisions are 
made about imported malaria have also become apparent from chapter two. For 
example, with respect to the use of chemoprophylaxis, Morgan and Figueroa-Munoz, 
who used a focus group methodology, discovered that many African migrants perceive 
malaria as a mild, easily treatable illness, and one influence on this might be witnessing 
it being treated as such in African countries (Morgan and Figueroa-Munoz, 2005). This 
contrasts with the findings reported from Schilthuis and colleagues who, using a 
questionnaire study, reported one reason for not taking chemoprophylaxis as ". am from 
West Africa, so I don't need vaccinations" (Schilthuis et aI., 2007), which did not 
provide sufficient detail to explain the reasons for the link made by the study participant 
between country of origin and perceived healthcare need. 
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4.2.1 The epistemologies of quantitative and qualitative research 
Underlying quantitative and qualitative research methodologies are two different 
epistemologies. Quantitative research is based on an epistemology grounded in the 
philosophical theory of positivism, that is: "based on the belief that phenomena can be 
reduced to their constituent parts, measured. and then causal relationships deduced" 
(Baum, 1995 p.461). Crucial to this is the idea that there is a single truth that is existent 
irrespective of people's beliefs. It is the role of scientists to discover this truth. in a 
value-free manner, without influencing or being influenced by the data (Sale et al.. 
2002). The methodologies used in much biomedical scientific research are of a 
positivist nature: hypothesis testing of observable data in order to discover such truths. 
An example is the discovery, using observation and testing that microorganisms were 
responsible for infection. Commonly, the methodology used in quantitative research is 
to select a carefully selected sample that is assumed to be representative of a wider 
population, and make inferences about the population from this (Sale et aI., 2002) 
Constructivism offers an alternative epistemological approach. This considers that 
reality is socially constructed, and is not independent of our minds (Sale et aI., 2002). 
It is not context or time-independent (Johnson and Onwuegbuzie. 2004). Research 
methodologies based on a philosophy of constructivism emphasise the importance of 
understanding (Baum, 1995). Specifically the aim is to understand the world from the 
viewpoint of the participants and the context within they live (Baum, 1995) It is also 
understood that the choice and interpretation of data is subjective and dependent on the 
realities constructed by the researcher (Baum, 1995). Qualitative research 
methodologies are typically used. Qualitative research can be defined as "any type of 
research that employs nonnumeric information to explore individual or group 
characteristics, producing findings not arrived at by statistical procedures or other 
quantitative means" (Last, 2001 p. 147). The same author goes on to say that 
"qualitative data can enrich understanding of complex problems and help to understand 
why things happen" (Last, 2001 p.147). Examples of qualitative research methodologies 
include in-depth interviews, and focus groups 
As with quantitative research methodologies, there have also been criticisms of 
qualitative methodologies. Mays and Pope have categorised these into three main areas 
(Mays and Pope, 1995b). Firstly, that it is "an assembly of anecdote and personal 
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impressions" (Mays and Pope, 1995b p.l 09). To refute this, Mays and Pope point out 
that in qualitative research, study participants are not selected randomly. Instead, there 
is a careful choice of individuals who are able to inform the topic under investigation. 
For example, they should have personal characteristics, and/or live in a particular area 
which enables the researcher to explore the research topic effectively (Mays and Pope, 
1995b). 
A second criticism is concerned with the reproducibility of qualitative research, as 
interpretation is dependent on the perspective of the researcher. As noted above, 
subjectivity is the basis upon which qualitative methodologies based on a constructivist 
philosophy are conducted. However: Mays and Pope recommend that qualitative 
researchers must openly report on the methodologies used, and explicitly state the 
subjectivity surrounding their interpretation of the results (Mays and Pope, 1995b). 
Hellman makes the point that subjectivity, rather than being a weakness, is in fact a 
strength of qualitative research, as explicit information is supplied about the research 
process (the attributes of the researcher, the attributes of the research technique, and the 
context within which the research takes place) which readers may use to evaluate the 
findings (Helman, 2001 p.266). 
The third criticism is that the results of qualitative research cannot be extrapolated to 
larger populations, that is, there is no selection of a sample which is thought to be 
representative of a wider population, as is the case with quantitative research (Mays and 
Pope, 1995b). However, many qualitative studies do not aim to produce statistically 
representative results that can be generalized to the broader popUlation, but rather aim to 
explore a problem and develop an understanding of factors which may influence 
particular behaviours (Mays and Pope, 1995b). Quantitative research methods may then 
be used to investigate the extent to which these findings can be extrapolated to a broader 
population (Mays and Pope, 1995b). 
4.2.2 How the research will be undertaken: mixed methodology 
In this chapter, the value of both quantitative and qualitative research methodologies has 
been described. Both will be employed in this thesis, as each can contribute to 
explaining the reasons for the burden of imported malaria in the Nigerian and Ghanaian 
communities. Mixed methodologies in research have been defined as: 
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"the class of research where 'he researcher mixes or combines quantitative and 
qualitative research techniques, methods, approaches, concepts or language into a 
single study" (Johnson and Onwuegbuzie, 2004 p.17). 
The usefulness of combining mixed methodologies is becoming increasingly recognised 
(Sale et aI., 2002). One reason is that using both offers a pragmatic way to answer 
complex research questions (Johnson and Onwuegbuzie, 2004). However commentators 
have noted that studies which combine quantitative and qualitative methodologies have 
been criticised on the grounds that underlying each are incompatible epistemologies 
(Johnson and Onwuegbuzie, 2004, Sale et aI., 2002). Specifically, these may involve 
quantitative research based on an underlying philosophy of positivism, and qualitative 
research based on a philosophy of constructivism. However, it has been asserted that 
they can be legitimately used together in a complementary way to both describe and 
understand communities (Baum, 1995, Sale et aI., 2002). Sale and colleagues give the 
example of a study of nurse "burnout". Quantitative methods can be used to measure the 
extent of "burnout" , whilst qualitative methodologies can be used to explore the 
experiences of nurses who suffer from this (Sale et aI., 2002). 
The research question in this thesis requires a description of which populations are most 
affected by imported malaria, and also an understanding of the contextual factors which 
cause this burden within these groups. Therefore, mixed methodologies will be used in a 
complementary way as follows: 
• an analysis of reports made to the MRL between 2001 and 2008 to determine 
which groups are currently at risk of imported malaria and to describe the 
epidemiology of these in more detail 
• a qualitative study to understand why these groups are at risk of acquiring 
imported malaria, exploring the context within which decisions about protection 
against malaria are made. 
4.3 Method of exploring the epidemiology of imported malaria in the UK: 
data sources and limitations 
The most recent publication describing the epidemiology of imported malaria was 
published in 2008 and covered a 20 year period between 1987 and 2006 (Smith et aI., 
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2008). In this section, the data sources that are available to examine the epidemiology of 
imported malaria in the UK, including both numerator and denominator, are appraised. 
Using the best available sources of data, a description of the most up-to-date 
epidemiology of imported malaria is provided. In this, those groups most at risk of 
acquiring imported malaria are described, as measured by geographical area of 
residence, species of plasmodium parasite acquired, ethnicity and reason for travel. 
More detail of those who constituted this group is then given. 
4.3.1 Choice of data source for the numerator and its limitations 
The source of data used for the number of cases in this epidemiological analysis is that 
collected by the HPA's MRL. All reports are laboratory-confirmed, and reporting 
clinicians are requested to complete a short form providing demographic, 
epidemiological and clinical information about each patient (Health Protection Agency 
2007). This passive reporting system has been in place since 1977 and the variables 
collected have remained fairly constant since this time (Health Protection Agency 
2007). 
The use of data from an alternative UK-wide reporting system, "Notifications of 
Infectious Diseases System" (NOIDS) was also considered for this analysis. As malaria 
is a statutorily notifiable disease, all clinically suspected cases should be reported to an 
individual termed the "Proper Officer", usually a Consultant in Communicable Disease 
Control. However, the extent of under-reporting of malaria cases via the NOIDS 
system is considerable. For example, of 293 laboratory-confirmed cases reported to the 
MRL in 2000 in South East London, only 20 (7%) were notified via NOIDS (Cleary et 
aI., 2003). One further drawback of NOIDS data is that reports are of diagnoses made 
upon clinical suspicion, rather than being laboratory-confirmed cases (Health Protection 
Agency, 2011c). These two limitations severely restrict the usefulness of NOIDS data 
for this analysis, and this system was therefore not considered appropriate. 
Limitations include under-reporting to the MRL and issues associated with data quality. 
4.3.1 a Under-reporting 
Although the extent of under-reporting of malaria cases via the NOIDS system is one 
reason why it is an unsuitable data source for this epidemiological analysis, there is also 
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evidence of some under-reporting of malaria cases from reports made to the MRL. This 
comes from a capture-recapture study, comparing the number of reports made to the 
MRL with Hospital Episode Statistics (HES). The latter are records of the diagnosis of 
patients admitted to hospitals, including the reason for admission. The study examined 
data reported to both systems between July 2003 and December 2004 in England. It 
concluded that only 56% of all cases were reported to the MRL (Cathcart et aI., 2009). 
Complete reporting was estimated to be higher in London (62% of cases) and for cases 
offa1ciparum malaria (66%) (Cathcart et aI., 2009). However, MRL data is the only 
alternative source of reports for malaria other than those made via NOIDS, and so was 
chosen as the data source for the analysis. 
4.l.1b Data quality 
Measures of data quality with respect to reports made to the MRL include both the 
completeness of data that are entered onto the surveillance form by the reporting 
clinician, and the accuracy of these data. 
4.3.1.hi Completeness of data 
The analysis of reports made to the MRL between 1987 and 2006 carried out by Smith 
and colleagues showed that whilst some variables were completed for nearly all reports 
(age; 96%, sex; 94%), others were less well completed. For example, details of the 
country visited was completed for 88% of reports, the reason for travel for 71 %, the 
country of birth for 64% and the use of chemoprophylaxis for 62% (Smith et aI., 2008). 
4.3.1.hii Accuracy of data 
The extent of the non-completion of variables on the MRL reporting form, and the 
accuracy of those which were, was investigated in a postal survey of UK- resident 
patients whose episode of malaria had been reported to the MRL in 1987 (Phillips-
Howard et aI., 1990a). Patients were asked to verify information on 10 variables that 
had been recorded on the MRL report form, and to provide any missing data. The 
results showed that the number of missing values was significantly greater in reports of 
patients who belonged to ethnic minority groups, particularly with respect to the dates 
that trips had been taken and whether malaria chemoprophylaxis had been used. Those 
of African and Asian ethnicity were also more likely to interchange the reason for travel 
between "holiday" and "visiting friends and relatives." Respondents who stated in the 
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postal survey that they were foreign students resident in the UK had not all been 
categorised in this way on the MRL reporting form. Overall, one in four of all patients, 
irrespective of ethnicity, gave a different reason for travel when later surveyed to that 
given on the original MRL report form. Postal survey results suggested that nearly 8% 
who had not taken chemoprophylaxis were reported to have done so on the surveillance 
form. Conversely, 24% reported they had taken chemoprophylaxis from their responses 
to the postal survey, but according to the surveillance form had not. The authors 
accepted that recall bias on the part of patients may have contributed to the results, but 
these findings demonstrate the extent to which inaccurate data may be recorded on the 
MRL report form. As pointed out by Philips-Howard and her colleagues in the 
conclusion to their 1990 postal survey, any epidemiological analyses and Public Health 
recommendations based on this data set must be undertaken with the limitations 
described above in mind (Phillips-Howard et aI., 1990a). 
4.3.1.hiii Other data quality issues 
Four other data quality issues affecting the robustness of the epidemiological analysis 
undertaken in his thesis should be noted. Firstly, the MRL changed the variable 
requested on the surveillance form from "nationality" to "ethnicity" of patient" in 2004 
(personal communication: Valerie Smith, MRL). This new variable enabled a 
comparison to be made with ethnicity data collected by the UK census. Before this time, 
the variable "nationality" was requested to be completed by clinicians, and was 
recorded as the name ofa country, for example "France" or "Nigeria". This change in 
categorisation raises questions of the comparability of data before and after 2004. This 
is discussed further in section 4.5.4. 
The second data quality issue is that in order to reduce the number of missing values 
relating to nationality (before 2004), or ethnicity (after 2004), the MRL themselves 
categorise patients as of "African descent" or of "Asian descent" if other variables 
completed, such as the patient's name and country of birth strongly suggest this to be 
the case MRL (personal communication Valerie Smith: MRL). However, this is likely 
to lead to some misclassifications. 
Thirdly, reports are considered to originate from London if the home address of the 
malaria case is from that area. Alternatively, if this information is missing, those reports 
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originating from hospitals in London are categorised as cases in London residents by 
staff at the MRL (personal communication Valerie Smith: MRL). This attribution of 
residency is to reduce the missing values or invalid entries that may be made by 
clinicians when entering the postcode of the patient onto the form. Thus, it is likely that 
some patients not resident in London are included in this category. 
Fourthly, it was not known if clinicians completed surveillance forms after speaking to 
each patient, or made assumptions, for example about individual's use of 
chemoprophylaxis. If the latter were the case, misclassifications may result. 
4.3.2 Data sources for denominator data 
Two different sources for the denominator were used for this analysis: mid-year 
population estimates and mid-year population estimates by ethnicity. 
4.3.2a Mid-year population estimates: description and evaluation 
Mid-year population estimates are calculated using a "cohort component model". 
Estimates are made by the ONS by adding one year in age to each member of the 
population counted in the census or the previous mid-year population estimate, as 
appropriate, and making additional adjustments based on the annual number of births, 
deaths and migrations. Migrations may be sub-divided into internal migrations and 
international migrations. Counts of internal migrations are made using data on the 
movement of people between geographical areas within the UK. This consists of 
records from GP patient registers and Health AuthoritylPCT data (Office for National 
Statistics, 2002). International migrations are calculated using: 
• information from the International Passenger Survey (IPS) on long term 
migrants (i.e. those who intend to stay longer than one year in the UK) 
• estimates from the IPS on the number of "switchers" (people who originally 
intended to stay for less than a year in the UK, but changed their mind, or who 
intended to stay longer than a year, but who stayed for less time) 
• IPS estimates of the numbers of asylum seekers 
• migrant flows to and from the Republic of Ireland estimated from the IPS 
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Mid-year population estimates are calculated several years after the census may be more 
inaccurate, as estimates are based on other estimates without verification of an actual 
count of the population. However, they are used extensively by national and local 
Government, and in publications used in academic research. 
A brief description and evaluation of each component of mid-year population estimates 
(census data, births and deaths and internal and external migration) follows. 
4.3.2.ai Census data 
The UK census takes place once every ten years and counts those people normally 
resident at each address on one particular night of the year. 
The ONS, in a review of the quality of the 200 I census, identified several limitations 
which are pertinent to the epidemiological analysis in this thesis (Office for National 
Statistics, 2005). Whilst overall in England and Wales 94% of the population returned a 
census form, this fell to 84% amongst inner London residents, making the returns 
provided less representative of the total population in the capital. Specifically, 
verification of the census count using other methods of estimating the population, 
revealed a shortfall of some 187 000 men, mostly between the ages of 25 and 34. 
However, the mid-year population estimate for 2003 was adjusted by the ONS to 
account for this discrepancy. 
Where there were inconsistencies in the information provided in different sections of the 
census form by individual members of the population, or data were missing, but could 
be derived from other responses given by these individuals, the data were imputed. This 
included 2.5% of responses concerning country of birth, and 2.9% for ethnic group. 
Algorithms were used when imputing these data to ensure consistency in the 
methodology used. However, the ONS data quality review referred to above, concluded 
that it was possible that some misclassification may have occurred using this method 
(Office for National Statistics, 2005). 
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4.3.2.aii Births and deaths 
The ONS considers the number of births and deaths acquired from national registers and 
used to calculate mid-year population estimates to be reliable, as all data are included 
(Office for National Statistics, 2004). 
4.3.2.aiii Internal and external migrations 
A combination of GP data and Health Authority/peT data are used to gather as accurate 
an estimate as possible about internal migrations. However, it is recognised that the 
component derived from NHS patient registers are subject to delays. This is because the 
details of people moving between GP services in different geographical areas may not 
be registered in the new area before the next mid-year population estimate is made 
(Office for National Statistics, 2004). 
The International Passenger Survey (IPS) counts the number of travellers leaving and 
entering the UK by sea, air or through the channel tunnel. A random sample of about 1 
in 500 travellers is surveyed, and it is thought to cover about 90% of passengers leaving 
or entering the country (Office for National Statistics, 2010). The response rate in 2008, 
the most recent year for which mid-year population estimates were included in this 
analysis, was 84%, meaning that the results may not be entirely representative of the 
true number of migrants. 
4.3.2b Mid-year population estimates by ethnicity 
These are annual estimates of the ethnic composition of each country of the UK, and are 
provided by ONS. Like mid-year popUlation estimates, a "cohort component method" is 
used to calculate these. Data are derived partly from the census form, on which all 
citizens of the UK are asked to record their ethnicity, and also indirectly from records of 
births and deaths. International and national migration data are also used. The ONS has 
tenned these ethnicity data "experimental statistics", as their quality is in the process of 
being evaluated (Office for National Statistics, 2006). 
Like mid-year population estimates there are several limitations to the accuracy of mid-
year population estimates by ethnicity, and these have been described by the ONS 
(Office for National Statistics, 2006). Firstly they are dependent on the completeness 
and accuracy of the data included in the census and mid-year population estimates, the 
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limitations of which have been described in 4.3.2a. Secondly, infonnation relating to 
ethnicity is not collected routinely on birth certificates. As an indirect measure, the 
number of births in each ethnic group is estimated from age-specific fertility rates 
calculated from the census. Cross-checks with the actual number of births in an area, 
taken from birth certificates, are used to ensure the fertility rates are based on a 
reasonable estimate, and are adjusted if needed. Mortality by ethnic group used in mid-
year population ethnicity estimates is derived by taking age-specific mortality rates in a 
particular area from death certificates, and assigning proportions to each ethnic group. 
As ethnic groups are not evenly distributed across geographical areas, it is accepted that 
this method of calculation of mortality is likely to be inaccurate (Office for National 
Statistics, 2006). 
Internal migration by ethnicity is estimated using OP registration data and Health 
Authority/PCT data in the same way as mid-year population estimates. Delays in 
transferring OP registration data between areas which may affect the accuracy of these 
estimates, and limitations of the IPS relevant to this analysis have already been 
described in section 4.3.2 aiii. 
Two other measures were also used to calculate rates. One of these was standardised 
rates. Whilst crude incidence rates provide a useful summary estimate of the burden of 
diseases such as malaria, to control for possible differences in age categorisations 
between residents of England and London, age-standardised rates can also be 
calculated. 
The other measure was unpublished data from the IPS. It was noted in section 4.3.2 that 
mid-year population estimates were used as a denominator in the calculation of 
incidence rates. It would have been preferable to instead use an estimate of travellers as 
a denominator, rather than mid-year population estimates, as not all the population will 
travel and so do not constitute a population "at risk". Although the IPS collects data on 
UK citizens who visit overseas, countries in Africa are categorised in the publications 
produced by the ONS as "Egypt", "Tunisia", "Other North Africa", "South Africa", 
"Other Africa" (Office for National Statistics, 20 I 0). This means that no data were 
available on the number of trips made by travellers from the UK to each African 
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country, which would enable a more accurate denominator for the calculation of malaria 
incidence rates. 
To overcome this problem, data collected by the IPS for five years (2004-2008), which 
included the number ofVFRs in the UK travelling to Nigeria and Ghana were provided 
by Dr Ron Behrens. These data are not routinely available, but access to these allowed 
an alternative denominator to be used for the calculation of rates. 
The limitation of these data was that the IPS request data to be collected on a single 
main purpose of travel, which is reported by each respondent. This means that 
additional reasons for the same trip, such as "visiting friends and relatives" would not 
be included. There is no estimate available of the number of people who may be 
travelling overseas for more than one reason, but the study carried out by Phillips-
Howard and colleagues and referred to in section 4.3.1 bii, found that travellers of 
African and Asian ethnicity were likely to interchange "holiday" and "visiting friends 
and relatives" as a reason for travel. Therefore, the IPS data may under-estimate the 
number who visit for these purposes. However, as explained above, they give a more 
accurate assessment of rates of disease than mid-year popUlation estimates. 
4.3.3 Choice of time period 
The analysis carried out for this thesis initially covered the period between 2001 and 
2006, and was carried out in 2007. The year 2001 was the year when the most current 
census was undertaken. Therefore, mid-year population estimates were as accurate as 
possible at the beginning of the study period, as the 2001 mid-year population estimate 
was derived from the 2001 census. The analysis was up-dated in 2009 to include MRL 
data for 2007 and 2008. 
4.4 Collection of numerical data 
The MRL provided eight MS Excel spreadsheets containing all reports made by 
clinicians of imported malaria between 2001 and 2008 in England, Wales, Scotland and 
Northern Ireland. The names of patients were removed before the spreadsheets were 
received, and ethical approval from the London School of Hygiene and Tropical 
Medicine was granted for their use (LSHTM ethics reference 5086). Other data used to 
calculate denominators (mid-year popUlation estimates and mid-year population 
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estimates by ethnicity) were accessed from the Office for National Statistics website 
"publication hub". As explained in section 4.3.2b, Dr Ron Behrens provided 
unpublished data from the IPS, which enabled an alternative infection rate to be 
calculated for travellers to Nigeria and Ghana. 
4.5 Method of epidemiological analysis 
All data analysis was carried out in MS Excel. All confidence intervals were calculated 
at 95%. 
4.5.1 Completeness of data 
The Excel datasheets were comprised of line listings of records for individual patients 
and included the variables requested for completion by clinicians on the MRL report 
form, with the exception of the patient's name (see Appendix one for MRL reporting 
form). There were some variables where values had not been entered for individual 
records. In other instances, the entry was not valid. For example, for the variable "sex". 
some values other than male or female were recorded. Variables with missing or invalid 
entries were defined as "incomplete data" and were omitted from the data analysis. 
4.5.2 Calculation of incidence. crude and standardised incidence rates 
The geographical area of the report was assigned using the location of the hospital 
which made the report to the MRL, as a proxy measure, rather than the borough or 
county of residence of the patient. This method was chosen because 60% (8280/13813) 
of the reports had data relating to borough or county of residence missing, whilst 100% 
of reports had data relating to the hospital from where the report was received. 
The number of reports of imported malaria each year in the UK was calculated by 
counting the total number of reports in each spreadsheet. The number of reports in the 
London area was calculated by counting those reports made from hospitals in that area. 
The number of cases in the UK excluding London was calculated by subtracting the 
number of reports from London hospitals from the number of reports in the UK. 
Crude incidence rates for each year for the UK and for the London area were calculated 
by using the number of reports from the MRL as a numerator (categorised by 
geographical area as appropriate) and mid-year population estimates (for the UK and for 
98 
London respectively) as a denominator. These were multiplied by 100 000. The 
confidence interval around the rate for each year was calculated using the formula: 
( 100000)( ) 95% upper confidence limit = n d + (1.96 X Id) 
( 100000) ( ) 95% lower confidence limit = n d - (1.96 X /d) 
(where d is the number of reports, and n is the sample size). 
The number of reports made in England excluding London was calculated by counting 
the number of reports which came from hospitals in England, excluding those which 
originated from hospitals in the London area. 
The crude incidence rate for England was calculated in the same way as for the UK, but 
using as a numerator those reports which originated from hospitals in England, and as a 
denominator, mid-year population estimates for England. 
To obtain standardised rates in the template sourced from the LHO, the numbers of 
MRL reports that originated from London hospitals and from English hospitals 
excluding the London area for the years 2001 to 2008 were inserted into the 
spreadsheet, and the rates and confidence intervals extracted from this. 
4.5.3 Species of malaria acquired 
The mean number of reports for the UK excluding London was calculated by summing 
the number of reports caused by each plasmodium species which were reported by 
hospitals in this area, and dividing this by eight (the time period included in the 
analysis). The same method was used to calculate the mean for London, using the 
number of reports from London hospitals and dividing this by eight. The confidence 
interval around the mean was calculated using the equation: 
95% confidence interval = x ± (1.96 X ;-;) 
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(where ~ is the mean and s/"";n is the standard error). 
4.5.4 Estimates of infection rates per 1 00 000 population by ethnicity 
There were only three ethnic groups for which the categorisation of numerators (MRL 
reports) and the denominators (ONS categorisations by ethnicity) could be matched 
(table 4.5.1). A fourth ethnicity categorised as "Indian Sub-Continent" on the MRL 
report form was also considered for inclusion. However, on this form, no definition of 
"Indian Sub-Continent" is given. Possible categories included by the ONS in their mid-
year population estimates by ethnicity include "Asian or Asian British: Indian"; "Asian 
or Asian British: Pakistani"; "Asian or Asian British: Bangladeshi": Asian or Asian 
British: other Asian" or "Asian or Asian British: Chinese". The uncertainty about 
comparable categorisations meant that rates were not calculated for this ethnic group. 
Table 4.5.1 Ethnic group categorisations used for numerator and denominator calculations for 
three ethnic groups included in the epidemiological analysis 
Etbnic group 
Numerator White Black Black Caribbean 
(MRL data) British African! African 
descent 
Denominator White Black or Black Black or Black British 
(ONS British British Black Caribbean 
etbnicity Black African 
categorisation 
4.5.4a Calculating trends in ethnicity rates from the MRL report form 
(2001-2008) 
In section 4.3.1biii, it was explained that after 2004, the MRL changed the variable 
"nationality", used before this time, to "ethnicity". This raised the question of whether 
these different categorisations signified membership of the same ethnic group for the 
purpose of the analysis presented in this thesis. 
To explore this, re-coding of the variable "nationality" was undertaken for the years 
2001 to 2003. Those whose nationality was recorded as a country in Africa for these 
years were recoded as "Black African". Similarly, those with nationality recorded 
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between 2001 and 2003 as a country in the Caribbean were re-coded as "Black 
Caribbean". Those reports which categorised nationality as "UK" from 2001 to 2003 
were re-categorised as "White British". 
The means and confidence intervals around the means of reports made to the MRL from 
2001 to 2003, using these re-coded categories, were compared to reports made from 
2004 to 2008. This was carried out for the three ethnic groups for which infection rates 
could be calculated, as described above. 
Table 4.5.2 shows there was a significant difference in the means for each of three 
nationalities/ethnicities (as the confidence intervals did not overlap). One explanation 
for this may be that after 2004, some people born in the UK but of African ethnicity 
described themselves as "Black African" but before this time would have categorised 
their nationality as "UK" on the MRL report form. Whatever the reason for the 
difference might be, it was decided that "nationality" and "ethnicity" could not be 
matched. 
Table 4.5.2 Mean number of reports of malaria using the category of "nationality" between 2001 
and 2003 compared to the category "ethnicity" used after this time 
UKI Country in Africa! 
Country in the 
Caribbeanl 
White British Black African 
Black Caribbean 
- -
x x 
-
x (CI95%) (CI95%) 
(CI95%) 
England excluding London 
2001-
2003 
177.3 (141.2-213.4) 218.7 (201.6-235.7) 0.7 (0.1-1.3) 
2004-
2008 
92.2 (86.0-98.4) 324.6 (288.8-360.8) 2.6 (1.3-3.9) 
London 
2001-
2003 
65.3 (45.9-84.8) 787 (757.0-818.3) 0.3 (-0.3-1.0) 
2004- 20.6 (14.8-26.4) 676.8 (608.7-744.9) 11.2 (6.5-15.9) 
101 
2008 
Therefore, all analyses by ethnicity was conducted on data from 2004-2008. 
4.5.4b Calculation of means and rates by ethnicity 
For the three ethnic groups included, the mean number of cases in England excluding 
London caused by all species was calculated by dividing the sum of the number of 
reports which came from patients of each ethnicity which came from hospitals outside 
London by four (the number of years included). 
To calculate the mean number of reports for London, the number of cases was 
calculated by dividing the number of reports from London hospitals by four. 
To calculate the mean number of reports of infections caused by P. Jalciparum, a subset 
of the dataset was firstly extracted, which included only those reports where it was 
recorded that the plasmodium species which caused the infection was P. Jalciparum. 
Confidence intervals were calculated using the equation shown in section 4.5.2. 
Rates per 100000 by ethnic group were calculated for the years 2004 and 2008. To 
calculate rates for England excluding London, the numerator was the number of reports 
in each ethnic group reported for English hospitals excluding those outside the London 
area. The denominator was the size of the population estimated to be in each ethnic 
group. The numerator was divided by the denominator and this was multiplied by 100 
000 to obtain a rate. The confidence interval for each year was calculated using the 
same formula as in section 4.5.2 above. 
4.6 Number and proportion of infections in VFRs 
The number of reports in VFRs from throughout the UK was calculated by counting the 
number of reports where VFR was recorded as the reason for travel for each year 
between 2001 and 2008 and summing them. The mean number of reports was 
calculated by dividing the sum by eight. Confidence intervals around the mean were 
calculated using the equation in section 4.5.2. 
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The dataset was sub-divided to obtain a count of reports of imported malaria in VFRs 
which came from hospitals in the London area, and by those infections caused by P. 
falciparum. Confidence intervals around the mean were calculated as described above. 
The proportion of all infections that were in VFRs was calculated by dividing the 
number of reports where VFR was given as the reason for travel by the total number of 
reports. This was calculated for each year. The proportion of falciparum infections that 
were in VFRs was calculated by taking the number of those which were categorised as 
having VFR as the reason for travel and P. falciparum as the species causing the 
disease, and dividing it by the number of falciparum infections in all travellers. This 
was carried out for the London area, and for the rest of the UK. 
4.7 Number of infections using IPS data as a denominator 
To calculate infection rates per 100 000, the numerator was the number of reports made 
to the MRL from throughout the UK in each year between 2004 and 2008 which were 
acquired in Nigeria or Ghana. The denominator was the number of VFR travellers 
visiting these countries. 
4.8 Description of the group most at risk of imported malaria 
The first part of the epidemiological analysis estimated which group was most at risk of 
imported malaria, using rates of infection in the way described above. The second part 
of the analysis described this group in more detail. A subset of MRL data from 2004 to 
2008 was used to carry out this analysis, with three criteria all needing to be fulfilled for 
inclusion in it. The first was that the species of parasite acquired must be P. falciparum. 
Secondly, the reason for travel must have been categorised as "visiting friends and 
relatives". The third criterion related to ethnicity, with all those whose ethnicity was 
categorised as "Black African" or "of African descent" included. As described in 
section 4.3.1 biii, as it was not certain if the same populations were included in the 
variable "nationality", used by the MRL before 2003, compared to the variable 
"ethnicity", used by them after this date, only data after 2003 were included in the 
analysis. 
All hospitals in the London area were included in the analysis. As was the case for the 
UK-wide analysis, those hospitals in the London area, instead of borough or county of 
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residence of the patient was chosen because of the poor completion of data relating to 
the latter, which was only available for only 33% (501/1498). 
Frequency distributions from the MRL dataset were calculated for the variables "age" 
and "sex". Other frequency distributions calculated included "area of London", 
"duration of travel" "month of travel", and "deaths". Where the analysis included two 
variables, cross-tabulation tables were constructed in Excel. 
A map of Africa showing the theoretical suitability of the climate for malaria 
transmission (MARA, 2004) was also used. The compilers of the map stress that the 
map does not show the incidence of malaria in different countries, but rather, whether 
the climate makes it likely that malaria transmission can occur. They note that those 
areas labelled as "suitable" may in fact have no malaria because of control efforts, 
whilst those considered "unsuitable" may have malaria because of the presence of water 
in usually dry areas (MARA, 2004). However, this map was considered to be a useful 
indicator of the malaria risk. 
Onto this map was noted the number of infections acquired in countries where more 
than 10 000 London residents were born who acquired falciparum malaria whilst 
visiting friends and relatives between 2004 and 2008. 
To carry out an analysis of the use of chemoprophylaxis, firstly, a frequency distribution 
was constructed, counting the numbers who took each type of chemoprophylaxis, and 
where the entry was recorded as "none". Where brand names only were given on the 
Excel spreadsheet these were re-categorised to include the active ingredient, for 
example "chloroquine". 
To calculate the rate per 100000 of those who did not take chemoprophylaxis in LSL 
and other areas of London, the numerator was the number ofMRL reports where it was 
stated that no chemoprophylaxis was taken in 2004 and 2008 (in LSL and in other areas 
of London), and the denominator was the mid-year population estimate for each of these 
years in the same geographical areas. Confidence intervals were calculated as in section 
4.5.2 above. The rate was also calculated using mid-year population estimates by 
ethnicity as a denominator. 
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4.9 Qualitative Methods 
4.9.1 Choice of study participants 
In section 4.2.1, it was explained that qualitative, unlike quantitative research is not 
based on choosing a randomly selected sample of study subjects and extrapolating the 
findings to a wider population. Rather, the aim is to explore an issue in greater depth, 
using methods such as semi-structured interviews. The findings of the qualitative 
research can subsequently be tested, using quantitative methods, to find out the extent to 
which they are valid in a wider population. 
In the qualitative part of this study, purposive sampling was used to recruit respondents. 
This has been defined by Bernard as follows: "In purposive sampling, you decide the 
purpose you want individuals or communities to serve, and you go out to find some" 
(Bernard, 2006 p.189). In this study, the aim was to understand the reasons for the 
burden of imported malaria in the Nigerian and Ghanaian communities in London. 
Therefore, participants were chosen which could provide useful information to explain 
this. As noted in section 3.10, no studies carried out in the UK had included the 
perspective of health care providers and community pharmacists, and that they may be 
able to impart important information about structural factors impacting on the burden of 
imported malaria. The justification of the specific groups of respondents chosen is given 
below. 
In section 2.5.4, it was noted that there were three PCTs in London in which malaria 
chemoprophylaxis was subsidised. In order to understand any impact this had on 
decision making about malaria prevention, all groups of respondents described below 
were drawn from these areas, and also from those PCTs where it must be purchased on 
a private (i.e. non-subsidised) prescription. 
Discussing imported malaria with VFRs themselves was clearly of fundamental 
importance. It was considered necessary to include some who had sought pre-travel 
advice and some who had not, in order to find out the factors which influenced both 
behaviours. It was decided to include those who were planning to travel in the near 
future so that the discussion could be linked to a particular event, although decision 
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making relevant to previous travel would also be explored, where appropriate. 
Interviewing VFRs both before and after travel would allow the opportunity to find out 
the extent to which behaviours matched intentions. It was also decided to interview both 
those who had been born in Nigeria and Ghana and those who were born in the UK, to 
find out the extent to which country of birth influenced decision-making. 
Nurse-led travel clinics in GP practices are a common source of providers of pre-travel 
advice in the UK. It was felt that nurses may be able to provide a valuable perspective 
on the knowledge, attitudes and behaviours ofVFRs who sought such advice. 
Interviewing practice nurses would also offer an opportunity to explore structural 
factors which may impact on VFRs' ability to access pre-travel health advice, and 
obtain chemoprophylaxis. 
GPs were a third group of respondents included. It was considered possible that they, as 
well as practice nurses may be asked for pre-travel advice by their patients, and so 
would be able to provide useful information about this. They would also be the first 
source of requests for treatment for some patients returning with symptoms suggestive 
of malaria, and so able to discuss issues relevant to this. In addition, alongside practice 
nurses, they would be able to provide a useful perspective about structural factors which 
may affect the seeking of pre-travel advice by VFRs, and treatment options. 
From my professional knowledge, it was considered possible that the service provided 
by GPs working in single-handed, compared to group practices may be of a lower 
quality than for those working in group practices. Therefore, it was decided to include a 
range of GPs, some who worked alone, and others who worked in larger practices. 
From the literature review in chapter two, it was known that retail outlets such as 
pharmacies are commonly used for the purchase of medicines for self-treatment of 
malaria in Nigeria and Ghana, and that some VFR travellers may use chloroquine as a 
chemoprophylaxis, which can be purchased without a prescription from community 
pharmacists. It was therefore considered useful to include community pharmacists as 
interview respondents to discover more about whether VFRs sought pre-travel advice 
and treatment from these outlets. 
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Two groups of participants were subsequently added. From the GP interviews, it was 
recognised that A&E Departments may be the chosen source of primary care treatment 
for many patients. It was decided therefore to include some hospital consultants who 
would be likely to see these when these. 
Finally, having interviewed a number of VFRs, it was decided to compare their 
knowledge, attitudes and practices vis a vis malaria with some patients who had 
recently acquired malaria and who had been admitted into hospital in the UK. This 
would also provide an opportunity to compare issues about access to pre-travel health 
advice, and to prompt and effective treatment. 
4.9.2 Initial choice of location in London for interviews 
The choice of location in which to recruit participants was decided by three criteria. 
Two of these were number of reports made to the MRL and the size of the Nigerian and 
Ghanaian community between 2001 and 2006, the time period during which the initial 
choice of location was considered. The third criterion was the inclusion of some PCTS 
in which malaria chemoprophylaxis was subsidised, and some where it was not. Only 
three PCTs contained hospitals which made cumulatively over 500 reports to the MRL 
between 2001 and 2008, and that also had over 5000 residents born in Nigeria and 3000 
born in Ghana according to the UK 2001 census. These were Southwark (4410 born in 
Ghana and 10673 in Nigeria), Lambeth (4421 born in Ghana, and 6121 in Nigeria) and 
Hackney (3209 born in Ghana and 6633 in Nigeria). Two other locations were added. 
According to the 2001 UK census, the London Borough of Newham was home to one 
of the largest Nigerian and Ghanaian communities in London (3776 born in Ghana and 
5423 in Nigeria) and it was surmised that under-notification to the MRL from Newham 
hospital may have accounted for the low number of reports made to the MRL between 
2001 and 2008 (n=332), and a range of 13-118. The Queen Elizabeth Hospital in 
Greenwich, which serves the community local to that area, had made over 500 reports to 
the MRL but results from the 2001 census did not suggest a substantial Nigerian and 
Ghanaian communities live in this area (1197 born in Ghana and 3918 in Nigeria). 
However, infonnal infonnation received from professional colleagues indicated that 
there was a large Nigerian community who had settled in Greenwich after 2001 and so 
would not have been included in the 2001 census. A third hospital, HTD, was also 
considered. Over 500 reports were made to the MRL between 2001 and 2006, but this 
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hospital could not be easily classified as serving a particular geographical area as it is 
also a tertiary referral centre from other areas of London. 
It was therefore decided initially to seek interviews with YFRs, GPs, practice nurses, 
community pharmacists and hospital consultants from Lambeth, Southwark, Newham, 
Hackney and Greenwich. This would also facilitate investigation of the policy of 
offering malaria chemoprophylaxis on prescription, as some areas were included which 
followed this policy (Lambeth and Southwark) and some which did not (Hackney and 
Greenwich and Newham). 
Having chosen the study respondents to include in the study and the location in which 
these would be sought, the choice of research methodology remained to be decided. 
This was influenced by both practical and theoretical issues. 
4.9.3 An evaluation of the potential qualitative research methodologies 
Methodologies considered included case studies, ethnography, telephone interviewing, 
focus groups, telephone or face to face interviews with individuals (either structured, 
semi-structured or unstructured interviews), or a combination of these methodologies. 
4.9.3a Case studies 
Case study research may be defined as: 
"an empirical enquiry that investigates a contemporary phenomenon within its 
real-life context, especially when the boundaries between phenomenon and context 
are not clearly evident" (Yin, 2003 p.9). 
For this thesis, the application of this research methodology would have involved a 
detailed investigation of the context within which one or more individuals made 
decisions about protecting him or herself against malaria, and how any subsequent 
suspected malaria infections were managed. This would have included interviews about 
a range of topics with the individual, with his or her healthcare providers, and with 
friends and relatives both within the UK and in Nigeria or Ghana. In addition, other 
sources of evidence including the availability of health care in the UK for the 
individual, and the affordability of chemoprophylaxis and mosquito avoidance measures 
that could be purchased before travel would have been examined. In Nigeria or Ghana, 
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infonnation about the usual protections used against malaria would have been included 
and common methods of treating infections within the family. 
Despite the obvious benefits of this methodology in enabling an in-depth exploration of 
the context within which the prevention and management of malaria is managed, the 
potential difficulties included identifying one or more individuals to approach. At the 
time in which the study was designed, contact with likely participants was limited. 
Aside from the lack of funding for travel to Nigeria and Ghana, success could not be 
assured in persuading one or more individuals to act as participants in research which 
would have taken several months and necessitated contact not only with friends and 
family, but with their healthcare providers. GPs could have reasonably viewed the 
request for infonnation to be intrusive and breaking a confidential relationship between, 
even if ethical approval had been granted. These confidentiality issues also meant that 
the gaining of ethical approval for such a study would have been doubtful. 
4.9.3b Ethnography 
This methodology has been described as "the systematic, detailed observation of 
behaviour and talk, watching and recording what people do and say" (Mays and Pope, 
1995a p.182). Over a period of time, for at least around three months, but typically one 
year, a range of data are collected which are considered by the researcher as pertinent 
for exploring the research topic (Bernard, 2006 p. 349). These may include the 
researcher's notes, photographs and transcripts of conversations held in the natural 
environment of the group being observed (Bernard, 2006 p. 344). One of the main 
advantages of this methodology would have been the unique capacity to observe people 
within their own environments in which they may have expressed beliefs and attitudes 
about malaria which may not have been so easily collected within the confines of other 
research methodologies. There would also be the opportunity to compare behaviours 
with attitudes, for example the actual use of chemoprophylaxis and other malaria 
prevention methods compared to the intention to use these. 
Ethnography was quickly discounted as a potential research methodology for all groups 
of participants. For VFRs, because of practical constraints, particularly related to time, 
attempts to integrate would have been restricted to one particular sector of the 
community, most likely those attending a church or community group. As the 
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heterogeneity of beliefs with respect to imported malaria within the Nigerian and 
Ghanaian communities was to be explored, collecting data from only one particular 
group would have been inappropriate. Cost and time constraints would have made it 
impossible to accompany VFRs on visits to Nigeria or Ghana in order to observe 
malaria-related prevention and treatment behaviours and it would have been difficult to 
find volunteer VFR families for this. The ability to become integrated within the 
chosen section of the Nigerian or Ghanaian community would have been problematic 
and so its success not certain. Conducting an observational research study with health 
care providers and community pharmacists in their workplace environments or indeed 
with patients in these situations would have been intrusive and compromised the 
confidentiality of other patients. In addition, the observing of patients when they may 
have been seriously ill after their admission would have been inappropriate. 
4.9.3c Focus groups 
A useful definition of focus groups and their uniqueness as a research methodology has 
been made by Morgan (Morgan, 1997 p.2) 
" .. ,focus groups are basically group interviews, although not in the sense of an 
alternation between a researcher's questions and the research participant's 
responses. Instead, the reliance is on interaction within the group, based on topics 
that are supplied by the researcher who typically takes the role of a moderator. 
The hallmark of focus groups is their explicit use of group interaction to produce 
data and insights that would be less accessible without the interaction found in a 
group 
Groups typically consist of between six to 10 people who meet together for a period of 
one to two hours to discuss a range of issues that may be initiated by the moderator, but 
explored by group members (Morgan, 1997 p.34). Homogeneity as far as possible of 
participant selection with respect to their backgrounds is recommended, in order to 
provide an atmosphere where group members can speak freely to each other (Morgan, 
1997 p.35). 
The most feasible way in which focus groups could have been conducted would have 
been to gather together individuals from each group of interest (VFRs, patients, GPs 
etc.). Focus group research had been previously used as a research methodology in one 
of the only pieces of primary research carried out previously on this topic (Morgan and 
Figueroa-Munoz, 2005). There were several reasons why focus groups were not chosen 
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as a research methodology. Firstly, for this research, group interactions were not the 
priority. Rather, it was to explore at an individual level, the context within which 
knowledge, attitudes and behaviours were formed and acted upon. The opportunity to 
do this on an individual basis in a focus group setting is limited, as the unit of analysis is 
the group, rather than the individual (Kitzinger, 1995). 
Although gathering together a group of individuals may make them more willing to 
voice their opinions, views held by less articulate members might not be heard, andlor 
discussions may become polarised (Kitzinger, 1995). Potentially, this could have been 
a disadvantage for focus groups with all sets of study participants. With respect to 
patients in particular, Kitzinger has shown that in focus group settings with users of 
healthcare systems, some may prevent others from expressing criticisms of the service, 
particularly when there is a reliance on these for current or future care (Kitzinger, 1995). 
Alternatively, patients may have been keen to focus on structural factors such as cost 
and access to healthcare as being the sale determinants for having acquired imported 
malaria, and be less willing to explore other factors which influenced decision making. 
There was also a concern that some patients may feel they had been called upon to 
explain themselves, which could lead to defensiveness. Any such anxieties, it was 
surmised, could be more readily managed in an individual interview setting in which 
reassurance could personally be given. 
Practical difficulties were equally valid reasons why focus groups were not chosen. It 
would have been doubtful whether groups of individuals could be gathered together in 
one place and at one time. For example, with respect to VFRs it would have been 
necessary to find enough individuals from similar backgrounds who were about to 
travel who fitted the inclusion criteria. This also held true for patients. It was also felt 
that busy doctors and nurses would be unlikely to volunteer time to take part in the 
study, unless this could be done at their own convenience. Previous experience of 
working with GPs suggested that requests for payment to employ a locum might be 
made when they have to leave their workplace, and no funding was available for this. 
Given that there was only access to a small number of African community groups, it 
was likely that some focus group members may have known each other, which may 
have adversely influenced their ability to speak freely (Morgan, 1997 p.38). This would 
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also have been the case for doctors, nurses and community pharmacists, particularly 
given the need to run groups within locations geographically convenient to group 
members. 
A neutral space in which to carry out the focus groups would have been difficult to find. 
Free of charge options were peT offices, which may have augmented any perceived 
power imbalance between myself and study participants, especially if I was viewed as 
being a representative of the Health Authority. For example, it may have made some 
participants fear implied criticism and judgement of those who did not take preventive 
measures. Rooms available at the London School of Hygiene and Tropical Medicine, 
the academic institution where I was enrolled for my PhD would have been difficult for 
some respondents to reach, and no money was available for help with their travel costs 
to this location. 
The use of focus groups to confirm the findings of interviews held with individuals 
from all groups was also considered. This was discounted for two reasons. Although 
very little primary research has been carried out to investigate this topic, focus group 
methodology had already been used by a different researcher (Morgan and Figueroa-
Mufioz, 2005), and so there was already the opportunity to compare the results of this 
research with that. More importantly no other research had compared the findings of 
interviews of travellers with those of patients and it was felt that this was an effective 
use of the time available to carry out the research. 
4.9.3d Rationale for the choice of semi-structured interviews 
With semi-structured interviews a discussion takes place between the researcher and 
one study participant. The interviewee is encouraged to speak freely, but the use of a 
study guide determines the subjects covered (Bernard, 2006 p.212). This was 
considered preferable to structured questionnaires, where the questions asked are 
controlled by the interviewer, and the participant has less opportunity to voice their own 
opinions (Bernard, 2006 p.251). Given the time constraints of both interviewer and 
study participants, the use of a topic guide would ensure that focus to the subject of 
interest was maintained in a way that would not be possible with unstructured 
interviews, where, although there is a clear research plan in mind, individuals are 
encouraged to express themselves freely in their own time (Bernard, 2006 p.213). It was 
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also thought to be a sensible choice, as this methodology works well with individuals 
such as doctors and nurses, who are used to an efficient use of their time, and may 
become impatient with unfocused questions, Indeed, VFRs and patients would also 
giving up their time free of charge and so this methodology would also be suitable for 
them. 
Another advantage influencing the decision to use semi-structured interviews was that 
study participants would have the opportunity to "tell their own story". This would 
elucidate how contextual factors pertinent to the individual affected their decision 
making. The interviewer would also have the freedom to follow-up on any topics that 
had not been covered in the topic guide, but which were considered pertinent. 
The choice of semi-structured interviews with individuals avoided many of the 
disadvantages associated with the use of focus group methodology. There would be an 
opportunity for a direct personal conversation between two individuals in a neutral 
space. If respondents wanted to criticise healthcare services they could do so without 
others preventing them. Of course, concerns about the possible consequences of voicing 
criticisms, or a wish not to appear provocative might still prevent individuals from 
speaking freely. However, it was felt that signs of unhappiness with healthcare services 
provided could be probed much more effectively on an individual basis rather than in a 
group situation. More introverted individuals would have the opportunity to speak 
freely about topics that were pertinent to them, without the risk of being intimidated by 
others present. 
Although the personal nature of the interview, especially when the conversation was 
being recorded could arguably make some individuals more anxious than when part of a 
group, it was considered that the assurance of confidentiality and anonymity and 
evidence of ethical approval for the study, shown before the interview, would overcome 
this. 
Using semi-structured interviews would also avoid the need to find a number of 
individuals simultaneously, who were about to travel to Nigeria or Ghana, and who 
were considered suitable for bringing together into a focus group. Instead, differences 
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between individuals, in tenns of socio-economic deprivation and frequency of travel 
which might affect behaviours could be explored just as effectively. 
Some of the advantages of case studies could be included, most importantly the capacity 
to gather together multiple sources of evidence, as interviews with pre-travel health 
providers, community phannacists and doctors who saw patients could be included. 
These would all provide valuable infonnation about the context within which decisions 
about malaria prevention and control are made. However, the difficulties of recruitment 
noted in section 4.9.3a could be avoided. 
One option considered was to carry out semi-structured interviews, but by telephone. 
The need to record the interview to allow a verbatim transcription precluded this choice 
of interviewing without further consideration of other advantages and disadvantages of 
this method. If specialist equipment had been available to record interviews, the cost-
effectiveness of this methodology and convenience for all participants in choosing the 
time and location of the interview would have been of advantage. For VFRs and 
patients in particular this would have also enabled the interview to be carried out from 
the comfort of their own home, without the need to invite in a stranger for this purpose, 
and, it was thought, this may have increased the number of people who were willing to 
take part in the study. However, limitations of this methodology with respect to the lack 
of an opportunity to pick up on non-verbal cues during the interview may have been a 
barrier to effective exploration of some topics (Simmons, 2001 p.89). 
4.9.4 Development of the topic guide 
Appendix two gives details of the topic guides used for each group of respondents. 
It was decided that discussions with VFRs would be initiated by asking details of their 
most recent trip, including the country and area within the country visited, the number 
of people travelling and duration of travel. These questions would serve not only as an 
"icebreaker", but also enable the gathering of useful infonnation. Respondents would 
then be asked about any general health concerns they had when visiting Nigeria or 
Ghana, and whether they were aware of travel health advice on airline tickets purchased 
before travel. The decision to ask this latter question was the result of discussions in the 
"London Malaria Group"; a group of malaria experts which met four times a year, 
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which I chaired. One solution to increasing awareness about malaria amongst VFRs and 
other travellers proposed during these meetings was to ensure that travel health 
information was provided on airline tickets. 
Topics concerning malaria more specifically would then be discussed with VFRS. 
Issues to be discussed in detail were those which had been identified in the literature 
review in chapter two, including knowledge about how malaria is transmitted, and 
individual perceptions about the potential and personal risk of acquiring malaria when 
visiting a malarious country. A greater emphasis on mosquito prevention measures than 
had been examined in previous studies would be made, as very little data had previously 
been collected on this topic. Questions exploring why malaria might be perceived of as 
a serious or mild health problem, and the use of chemoprophylaxis would then be 
addressed. It was recognised that involvement in the research study may affect the 
behaviours of some VFR respondents while abroad. In particular being interviewed 
before travel may have made respondents more likely to adhere to chemoprophylaxis 
and to use mosquito prevention measures in a different way to that used in previous 
visits. To help overcome this, VFRs would be asked about their general practices 
concerning malaria prevention, as well as focusing on their behaviour on their most 
recent trip. 
As it became apparent during the course of the interviews that it was not always easy to 
assess perceptions about the seriousness of malaria, an additional question was asked of 
VFRs 14-20, namely, could VFRs die from malaria? Recognising that there may be 
different perceptions of risk about malaria between different VFRs and also between 
individual travellers and their host families in Nigeria and Ghana, the issue of possible 
peer pressure would also be raised. 
VFR respondents would be asked about what they would do if they developed 
symptoms in Nigeria or Ghana and in the UK, and similarities and differences were 
explored between how malaria is commonly managed in each context. The question of 
what might cause convulsions had not previously been explored in the academic 
literature, but a discussion about whether there were two "types" of malaria in the focus 
groups carried out by Morgan and Figueroa-Munoz (Morgan and Figueroa-Munoz, 
2005), and the linking of convulsions to supernatural forces discussed in the literature 
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about malaria perceptions in Nigeria or Ghana (McCombie, 2002, Williams and Jones, 
2004, Adongo et aI., 2005, Onwujekwe et aI., 2005a) were the rationale for convulsions 
being included in the topic guide. 
Some demographic and travel-related information would also be collected for each 
respondent (age, sex, country of birth, month and duration of travel) in order that these 
could be compared to the epidemiological analysis of MRL reports. Details of 
occupation, country of birth and of previous residence, and frequency of travel would 
also be included to provide more detail of factors which may affect decision making. 
Questions to be asked of those VFRs who were interviewed after their return included 
the use of mosquito avoidance measures, and adherence to chemoprophylaxis for those 
who had taken this. VFR participants would also be asked if they experienced any 
symptoms which could be caused by malaria. These questions were also on the list of 
topics to be discussed with those VFRs who were only undertook one interview after 
they returned from Nigeria or Ghana. 
Structural factors, including access to healthcare, and the cost of chemoprophylaxis 
would also be discussed to determine the extent to which these affected decision 
making. 
For interviews with patients, all the information to be asked ofVFR participants would 
be included. The initial questions would be concerned with their last episode of illness, 
the symptoms, diagnosis and treatment, rather than about their most recent visit, as was 
the case with VFRs. This was to immediately acknowledge the event which led to their 
hospitalisation. They would also be asked where they thought they have may have 
contracted their recent episode of malaria, which would enable an exploration to be 
made of those environmental factors which were thought to be most likely for malaria 
transmission. 
Practice nurses would be initially asked about how long they had been employed in this 
role. This was to show a personal interest in them from the onset, as well as to gauge 
their expertise. They would then be asked to conftrm that they did give pre-travel health 
advice. The focus of the interview would then be on gathering information about the 
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operation of pre-travel advice clinics, on their perceptions of the knowledge of VFRs 
with respect to how malaria was transmitted, VFR's attitudes about potential and 
personal risk, and the seriousness of malaria. Discussions practice nurses had with 
VFRs about planned mosquito avoidance measures and chemoprophylaxis would also 
be included. In line with other groups of respondents, they would be asked about the 
cost of chemoprophylaxis. Practice nurses would be asked to give an indication of the 
frequency and duration of travel of their Nigerian and Ghanaian VFR patients, any 
travel patterns associated with seasonality, and who initiated travel health advice. A 
check would also be made of the sources of information available to practice nurses, 
and whether they considered these to be sufficient. 
Like practice nurses, GPs would initially be asked about their employment history. 
They would then be asked if they gave pre-travel health advice, and for those who did, 
the same questions would be asked of them as for nurses. The main focus of the 
interview would be concerned with their actions when they saw a patient with suspected 
malaria. An estimate of the number of patients seen with malaria type symptoms would 
be asked, to find out the extent of their personal experience in managing such patients. 
If GPs had not personally seen any patients, they would be asked what they would do if 
presented with a patient with symptoms suggestive of malaria. 
GPs would also be asked the more general questions asked of other healthcare 
professionals, relating to VFRs' knowledge of malaria transmission, the seriousness 
VFRs attributed to malaria, VFR beliefs about their own immunity and their 
understanding of the potential and personal risk to themselves when travelling to a 
malarious country. Questions about access to healthcare and the cost of 
chemoprophylaxis would also be included. 
During the course of the interviews with the first few GP respondents, it became clear 
that very few GPs gave pre-travel health advice, and that their role appeared to be 
limited to providing advice to practice nurses for patients with particular needs, for 
example pregnant women. Furthermore, the perspective of GPs about pre-travel health 
advice appeared to be influenced by their conversations with practice nurses. Therefore 
it was decided to limit the analysis of GP interviews to the information they provided 
about malaria diagnosis and treatment 
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One focus of the intelViews with community pharmacists would be to seek information 
on the number of travellers who used their selVices to seek pre-travel health advice, and 
malaria treatment, and to determine if there were any defining characteristics of these 
groups. They would be asked about the resources available to them to ensure their own 
expertise was maintained, and if the prescriptions issued by GPs were appropriate. 
Details of their employment history would be sought in the same way as for other 
healthcare professionals. Their perceptions ofVFR's understanding of the risk of 
malaria, its seriousness, immunity to this disease, the cost of chemoprophylaxis and 
whether they believed VFRs understood how malaria was transmitted would be asked 
of these participants to enable comparisons with other respondent groups. 
Hospital consultants would be primarily asked about the treatment of patients when they 
presented at A&E Departments. They would also be asked the questions about access to 
primary care, the cost of chemoprophylaxis and the other questions asked of other 
respondents about VFRs' risk of acquiring malaria, the seriousness with which they 
regarded malaria, about the cost of chemoprophylaxis, and whether VFRs knew how 
malaria was transmitted. 
It was recognised that although practice nurses, GPs, community pharmacists and 
hospital consultants would be told before the intelView that the focus of the study was 
imported falciparum malaria in the Nigerian and Ghanaian communities, they might 
discuss their experiences and beliefs about all patients. To overcome this, it was decided 
that at the beginning of the intelView, they would also be reminded at the beginning of 
the intelView and throughout about the topic of interest. 
4.9.5 Reflexivity 
In addition to the topic guide, it was recognised that a record should be kept of how my 
personal perspective and involvement in the study may have influenced the results. This 
has been referred to as "reflexivity", a definition of which has been made by 
Nightingale and Cromby: 
"Reflexivity requires an awareness of the researcher's contribution to the 
construction of meanings throughout the research process, and an 
118 
acknowledgment of the impossibility of remaining 'outside of one's subject matter 
while conducting research. Reflexivity then, urges us "to explore the ways in which 
a researcher's involvement with a particular study influences, acts upon and 
informs such research. " (Nightingale and Cromby, 1999 p.228) 
To recognise the importance of this, it was decided that after each interview, notes 
would be taken of any other pertinent information that did not fall in the remit of the 
topic guide. This might include my impression of the interaction between myself and 
the respondent, and contain, for example, differences in ethnicity, sex, or socio-
economic status. However, no guidelines would be constructed about the content of 
these notes, but rather any issues which came to mind would be documented. These 
notes would be taken as soon after the interview as possible, in order that impressions 
would not fade. 
4.9.6 Ethical issues 
Ethical approval was granted from LSHTM (ethics reference 5086) to carry out 
interviews with the families of children that would be recruited through schools and 
with GPs, practice nurses, hospital consultants and community pharmacists. When the 
school recruitment method proved to be unsuccessful, an amendment was successfully 
submitted to extend the method of recruitment by asking colleagues to suggest possible 
participants. 
Further amendments to ethics application form 5086 were approved from LSHTM to 
carry out interviews with patients who had been recently discharged from King's 
College Hospital and the Hospital for Tropical Diseases, after being admitted with 
laboratory-confIrmed infections caused by P. falciparum upon return from Nigeria or 
Ghana. 
The National Research Ethics Service was contacted by email to clarify if they required 
ethical approval to be granted from them to carry out interviews with VFRs, GPs, 
practice nurses, and hospital consultants. In appendix two (ethical approval) their 
confIrmation that no such requirement was necessary is shown. 
Each R&D Department of the three hospitals in which the consultants worked who 
agreed to be interviewed were contacted. One requested a list of the interview questions, 
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and another confinned they did not need to take any further action with respect to 
registration of the study. The third provided a letter of access. This correspondence is 
not included in the appendices to protect the identity of the hospital consultants. 
Before carrying out interviews with patients at King's College Hospital, ethical 
approval was received from the Riverside Research Ethics Committee, on behalf of 
NRES. An amendment was accepted by the same ethics committee to include HTD as a 
centre for recruiting patients (see appendix two). 
Pennission to carry out interviews with patients was also obtained from the Research 
and Development Department at King's College Hospital, and from the joint 
UCHIUCLH Biomedical R&D Department (see appendix two). 
4.9.7 Method of recruitment 
The following section describes the method used for the selection of participants. In 
cases where initial attempts were unsuccessful (VFRs and GPs) or lower than intended 
(patients and hospital consultants), an evaluation of the possible reasons for this are 
given. Appendix five shows the method by which VFRs, GPs, practice nurses and 
community pharmacists were recruited to the study. 
4.9.7a Attempted recruitment of VFRs through schools 
In section 4.9.2, details of the London boroughs that would be targeted for the study 
were provided. For this initial recruitment drive, it was decided to focus on Newham 
and Southwark. The schools in these areas with the highest numbers of reports made to 
the MRL from within these boroughs were included. These were identified by counts of 
reports made to the MRL from each postcode area within the London boroughs. Details 
of each school contacted are not included to maintain their anonymity. 
Successive attempts at recruitment were planned, whereby a number of schools within 
particular geographical areas would be contacted at the same time. Coordinated visits to 
schools could then be made to discuss the research. One further advantage of running 
successive recruitment drives was that if recruitment in one geographical area were 
successful, then further recruitment drives would not be necessary. 
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The names and telephone numbers of head teachers in schools in the selected areas were 
found from the Internet. A draft letter providing information about the proposed study 
was reviewed for clarity by a personal friend who was a retired head teacher. The letter 
requested permission from Head teachers of both primary and secondary schools within 
the selected areas of London for the school to take part in the study. If this were granted, 
letters were to be sent to parents of African origin, asking if they were visiting friends or 
relatives in Nigeria or Ghana, and if so, requesting permission for an interview. Two 
interviews would be requested, one before, and one after travel. In return an offer would 
be made to the head teacher to teach a lesson on malaria at a level appropriate to the age 
of the class. 
Table 4.9.1 Recruitment through schools: times, actions and outcomes 
Last week October 151 recruitment drive: Letters sent to nine schools in Newham 
2007 and Southwark (eight secondary/one junior in Newham) 
151 week November Follow-up phone calls and emails 
2007 
Last week 2na recruitment drive: 14 letters sent to junior schools in 
November 2007 Lambeth 
December 2007 End of school term: reminders to junior schools 
January 2008 Follow-up phone calls/emails to junior schools 
Visits made to schools 
4.9.7.ai Results of first school recruitment drive 
An average of four attempts at contacting each school by telephone was necessary 
before being connected to the head teacher. Of the initial nine schools contacted: 
• Five would not participate. Reasons given included that they were already taking 
part in other research (one school), were not interested (three schools), or were 
moving sites (one school). 
• One said this required discussion at senior management team meeting: no further 
contact was received, despite reminders 
• Two head teachers said the letter had been sent to another member of staff. No 
reply was received from emails sent to these staff members. 
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• One head teacher at the only primary school contacted agreed to participate, but 
he did not reply to further emails. 
4.9.7.aii Second recruitment drive through schools 
As no VFRs were recruited from the first drive, the number of schools to be contacted 
in the second round was increased to 15. Recruitment focused on junior schools because 
the only school which agreed to participate from the first recruitment drive was of this 
type. It was thought that contact would be easier to make than with Head teachers of 
secondary schools and the decision to participate could be made without needing to be 
discussed with Departmental staff. 
Schools in the London Borough of Lambeth were chosen for the second recruitment as 
it had not been included in the first, and fitted the criteria for the choice of areas from 
which to attempt recruitment. The same method of contacting the schools was used as 
for the first recruitment drive. 
4.9.7.aiii Results of the second recruitment drive 
• Five were not interested. 
• There were no replies to emails and telephone calls for a further five. 
• Three head teachers agreed to send out letters to families before Easter 2008, 
however, no replies were received to my emails or telephone calls to confirm 
these had been sent. 
• One head teacher volunteered to encourage participation from families who 
requested taking their children from school in term time for family trips to 
Nigeria or Ghana, but supplied no names. 
• One school provided contact details of a member of staff working with refugees, 
who, although she said that she had a number of possible contacts, did not 
provide any. 
4.9.7.aiv Possible reasons for the failure of the school recruitment strategy 
Whilst some head teachers in junior schools were initially willing to help, their interest 
seemed to quickly wane, but it was unclear why. In secondary schools, it sometimes 
appeared difficult for anyone individual to make a decision. Some Head teachers 
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passed on the request to colleagues, who did not reply to emails. Recognising the busy 
schedules of both Head Teachers and their staff, as exemplified by the difficulty in even 
contacting them to speak directly by telephone, it felt uncomfortable to pursue them. 
Head teachers identified the practical problem that children may not take the letter 
home. In addition, there were concerns voiced by some, that Nigerian and Ghanaian 
parents may feel discriminated against by being asked to participate. Alternatively, 
parents of other nationalities may feel left out by not being asked to participate if they 
became aware of the study. 
A major barrier seemed to be that schools were extremely busy with a curriculum that 
did not allow any time for participation in ad-hoc projects. The offer to teach a lesson 
on malaria was not seen as an incentive, possibly because work plans for the year had 
already been devised. 
4.9.7b Recruitment of VFRs through work colleagues 
Recognising the problems of recruiting VFRs through schools, the method of 
recruitment changed to one of "snowballing." This is one where one respondent is asked 
to suggest potential participants who may be interested in participation (Bernard, 2006 
p.193). I used my professional role as the lead on malaria strategy for the South East 
London Health Protection Group (a local Unit of the HPA), and as the Chair of "The 
London Malaria Group", a multi-disciplinary group of malaria experts, to inform 
colleagues about the study and ask for their help with recruitment. Following their 
recommendations, African community groups in London were visited whose members 
suggested friends and acquaintances who matched the inclusion criteria. Through 
working with another colleague, I also ran a workshop on TB, HIV and malaria in the 
African community on behalf of the Lambeth, Southwark and Lewisham African Health 
Forum, and spoke at this. As a result, I was asked to speak at other workshops in 
London. This enabled me to develop further contacts and recruit more participants. In 
October 2008 I coordinated and spoke at a national conference on imported malaria in 
London and took the opportunity to request participation in the study at this event. In 
December 2008, I included a request for participation in a newsletter sent to employees 
at Lambeth PCT. Finally, in February 2010, a colleague approached me to run a 
teaching session on infectious diseases for a Ghanaian congregation and through contact 
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with members of a local charity attending this event, the final VFR was recruited to the 
study. 
VFRs were given choices of location to meet. Suggestions made to them about possible 
venues included their own homes, a cafe local to their home or their or my workplace. 
Although it was originally intended to only include those who were about to travel, 
some members of community groups volunteered to ask friends and relatives who had 
recently travelled to participate. As it had proved very difficult to recruit to the study, 
this offer was accepted and six respondents were interviewed only after travel. 
For those fourteen VFRs interviewed before travel, a request was made for a second 
interview upon return. At an early stage of the study, it was found that few participants 
were interested in meeting after the interview, and it was decided that the second 
interview would be confined to a telephone conversation or email exchange, limited 
only to checking on the use of planned mosquito avoidance measures, of 
chemoprophylaxis, the occurrence of any malaria-type symptoms, and the measures 
taken to manage these. 
4.9.7.hi Limitations of the recruitment method ofVFRs and patients through 
colleagues 
The problems with recruitment which necessitated a change in the methodology were 
described earlier in this chapter. There were other limitations associated with 
recruitment which also merit consideration. For instance, it was not known how many 
VFRs, who were invited to participate, declined to do so. Several of the leaders of the 
community groups contacted were initially confident that they could help with 
recruitment, as several of their Nigerian and Ghanaian friends travelled frequently. 
However, despite several reminders by email and by 'phone to these community group 
members, very few names were put forward. Whether this was because few friends 
were travelling, were unwilling to participate, or whether they for some reason were not 
asked by my contacts to do so, was difficult to judge. Furthermore, attempts to recruit 
directly by asking for help with participants at a national malaria conference and at a 
training session for members of a local Ghanaian community group both only produced 
one response each. It was suggested informally that concerns about being asked about 
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their immigration status may have been a reason for non-participation by some 
participants. Some evidence of this was that the rationale for the interview question 
about length of residence in the UK was subsequently questioned by one participant via 
the person who had facilitated the interview. Some potential participants appeared 
willing to be interviewed by telephone, but changed their mind after finding that the 
interview needed to be carried out in person. This suggests they were anxious about 
being identified face to face. On the other hand, they may have not had enough time to 
meet a researcher. Other reasons for non-participation may have been because the topic 
of the study was not considered to be of interest. I was aware, through my professional 
work, that malaria is not a particularly important health priority in African community 
groups, particularly in comparison with other infectious diseases such as TB and HIV. 
Therefore, it may not have been considered sufficiently important by some people to 
warrant the time and effort needed. However, the non-importance of malaria as a health 
concern was also voiced by several of the VFRs who did agree to be interviewed, 
suggesting that this was not an issue preventing participation by all. 
Given the time-consuming and difficult nature of recruitment of VFRs described above, 
snowballing was the only option available. A limitation of this method of data 
collection is that the participants suggested by one individual may have similar 
knowledge, attitudes and practices to him or her, but the responses of these participants 
may erroneously be thought to represent those of the wider population 
(Bernard, 2006 p.193). There were three ways in which this limitation was managed. 
Firstly, no more than three respondents were interviewed after being recommended by 
one individual. The inclusion of multiple groups of respondents (GPs, practice nurses, 
community pharmacists and hospital consultants), who had interacted over many years 
with a wide variety of Nigerian and Ghanaian VFRs meant that a broad range of 
perspectives was obtained. Thirdly, the patients interviewed for the research were 
recruited using a different method. Although they were themselves self-selected, there 
was no reason why their knowledge, attitudes and behaviours towards malaria control 
would have been similar to each other. 
It was originally intended to interview both first and second generation Nigerians and 
Ghanaians. However, the difficulties with VFR recruitment meant that only four who 
volunteered to take part were born in the UK, and of these, only one had lived here 
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since birth. Another of the four had spent nine years in Nigeria from the age of seven, 
and the other two had left the UK in early childhood and had not returned for 22 years. 
Thus, the viewpoints and practices of those born in the UK were limited in the VFR 
interviews. This was one of the major limitations of the study, but little that could be 
done to avoid this, given the resources available. 
4.9.7c Recruitment of GPs 
It was initially decided to attempt recruitment from the boroughs of Lambeth and 
Greenwich. The selection of the GP to contact was made at random from the list ofGPs 
on each Practice's website, but included two GPs who worked alone in each borough. 
Telephone calls were made to GP practices during November and December 2008 with 
the aim of either speaking directly with the GP to arrange an interview, or with the 
Practice Manager so that he or she could do this. 
In total 16 GP surgeries were contacted, eight in each PCT. Of these, the telephones of 
seven surgeries were constantly engaged. Contact was made with nine surgeries. For 
seven of these it was agreed that either practice managers or GPs would return the call, 
but none were received. A further two practices indicated they were too busy to 
participate. As had been the case with VFRs therefore, initial attempts to recruit GPs 
were unsuccessful. 
From previous professional experience of working with GPs, it was considered likely 
that time pressures were one of the main reasons why calls were not returned by GPs. 
It was also felt possible that GP receptionists and Practice Managers may have acted as 
"gatekeepers" to the service, protecting GPs from what may have been perceived as 
unnecessary calls. Evidence of this came from the way in which the initial telephone 
call, taken by GP receptionists, influenced the outcome. Mentioning that the call to the 
GP was coming from the HP A (my professional employer), rather than as a student at 
LSHTM, increased the likelihood of being transferred to at least the Practice Manager. 
This was possibly because GP receptionists are familiar with dealing with this 
organisation on practical issues, but less keen on assisting students whose interests may 
not be priorities for GPs. 
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As recruitment was unsuccessful, it was decided after one month of attempts to contact 
GPs by telephone, that the method of recruitment should be changed to a "snowballing" 
method, as used for VFRs. One GP was already known to me professionally, and he 
agreed to be interviewed. My professional role, which gave me access to colleagues 
with links to GPs, was also used to help recruit them to the study. Help was requested 
from two work colleagues to suggest possible study participants. Each emailed two 
GPs, informing them about the study and asking if they would be willing to take part. 
All four agreed to do so. Once these interviews had been carried out, these GPs were 
also asked to suggest other potential participants, and once the latter had agreed, they 
were contacted by email addresses to arrange a suitable time for the interview to take 
place. One additional GP was recruited from a colleague at LSHTM. This change in 
strategy for the recruitment of GPs meant that the initial plan to include some who 
worked in single practices was not possible to implement. 
The same limitations of the snowballing method described with respect to VFRs were 
also valid for GPs. To manage this, no more than two GPs were interviewed from one 
source. 
Time pressures were thought to be the reason for non-participation in the early stages of 
attempts to recruit GPs to the study. These could also affect the quality of care given to 
patients, and the experiences of those who were interviewed may have been different to 
those who did not participate. The lack of inclusion of GPs working in single practices, 
as mentioned above, was a particular concern for these reasons associated with the 
quality of patient care. It was believed however that most GP participants who took part 
did so as a favour to those who approached them, rather than because they had free time 
to participate, though this could also have affected their decision. 
Those who suggested possible interview respondents may have recommended those 
whom they knew had a particular interest in malaria, or who were likely give a 
favourable impression of the profession. The inclusion of a range of respondent groups, 
mentioned above as a method of ensuring that a wide range of perspectives were 
included, was one way in which this limitation was managed. For example, all 
respondents would be asked about issues of access to primary care, both for prevention 
and treatment. 
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4.9.7d Recruitment of practice nurses 
Given the initial problems of recruiting GPs by telephoning randomly selected 
practices, it was thought likely that there would be the same difficulties in recruiting 
practice nurses using this method. The most efficient way of recruiting practice nurses 
therefore was to ask the GP who had been interviewed to suggest a practice nurse from 
the same practice, who could be approached to ask if they would be willing to 
participate. This would also provide the opportunity to compare the perspective of two 
key professionals working in the same practice. 
This was the method used for seven of the practice nurses recruited. After a practice 
nurse was suggested by a GP, they were contacted by telephone, told about the study, 
given the name of the GP who suggested they might be able to participate, and asked if 
they would consider this. One GP requested payment for the time that would be taken to 
interview the practice nurse, which was not available, and this practice nurse was not 
interviewed. 
An interruption to the recruitment of practice nurses came when there was an outbreak 
of pandemic HINI virus throughout the UK beginning in April 2009. Practice nurses 
throughout London were overwhelmed with dealing with patients. In addition, I was 
requested to stop working on my PhD from April 2009 to the middle of June of that 
year, to help manage the Public Health response to the outbreak. After this time, it did 
not feel appropriate to contact the practice nurses who had been recommended by GP 5 
and GP6 several months previously. 
The last three practice nurses were recruited in the following way; firstly, contact was 
made with a practice nurse who had already been interviewed, and she recommended a 
nurse from a different practice, who agreed to participate. Secondly, a work colleague 
asked a Lambeth PCT employee who worked with GP practice nurses to email all those 
nurses working in Lambeth GP surgeries with details of the study and a request for 
participation. This PCT was chosen as it fitted the criteria for inclusion described in 
section 4.9.2, and with which my office had direct links with staff, through a partially 
shared office. Four practice nurses had already been interviewed from areas outside 
LSL, and so their perspective on the cost of malaria chemoprophylaxis in an area in 
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which it was not subsidised was known. Additionally, some nurses interviewed had 
been employed in both LSL and non-LSL areas, and so had experience of the effect of 
both policies. The first two practice nurses who responded to the request from the peT 
employee were interviewed. 
It was recognised that GPs may have recommended the most experienced and skilful 
practice nurses to take part in the study, and/or those who were unwilling to criticise the 
practice. The same way of managing these limitations used for VFRs and GPs were 
used. For example, no more than one interviewee was recommended by any other 
person. Although the most experienced practice nurses available may have been 
interviewed, there is likely to have been some variation in the skills and experiences 
within the ten interviewed, meaning that a range of perspectives would be included. 
4.9.7e Recruitment of community pharmacists 
Community pharmacists were chosen from the London boroughs of Lambeth and 
Newham. The latter was an area selected in the initial recruitment efforts for VFR 
participants, as it had a large Nigerian and Ghanaian community (see section 4.9.2) but 
no respondents had been interviewed from this area. Areas were targeted within these 
boroughs which had made the most reports to the MRL between 2001 and 2006. The 
contact details of pharmacists working in these areas were obtained from the internet, 
and each was contacted by telephone, beginning in the summer of 2008, told about the 
study, and asked if they would be interested in participating in an interview at their 
workplace at a time convenient to them. The first three telephone calls resulted in three 
interviews. As it became gradually more difficult to recruit during the autumn, the time 
of year when, as was anecdotally reported to me, that their workload increased, the 
number of requests was expanded to include other geographical areas within these 
boroughs. In total 16 community pharmacists were contacted, and seven interviews 
carried out. 
4.9.7f Recruitment of hospital consultants 
All three of the consultants approached initially agreed to be interviewed. Two of these 
were professional acquaintances, one of whom was a paediatrician. The third 
respondent agreed to participate after being approached by a colleague whom I knew 
professionally. All three worked in different hospitals in London. 
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Although at least two more interviews with hospital consultants would have been 
useful, to see if any new themes emerged, ethical approval had to be sought from each 
hospital's Research and Development (R&D) Department before the interview could be 
carried out. This, it was recognised, could take several months. Although a fourth 
consultant agreed to take part in the research, he did not attend when I visited the 
hospital to interview him, and subsequent attempts at contacting him by telephone via 
his secretary were unsuccessful. This was explained by the secretary as due to work 
pressures. 
4.9.7g Decision to end recruitment 
For all these groups of study participants, with the exception of hospital consultants, 
recruitment stopped when saturation point was reached, that is, when no new themes 
were elicited from the interviews. 
4.9.7h Recruitment of patients 
As was explained in section 4.9.1, it was decided to also include interviews with 
patients who had recently acquired imported malaria. The only feasible way to access 
patients was to request participation from those who had been recently admitted to 
hospital with falciparum malaria. To maintain their confidentiality, it was recognised 
that patients could not be approached directly by a researcher. Instead, a research 
collaboration was set up with an A&E Department. King's College Hospital was 
chosen, as it is a hospital serving a large African community, and between 200 I and 
2008 made the second largest number of reports of imported malaria to the MRL in the 
UK. (n=972) (x =21.5) (range 90-160). The lead consultant was a professional 
acquaintance and thought likely to agree to help with recruitment via his staff. Although 
it was felt that the majority of patients admitted to this hospital would have had access 
to subsidised chemoprophylaxis on NHS prescription if they lived in the borough local 
to the hospital, it was decided that that sufficient data had been collected about this 
theme. 
Having gained permission for collaboration from the lead consultant, and the necessary 
ethical approval, I arranged and attended a meeting of doctors and nurses in the A&E 
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Department, where the study protocol was described to them and their assistance 
requested with recruitment. This would involve patients with suspected malaria being 
told about the study and encouraged to participate by the clinician caring for them. They 
would not be told about the study until all clinical care had been completed and they 
were ready to be discharged. This was critical to avoid potential patient concerns of 
coercion. The contact details of those who agreed to participate were collated in a 
folder in the A&E Department by the clinician who had acquired this from the patient, 
and I checked this folder weekly. After confirming that each referral was of laboratory 
confirmed falciparum malaria, I telephoned patients after they had been discharged to 
arrange an interview. 
A senior nurse in the Department was given the role of acting as a liaison between me 
and the clinical team. I contacted her regularly, and asked her to help remind colleagues 
about the study. 
In November 2009, after permission was obtained from the lead consultant at King's 
College Hospital, a request for help with recruitment was made to a junior doctor of 
professional acquaintance, who was carrying out a three month attachment in the A&E 
Department. Her role would be to personally request participation from participants 
who fitted the inclusion criteria after their treatment had ended. 
Attempts to recruit patients from King's College Hospital lasted from July 2009 to 
December 20ID. This resulted in four interviews, which were carried out between 
September 2009 and December 2010. Although an additional six patients expressed an 
interest in participating, none had laboratory-confirmed falciparum malaria. After 
December 2010 no more potential participants were referred. 
Because only four patients had been recruited from King's College Hospital, another 
hospital was asked to help with recruitment to the study. The Hospital for Tropical 
Diseases (HTD) was chosen for two reasons. Firstly, as well as receiving direct referrals 
of patients from GPs, a tertiary service is offered, and as a result, the third largest 
number of reports made to the MRL between 2001 to 2008 came from this hospital, a 
total of814 (mean 101.8; range 79-118). Secondly, one of the clinical consultants 
working part-time in the Department was also one of my PhD supervisors, who agreed 
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to facilitate initial introductions with clinical colleagues and remind them about the 
study. 
An introductory meeting was held with the junior doctors and nurses who cared for 
patients admitted with falciparum malaria, and personal introductions were made with 
hospital consultants. All were briefed in the same way as for doctors and nurses at 
King's College Hospital described above. 
Between the middle of October 2010 and the middle of January 2011 weeklyemails 
were sent to those hospital doctors known to be treating malaria patients on the hospital 
wards to ask if any patients who fitted the recruitment criteria had been admitted, and if 
so, for them to ask the patient to participate. 
During this time two patients were recruited. A further four were identified by HTD 
clinical staff as possible participants. For two ofthese four, administrative errors 
(incorrect patient telephone contact details) meant that these patients could not be 
contacted. Although for one of these an address was available, and a letter written 
asking the potential participant to make contact, no reply was received. For the third 
potential participant, contact details were not passed to the researcher before the 
clinician who gained agreement from the patient left the UK, and no other member of 
staff knew the identity of the patient. The fourth potential participant did not meet the 
inclusion criteria of having travelled to Nigeria or Ghana. It was not known if any other 
patients were invited to participate, but declined. 
At the beginning of February 2011, six years of part-time PhD study had been 
completed and recruitment to the study stopped. 
4.9.7.hi Reasons for the low number of patients recruited to the study 
During the recruitment period, it was not known how many patients who fitted the 
inclusion criteria were admitted to either hospital. It was also not known how many 
patients in total were approached by staff and declined to participate, or whether staff 
did not request participation. 
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There were several reasons why recruitment of patients to the study was low. For 
example, it was necessary to consider all aspects of how the study would be conducted 
before the study commenced, in order to obtain ethical committee approval. This meant 
that no minor or substantial amendments could be made subsequently without returning 
to both the ethics committee of the hospital, and LSHTM, a process that could take 
several months. Although these issues were discussed at a meeting with clinicians 
before ethical approval was sought, there were several suggestions of how to improve 
recruitment to the study from Kings College Hospital in particular only after ethical 
approval had been received. This was indicative of the time pressures that staff faced, as 
although they appeared to be willing to help and recognised the importance of the study, 
they did not have time to devote to one issue. 
This pressure on clinical staff at both hospitals caused by their routine work was 
obvious throughout the study, as telephone calls and emails to clinicians were 
frequently not returned. Recognising this, it was considered inappropriate to follow up 
on unreturned calls too frequently. At HTD, it was suggested informally that regular 
email reminders about the study may have caused resentment amongst some staff, since 
it may have appeared that they were asked to assist with recruitment into a study of no 
perceived benefit to them. Their frustrations may have been exacerbated as there was 
little perceived personal participation from myself, since I was not present on the 
hospital wards during the period of data collection. However, given the need for 
confidentiality, my presence on the hospital wards would not have been possible. 
Despite attempts to arrange one individual to liaise with at each hospital, the frequent 
rotation of staff made it difficult for them to ensure that all those seeing patients were 
informed about the study, and it was likely that several staffwho may have seen eligible 
patients at both sites were not aware that the study was taking place. 
A further problem was the consideration that patients should be informed about the 
study only when all clinical interventions had been completed. This was necessary so 
that patients would not feel their care was dependent on participation in the study. 
However, it meant there was little opportunity for staff to remember about the study 
before discharging patients. Administrative errors, particularly at HTD, and described 
above, meant that three patients who expressed an interest were not able to be contacted. 
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The decision to attempt recruitment through a second hospital, when it was clear that 
recruitment in the fIrst had been slow, was a diffIcult choice, as it took several months 
to acquire ethical approval. However, no other practical way to recruit patients was 
available and it was hoped that the personal involvement of a consultant who was also 
my PhD supervisor would make recruitment easier than at King's College London 
Hospital. That this was not the case demonstrates the many diffIculties in recruitment to 
such a study. 
As was the case with VFRs, it was not known why some patients did not volunteer to 
take part in the study. Possible reasons were the same as for VFRs, such as a lack of 
interest in the topic or fears associated with immigration status. It is also possible that 
patients in particular may have been concerned that they would be criticised for not 
taking chemoprophylaxis. However, there is no way of knowing whether the 
knowledge, attitudes and practices of those who chose to participate were similar to 
other patients. Having said this, no new themes emerged from the interviews with 
patients than had already been identified from the interviews with other groups of 
participants. 
4.9.8 Method of qualitative analysis 
After each interview, each respondent was allocated a personal identifier. These were 
comprised of letters and numbers. The letters referred to the type of respondent (VFR: 
visiting friends and relatives); PT (patient); GP (General Practitioner); PN (practice 
nurse): CP (community pharmacist) and HC (hospital consultant). The numbers related 
to the sequence in which the interviews took place, thus, for example, VFR 1 was the 
first VFR to be interviewed, and PNIO was the last practice nurse to be interviewed. A 
spreadsheet was made which linked personal identifier with the respondent and this was 
password protected. 
A series of spreadsheets were then set up on MS Excel. Personal identifiers as 
constructed above were used for each respondent in these spreadsheets. They contained 
the following information: 
For VFRs and patients: 
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• the method of recruitment, the time before and after travel (where applicable) 
that the interviews took place, and the location of the interview, age, sex, peT of 
residence, occupation, country of birth, and country of residence before 
immigration to the UK (where applicable), number of years resident in the UK, 
country being, or just visited (as appropriate); frequency of travel, number of 
travellers on planned or most recent trip; use of chemoprophylaxis on this trip 
and on previous trips. 
For GPs, practice nurses, community pharmacists and hospital consultants: 
• sex, ethnicity, number of GPs or practice nurses working in the practice (as 
appropriate); the number of patients enrolled in the practice, the PCTlhorough 
where the respondent worked and the number of years respondents had worked 
in this particular role. 
GPs were often not sure of the number of full-time equivalent colleagues working in 
their practices, particularly when some worked part time, nor were they certain of the 
number of patients registered with their practice. Therefore, these details were taken 
from individual practice profiles available from the London Health Observatory 
(London Health Observatory, 2011), or from information provided on the GP practice 
website. 
All interviews were transcribed verbatim, by listening to each sentence on the digital 
recorder, and typing it into MS Word. An attempt was made to use voice recognition 
software to speed up the process. However the accuracy of the software was poor and 
the time required to manually edit the transcript produced was considerable, so this was 
abandoned. 
Transcripts of each interview were then exported into the qualitative data analysis 
package NVivo version 7. Different folders were made within this package which 
contained the transcripts from each group of respondents (VFRs, patients, community 
pharmacists, GPs, practice nurses and hospital consultants). 
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A conceptual framework, was constructed in chapter four, drawing on the conclusion 
reached by Morgan and Figueroa-Munoz that VFRs that there is "an intenneshing of 
ideas and practices that are widespread in the general UK population with the particular 
beliefs and circumstances associated with their ethnic origin" (Morgan and Figueroa-
Muiioz, 2005 p.368). A literature review had also been undertaken to infonn the topics 
to be discussed during the interviews. Thus, the analysis was not conducted from a 
purely inductive perspective. The aim of the qualitative analysis in this thesis was not 
however to seek for evidence to support the conceptual framework, but rather to explore 
the subjective experience of respondents, and discover how these might impact on the 
burden of malaria. Thus, it was understood that the respondents might provide evidence 
that stood in contradiction to the conceptual framework. 
Bernard and Bazeley provided detailed methods to understand the concepts and 
practical application of data coding and development of themes (Bernard, 2006 pp. 505-
519, Bazeley, 2007 pp. 59-111). Transcripts from each respondent group were printed. 
and read several times. Using NVivo, key words were identified. These were words 
which were related to the questions asked of each participant, for example, 
"transmission" or "bednets". Paragraphs spoken by each respondent which contained 
these words were then moved into separate folders within NVivo, but each still 
separated by respondent group, for example, all paragraphs of YFR transcripts which 
contained the word "transmission" or "bed net" were collated. 
Each paragraph was re-read. In this part of the analysis, it was noted where there were 
similarities and differences in the responses given by individual respondents concerning 
each topic, and these were grouped accordingly. For example, with respect to the cost of 
chemoprophylaxis, the responses of those who mentioned this as a barrier were 
separated from others who did not consider this to be so. Each set of responses was 
then re-read to draw a more detailed interpretation. At this point, a distinction was made 
between those factors which influenced decision making in Nigeria and Ghana, and in 
the UK, where these appeared in the transcripts. 
The next part of the analysis included comparing the findings of each group of 
respondents about each topic. Similarities and differences between groups of 
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respondents were considered, and evidence sought for where the responses of one group 
of participants provided further evidence supporting that given by other groups 
contradicted this, or provided different information. At this point, it was considered 
more convenient to print and read the analyses, rather than to continue using the 
electronic software package. 
The penultimate part of the analysis involved categorising the findings into the broader 
themes of malaria prevention, diagnosis and treatment, to match the order in which 
these were discussed in the literature review in chapter three. The final analysis 
involved using the findings to provide more detail to the conceptual framework that is 
discussed in the final chapter of this thesis. 
An additional analysis included a second reading of the notes that I had made after each 
interview, and these were categorised into themes, for example about my personal 
safety, the effect of using a digital recorder and factors relating to the differences in 
ethnicity between myself and the respondents where appropriate. These were to be 
included in a separate section of the analysis. 
4.10 Summary 
Despite the limitations of ascertainment and data quality, the data collected by the staff 
at the MRL, compared to reports made to the alternative surveillance system (NOIDS), 
were the better source to carry out an epidemiological analysis of imported malaria in 
the UK. Its strengths lay in that all reported cases are laboratory-confirmed, the 
reporting system has been in place for over 30 years, and that for many variables there 
is a high completion rate. Although there have been few changes in the variables 
collected by the MRL staff over time, one change that was made in 2004 meant that the 
data relating to nationality, collected until the end of 2003, could not be matched with 
ethnicity, the variable collected after this time. 
With respect to the denominator data, the major limitation was that there was limited 
data available to describe the population at risk. As such, mid-year population estimates 
and mid-year population estimates by ethnicity were used to calculate incidence rates. 
These provide an inaccurate estimate, as not all members of the population will travel. 
The use of IPS data provided by Dr Ron Behrens allowed an alternative, more accurate 
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measure to be made, but categorisation by age and sex would have enabled more 
detailed information to be analysed. As noted, the IPS data is not without its limitations, 
as only one reason for travel is recorded. 
The reasons for the immense difficulties and time needed to recruit VFRs and patients 
was not clear, but possible reasons were a lack of interest by potential participants in the 
subject, a fear of being identified because of immigration issues, and/or with respect to 
patients, concerns about being criticised during the interview for not protecting 
themselves against malaria. The initial unsuccessful attempts at recruiting GPs and 
practice nurses, and the reasons for the low recruitment of hospital consultants were 
thought to be mainly due to a lack of time, and this gives some indication of the 
pressures under which these professionals work. Nevertheless, it was possible to 
interview 56 participants from six different groups (VFRs, patients, GPs, practice 
nurses, community pharmacists and hospital consultants) which allowed a range of 
perspectives to be explored. 
The aim of the qualitative analysis was not to seek confirmatory evidence to support the 
conceptual framework, but to explore the subjective experience of respondents. 
Additional information, for example duration of travel, number of travellers and time of 
year of travel for VFRs and patients, and occupational data for healthcare providers and 
community pharmacists was collected to provide more context to the content of the 
interviews. 
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Chapter five: results of the epidemiological analysis. 
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5.1 The current epidemiology of imported malaria in the UK 
The first section identifies the location in the UK where most infections of imported 
malaria in the UK were acquired between 2001 and 2008. It describes the species of the 
plasmodium parasite which most commonly caused infections, and shows the crude and 
standardised infection rates per 100 000 in England and London, the ethnicity of those 
cases reported between 2004 and 2008, and gives their reason for travel. 
The second section describes in more detail the epidemiology of the group who bear the 
greatest burden of disease, and includes the period 2004 to 2008. A particular focus is 
given to the use of chemoprophylaxis, and how this compared in one geographical area 
which offered subsidised chemoprophylaxis to one where it was not provided. 
5.1.1 Completeness of data 
Details of the area of residence and plasmodium species were each completed for 100% 
of reports made to the MRL between 2001 and 2008. The reason for travel to a 
malarious country was recorded for 59% (8199/13813) of these reports. Ethnicity was 
completed for 84% (8189/9726) for the period 2004 to 2008 inclusive. 
5.1.2 Crude incidence and incidence rates: London compared to other areas of 
the UK 
There were 13813 reports of imported malaria in the UK between 2001 and 2008. Fifty 
eight percent of reports overall came from London, and the crude incidence rate per 100 
000 was at least four times higher for reports originating from London, (compared to 
those which came from other areas) for each of these years (table 5.5.1). 
Table 5.1.1 Comparison of the number of reports of imported malaria in the UK, the UK excluding 
London, and the London area, and rates per 100 000 population in these areas (1001-2008) 
UK UK excludine London London 
Number Rate per Number Rate per Number Rate per 100 
of 100000 of 100000 of 000 
reports population reports population reports population 
Year (el) (el) (el) 
2001 2050 3.5 786 1.5 1264 17.2 
(3.3-3.6) 0.4-1.6) 06.3-18.2) 
2002 1945 3.3 751 1.4 1194 16.2 
(3.1-3.4) (1.3-1.5) 05.3-17.1) 
2003 1728 2.9 652 1.2 1076 14.6 
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(2.8-3.0) (1.1-1.3) (13.7-15.5) 
2004 1660 2.8 753 1.4 907 12.3 
(2.6-2.9) (1.3-1.5) ( 11.5-13 .1) 
2005 1754 2.9 770 1.5 984 13 .1 
(2.8-3.1) (1.4-1.6) (12.4-14.0) 
2006 1758 2.9 777 1.5 981 13.0 ( 
(2.8-3.0) (1.4-1.6) 12.2- 13.9) 
2007 1548 2.5 706 1.3 842 11.1 
(2.4-2.7) (1.2-1.4) (10.4-11.9) 
2008 1370 2.2 639 1.2 731 9.6 
(2.1-2.4) (1.1-1.3) (8.9-10.3) 
The total decrease of 680 (33%) in the number of reports made from throughout the UK 
to the MRL between 2001 and 2008 was largely attributable to a decrease in the number 
of reports made from the London area over this time period. This reduction was of 533 
reports (42%) in London, compared to 147 (9%) decrease in reports made outside of 
London. 
5.1.2a Crude rates and standardised rates for England and London 
Figure 5.1.1 shows the crude incidence rate per 100 000 for England excluding London, 
and for the London area. To control for the possible different age structures in the 
population in London compared to England, figure 5.1.2 shows the standardised rate for 
the same geographical areas. These both confirm the higher incidence of imported 
malaria in the London population. 
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Figure 5.1.1 Crude rates and confidence intervals of reports of all species of imported malaria in 
England excluding London, and the London area 2001 to 2008 
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Figure 5.1.2 Standardised rates and confidence intervals of reports of all species of imported 
malaria in England excluding London, and the London area 2001 to 2008 
5.1.3 Species of malaria acquired 
Table 5.1.2 shows which species of malaria parasite caused malaria infections acquired 
between 2001 and 2008 in the UK, and in London. There were statistically significant 
differences in the numbers of infection caused by two species of malaria parasite, (P. 
Jalcipantm and P. vivax) between the UK and the London area. 
Whilst 67% (489/730) of the average number of infections were of P. Jalcipantm 
throughout the UK excluding London, this increased to an average 0 f 83 % (831 /997) 0 f 
all infections reported from within the capital. 
Table 5.1.2 Mean number of reports and confidence intervals categorised by plasmodium species: 
London compared to other areas of the UK (2001-2008) 
UK excluding London London 
Species Mean Confidence Mean Confidence 
number of interval number of interval 
reports reports 
P. Jalciparum 489 462.4-515.6 831 708.5-936 
P. vivax 160 137.3-186.6 82.9 76.4-89.4 
P. ovale 60 51.9-68.1 59 48.8-69.2 
P. malariae 13.8 1l.l-16.5 16.3 13.4-19.2 
Mixed 6.5 3.9-9.1 7.3 5.3-7.3 
Unknown 0.25 -0.05-0.55 1.3 0.5-2.1 
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5.1.4 Ethnicity of those infected with malaria 
In England excluding London between 2004 and 2008, the mean number of infections 
for the three ethnic groups for which these were calculated was as follows: 
Infections caused by all species: 
-
• Black African! African descent: x =324.6 (CI: 288.8-360.8) 
• White British: x =92.2 (CI: 86.0-98.4) 
• Black Caribbean x =2.6 (CI: 1.3-3.9) 
Infections caused by P. Ja/Ciparum: 
• Black African/African descent: x =286.4 (CI: 256.5-316.3) 
• White British x =56.6 (CI: 48.4-64.8) 
• Black Caribbean ethnicity it was x =2.4 (CI=1.4-3.4) 
In London, between 2004 and 2008 inclusive, the comparative means and confidence 
intervals were: 
Infections caused by all species: 
-
• Black African/African descent: x =676.8 (CI: 608.7-744.9) 
-
• White British: x =20.6 (CI: 14.8.5-26.4) 
• Black Caribbean: x= 11.2 (CI: 6.5-15.9) 
Infections caused by P. Jalciparum: 
-
• Black African/African descent x =613.8 (CI: 552.2.-675.4) 
• White British x =14.2 (CI: 9.9-18.5) 
• Black Caribbean x =9.6 (CI: 6.3-12.9) 
The rates of infection per 100 000 population by ethnicity in both 2004 and 2008 
inclusive for infections caused by all plasmodia and by P. Jalciparum are shown in table 
5.1.3 
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Table 5.1.3 Rate of malaria infection per 100 000 population in England excluding London and in 
the London area, for all plasmodium species and P. faklparum for three ethnic groups 2004 and 
2008. 
Incidence rate per 100000 (CI) Incidence rate per 100000 (CI) 
England excluding London London 
All species P. /aiciparum All Species P. /alciparum 
Black African/African descent 
123.5 109.7 153.3 139.6 
2004 ( 108.5-138.4) (95.6-123.9) (141.3-165.3) (128.1-151.0) 
94.2 85.3 142.0 131.0 
2008 (84.0-104.4) (75.5-95.0) (130.5-153.5) (120.0-142.1) 
White British 
0.2 0.1 0.3 0.2 
2004 (0.1-0.3) (0.0-0.2) (0.0-0.5) (0.0-0.3) 
0.3 0.2 0.4 0.3 
2008 (0.2-0.4) (0.1-0.3) (0.2-0.6) (0.2-0.5) 
Black Caribbean 
1.2 1.2 3.9 3.3 
2004 (0.2-2.5) (0.2-2.5) (1.8-6.0) ( 1.4-5.2) 
1.7 1.4 6.1 4.8 
2008 (0.2-3.2) (0.0-2.7) (3.4-8.8) (2.4-7.2) 
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5.1.5 Visiting friends and relatives as a reason for travel 
Where infonnation on the reason for travel was recorded (59% of reports), there were 
4504 reports of malaria infection acquired whilst visiting fri ends and relative abroad. 
This was the purpose of travel in 68% (3045 /45026) of the reports which originated 
from London hospitals. In other areas of the UK, 39% (1459/3697) of reports were in 
VFRs. 
The mean number of reports of malaria in YFRs originating from the London area 
between 2001 and 2008 was 380.6 (CI: 347-414), statistically significantly grea ter than 
that for YFRs reported to the MRL from areas of the UK outside London (x = 182 (CI: 
159:205.2). 
There was a small increase between 2001 and 2008 in the number of reported malaria 
infections caused by all plasmodium species in YFRs resident in the UK excluding 
London, from 176 to 221 (see figure 5.1.3). The number of reported infections caused 
by P. Jalciparum in YFRs outside London also increased, fTom 115 to 167. However, 
the proportion of all malaria reports that were in YFRs compared to those travelling for 
other reasons decreased slightly, from 36.8% to 33 .6% of infections. The proportion of 
all malaria reports caused by P. Jalciparum that were in YFRs however increased from 
65.3% to 75.6%. 
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The number of reports of London residents who contracted malaria caused by all 
plasmodium species when visiting friends and relatives between 200 I and 2008 fell , 
from 466 to 331 between 200 I and 2008 (figure 5.1.4) . There was also a decrease in the 
number of reports of those residents in London who contracted P. Jalciparum whilst 
visiting friends and relatives abroad between 2001 and 2008, from 41 2 to 293. 
However, the proportion of reported infections caused by all plasmodium species in 
London VFR residents increased from 64.7% to 74.2% between 200 I and 2008. The 
proportion of all P. Jalciparum infections reported in London which were in VFRs 
stayed broadly similar (88.4% in 2001 and 88.5% in 2008) (figure 5.1.4) 
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Figure 5.1.4 Number and percentage of total reports of malaria infections where VFRs was the 
reason for travel in London residents 2001-2008. 
5.1.6 Infection rates calculated using number of travellers as a denominator 
In section 4.3.2b, it was noted that rates of infection in VFRs travelling to Nigeria and 
Ghana using IPS data collected between 2004 and 2008 were made available for use in 
this thesis. These showed that showed that whilst the numbers of VFRs travelling to 
Nigeria increased from 59 975 to 70 897, the number of reports of malaria in VFRs who 
visited this country only increased from 229 to 271. The rate per 100000 person-years 
remained similar (381.8 per 100000) (el: 332.4-431.3) in Nigeria in 2004 compared to 
2008 (382.2 per 100000) (el: 336.7-427.8). The rate of infection per 100000 person 
years caused by PJalcipantm was also similar (355.1 per 100000) (el: 307.5-402.8) in 
Nigeria in 2004, and 359.7 (el: 315.5-403 .8) in 2008. 
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Comparative data for Ghana showed an increase in the number ofYFR travellers to thi s 
country from 43,159 in 2004 to 57,397 in 2008, but the number of reports of malaria 
infection in YFRs who visited this country increasing by only one, from 78 to 79 cases. 
The infection rate per 100000 were 180.7 eCl: 163-220.8) in 2004, but this reduced to 
137.6 per 100000 (Cl: 120.2-168.0). For fa\Ciparum infections, there was a decrease in 
the rate per 100000 from 169.1 per 100 000 in 2004 (Cl: 130.3-207.9) to 132.4 per 100 
000 (CI: 102.6-162.1) in 2008. 
5.2 Epidemiology of those most at risk of acquiring imported malaria 
The second section of this chapter describes what is known about the epidemiology of 
imported malaria in the cohort identified in the previous section as the largest "at ri sk" 
group between 2004 and 2008. This was those of African origin (measured either as 
those of "Black African" ethnicity or "of African descent") who lived in London and 
who contracted falciparum malaria whilst visiting friends and relatives abroad. 
5.2.1 Completeness of data 
The dataset comprised 1498 reports. The completeness of data was: age; 1494 (99.7%); 
sex: 1492 (99.6%); country visited: 1494 (99.7%); duration of travel: 1086 (72.4%); 
month of travel: 1498 (100%); whether prophylaxis was taken: 1243 (83.1 %) 
5.2.2 Age and sex 
The median age was 39 years, (interquartile range 28-48). There were reports of 586 
females and 906 males between 2004 and 2008, a ratio of I: 1.5. A third of the total 
number ofreports was of males aged between 30-49 years (see figure 5.2.1). 
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Figure 5.2.1 Age and sex of patients of African ethnicity who lived in London and who acquired 
falciparum malaria when visiting friends and relatives abroad (2004-2008). 
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5.2.3 Country where malaria was acquired 
There were 28 countries from where fa1ciparum infections were acquired (see appendix 
five). All were in Africa. In addition, four were recorded as being acquired in "West 
Africa" and 12 as "Africa". Where an African country was identified as the origin of 
infection there were: 
• 18 in which fewer than 10 infections were acquired 
• six in which between 10 and 49 reports were acquired 
• four in which more than 50 reports were acquired: (Nigeria: 55% (823/1494); 
Ghana: 19% (285/1494); Sierra Leone: 7.9% (118/1494); Uganda: 6.3% 
(9411494). 
Figure 5.5.2 shows how the number of infections broadly relates to the suitability of the 
climate in African countries for malaria transmission. 
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Figure 5.2.2 Climate suitability for malaria transmission in African countries and number of infections (2004-2008) caused by P. falciparum in each African 
countries in which >10000 London residents of African ethnicity were born who visited friends and relatives. 
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5.2.4 Areas of London from where reports originated 
The number ofMRL reports made in the London area was not uniformally distributed 
between boroughs. Where postcode of patient residence could be assigned to a London 
Borough (n= 1308: 87%), more than 100 reports were received from only two boroughs 
in the period between 2004 and 2008 (Lambeth (151 reports) and Southwark (302 
reports) . 
5.2.5 Duration of travel 
Approximately 63% of females and 66% of males travelled for between two and four 
weeks, with approximately 20% travellers of each sex travelling for two, three and four 
weeks (median: 25 days, inter-quartile range: 14-35 days). Eighty nine were reported to 
have travelled more than 14 weeks (median 180 days, interquartile range: 150-270 
days), with the longest duration of travel recorded as 270 days (figure 5.2 .3) 
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Figure 5.2.3 Duration oftravel of those patients of patients of African ethnicity who acquired 
falciparum malaria when visiting friends and relatives abroad (2004-2008). 
5.2.6 Month of travel categorised by sex of patient 
The month oftravel is shown in figure 5.2.4. There was an average of 125 reports each 
month. The distribution was bi-modal, with higher than the average number of reports 
made for the four months between June to September and also in January. Six hundred 
and ninety three (46%) of all reports received were of infections acquired during visits 
made between July and September, and 149 (10%) in January. The remaining 656 
(44%) of infections were reported during other months of the year. 
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In each month there were more reports of infections in males compared to females. 
There were only four months (January, June, July and August) in which there were 
more than 50 reports of falciparum malaria in females , but only one month (February) 
in which the numbers of infections in males fell below 50. September was the only 
month in which the numbers were similar (99 reports in females and 102 in males) . 
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Figure 5.2.4 Month of travel for patients of African ethnicity who acquired falciparum malaria 
when visiting friends and relatives abroad (2004-2008) 
5.2.7 Use of chemoprophylaxis 
The use of chemoprophylaxis in this cohort is summarised in figure 5.2.5 . Where 
information was available, (1243: 83 .1 %) of reports), 81 % (100811243) were reported 
not to have taken any chemoprophylaxis. Sixty percent (605/ 1008) of those who did not 
do so were males. Eight percent (99/1243) were reported to have become ill despite 
being reported as using chemoprophylaxis suitable for travel to sub-Saharan Africa, 
namely mefloquine (n=48: 3.9%); AP (n=15: 1.2%), or doxycylcine (n=36: 2.9%). 
Data on adherence to chemoprophylaxis is not collected by the MRL. 
Thirteen patients were reported to have used chemoprophylactic drugs, but the regimen 
was not recorded. For a further two, the use of chemoprophylaxis was unclear and 
recorded as "Y?" 
Of the remainder (n=121) of those who reported taking some form of chemoprophylax is 
other than that suitable for use in Sub-Saharan Africa, 97 (8%) of the total number for 
whom information was available (n=1243) were reported to have taken either 
chloroquine (n=38), proguanil (n=33) or a combination of these (n=26). 
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Of the rest, (n=24) eight took SP, ten took Pyrimethamine, and two took Pyrimethamine 
plus dapsone. The other four took homeopathic drugs. 
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Figure 5.2.5 The use and non-use of chemoprophylaxis. 
As noted in section 2.5.4, there were three peTs in London (Lambeth, Southwark and 
Lewisham) in which the cost of malaria chemoprophylaxis was subsidised for the 
duration of the study. Of the 1008 who were reported as not having taken any 
chemoprophylaxis (figure 5.5.2), (428) (x =85 .6) (el : 76.4-94.9) were reported from 
hospitals in LSL. The comparative number of reports for hospitals in London but 
outside LSL was 580 (x =116) (el: 105-127.4). 
The rate per 100000 of those who were reported as not having taken chemoprophylaxis 
in LSL in 2004 was 9.2 per 100000 (el: 7.1 -11.4). In 2008 it was 11.8 per 100 000 (el: 
9.4-14.2). 
In areas of London outside LSL, the rate was 1.8 per 100 000 (el: 1.5-2.1) in 2004, and 
1.5 (el: 1.2-1 .8) in 2008. 
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Using "Black African" ethnicity as a denominator, in 2004, the rate per 100000 of 
those who were reported as not having taken chemoprophylaxis in LSL was 83.7 (CI: 
64.4-103.1) per 100000. In 2008 it was 122.9 (98.3-147.5) per 100000. 
In areas of London outside LSL, using "Black African" ethnicity as a denominator, the 
rate was 37.1 (CI: 30.5-43.8) per 100000 in 2004. In 2008, the rate per 100000 was 
30.1 (CI: 24.1-35.9). 
Two hundred and fifty eight (60%) of those in LSL who did not take chemoprophylaxis 
in LSL were males, compared to 358/580 (62%) in other areas of London. 
5.2.8 Deaths 
There were five reports of deaths. Three of these were females and two were males. 
The median age of those who died was 39 years (range 6-70). The countries where 
malaria was acquired were: Nigeria (n=2); Sierra Leone (n=2); Uganda (n= I). Three 
were recorded as having visited their country of origin; Nigeria (n=I); Sierra Leone 
(n=I); Uganda (n=I). One of the remaining two was born in the UK, and the other was 
born in Zimbabwe. The duration of travel was only available for two of the five, and 
each of these had each travelled for three weeks. 
Two of the five were reported not to have taken any chemoprophylaxis. One was 
recorded as having taken inappropriate chemoprophylaxis (chloroquine). For one of the 
five patients, information on whether chemoprophylaxis was not taken was missing, and 
for the other it was recorded as being uncertain. Two of the five had postcodes of 
residence in Lambeth, Southwark or Lewisham, the areas in which malaria 
chemoprophylaxis is subsidised. 
5.3 Discussion 
There were three limitations related to the quality of the data, which may have affected 
the results. The first was concerned with the completeness of reports. Whilst many of 
the variables were well completed by clinicians, others were less so. Reason for travel, 
in particular, was recorded on only 59% of reports. However, similar findings, that the 
majority of cases are in those of African ethnicity who acquired P. !alciparum 
infections whilst visiting friends and relatives abroad has come from other 
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epidemiological studies (Smith et aI., 2008, Pavli and Maltezou, 2010, TropNetEurop, 
2010). Whilst each data collection system used will have its own limitations, (for 
example, TropNetEurop is a sentinel surveillance system, only collecting data from 
selected sources) (Jelinek, 2008), the similarity in conclusions drawn lend support to the 
reliability of the results in this analysis. 
Another limitation connected with data quality was possible under-reporting of cases 
from some hospitals in London, which may have under-estimated the incidence between 
2001 and 2008. Whilst the large number of reports made in certain geographical areas 
may reflect the large African community resident in these, under-reporting to the MRL 
from other hospitals is known to occur. Details of the number and range of reports made 
from Newham hospital were shown in section 4.9.2, and it was surmised that not all 
reports may have been notified. Another example comes from Lewisham hospital, 
where due to a lack of staffmg, reporting to the MRL is inconsistent (personal 
communication, Dr Mir, Lewisham Hospital). In this hospital, the number of reports 
made to the MRL ranged between one and 60 between 2001 and 2008. 
The third limitation was concerned with the use of a proxy measure of residence, that is, 
the hospital in which the infection was treated, rather than the borough of residence of 
the patient. This method of ascribing residence was chosen because of the poor 
reporting of data relating to borough or county on the MRL report form, as reported in 
section 4.5.2. However, it is possible that some patients treated in one area, for example 
London, lived outside this area. A related data quality concern was that although HTD 
is a hospital outside LSL, it is a tertiary referral centre for other hospitals in London. 
Patients from LSL may be transferred to this hospital, and therefore, using hospitals as a 
proxy for residence may under-estimate the number of patients who were resident in 
LSL. 
Taking these limitations into consideration, the first section of the analysis indicated 
that the highest incidence of imported malaria between 2001 and 2008 was in VFRs 
who acquired falciparum malaria when visiting friends and relatives. Reports were 
predominately made from hospitals in the London area. With respect to ethnicity, the 
results indicated that the greatest burden of disease was in those categorised as of 
"Black African" or "of African descent", resident in London. 
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Only the number of reports made of P. vivax was noticeably higher from outside the 
London area compared to those reported from within the capital. In the 20 year study 
carried out by Smith and colleagues, which reported similar findings, this was attributed 
to infections in migrants from India and Pakistan who live in large communities in the 
Midlands and North of England (Smith et aI., 2008). Although this was not investigated 
in this thesis, this explanation seems to be plausible. 
The annual mean number of reports (1727) during the period 2001 to 2008 in this 
analysis was lower than the average 1965 reports reported between 1987 and 2006. As 
described in section 1.3, a reduction in cases of imported malaria has also been reported 
elsewhere, and described as possibly resulting from increased urbanisation and the 
success of vector control methods in malarious countries of West Africa (Behrens et aI., 
2008). However the analysis in this chapter suggested that whilst the number of reports 
may be decreasing, the proportion of all reports in London that were in VFRs increased, 
and this suggests that VFRs may be increasingly affected by imported malaria. 
The use of an alternative denominator to calculate the rates of infection (i.e. one which 
used the number of travellers rather than the resident population) was only available for 
the UK, so was not calculated separately for London and other areas. The results 
showed that where a more accurate population at risk was used for the denominator, 
rather than the mid-year population estimate, the incidence rate increased significantly. 
However, despite an increase of nearly 11 000 in the number of visits made to Nigeria 
by VFRs between 2004 and 2008, and an increase of over 14 000 trips made to Ghana 
by these travellers, the rate of infection remained similar for Nigeria during this time 
period, and decreased for travellers to Ghana. One explanation for these findings may 
be changing environmental conditions which may affect the risk of acquiring malaria 
infections, as suggested by Behrens and colleagues (Behrens et aI., 2008). However, 
limitations associated with data quality may also have contributed to these findings. 
These need to be taken into consideration, and more data collected over a longer time 
period before a justifiable claim can be made about true changes in incidence over time. 
The second section of the analysis in this chapter provided more detailed analyses of 
VFRs resident in London, who acquired falciparum malaria when they visited friends 
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and relatives abroad between 2004 and 2008. This showed some similarities in the 
characteristics of those reported to the MRL with respect to age, sex, duration of travel 
and month of travel. In particular, there appears to be one group of individuals who 
contract malaria whilst travelling during the UK summer or winter holidays. However, 
the analysis also revealed some variability within the sample with respect to all these 
variables, suggesting that that those most at risk of imported malaria in the UK cannot 
be considered entirely as a homogenous group in terms of their epidemiology. For 
example, the rate of infections per 100 000 in men and women differed considerably. 
Whilst most patients had travelled for between two to four weeks, others travelled for 
much longer and 44% of reports received were of infections in those who had travelled 
throughout other months in the year. 
In section 2.5.4 and in section 3.6.2, it was shown that the cost of chemoprophylaxis 
was put forward as one reason why it might not be used, by health care providers and by 
travellers respectively. Using two different denominators, the rate per 100000 of those 
who took no chemoprophylaxis before travel was higher in LSL compared to areas of 
London outside this area. This is despite the policy of offering chemoprophylaxis for 
the price of an NHS prescription current during the study period. This requires further 
investigation to explore the reasons why this might be so, and will be discussed further 
in chapter six. 
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Chapter six: qualitative research: demographic, 
migration and travel-related data, responder and 
respondent interactions and the interview context. 
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This chapter turns to the results of the qualitative part of the research. I begin by 
describing the location, time and duration of the semi-structured interviews. 
Demographic, migration and travel-related information are then provided for VFRs and 
patients. Demographic and occupation-related data are included for other groups of 
respondents (GPs, practice nurses, community pharmacists and hospital consultants). 
Finally, in this chapter there is a discussion of how I believe my personal perspective 
and interaction with respondents and the context within which each interview took place 
may have influenced the analysis. 
6.1 Respondent details: number, locations. durations and times of 
interviews 
Face to face interviews were undertaken with 56 participants: 20 VFRs, seven 
community pharmacists, 10 GPs, 10 practice nurses, three hospital consultants, and six 
patients. A chart showing the time period over which interviews were carried out is 
provided in appendix six 
Respondents either lived (VFRs and patients) or worked (GPs, practice nurses, and 
community pharmacists) in eleven of the 32 London boroughs (figure 6.1.1) Nine VFRs 
and four patients lived in the three boroughs (Lambeth, Southwark, and Lewisham) 
where malaria chemoprophylaxis was subsidised during the time period of the study. 
Sixteen of the other respondents also worked in these areas. As only three hospital 
consultants were interviewed, the area in which they worked is not provided to maintain 
their anonymity. 
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The location of the interviews with VFRs and patients is given in appendix seven. The 
majority of the interviews were carried out in the early evening. Where interviews were 
carried out in VFR's homes, it was requested that the television was turned off, or the 
volume turned down to help us concentrate. In the different cafes where interviews were 
carried out, background music was being played in all but one, and all were very noisy. 
Two female respondents had pre-school age children with them during the interview. 
They demanded regular attention, which as well as causing interruptions to the 
interview, made it sometimes difficult for both the study participant and for me to 
concentrate fully on it. One of these interviews was also carried out in a cafe, which 
added to the difficulty of hearing everything that was said. Interruptions from 
respondent's incoming mobile 'phone calls or text messages were common. In all cases, 
participants were asked if they would like to deal with the call or message before 
continuing with the interview. 
Those interviews conducted at my work place were carried out in a different department 
to the one in which I worked. 
All the GP and practice nurse interviews were conducted in private rooms within GP 
practices except two interviews with GPs, each of which took place in a private office in 
two different peTs. All interviews with community pharmacists were conducted in 
community pharmacies. All except one were carried out behind the customer counter, 
except for one which was carried out in a quiet comer of the pharmacy accessible to 
customers. The three interviews with hospital consultants were carried out at their work 
place in private offices. 
Interviews with VFRs, GPs and practice nurses took an average of 30 minutes. For 
community pharmacists, interviews lasted approximately 25 minutes, and interviews 
with hospital consultants took about 40 minutes on average. All these interviews were 
carried out during working hours. 
All the offices of GPs practice nurses and consultants were quiet locations, with few 
interruptions from telephone calls or colleagues. In all cases where healthcare providers 
were interrupted by colleagues or by 'phone calls, they were given the option of 
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stopping the interview to deal with these. These interruptions did not appear to distract 
them unduly. 
Community pharmacists were often interrupted by colleagues or by customers. As with 
the other healthcare professionals, participants were always given the option of dealing 
with the reason for the interruption before returning to the interview. 
6.2 Demographic. migration. travel-related information and use of 
chemoprophylaxis by VFRs and patients 
6.2.1 VFRs 
Eleven of the 20 VFRs were interviewed before and after travel. Three of the VFRs 
(VFR2, VFR8 and VFRI3) who were interviewed before travelling did not respond to 
attempts to contact them after travel and were categorised as "'ost to follow up". The 
other six VFRs were interviewed only once, and this was upon their return (appendix 
seven). 
VFRs were interviewed between one and four weeks before travel, and those 11 
interviewed after travel were contacted between one and four weeks after their return. 
At the time of the interview it was found that one VFR who had agreed to participate in 
the study was not of Ghanaian or Nigerian origin. He had been born in France and his 
parents were born in Mauritania. However, he had lived for a number of years in 
Nigeria and made regular visits to both Ghana and Nigeria. It was considered that he 
could make a valuable contribution to the study, and so was included. 
Demographic, occupational, residence-related and travel information relating to VFRs 
are shown in appendix eight and appendix nine. The median age of VFR respondents 
was 40 (interquartile range 31-46). They had a variety of occupations, ranging from 
three who worked as cleaners to one who was employed as a lawyer. Five worked in 
healthcare in some capacity, and three of these were judged to have some knowledge of 
malaria through their work. One not currently working in healthcare was however 
medically qualified. Participants were not asked routinely about the work status of their 
partners, as this was considered to be potentially intrusive. However, two male 
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participants who themselves had no knowledge of health care, volunteered the 
information that their wives worked in this discipline, one as a nurse, and one as a GP. 
Ten VFRs were travelling to Ghana, nine to Nigeria and one to both countries. Fourteen 
were born in the country which they were visiting. Another four were born in the UK, 
but spent their childhood and early adulthood in Nigeria. One, although not born in 
Nigeria, was of Nigerian parentage and had lived in that country for a considerable 
period of time. Two of the younger VFRs were taking their first trip to their country of 
origin since emigrating to the UK. Only one VFR had been born and spent all her Ii fe in 
the UK. At the time of the interview, VFR respondents not born in the UK (n=19) had 
lived in this country for a median period of 16 years (interquartile range 10-22 years). 
Travel to Nigeria or Ghana was frequent, and half reported travelling every year. Those 
who had lived longer in the UK than other VFRs did not seem to travel less frequently. 
Whilst some explained that they travelled infrequently during the first few years they 
were in the UK, predominately due to financial constraints, once these eased, they 
travelled more often. Others, who travelled less frequently did so because of a lack of 
money, and saved regularly to enable them to do so. 
All the trips that VFRs were taking, except for one who was attending a funeral and was 
unsure when this might take place at the time of the interview, and another who had 
arranged the trip just two weeks before travelling, had planned their travel at least eight 
weeks before leaving. For these 18, the median time before travelling that they had 
planned the trip was 19 weeks (interquartile range 12-28 weeks). The median duration 
of travel was 23 days (interquartile range 14-30 days). 
Eleven of the 20 were travelling alone, and seven were travelling as part of a family 
group which included children. For many, the trip was their main holiday, and 11 ofthe 
20 (55%) were travelling during the summer months: nine in July and two in August. 
Three were travelling during the Christmas holidays, and two over the Easter break. 
Three had additional reasons for travel (one was going to a conference, one to a funeral 
and another taking part in a speaking tour), and were incorporating within this a trip to 
see friends and relatives. One had bought a property in Nigeria in which he intended to 
retire. He currently used it as a holiday home. The entire family of another VFR 
162 
maintained two homes, one in Lagos and one in London, and he commuted frequently 
between the two. Although a few mentioned that previous travel had been necessitated 
by the illness of their parents, or that they were travelling to honour the first 
anniversary of the death of a parent, all VFRs gave the impression they enjoyed their 
trips to Nigeria or Ghana and did not appear to be travelling solely from a sense of 
family duty. 
The use of chemoprophylaxis (for previous trips where appropriate and for the most 
recent trip) for individual VFRs is shown in appendix nine. It could be summarised as 
follows: 
• Yes on this trip and also on previous trips (n=8) 
• Yes on this trip but intermittent use previously (n=3) 
• Intended to on this trip, but did not purchase, used on previous trips (n= 1 ) 
• Not on this trip and not on previous trips (n=3) 
• Not on this trip. First time travelled since coming to the UK (n=2) 
• Intended to on this trip, did on previous trips and lost to follow up (n=l) 
• Provided contradictory information and lost to follow up (n=l) 
• Intended to on this trip but intermittent previously and lost to follow up (n= 1) 
6.2.2 Patients 
At the time of the interview, it was found that one patient (PTl) was born in Sierra 
Leone. He had just returned from his ftrst trip to Nigeria, where he had contracted 
malaria, and had also been infected with this disease on a previous trip to Sierra Leone. 
It was decided to include him in the study, as like VFRl, it was thought that his 
contribution could be valuable. 
Patients were interviewed between one and three weeks after being discharged from 
hospital. Demographic, occupational, residence-related and travel information of 
patients are provided in appendix 10. 
All patients were males. One was unwilling to give his age. The median age of the 
others was 54 years with an interquartile range of 49-59. As with VFRs, they had a 
range of occupations. None were judged to have any professional knowledge of malaria. 
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Five were travelling to Nigeria, and one to Ghana. Except for the patient from Sierra 
Leone, all were travelling to the country in which they were born. They had lived in the 
UK for a median 23 years (interquartile range 20-25) at the time of travelling. 
Three travelled at least once a year. Of these, one was a businessman in Nigeria, which, 
he explained, necessitated frequent travel to that country. Another had a property in 
Nigeria, which he visited as frequently as he could. One of those who travelled less 
frequently was going because his mother was ill. Two pastors volunteered to take part in 
the study. Both were going on an evangelical mission, as well as visiting family. 
For four patients there was less than a week between planning the trip and going. One 
had two months to prepare, and one had two weeks. Patients travelled from June to 
November. The median duration of travel was 17 days (interquartile range 14-21 days). 
The use of chemoprophylaxis by patients was as follows: 
• intermittent previously but not on this trip (n=2) 
• intermittent use previously. If not purchased in UK, regular purchase of 
chloroquine-based drug upon arrival in a malarious country, but not on this trip 
(n=l) 
• not on this trip and not on previous trips (n= I) 
• regular purchase of chloroquine and proguanil upon arrival in malarious country 
(n=l) 
• not aware anti-malarials available in the UK (n= I) 
6.3 Demographic data. practice details and employment history for GPs. 
practice nurses. and community pharmacists 
6.3.1 GPs 
The sex, ethnicity, practice details and employment history of GPs is shown in appendix 
II. 
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Seven GPs were male, and three female. All but two were of Caucasian ethnicity. Three 
worked in smaller practices of between one and three GP practitioners, the others in 
larger practices. Five interviews were with Lambeth GPs, one with a Southwark GP and 
four with those working in Greenwich. 
The number of years each one had spent working as a GP was categorised to maintain 
the anonymity of the respondents. Only one GP had been employed in this role for less 
than five years. Two had been GPs for between 10 and 14 years, and six for between 20 
and 24 years. One had over 25 years' experience in this role. 
6.3.2 Practice nurses 
The age, sex, ethnicity, practice details and employment history of practice nurses is 
shown in appendix 12. 
All practice nurses involved in the interviews were female. Five were of Caucasian 
ethnicity, three were Black Caribbean, one was Black African, and the tenth from the 
Indian Sub-Continent. Five worked in Lambeth, and five in Greenwich As with the 
GPs, other details are categorised and some details sourced from the London Health 
Observatory (London Health Observatory, 2011) and from the practice details provided 
on the internet. All except one worked in practices with between one and four other 
practice nurses, although the ratio of practice nurses to GPs and the number of patients 
varied between practices. One practice nurse had been working as a practice nurse for 
between one and four years, four for between five and nine years, three between 10 and 
14 years, one and between 15 and 19 years, and one for more than 25 years. 
6.3.3 Community Pharmacists 
Appendix 13 shows the sex, ethnicity, PCT of employment and number of years each 
had worked as a pharmacist 
Five of the community pharmacists who were interviewed were male and two were 
female. Four were from the Indian Sub-Continent, one was Black Caribbean, one 
Caucasian and one Black African. Four interviews were carried out in Lambeth, and 
three in Newham. As with the other respondents, the time they had worked in their 
profession was categorised to help ensure their anonymity. Only one had worked as a 
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pharmacist for less than five years. The others were more experienced, two having 
worked for between five and nine years in this role, two between 10 and 14 years, one 
for between 15 and 19 years, and one for more than 25 years. 
6.3.4 Hospital consultants 
All three of the participating hospital consultants were male, and of different ethnicities 
and all had at least five years' experience of working in this role. There are fewer 
hospital consultants than GPs or practice nurses working in London, and as one is 
identified in chapters seven to nine by his country of origin and another by his speciality 
(paediatrics), it was decided not to provide any further details, in order to preserve the 
anonymity of this group of respondents. 
6.4 Personal perspective and involvement in the study 
In section 4.9.5, the importance of reflexivity was noted. In this section, I discuss how I 
felt my personal perspective and involvement may have influenced my interactions with 
respondents, both in terms of my reactions to the participants and their reactions and 
responses to me. 
6.4.1 My status 
As well as being a PhD student, I worked for the HP A throughout the data collection 
process. This is the UK agency responsible for protecting the public from infectious 
diseases, chemicals and radiation hazards. Specifically, I was employed as a Health 
Protection Specialist at the South East London Health Protection Unit (SELHPU) which 
is one of four units of the HP A in London. I worked primarily on the epidemiology of 
infectious diseases and on the development and implementation of strategies for 
imported malaria and for hepatitis B and C. I was employed at SELHPU for 
approximately nine years by the time the research concluded, and had a total of fifteen 
years' work experience in health strategy and research. As a result of this work, much 
of it carried out in areas of high socio-economic deprivation and in areas with large 
migrant communities, I had developed a keen interest in the wider determinants of 
health, health inequalities, and migrant health. Thus, I approached the research with a 
great deal of enthusiasm. 
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I already had several years' experience of working with a wide range of health care 
professionals, such as hospital consultants, nurses and colleagues in PCTs, by the time 
the study started. I had also worked with African community groups on malaria 
prevention projects, and during some of the time in which I was undertaking the PhD, I 
was also setting up a research project investigating the prevalence of hepatitis C 
prevalence in the African community. This also involved working with African 
community groups. Much of the success of my professional work had been dependent 
on building up constructive working relationships with a wide range of people, and 
having strong interpersonal skills. As a result of this, I felt experienced and confident 
from the outset of the research in my ability to quickly establish a rapport with 
individuals who would be interviewed for this research. 
I lived in London from 1987 to 2005, and was familiar with all the geographical areas in 
which the interviews were conducted. 
6.4.2 Personal safety 
The community pharmacies which I visited were all located in busy shopping areas, and 
as such, although some were in areas with high levels of deprivation, I felt comfortable 
walking in these areas. Interviews with hospital consultants in hospitals also posed no 
anxiety. Personal safety, in particular the fear of being physically assaulted, was 
however sometimes of concern to me when I was visiting areas of London with high 
crime rates, either to visit GP surgeries or to interview VFRs or patients. My 
apprehension was increased particularly when carrying out interviews in apartments 
within large housing estates when it was dark. In some instances I used taxis to take me 
as close to the home of the respondent as possible, though this was not always possible. 
A further concern for me was that in nearly all cases I had not met VFRs before the 
interviews, and had also had very little previous contact with the facilitators of some of 
these interviews. Patients volunteered for the study whilst in hospital, and so I had no 
previous contact with them either. Thus, I was slightly apprehensive about my own 
security, especially on the occasions when I thought I may be alone in a house or flat 
with a male participant. 
I had attended training on risk assessment through my professional work and followed 
the advice given. In all instances in which I was interviewing in private homes, I 
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'phoned a friend or work colleague before entering the home of the respondent and 
again after the interview, when I reached a place where I felt comfortable using a 
mobile 'phone. I also made sure that the friend or work colleague had the name and 
address of the person I was interviewing, and gave instructions on what to do if they did 
not hear from me within a certain period of time. As well as this, I employed standard 
"streetwise techniques" to minimise risk to myself. For example, I avoided the use of 
my mobile phone in the street, made sure I was aware of who was around me, and tried 
to appear as if I knew where I was going. 
Despite these concerns, once I had met the participant, I never felt anything other than 
welcomed and safe. On very few occasions was I alone in the house with a male 
respondent, and indeed wondered whether they may have asked a female family 
member to be present to protect themselves from possible allegations of inappropriate 
behaviour. I also encountered no danger when travelling to and from locations. I do not 
feel that my anxieties had an effect on the conduct of the interview as I was careful not 
to express them, but this provides information about the context in which some 
interviews were carried out. 
6.5 Use of a digital recorder 
A digital recorder was used to record the interviews, and this was placed between me 
and the interviewee, most commonly on a table. All participants were asked if the 
interview could be recorded before it was started, and none declined. They were all 
reminded that the interview was both confidential and anonymous. In all interviews, I 
took care to show that I was relaxed with using the recorder, both in my body language, 
and by talking in the same natural way that I used before the recorder was switched on. 
lt was not possible to evaluate how the presence of the recorder affected the 
participants' responses as no interviews were carried out without it. During the 
conversations there was much shared laughter and the spirit in which all interviews was 
convivial, suggesting that respondents were not intimidated by its presence. After it was 
turned off, several participants continued talking about the topic, but none with an air of 
divulging information "off the record". 
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6.6 Participant and interviewer interactions 
6.6.1 VFRs 
The act of a white person carrying out research into knowledge, attitudes and practices 
of a different ethnic group highlighted the differences in ethnicity both in my mind, and 
possibly in those of the study participants. This may have been compounded by the 
fact that I have not travelled in West Africa, from where nearly all participants 
originated. In many ways I recognised during the course of the interviews that these 
differences between interviewer and study participant were favourable to me, as many 
participants voluntarily adopted the role of informant, and sought to teach me about 
how Africans perceive and manage malaria. This was obviously received with 
enthusiasm, as it formed the key element of the research. However, in some instances 
the lack of knowledge that it was assumed I had (such as telling me that the names of 
the capital cities of Nigeria and Ghana), reinforced the perceived and actual gulf 
between our ethnicities and backgrounds. 
Despite many VFRs and patients being keen to educate me, it appeared that there was at 
least one issue which one participant felt to be beyond my comprehension. This became 
apparent when one VFR explained to me after the interview had finished that his wife 
had thought he had been bewitched when he developed malaria-type symptoms, and 
then confided in me that there were some things about the African community that I 
could not understand. Differences also surfaced in other ways. Whilst some participants 
were comfortable in explaining that they did not consider malaria to be a serious health 
concern, others' avowal of its importance may have been explained by a desire to agree 
with what they may have thought would be my cultural perception of it as being a 
serious illness. 
Language, specifically differences between my accent and that of some respondents also 
highlighted the ethnic difference between us. This also occasionally threatened the 
rapport that had been built up during the interview as it was sometimes clear that we 
were having difficulty in understanding each other. I always managed to diffuse any 
tensions by smiling at these difficulties, but in one instance made a note after the 
interview that I wondered how much the respondent mixed with people outside his own 
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ethnic group, as it was clear he sometimes had difficulty understanding what I said, and 
some questions asked him needed more than one repetition or clarification. 
Aside from these differences, as fellow UK residents, both I and VFR participants and 
patients did share some common experiences such as living in London and use of the 
NHS for healthcare. Here, social class, professional and gender differences may have 
been more pertinent to the interaction than cultural factors. With respect to social class, 
I was unaware of the factors that identify someone as being ofa certain class in Nigeria 
or Ghana. From my perspective, this lessened any class-related tensions that may have 
affected the interaction between us. It was clear however, from the context in which the 
interviews took place (from a private club in central London to apartments on housing 
estates with high crime rates) of the differences in the lives of individual respondents. 
One of my foremost concerns was to ensure that VFRs and patients did not feel 
patronised during the interview, as this could have been interpreted as assumed ethnic, 
cultural, educational or class superiority on my part. To overcome this, I took care to 
assume a certain level of knowledge and intelligence on the part of interviewees, and 
was keen to adopt the role of naIve researcher. The perception referred to earlier in this 
section, that many participants appeared to be educating me about malaria control, I 
feel, meant that their fears of being patronised were averted. 
From my professional work, I was aware that HIV and to a lesser extent, TB, rather than 
malaria, were the predominant healthcare concerns of many members of the African 
community, at least those who were members of community groups with whom I had 
interacted. As such, I was aware that some at least were taking part in the interview as a 
favour to their friends rather than because of a particular interest in malaria, or because 
they were keen to impart a particular message. On the other hand, I wondered if a few 
VFRs did take part specifically to complain about the prohibitive cost of 
chemoprophylaxis. I also had the impression that some patients were keen to assist, so 
that they could help others avoid contracting malaria. One patient informed also 
informed me that he volunteered to take part to express his discontent with his attempts 
to access chemoprophylaxis from a community pharmacist. 
170 
With VFRs who were students, I felt immediately to share a common interest in 
learning, and found them easy to engage with. Others worked in healthcare, and with 
these also, I felt a professional bond which made them easy to talk to. I also had a slight 
professional acquaintance with two VFRs before interviewing them, but had only 
spoken to them very briefly once or twice before on work-related issues and knew it 
was unlikely that I would work with them in future. Such a brief professional 
relationship I feel, did not affect the conduct of the interview as I noticed no differences 
between these interviews and others in terms of the responses given. 
With respect to gender differences, I detected a slight discomfort from two male VFRs 
when their knowledge about malaria transmission was explored. The question was 
avoided by them asking it back to me, and was the only time that I detected any unease 
in responding to the questions I asked. I assumed that it may have felt uncomfortable for 
them to risk appearing ignorant to a female interviewer. 
It was perhaps inevitable that I often found myself comparing what my own likely 
health protection plans would be when travelling to Nigeria or Ghana to those made by 
the VFRs I interviewed, and in some instances the lack of concern expressed by many 
did seem unusual. However, I recognised that my professional occupation and lack of 
previous travel in these areas might make me particularly concerned about the dangers 
associated with infectious diseases. To help me consider the issues from a different 
perspective I often found it helpful to instead compare their actions with what I might 
do when travelling back to the UK after living abroad with respect to protecting myself 
against an illness such as influenza. 
During the course of the interviews with patients, I became aware that care was being 
taken by participants to stress the individual circumstances which led to their becoming 
infected. This, I felt, may have been as a result of their fears about being reprimanded 
by me for not having taken appropriate precautions before travel. Having realised this, I 
took care to show sympathy with them, not only for the symptoms experienced but also 
for the circumstances they described. These will be explained fully in chapter nine, but 
the range and succession of events they described emphasised to me how the individual 
context of each particular situations is fundamental to the outcome. 
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6.6.2 GPs and practice nurses 
From my professional occupation I was aware of the daily time pressures under which 
healthcare professionals worked. This caused some feelings of guilt on my part when I 
asked them to volunteer to be interviewed and occasionally during the interview itself. 
In some cases it was obvious from the number of interruptions that they were under 
pressure, whilst others specifically said they were busy. This affected the interview 
process to some extent, as I was concerned that I sometimes may have rushed through 
the interview, but on no occasion did any GP, practice nurse or hospital consultant ask 
me to finish the interview early, or appeared to become impatient. Indeed, everyone 
took care to answer the questions thoroughly. 
At times, I felt that some doctors, nurses, and community pharmacists may have been 
searching for answers to give me. It was also clear that in some cases, the views and 
practices of particular patients had stood out in their minds and these were being 
reported to me. It was difficult to evaluate the extent to which these reflected their more 
common experiences. 
Although all interviews with GPs were carried out in a friendly manner, I have had 
relatively little contact with this professional group compared to other healthcare 
workers, and have a keener sense of an imbalance of power when talking to them. 
Unlike with other healthcare professionals, the occasions when I interact with GPs most 
are as a patient, or in the past, trying, often unsuccessfully, to get information to help 
me ensure the best care for my elderly parents. In the event, I found all the GPs I 
interviewed keen to engage with me and provide me with the information I needed. 
Indeed, some were, or became aware of, my link with peTs either before or during the 
interview, and I feel may have been concerned to avoid giving the impression that they 
might not always follow good clinical practice. On the other hand, a few assumed that I 
was a nurse, perhaps displaying a certain gender stereotyping. 
From many years' experience of working professionally with nurses from a variety of 
disciplines, I found nearly all practice nurses easy to talk to in a warm and friendly 
manner. I also felt this to be a result of the absence of a feeling of power imbalance on 
my part. Aware that they may themselves have felt a disparity, and to encourage them to 
express themselves freely, I emphasised when arranging many of the interviews that 1 
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just wanted to "pick their brains". To fonn a bond before the interview started, I 
discussed subjects such as workload, the prevalence of chronic and infectious disease 
amongst their patient population, or patient demographics. A few did give the 
impression of being slightly anxious at the beginning of the interview, which I 
interpreted as uncertainty about what might be asked of them, fears of their responses 
being fed back to the GPs they worked with, or time constraints. To help alleviate these 
anxieties, I explained the confidential nature of the interview. Any overt anxiety at the 
beginning of the interview did not last more than a few minutes, and everyone, I felt, 
spoke freely about their experiences and opinions. I did feel at times that some may 
have emphasised their skills and knowledge in order to appear professional and 
competent. I also had the impression that a few were obviously very pleased to be asked 
their opinion as experts, as many were very keen to talk. When, at times, some were 
interrupted by colleagues, they explained that they were taking part in research, with an 
air that this was important and they were part of it. 
6.6.3 Hospital consultants 
Of the three interviewed, I had a professional acquaintanceship with two before the 
interviews were carried out, who I knew to be interested in imported malaria and in tum 
they knew of my work in this area. This helped me to conduct the interview as a 
friendly discussion between people who have common interests. Interestingly, I felt 
none of the imbalance of power noted earlier with respect to GPs. I feel that this may 
have been because I interacted more regularly with hospital consultants than with GPs, 
and in these situations I felt my Public Health knowledge was understood and 
appreciated. 
6.6.4 Community pharmaCists 
I had never worked with community phannacists, and had little previous interaction 
with them. In some respects this made a rapport more difficult to build, as there were 
fewer shared professional experiences that could be drawn upon. I found them without 
exception keen to participate, and to share their thoughts and experiences freely. Several 
gave the impression of being pleased to be asked about these. A few of the younger 
participants appeared slightly nervous at the start of the interview, which I interpreted as 
an uncertainty about what might be asked of them, but after a few minutes, any sense of 
anxiety disappeared. Being interested in their experiences and asking them to explain 
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issues in which they had particular expertise, such as the suitability of individual 
chemoprophylactic drugs may have helped to give them confidence and carry out the 
interview in a relaxed manner. 
6.7 Discussion 
Despite the considerable time and effort it took to recruit study participants (the first 
being recruited in December 2007, and the last in January 2011), 56 respondents were 
recruited. These included some either resident or working in areas where subsidised 
chemoprophylaxis was offered, an some who lived or worked in areas where it was not. 
This meant that the effect of this policy difference could be explored in the interviews. 
This will be discussed in the next chapter. 
As noted in section 6.2.1, only one VFR respondent and no patient had lived in the UK 
since birth, and this was recognised as being a major limitation of the study. As a result, 
with the exception of one respondent, only the views of a group of first generation 
Nigerian and Ghanaian migrants were collected. Having said that, a range of travellers, 
with different demographic, migration and travel patterns did participate. This meant 
that a broad range of perspectives could be gathered. The valuable contribution of 
healthcare professionals and community pharmacists to the study also allowed the 
viewpoint of these stakeholders to be included. 
There were some noticeable differences between VFRs and patients. For example, the 
former had a median age fourteen years lower than the latter. All patients were men, 
whilst half of the VFR respondents were females. Another difference between VFRs 
and patients was in the amount of time in which the trip was planned. Whereas most of 
the VFRs were taking trips arranged months before travel, four patients decided to 
travel no longer than a week before departure. Just over half of VFR respondents (55%) 
were travelling in July and August, and six of these were families travelling with at least 
one child. Although the family members of one patient came to visit him during his 
trip, to support him during his mother's unexpected death, all others were travelling 
alone. Two patients were also travelling in the summer holidays, but in contrast to the 
VFRs travelling during this time, who planned their trips well in advance, one of these 
arranged his trip less than one month before departure. 
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From the contexts in which the interview took place, it was possible to gain a sense of 
the economic circumstances in which the different VFRs and patients lived. The 
overriding impression was that even from this small sample, the heterogeneity within 
the Nigerian and Ghanaian community living in London was apparent. Evidence of this 
comes from two examples: firstly the remarkable difference in the locations in which 
some interviews was carried out; secondly, the frequency of travel to Nigeria and 
Ghana, which was influenced to some extent by financial considerations. 
Although some VFRs and patients were consistent in their use of chemoprophylaxis 
(either always taking it or never doing so), the intermittent use of it by others, the 
decision by some to purchase drugs in Nigeria or Ghana, and the purchase of 
inappropriate drugs by others begin to demonstrate the different options available and 
adherence to these. 
There was some homogeneity with respect to the sex of GPs and practice nurses, with 
most of the GPs being male, and all of the nurses being female. There was a broader 
range of ethnicities amongst the practice nurses and community pharmacists, compared 
to the GPs, the majority of whom were Caucasian. Levels of experience, as evidenced 
by the amount of time spent by each employed in their respective roles was high for 
nearly all healthcare professionals and community pharmacists. 
One lasting impression of the interviews with healthcare professionals and community 
pharmacists was of their willingness to participate in the interviews and provide their 
expertise. Several community pharmacists and practice nurses in particular appeared to 
be pleased that their viewpoint had been requested. Another impression was of the 
commitment of GPs, practice nurses and hospital consultants to their patients. I felt 
privileged to have the opportunity to be able to discuss with these participants a subject 
which was of great interest to me. 
In the next chapters, I turn to the analysis of the interviews with respect to the 
knowledge, attitudes and practices of VFRs. 
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Chapter seven: factors influencing malaria 
prevention and adherence to chemoprophylaxis. 
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The analysis of the interviews is divided into three chapters. This chapter explores a 
wide range of factors which were relevant to malaria prevention, including firstly health 
concerns before travel, knowledge about transmission, perceptions of personal risk and 
the provision of travel health advice on airline tickets. It continues by discussing factors 
which were relevant to the avoidance of mosquito bites. Beliefs about the seriousness of 
malaria are described next. Peer pressure amongst YFRs' family members is then 
included. Choice of chemoprophylaxis, issues relating to its cost and drug adherence are 
the final topics discussed. 
As described in section 4.9.8, respondents were given unique identifiers which are used 
in the following three chapters. Where GPs, practice nurses and hospital consultants are 
referred to as one group, they are described as "healthcare professionals". 
There were no sole determinants of behaviour, but rather several factors influenced this 
for each YFR and patient. These factors have been categorised in these three chapters 
for clarity. 
7.1 Health concerns before travel 
Fifteen of the 20 VFR respondents and all six patients had concerns about their health 
when visiting Nigeria or Ghana. Malaria was the most frequently mentioned, although 
this may been influenced by respondents' desire to show interest in the topic under 
discussion, that is, a response bias. Whilst it was specified as a health concern, it was 
often listed alongside others. It was the sole concern for very few. 
Other common issues raised were about gastrointestinal illness and the associated 
anxiety of drinking untreated water or foods which could cause these. Specific diseases 
associated with gastrointestinal symptoms were also cited, in particular typhoid, which 
was mentioned in the course of some interviews as being more serious than malaria. 
Many had suffered from stomach upsets on former visits, thus linking their concerns to 
previous experiences. One man had previously had concerns about contracting HIY on 
visits he made before he was married. A mother with teenage children was also 
concerned about them contracting HIV whilst abroad. Other health-related concerns 
cited were connected to poor access to emergency services, for example in the event of 
a road traffic accident or in other situations where swift medical interventions could be 
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life-saving. Other worries were about being robbed, or the consequences of becoming 
inadvertently involved in scenes of political unrest. 
Practice nurses and community pharmacists confirmed that malaria and gastrointestinal 
illness were the most common concerns raised by patients seeking pre-travel advice. 
7.2 Knowledge about how malaria is transmitted 
Whilst there was some confusion among the participating YFRs about the infectious 
agent responsible for malaria, with the terms virus, bacteria and parasite used, all YFRs 
and patients confidently asserted that malaria was transmitted via mosquitoes. One 
thought it could, in addition, be transmitted by drinking water that had been 
contaminated with mosquito larvae and another who had medical knowledge, explained 
correctly that transmission could occur via unscreened blood used for transfusions. 
All but three healthcare professionals and community pharmacists thought that YFRs 
knew how malaria was transmitted. One GP was uncertain, and one practice nurse and a 
community phannacist felt that YFRs were not aware. However, very few healthcare 
professionals or community phannacists had specifically asked patients/customers that 
question, but rather, had assumed it from the context of conversations. 
Some YFRs in discussing this topic were keen to stress that malaria cannot be 
transmitted directly from person to person, and that YFRs returning to this country with 
malaria are not infectious. This assertion might be interpreted as a need to reassure 
healthcare professionals, of whom I appeared to be considered a representative by 
many, that VFRs are not wilfully putting others at risk by contracting malaria, thus 
deflecting any possible criticism that could be directed towards them for irresponsible 
behaviour. It could also reflect the view of some VFRs that UK-based healthcare 
professionals do not have a detailed knowledge of malaria. 
7.3 Knowledge of a potential risk of acquiring malaria 
All participating YFRs and patients knew that that there was a potential risk of 
acquiring malaria in Nigeria or Ghana. 
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Health care professionals and community pharmacists also felt that their 
patients/customers were aware that they could contract malaria in the country they were 
visiting, although as was the case with malaria transmission, few had specifically asked 
that question, but rather had assumed it from the context of discussions with patients in 
consultations. 
7.4 The provision of information about malaria protection provided on 
airline tickets 
VFRs and patients bought airline tickets either on-line or at travel agents. The use of 
tickets to impart health advice appears to have been ineffective as a means of providing 
information to these respondents. Half did not notice it was there and none proactively 
used this means of informing themselves about potential health risks. Some only 
checked to find out if there were any mandatory health requirements before travel, 
whilst others explained that their only interest in the information supplied with the 
airline ticket was with the size of their luggage allowance, suggesting that tickets were 
associated with the provision of information related to the practicalities of the trip. 
Those who did read it, whilst acknowledging that it might be useful for first time 
travellers to Nigeria or Ghana, found it personally irrelevant as they were visiting their 
home, where, as they explained, they were aware of likely health threats and knew how 
to manage them. A typical response was that ofVFR20 who was returning to Nigeria to 
see her family for the first time in a year and a half after studying in the UK: 
And did you notice any health advice on the ticket? 
Um, health advice, I don 'I Ihink I did notice Ihat, no I didn 'I. 
And would it be the sort of thing you would look for, or not really? 
Um, not really since it's not a strange country. That was where I grew up. Um, ~r I 
was going to, like, let's see, Somalia, or some war area, I probably would look out 
for advice for such things. But since it's like my family place, it's like my homeland, I 
don 'I look out for ... I really know what to do or not what to do, so I don 't' real~v look 
out for advice or health issues (VFR20). 
Even the one VFR who was born and brought up in the UK explained that she would 
not read the advice, as experience gained on previous visits had taught her how to 
protect her health. 
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7.5 Mosquito Avoidance 
7.5.1 VFRs' and patients' knowledge about the local environment with respect to 
mosquito avoidance 
Although all VFRs and patients recognised the risk of acquiring malaria when travelling 
to a malarious country, many immediately asserted why the risk to them personally of 
acquiring the disease would be low. One reason was their knowledge of the local 
environment gained from previous residence, and/or subsequent trips made to Nigeria 
and Ghana as VFRs. In particular, the lack of breeding grounds for mosquitoes near to 
the places that they would be visiting and the corresponding relatively low perceived 
risk of being bitten in these areas were mentioned. These locations were often compared 
favourably to other local geographical areas, to other cities or to more rural areas. 
7.5.2 Planned methods of mosquito avoidance 
Knowledge of established mosquito avoidance methods that were employed regularly 
by their host families as protection against mosquitoes were described by those VFRs 
interviewed before travel. These included fixed structures such as window screens, 
which were often described as standard fittings, and fans. Some also described air 
conditioning as being available. 
Other methods of protection used included insect repellents. The use of mosquito coils 
was not popular because of the smell associated with them. Attitudes towards bednets 
were particularly negative, and are discussed separately in section 7.5.4. 
All but one VFR interviewed before travel described the spraying of bedrooms with 
insect repellents as a regular practice carried out by their host family, which took place 
between 30 to 60 minutes before bedtime. The use of body creams containing insect 
repellents were planned by some VFRs, but more commonly for children, and were 
described as being less routinely used by their host families. 
Some VFRs acknowledged that these planned measures may not always be effective, 
with activities such as sitting outside in the evening (sometimes taken as a measure to 
avoid the smell and perceived toxicity of the mosquito spray), power cuts, visits made 
to more rural areas where the facilities available in urban areas for personal protection 
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would not be assured, and the use of non-air conditioned taxis thought as potentially 
reducing protection. However, these were considered unavoidable. For example, many 
emphasised the more "outdoor" lifestyle in Nigeria or Ghana compared to the UK, the 
excessive heat which made them keen to wear as few clothes as possible, and the 
capacity for mosquitoes to breach the slightest gap in protection. Several VFRs and 
patients described their attitude to mosquitoes as if they were fighting a battle with a 
devious opponent, describing the insect as eager to bite them. 
Nurses reported that VFRs infrequently asked them for advice about methods of 
mosquito control. Some nurses imparted this information routinely, whilst others did 
not. One nurse said that such advice might not be given due to time pressures in the 
consultation, whilst another expressed a lack of confidence in imparting this 
information. She, along with two others, gave the patients leaflets on mosquito bite 
prevention, rather than providing this information directly. Three of those who did give 
advice routinely explained that they were required to impart this information, and 
needed to record on patient notes that this advice had been given. However, one of these 
three explained that there was no time available for a relaxed conversation about vector 
control methods. 
Whilst a few practice nurses felt that VFRs were responsive to the information about 
mosquito avoidance measures provided, others were under the impression that VFRs 
felt that they were exaggerating the risks associated with malaria, and said that patients 
did not appear to pay attention to the advice given. Personal sprays appeared to one 
means of protection that VFRs were keen to use, though it was felt by one nurse that 
this was to avoid the nuisance of mosquito bites rather than that of malaria specifically. 
Another felt that VFRs believed that chemoprophylaxis would provide all the protection 
they needed. 
Community pharmacists reported that few customers purchased insect repellents, or 
other items that could be used to control mosquitoes. However, it was acknowledged 
that these may alternatively be purchased in Nigeria or Ghana. 
One of the three hospital consultants interviewed who was himself of African ethnicity 
confirmed that many VFRs would be likely to stay in houses which had netting at the 
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doors and windows, and would use insect repellents, but questioned whether these were 
used at the times of day when mosquitoes would be most active. The other two focused 
their answers on bednet use by VFRs, which is discussed in section 7.5.4. 
7.5.3 Actual use of mosquito avoidance methods by VFRs 
Two of the eleven VFRs who were interviewed before and after travel confirmed that 
their bedrooms were sprayed regularly. The other nine said that the spraying of 
bedrooms was carried out intermittently. Reasons given by VFRs who had asserted 
before travel that spraying of rooms was routine for it not happening in practice were 
because of the existence of window nets, or simply because there were no mosquitoes in 
the vicinity. 
A variety of mosquito avoidance methods were reported to have been used by the six 
VFRs who were interviewed only upon return from travel. Two had shared a house 
together, and arranged for a pest control company to spray the room they were staying 
in before arrival. There were also nets at the windows of the house in which they were 
staying. Two said that the bedroom was regularly sprayed. One of these explained that 
despite this, mosquitoes would enter once the door was opened to cool the unpleasant 
temperature in the house. The heat also led her to sleep on the balcony covered in a 
sheet. One VFR would intermittently spray the room, but would mostly rely on air 
conditioning. This was the method also used by the sixth VFR interviewed only after 
travel, and who stayed in a hotel, rather than with her family. 
The six patients who had returned with malaria all slept in rooms with nets at the 
windows, although one felt sure that mosquitoes were able to penetrate the netting in 
one of the houses in which he slept. There was some variation in patients' routines with 
respect to room spraying with insecticide. Three always sprayed the room before 
sleeping. One explained that he had often arrived home too late to do this, and then 
leave enough time for it to become effective before he returned there to sleep. Another 
reported that he never used sprays, and the last had air conditioning available in one 
house in which he stayed, but not in another. Despite the lack of air conditioning in the 
second area in which he stayed, he did not spray the room. 
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Three of the patients felt they had been bitten by mosquitoes when they moved to an 
area in which they felt there was a greater prevalence of mosquitoes. Two of these trips 
were to rural areas, with one VFR having to make an unexpected trip as his mother died 
during his stay and he was forced to change his holiday plans. The third patient who 
moved location travelled to Benin city where he said there were many mosquitoes in the 
vicinity compared to his home town. The fourth patient was staying in a less wealthy 
part of Lagos compared to his usual area of residence, and described that the local 
sanitation was poor and mosquitoes frequently seen and heard. The other two patients 
described being bitten in the garden of their usual residence, one when attending a party, 
the other when sitting outside wearing few clothes because of the heat. His description 
of the reasons for not protecting himself highlights both a certain over-confidence and 
vulnerability . 
Let me tell you one thing. Of course, as I said, and I think I did it once whilst I was 
in Ghana recently, as I say, you feel so hot, you are so confident, so instead (~r 
wearing a pair of trousers, you may want to, you know, just to make sure you get 
more of the fresh air, and I think that might be why, 'cos, you know, over-confident. 
want to get the best out of the environment. you know, you wantfresh air. that sort 
of thing. I'm sure that's one of the things that would also probably. because some of 
this, the mosquitoes have, have come to be resistant to some of the medication we 
have. So I think when we go in for prevention, it should be fool proof You know. you 
don't give anything away, you know. So I think that is one. one thing. and it matters 
not wherever you are, in, in this country, you've got to be prepared. (Pt2) 
A few older VFRs and patients voiced shock at the poor levels of sanitation on their 
most recent visit, compared to the time when they had lived in Nigeria or Ghana and 
there was regular cleaning of mosquito breeding sites. The particular problems of living 
in an apartment block compared to a house were also described by one VFR as leading 
to poor sanitation, since it was difficult to ask neighbours to keep their gutters clear. On 
the other hand, those few who owned their own houses felt they had more control over 
the immediate environment, and could clear any areas where mosquitoes might breed. 
7.5.4 Use of bed nets 
Few VFRs regularly used bednets for themselves. Of the seven VFRs travelling with 
children, only three planned to provide bednets for them. Two others would consider 
their use; one, only if visiting a rural area; the other in places where window nets were 
not available. Upon return to the UK, of those three who intended to use nets, one 
reported that in fact her children did not do this, and she had indicated their 
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unwillingness to do so in the pre-travel interview. Another was lost-to-follow up and the 
third considered it to be too much effort to put up the net, particularly as air 
conditioning was available as an alternative means of avoiding mosquito bites. 
Two patients reported that they had slept under bednets. One of these, born in Sierra 
Leone and an infrequent traveller to Africa, did so on his recent trip to Nigeria. The 
other used them in one location in which he stayed, but not the other. 
Questions about the use of bednets were met by the majority of VFRs and patients with 
amusement. On occasion it was necessary to repeat the word, as if it were not 
understood. In other instances, respondents referred to window nets in their reply, and it 
was necessary to specify bednets. Indeed, whilst there was a concern that respondents 
might provide answers they thought were expected of them for some topics, no such 
concerns arose when the use of bed nets was discussed. More than with any other topic, 
it felt as if respondents were describing customs in a different culture when explaining 
why they would not use a net. Few travellers seemed to consider this to be an acceptable 
form of prevention against mosquito bites, and none expressed embarrassment in 
asserting that they would not use them, irrespective of their attitudes towards the 
seriousness of malaria For example, one VFR respondent, a specialist nurse by 
profession who was very concerned to avoid contracting malaria when visiting Nigeria, 
and who up-dated her knowledge about chemoprophylaxis regularly, cheerfully asserted 
"That's my excuse" when explaining that the facilities were not in place where she was 
staying in Nigeria for setting up a bednet, as if no one could seriously expect her to use 
one. 
As well as the practical difficulties in setting up a net, several other reasons for 
choosing not to use them were described by both VFRs and patients. A few references 
were made to perceptions of a physical strength to withstand any malaria infection 
without the need for nets, and to a greater reliance on chemoprophylaxis for prevention. 
More commonly, VFRs and patients described their experiences of using nets when 
living as children in Nigeria or Ghana. These memories were of them exacerbating the 
heat and closeness of an already uncomfortable atmosphere. Their use was discussed as 
an event connected with times long since passed. It was described by some VFRs that 
more modern ways of managing the risk of mosquito bites had now become available, 
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in particular the use of air conditioning and extensive netting around doors and 
windows. Even where they were available in host's homes, one respondent felt that 
they may have been set up for aesthetic rather than practical reasons, emphasising their 
perceived insignificance as a practical preventative tool. 
The social norm in Nigeria and Ghana as described by the majority of YFRs and 
patients in fact was that bednets are only used for children. For example, the 
conversation with YFR20 was as follows: 
And did you ever sleep under a bed net? Actually sleep under a bed net? 
No, I hate them (laughs). I think it's for babies. I really don't like them. And it's 
really not comfortable. 
Is it stuffy? 
Um, it's been a long time since I tried one, so I can't say. I think it's, I really can't 
say. It's a long time since I used one 
Everyone smiles when I talk about sleeping under a bednet. 
I think nobody likes it. Most people don't like it. 
So you said you think it's a thing for kids? 
Yeah, I think it does, 'cos you're not sofree underneath it. I think it does 
Did you sleep under a bed net when you were a kid yourself? 
I should have, 'cos that was the best way then. That was the best. I think I did, yes 
(VFR20) 
One patient felt that using bednets would be viewed by his family in Nigeria as being an 
overly cautious practice for protection against malaria, which in Nigeria he explained, 
was considered as no more serious than a headache. Another patient felt that that 
whether friends and relatives were supportive ofYFRs' efforts to protect themselves 
against mosquito bites was dependent on circumstances related to levels of education at 
an individual level, their own experiences of travelling abroad, and their economic 
circumstances: 
Did you feel comfortable using a bed net and spray over there, or was that a 
common thing amongst the people that you were staying with? I mean, did you 
get a feeling that they might think you were over-reacting, or was that not a 
problem for you? 
No, no, no. Infact, that is very, that again comes to education. People yes, or no, 
that's the truth. Because the reason why, if you go there, if you stay with the people 
who are well off in the city, who have travelled, they probably push you towards 
that, they'd say 'you've goUa be carefol", 'cos they know, but if you go to a village 
situation they think you're over-reacting. They say it's a lot offuss, what's it all 
about? Because you are just putting a lot of problems on their finances, you know. 
Unless you buy a net, but if you demand certain things, that's why I said it's a two 
way answer (VFR 1). 
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Confinnation of the customary use of bednets as being restricted to children only was 
given by the Nigerian-born hospital consultant, who also explained that the use of 
bednets for VFRs would differ for individual families: 
A lot of people I have spoken to so far have said it's almost as if the nets are for 
kids, and not for them, and that's what happened when they were growing up 
Yes, yes, that sounds about right. Um, but actually that'sfor people who locally 
want to reduce the frequency of malaria in the ... their children. They tend to see 
that as a useful way. For travellers, um, the practicalities of if just makes il d(fficult 
for the people who are going there, if they are going to a family where the children 
always have nets anyway. That makes it easy. 
So, it all depends pretty much on the individual circumstances? 
Yeah, and those people who are so clued into this would almost always have the 
right prophylactic as well, and also use it compliantly, so, again, you know, it works 
when people are absolutely clued-in, and engaged with the whole issues and 
principles around it. Um, it falls down completely when the individuals, either 
themselves or the people they are visiting, don't really mind about this (SC 1) 
This respondent also felt that the use of nets by VFRs might serve to somehow distance 
them from hosts and make them not part of the family. 
Both practice nurses and community phannacists confinned that Nigerian and Ghanaian 
patients rarely initiated a pre-travel discussion about bednets. The infrequency with 
which customers asked about this method of protection made it stand out in the memory 
of those two who did recall this. 
7.6 Beliefs about the seriousness of malaria 
Whilst detailed knowledge about the local environment and planned measures to 
prevent mosquito bites were voiced by many VFRs and patients as reasons why the risk 
to them personally of being bitten by a mosquito were low, beliefs about the likelihood 
of being infected with malaria and the potential seriousness of the consequences were 
also important with respect to perceptions of personal risk. There were various factors 
which influenced these beliefs. 
7.6.1 Personal susceptibility 
The first of these was connected to ideas of being personally susceptible to malaria. For 
example, two of the participants stated that they contracted malaria as children whilst 
their siblings did not, even though they shared the same sleeping space; a third decided 
to take particular measures to avoid being bitten, as he felt he had sensitive skin. None 
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of the others referred to a personal susceptibility to malaria. One for example described 
malaria as "not being my disease" whilst two young men referred to their current good 
health and physical strength to explain how they would be able to tackle any malaria 
infection, albeit with the use of malaria drugs. One VFR had sickle cell trait and 
recognised that it offered him some protection against malaria. Although no other VFR 
or patient had sickle-cell trait or disease, the former was known to be protective against 
malaria by another two who mentioned it. None discussed G6PD. 
None of the practice nurses stated that VFRs felt they were particularly susceptible to 
mosquito bites or to malaria, and two contrasted VFRs to some Caucasian patients who 
would describe during the course of pre-travel health consultations that they were often 
bitten by insects whilst on holiday. 
All but two nurses stated that patients seeking pre-travel health advice rarely mentioned 
sickle cell anaemia in the course of consultations. One said that a patient had mentioned 
that her sickle-cell trait afforded her protection but the nurse did not understand why 
this might be so. However, PNlO, the only practice nurse of African origin, said that 
patients did talk to her about their susceptibility with respect to either sickle cell trait or 
disease. None said that G6PD had been raised as an issue by VFRs in pre-travel health 
consultations. 
7.6.2 Previous experiences of malaria 
Another factor which influenced perceptions of the seriousness of malaria was previous 
experiences of this disease. Only one VFR had spent all her life in the UK. She, another 
VFR and one patient said they had never had malaria. A third VFR and one patient 
could not remember whether or not they had had it. The one patient who said he had not 
suffered from malaria previously attributed to this to being regularly dosed with quinine 
as a child. Apart from these respondents who did not believe they had previously had 
malaria, or who could not remember if they had had it, one other VFR recalled only 
having malaria when visiting Nigeria or Ghana on holiday whilst resident in the UK. 
Conversely, another only remembered episodes experienced whilst visiting the UK on 
holiday whilst resident in Nigeria. 
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Those VFRs and patient respondents who reported that they had had malaria were able 
to describe the symptoms that they first experienced during their childhood. These were 
depicted as feeling cold, vomiting, having a loss of appetite, weakness, dizziness, and 
headache. Several referred to discoloration of the eyes as being a symptom of the 
disease. On the other hand, other VFRs and patients could only remember symptoms, 
and at the time of the interview, stated that they assumed them to be malaria. 
Interestingly, six explained that they first had malaria after the age of ten and in their 
teenage years, although they were all born in either Nigeria or Ghana. The symptoms 
they described were no less mild than others, if these symptoms were indeed caused by 
this disease. Indeed, it is likely that some illnesses described had other aetiologies. Few 
could remember whether or not infections acquired in childhood and presumed to be 
malaria had been parasitiologically-confirmed. 
Only one VFR explicitly stated that she took chemoprophylaxis on each trip as a result 
of her childhood experience of malaria. For the remaining seven VFRs who always used 
chemoprophylaxis, more recent, rather than childhood experiences, appear to have had a 
noticeable impact on the decision to take chemoprophylaxis. These included an 
awareness of family and friends in Nigeria and Ghana who suffered from malaria, and 
of friends who had developed what was described as a serious, frightening illness 
diagnosed as being caused by this illness on return to the UK. 
Three of the VFRs said they did not purchase chemoprophylaxis in the UK when they 
travelled. Two others who were travelling for the first time since emigrating to the UK 
also did not intend to take it. Of these five, two explicitly described malaria as not being 
an illness that had affected them seriously in the past. However, one of these two 
described nearly aborting a baby from what could have been caused by malaria, but was 
explained by her as being an adverse reaction to chloroquine. The other, who was 
medically qualified, described his symptoms as follows: 
yeah I mean, for me I've had mild malaria, which is baSically vomiting, headaches. 
fever. but once I'd did have. like, lose consciousness. like faint. yeah. when I was at 
university, but uhh I'm kind of very aware of it. I see it all the time. I've worked in 
health care and that kind of·· a very common condition and. but I know il 's treatable 
as well 
Yeah 
so I've kind of treated myself a few times, except for one time. yeah even when I did 
lose conscious one year it was just very few minutes. I think I had a drip 
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Right 
In my own bedroom, you know, I could fix my own drip (VFR 1) 
Thus, this participant's attitude about the consequences of acquiring malaria was 
influenced in part by his confidence in managing previous infections. The perceived 
ease with which malaria can be treated was voiced by other VFRs who were not 
planning to take pre-travel advice, and this was described by them as one of the most 
important justifications for why malaria was not considered a serious disease. 
For patients, their personal recent experience made them particularly aware of the 
seriousness of malaria, and two of these who were planning to travel again in the near 
future asserted their intention to seek pre-travel advice and to recommend its use to their 
friends in the UK. 
Three of the six reported that they had been treated for malaria previously when 
travelling as a VFR. For two of these, these episodes had occurred approximately 20 
years previously, and it may be that the more recent episodes they had experienced 
refreshed their memories with respect to the previous illnesses they had experienced. 
They described extremely unpleasant symptoms, with one describing the experience as 
"intense". Nonetheless he also said that he had not been prepared for the severity of 
symptoms he experienced leading to his most recent admission to hospital. The second 
patient believed that he had had malaria previously when travelling as a VFR in 1990, 
but this was unlikely as he thought it had been acquired in Japan. His explanation 
concerning how the diagnosis was made was unclear, and is possible that he acquired 
malaria upon returning to Nigeria, or that he had some other disease. Whatever the real 
cause, he also connected this perceived malaria episode with severe symptoms. The 
third patient had more recent experiences of malaria, the most recent being in 2008. He 
reported that he had had malaria four times when travelling as a VFR and described the 
very unpleasant symptoms he had experienced on each occasion. His daughter had also 
been diagnosed with malaria when in Nigeria on a previous trip visiting friends and 
relatives. Thus, for these patients, it appears that the severity of previous infections, 
albeit several years ago for two of them, were not sufficient to ensure that 
chemoprophylaxis was not taken on subsequent trips. 
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Several community pharmacists and practice nurses considered that the impact of more 
recent experiences of malaria served to reinforce the perception of it being a serious 
illness in their patients or customers who sought pre-travel advice. These were either 
episodes of malaria they had witnessed in others, or were personal experiences. Some 
community pharmacists believed that a greater awareness of the potential seriousness of 
malaria amongst their Nigerian and Ghanaian customers could also be the result of a 
health promotion campaign about malaria run by the local peT, which included the use 
of posters placed in community pharmacy windows, stressing the risk of malaria from 
just one mosquito bite. 
GPs differed in their views about whether VFRs believed malaria to be a serious 
disease. They drew on their experiences of interactions with VFRs who attended for 
treatment, rather than prevention, to answer the question. The fact that VFRs presented 
with malaria type symptoms and wanted to have tests taken to determine if they were 
infected was given as evidence by some that VFRs took malaria seriously. However, 
two others described their VFR patients as being casual in their approach when they 
came for medical advice. Two reasons were thought by GPs to be pertinent to the 
perceptions ofVFRs about malaria. One of these was that some of their Nigerian and 
Ghanaian patients saw it as inevitable that they would become infected. The other was 
that previous experience of malaria-free trips made them consider it as not something 
likely to happen to them, and that if it did, they could get treated. 
Two of the three consultants believed that one reason why malaria was not seen as a 
serious disease in the Nigerian and Ghanaian communities was the ease with which 
previous malaria infections had been treated. One referred to the success of health 
promotion campaigns run locally (the same campaign referred to by community 
pharmacists), in beginning to make VFRs aware of the potential seriousness of this 
disease. 
7.6.3 Potential consequences of malaria infections 
To examine in more detail beliefs about the seriousness of malaria, as indicated in 
section 4.9.4, a question was added after 13 interviews, enquiring ifVFRs believed they 
themselves, or other VFRs could die from malaria. The results from seven interviews 
indicated a theoretical understanding that malaria could be fatal from all apart from one 
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of those asked this question. However, all believed that such an outcome was unlikely, 
and connected to specific factors, or the result of not accessing treatment promptly. 
These are illustrated in the following two extracts. 
Do you think that VFRs could die from malaria or do you think they would ju~·t 
become ill? 
Um, I thought they would just become ill. I thought they would just become ill. But I 
do know that cases have died from, um, from that, but then it could be that there are 
other confoundingfactors, they had the malaria and then something else, and they 
developed other things. I, I thought, but it also depends on where you go. Um. I do 
know that some people travel from here to very very, um very very remote areas (~r 
the country, and that's where their family is, that '.'I where they go, and it also 
depends on what you get involved in, and so yeah. it's possible, it is possible, hut 
urn, I wouldn't' sery probable (VFRI4) 
Do you think that you could die from it? 
No (laughs). No way 
Not at all? 
No way not at all 
Why 
I always take precautions, and once I realise the drug is not working I dash down to 
the hospital (VFR20) 
VFR14, cited above, also explained that her attitude about the potential serious outcome 
of malaria changed as a result of knowledge gained in her career: 
so I never thought that it was a very serious disease until, um, I travelled out and, 
then yeah, got into the medical profession and read about it, and realised that it can 
be very serious, but then ... I mean, when I was in Ghana, I never thought of it as a 
serious disease at all. (VFRJ4) 
In contrast, another VFR was unwilling to accept information acquired through the 
British media that differed from his personal experience: 
I mean I hear people talk about, um, "he's down with a bit of malaria" so, at home, 
it's almost like we talk about the common cold here. You know, sometimes J hear it 
being talked about as a killer disease in the press, and J guess. there are people it 
kills, but I have never personally known anyone who has been killed by malaria. 
(VFR16) 
Three VFRs were planning to take chemoprophylaxis because they did not want to 
return home with malaria symptoms, and one said this was particularly because the 
consequence of this would be that she would have to take time offwork immediately 
upon her return to the UK. 
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7.6.4 Immunity 
Another theme relating to perceptions of the seriousness of malaria involved beliefs 
about immunity. For some VFRs and patients, perceptions about immunity were linked 
to the concept of becoming a "stranger" after time spent away from Nigeria or Ghana. 
However, regular travel to these countries (maintaining familiarity) was seen as a reason 
for not needing chemoprophylaxis. These perceptions are illustrated in the following 
two extracts from VFR respondents. One (VFR7) who had lived in the UK for 19 years, 
the other (VFR8) who had been resident in that country for 25 years: 
If you've been here for a while, you know, 
there's no point of taking that risk, yeah, you go and see your doctor 
Why would it be important i/you'd been here for a while? 
Because, you know, you're living in a different, in a d{/ferent, how do I put it, a 
different environment, yeah, so it's like, you are a stranger there, as I can say 
because I've spent, what do you call it, my teenage years here, you know, so when 
you go there, it's like you don't live there any more so, everything is ... sometimes 
there is some certain food, I eat that, I get bellyache. When I was there, it wasn't 
like that, yeah, so everything has changed, so you have to, you know, take good care 
ofyourself(VFR7) 
In terms of the health concerns that you got, you mentioned, you know, food, 
water, insect bites, are there any of those that would be a priority or are they pretty 
much similar in terms o/priority? 
I don't know, because I travel regularly now, so I alwaysfeel I'm one o.fthem. So I 
mean, people talk about umm defences, about, what's the word I'm trying to look 
for? People talk about the defences of the body, so I, when you go regularly you're 
part of it. Perhaps, when I first started going, about once every four years, I used to 
take a lot of concern with umm, you know insect bites, you know, making sure I've 
got my malaria tablets, or doxycycline, but these days because I go regularly now, 
so it's like I've got my, I've always, you know, been used, I've built up umm, built up 
my own defence in my body (VFR8) 
Only one of the patients referred to his regular travel to explain why he did not take 
chemoprophylaxis. He explained that the reason he acquired malaria on the most recent 
trip was because he had become unusually fatigued, making him less able to withstand 
the infection. 
Several practice nurses described how some VFRs justified their decision not to take 
chemoprophylaxis by pointing out their African heritage. Other VFRs, they observed, 
focused specifically on the fact that they had been brought up in Nigeria or Ghana and 
had survived to adulthood without dying of malaria. 
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One hospital consultant summed up the attitude he believed was typical of many YFRs 
as follows when asked if patients believed they were immune to malaria: 
They don't understand it as that concept. They just understand that. their 
understanding is. when I was out there. I had loads of episodes of this. It never came 
to anything. I picked up a couple of tablets and it got better in two or three days. 
That's the worst it can be. 
So, it's not a question of "well, I'm now immune to it? 
No. It's just a question of, "well. I've survived it. It doesn't threaten me in any way. 
so .. . "(SCI) 
Another hospital consultant, who specialised in paediatric care, surmised that some 
parents believe that their own immunity is passed to their children to explain why 
children may not be given anti-malarials before travel. Other healthcare professionals 
however, felt that the majority of parents would prioritise malaria chemoprophylaxis for 
their children. 
Several of the community pharmacists also believed that YFRs felt they were immune. 
However, it was emphasised by two that this was based on an assumption on their part, 
rather than being based on actual conversations with customers. One pharmacist, herself 
of Ghanaian descent, who appeared to interact closely with the local Ghanaian 
community, perceived that YFRs believed they would not suffer serious symptoms 
because of the regular travel they made to Ghana, thus echoing the views of YFR8 and 
SCI. 
7.6.5 Peer pressure 
Many YFRs felt that their family and friends who lived in Nigeria or Ghana perceived 
malaria as to be a much less serious disease than they themselves did. This was because 
they were used to what they perceived to be easily treated episodes of mild illness. 
Some YFRs stated that their host family accepted the need for, and encouraged them to 
take anti-malarials, and indeed one who did not intend to take chemoprophylaxis said 
she was reminded by her family in Nigeria to do so. Others stated that the perception of 
malaria being a mild disease amongst their host family could result in some tension 
during their visit, for instance: 
Do you think that family and friends in Africa would have different attitudes 
(about the seriousness of malaria)? 
Yeah, they do 
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In what sort of way? 
It's like, you're living in there, it's like not any new to you or something like that, 
but when we from here go there, they say that we're doing things extreme, you 
know, we're being so protective and all that, yeah, but them, ii's a norma/thing to 
them, because ... 
Do you find it awkward when they think you are over the top? 
I do. I always argue with my mum you know, (laughter) 
So, she says you don't need to bother with it all? 
Sometimes "you were born here, so stop being like that, you know" (VFR7) 
Another explained that although criticism would not be made directly, it was assumed 
that it might happen: 
Would you think your friends and relatives in Nigeria would be surpri!l'ed if you 
started, showed that you were concerned about malaria and overtly ... tarted taking 
chemoprophylaxis? 
Yeah, I think some people would I mean, my parents probably wouldn't, obviously, 
they want the best for me, but there would be a bit ofsniggering in the background, 
surely. 
Not from your parents, or maybe from your parents? 
Maybe from them, but in the bedroom, away from me. 
Right 
Everyone would probably snigger. 
Why do you think they would snigger? 
Oh, just because they think, you know, we live here, we're not dead from this sluff. 
so what makes you think that just because you've lived away from us for a few years 
you've suddenly become so susceptible that and even if you did have malaria, what's 
the worst that can happen other than a few days in bed? (VFR 16) 
VFR12, one of the youngest VFRs to be interviewed was encouraged to take 
chemoprophylaxis by her mother, However, she described how peer pressure could be a 
deterrent to using chemoprophylaxis, not only in Ghana, but also from friends in the 
UK: 
What about friends in Ghana, would they think you were weird if you took 
chemoprophylaxis, drugs, or would they? 
Not weird, but, yeah, it sets you apart from the rest, 'cos, "you're still Ghanaian, 
why do you need to?". There is that. There is. Even amongstfellow Africans here, I 
have some friends from Zimbabwe, and I told one of them that I was, that I needed 
to get anti-malarials. He gave me the dirtiest look, like why do you need anti-
malarials? And they never take them, and they've been there for just as long 
Does that ..• is there any sort of peer pressure? 
(laughs) nO,no, no. you have to in the end don't you. You have to do what you have 
to do 
I don't mean peer pressure as in being teased 
I know what you mean. To an extent, because there's one thar I haven 'rrold I take 
anti-malaria/s, because I know he's just gonna have a go, but some I don't mind 
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telling, 'cos ... If 1 had my own way 1 probably wouldn 'I bolher, 10 be honest, and I 
would probably take the treatment, if anything 
What, a treatment if something happened? 
Yeah 
It's a weird question, but would it makeyoufeelless Ghanaian, if you started 
taking anti-malarials and doing all these things? 
It doesn't make me, but 1 can see how thaI would 
Do you think that would be important or not, or just be sort of, I mean, do you 
think that would be an important determinant o/people's behaviour, or mJt 
really? 
Nol really, because it really depends, there 's .~ome people who really enjoy, I mean, 
not feeling Ghanaian, so they would probably love to show off their anti-ma/aria/s, 
and some people would hide them, bUll think thaI's very individual 
Would you explicitly think that you don't want to show anti-malarial.f or ... 
(Laughs). I don't make an effort to hide them, bUll don', broadcasl il either 
And do you think that would be the same/or other people, or ... 
It really depends, 'cos for the people, 'cosfor Ihe Ghanaians born here iI's not an 
issue, they '1/ show iI, they '1/ say 1 have a travel clinic appointmenl, blah. hlah. blah. 
but for, let's say, Ghanaian students my age on holiday who end up staying.!lJr a 
year or so, umm, they probably would, umm, take the mickey a hit 
Do you think it's an age thing as well? 
No. 'Cos my dad makes fun of me as well 
(laughs) Does he? For doing it? 
Yeah 
So what does he say? 
You're losing your Ghanaianess. He always says that 
So it's just something to tease his daughter about? 
Exactly (VFR12) 
This respondent was keen to point out that peer pressure did not prevent her from taking 
anti-malarials, and also explained that she did not like taking tablets of any sort, which 
also influenced her decision making. However, these three extracts describe one aspect 
of the context within which decisions are made about taking anti-malarials by some 
VFRs. 
For no patient had peer pressure from friends and relatives in Nigeria or Ghana or in the 
UK acted as a deterrent to them purchasing chemoprophylaxis, and it was not 
mentioned by any other group of respondents as being a significant issue. 
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7.7 Chemoprophylaxis 
7.7.1 Choice of chemoprophylaxis 
Except for one VFR who worked as a nurse, none of the VFR participants appeared to 
be conversant with the various chemoprophylaxis options available to them. Instead, it 
appeared they would rely on the advice of the practice nurse with respect to which drugs 
to take, although one participant reported that she returned to her GP to change her 
prescription from AP to mefloquine because she preferred to take a weekly regimen. 
Five VFRs associated chloroquine with intense itching when used previously for 
treatment. This was the most common reason for the decision not to take chloroquine 
for any purpose. Only one VFR appeared to be aware of chloroquine resistance. 
For their part, practice nurses identified a range of issues that might influence the 
preference for one chemoprophylactic drug compared to another. They reported that 
some VFRs with children preferred mefloquine, as it only had to be taken weekly, 
whilst other adult VFRs asked to be prescribed alternatives to this drug because of the 
side effects they had personally experienced on previous visits. Nurses reported that 
other patients preferred AP because it could be started a few days before travel and only 
taken for one week upon return. Many VFRs were said by nurses to request the drugs 
they had been issued on previous visits, suggesting that once they found a regimen that 
suited them, they were keen to use it again. 
Other factors affecting the choice of chemoprophylactic drugs were also cited by the 
practice nurses. For example, one explained that patients who were pregnant, or were 
hoping to conceive while in Nigeria or Ghana, were mindful of any interaction between 
the drugs they might take and the unborn baby. Although the nurses said that they 
counselled these VFRs that it was safe to take mefloquine in the first and second 
trimester, some decided not to, or chose chloroquine-based drugs instead. Two practice 
nurses stated that younger Nigerian and Ghanaian patients were more likely to have 
researched the options for chemoprophylaxis on the internet and to be aware of 
appropriate drugs, compared to their older counterparts, who were more content to be 
guided by the nurse. 
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GPs were not asked about patients' choice of chemoprophylaxis, since, as explained in 
section 4.9.4, giving pre-travel health advice including recommendations about 
chemoprophylaxis was predominately the role of the practice nurse. 
None of the three hospital consultants felt that an awareness of parasite resistance to 
chloroquine would be a reason why patients might not take it. As was found with some 
VFRs, one of the consultants perceived that the association of intense itching 
experienced with taking chloroquine on previous occasions was a sufficient disincentive 
to prevent consumption of this drug. 
Community pharmacists explained that their priority was in dispensing the drug that had 
been prescribed, so their experience of travellers' choices of chemoprophylaxis was 
limited. One made the comment that some VFRs needed to be reassured that the 
chemoprophylaxis they had been prescribed would be effective. 
There was no consistent response given by community pharmacists about how many 
and why VFRs might seek to purchase chloroquine. Three of the seven respondents 
were rarely asked for this drug. The others reported that they were asked more regularly. 
The community pharmacist of Ghanaian ethnicity, who had worked in two different 
areas of London which operated different policies relating to the cost of malaria 
chemoprophylaxis, believed that in non LSL-areas, the cost of prescription-only drugs 
was the main reason why VFRs would seek to purchase chloroquine. None of the other 
community pharmacists mentioned this issue. The majority believed that their 
customers would be guided by their health advisor about what constituted the most 
appropriate chemoprophylaxis for them. 
7.7.2 Cost of malaria chemoprophylaxis 
The cost of chemoprophylaxis in the UK was a topic of discussion that, unlike many 
others, was initiated by some respondents rather than by me, particularly amongst those 
who considered cost to be a deterrent to its use. It was spoken about at times with some 
passion, highlighting the importance attributed to it by some respondents as a factor 
influencing all aspects of malaria prevention. 
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Of the eight VFRs who always took chemoprophylaxis, four considered the price of the 
tablets personally difficult to afford. One (VFR5) was a healthcare assistant, VFR 7 was 
a cleaner, VFR17 was a hairdresser and part time student, and VFRI9 was a housewife 
and also a part-time student. Three lived in areas of London where malaria 
chemoprophylaxis was not subsidised. Another also lived in one of these areas, but her 
GP would only subsidise the cost of chemoprophylaxis for her children. These 
participants had what appeared to be the least well-paid jobs among the VFR 
respondents. Three of the four were travelling with other members of their family. and 
the cost of chemoprophylaxis appeared to be a particular problem particularly when 
families were travelling together, as described by VFRI9, who was travelling for five 
weeks with her children 
Was that a problem for you? 
It was, because you're not expecting to buy that much, and after you've paidfor your 
tickets, and buying for £400, it's ridiculous, I mean, it's ridiculous, it is 
Did you manage to do it? 
Well, I have to, because I wanted the children to come in, I mean healthy after their 
holidays, and I wouldn't like any problem, but it's not something I can, most people 
can't afford to do it, especially if they've got three or four children. And ~fthey look 
at this, buying this medication, they will take the risk of going 
Without it? 
Without it. (VFRI9) 
A fifth VFR who always used chemoprophylaxis (VFR 11) had no problems affording 
the price of the unsubsidised chemoprophylaxis on her next planned trip as she was 
travelling alone, but described it as having been difficult to afford when she had 
previously travelled with her daughter and grandchildren. A sixth VFR (VFRIS) 
explained that the cost was not excessive for her personally, as she lived in an area 
where it was available for the cost of an NHS prescription, but described it as 
"prohibitively expensive" for her sister and her family who was travelling with her and 
lived in an area where it was not subsidised. 
The other two VFRs (VFR9 and VFR14), who regularly took chemoprophylaxis did not 
find it prohibitively expensive. One of these had not previously purchased it in the UK, 
but said he would purchase it irrespective of the cost as he was keen to protect his 
health. Both lived in areas where malaria chemoprophylaxis was only available on 
unsubsidised prescription. Both were travelling alone however, and one, (VFR9), was 
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an events organiser, whilst the other (VFR14) was a nurse, suggesting that they perhaps 
had more disposable income than some other participants. 
Two of the three VFRs who planned to use chemoprophylaxis on the most recent trip, 
but had only used it intermittently in the past considered that the cost was not good 
value for money. One of these, VFR 12, explained that her mother was paying for the 
chemoprophylaxis, as she was anxious for her daughter to protect herself against 
malaria, but the respondent considered the cost of chemoprophylaxis when purchased in 
the UK to be excessive: 
Last time I went I got given a prescription, and I can't remember if il was .Ii)r 
Mefloquine or the other one, but I remember I went to get itfrom Boots, and the 
person said "Oh, your GP must really love you to give you a prescription". I think il 
was a subsidised prescription because it came up to about £15 
So you went to Boots, and they said that your GP, or someone, must love you for 
giving it on prescription? 
Yeah, umm, and so I got the same one, I say, I can't remember which oflhe two it 
was, but when I went back, it hadn't been subsidised, or il was a lot more expensive, 
so the person said I would have to pay, I think £3 something per, per tablel, and it 
would come up to about £J 50 or something like that. So, I said, there's no way I'm 
paying that much for anti-malarial pills, so 1 went to get it changed, and then I got 
the weekly ones, which was fine because I don't like taking medicine that (~ften 
anyway (VFR 12) 
The other, who had sickle cell-trait, explained his viewpoint as follows: 
Is the cost of chemoprophylaxis a problem for you, personally? 
I would rather not spend that amount of money, but say, in the greater scheme of 
things, you know 
If you were travelling by yourself ... ? 
I certainly wouldn't get it 
Would cost be an implication? 
Yes, if I was travelling by myself, it would be a combination of cost and the fact that, 
look, I know what to do to protect myself, and I tend not to have malaria often 
anyway (VFR16) 
He also made the point that malaria chemoprophylaxis was not the only health-related 
expense that may be incurred for one visit, as other vaccinations may also need to be 
paid for, making the costs necessary for one trip excessive. 
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One consequence of the prohibitive cost, as asserted by one participant, was that VFRs 
would not take it, but instead use the option of buying cheaper drugs upon arrival in a 
malarious country: 
Do you think it would put people off or not? 
A lot of people, it would put them off, they wouldn 'I he bothered to get iI, yeah, I 
know for sure 
Do you? 
Some people they'd rather go home and take, buy it/rom there because the.v 'd get it 
cheaper 
Do they? Would they take it as chemoprophylaxis when they get over there, or ju.'it 
wait until they get symptoms, or if they get symptoms? 
Some, as soon as they get there they just start taking it cos it '.'1 cheaper, 
So do you think that's quite a big issue/or people, do you reckon? 
It is (VFRS) 
Of the three VFR respondents who never used chemoprophylaxis, none considered cost 
to be a deterrent. Two of these were in what appeared to be relatively well-paid jobs, 
one a senior nurse, and one a Government employee. The cost of chemoprophylactic 
drugs was not an issue raised by the two first-time travellers, nor for the VFR (VFR3) 
who intended to purchase it, but did not have enough time to visit the travel health 
clinic. None of the three who were lost to follow up indicated in the first interview that 
the cost of the tablets was an issue for them. 
None of the six patients who had acquired malaria (four who lived in areas where it was 
subsidised and two who did not) reported that cost had been a deterrent to its use. One 
patient explained that although he had purchased it for the price of an NHS prescription 
on a previous occasion, he did not realise that it was subsidised for all residents, but 
rather thought he was offered cheaper chemoprophylaxis because of his age. 
The majority of doctors and nurses working in LSL areas were broadly supportive of 
the policy of prescribing malaria chemoprophylaxis on an NHS prescription, although 
some GPs would avoid prescribing AP in particular because of the cost to the NHS. 
Some nurses working outside LSL stated that patients queried why they were expected 
to pay for the full cost, when subsidised chemoprophylaxis was available in a 
neighbouring PCT (an LSL area). The difference between the policy in LSL and that in 
other PCTs was described by nurses and some GPs as being confusing, and calls for a 
consistent approach across London were made, both for the malaria chemoprophylaxis 
policy and other pre-travel prophylaxis. 
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The nurses working in areas outside LSL recognised that the cost of drugs could be a 
deterrent to VFRs seeking pre-travel advice and starting chemoprophylaxis before 
travel. One for example, estimated that about 50% of her patients who were African 
male VFRs would not take chemoprophylaxis because of the cost. This was not always 
linked to the perception that chemoprophylaxis was prohibitively expensive, but also to 
the knowledge that other options were available: 
I. I think there's still this thing about. oh well my family will have something. and it's 
cheaper over there and I'll get it from them. and when you explain. well. it might not 
be the right stuff, you know. it's chloroquine based. it's "Oh well ii's worked bc:fiJre. 
so why shouldn't it work now"? And why do I want to give you. you know. or give 
the NHSfifty quid. or whatever? (PN3) 
For those community pharmacists who worked in LSL, the cost of chemoprophylaxis 
was only mentioned by their customers as being very expensive when the prescription 
was issued on a prescription for which they had to pay the full unsubsidised cost. This 
was either because the customer was not resident in LSL, or they were, but their OP had 
not written a subsidised prescription. However, community pharmacists felt that the 
majority ofOPs adhered to the policy within the area in which they worked. One 
however worked in LSL, where a few OPs within a practice would issue unsubsidised 
chemoprophylaxis and another was in an area where, although unsubsidised 
prescriptions should be issued, he believed that the personal relationship between OP 
and patient would determine how it was prescribed. Another community pharmacist 
described how some OPs working in an area where the subsidisation policy was not in 
place, they might ignore the policy with respect to children and issue them subsidised 
chemoprophylaxis. 
Of those community phannacists who worked in non-LSL areas of London, there was 
no consistent viewpoint about how the cost of chemoprophylaxis might affect decision 
making about its purchase amongst VFRs. This can be seen from the two following 
extracts, one from a community pharmacist who had just moved to an area within LSL, 
but had previously worked outside this area, and another who currently worked in 
Newham, an area where subsidised chemoprophylaxis was not available: 
So you do get Nigerians and Ghanaians coming in for health advice before they 
travel? Is this without going to their GP, but just sort of turning up at the 
chemist? 
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Some just tum up, because some of them won't, with the, in this area it's not that 
bad because you get the tablets on prescription, so, it's not that expensive to huy, 
and most of them are on income support so they do what they do. But those like, 
you have to pay for it on private, that is a lot of money, and most people try not to, 
10 avoid that, they '/I come in and askfor is there anything, like chloroquine which 
we don't, Ihey don't recommend any more. And most people, to avoid payinl{ 
hundreds of pounds for those tablets they would rather take the chloroquine, or not 
take anything at all and then go and come back with malaria (laughs) 
Do you think that, do you actually get people come in who haven't gone to the 
doctor's but just turn up and want to buy some sort of ... ? 
Yes because some of them don't have any idea and some o.fthem come and say, wel/, 
can we buy chloroquine, and you ask them what they want itfor, and then they say 
they wanna take prophylaxis, we travel, and then you have to tell them that they 
cannot 
(an interruption while she serves a customer) 
So you say that you get people turning up, and they come for chloroquine and 
stuff!. 
Yeah 
Can you quantify that, say in a month, how many would you get? 
Well, since I've been here, umm, not a lot, maybe about two came in, because they 
get, you know, the FP 10, so you don't actually get a lot of them because most of 
them don't have to pay for it, but when I was working in Croydon, it has to be a 
private prescription, you have to pay £10 for the prescription, and then you have to 
pay for the tablets. Most people try to avoid, avoid paying for it, they would rather 
buy the chloroquine over-the-counter, and then most of them say, we 'II leave it, wait 
till I get 10 Nigeria or Ghana, 1'1/ buy some malaria tablets and take them but they 
forget most of the malaria tablets there are for treatment but not for prevention 
That they want to buy? 
Yeah, 'cos most of them buy it when they go (CP2) 
Is cost a problem for people? 
Yeah 
Ok, how do you know? 
Well, ok. Cost is a problem in the sense that, I think, not a problem. 'cos they pay 
for it, but I think they're shocked by how expensive it is, umm, although I have had 
this year some patients who've, who left me prescriptions, but when they found out 
the cost, they've never been to pick them back up again 
Africans we're talking about? 
Yeah, they never come to pick them back up, but yeah. that was one-off, other than 
that, I think they all realise it's expensive, umm, and then I explain to them, and say 
why isn't it prescribed. and I tell them it's N HS policy, look, if you can afford a 
plane ticket then, they expect you to be able to afford your own health care out there 
as well, so, and generally they're alright 
They're ok about it? 
Yeah, I don '(' really get complaints as such, they might grumble a bil, but they '/I 
pay for it (CP7) 
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Of the three hospital consultants interviewed, all three considered the cost of 
chemoprophylaxis to be a deterrent for some patients. One considered that for this 
reason, chloroquine may be used as an alternative by some, particularly when they were 
travelling for longer periods of time. Another, himself of African origin, felt that the 
intense itching that chloroquine can produce would be a sufficient deterrent for some. 
Extracts from all three interviews with hospital consultants are provided below: 
The majority haven't taken any chemoprophylaxis. 
And do they say why? 
Um, a combination of reasons. Many who say "ah, I just can't be arsed", and a 
significant number who say it's too expensive. Some will say, "1 just can't handle it. 
It's just too revolting, doxycycline, that makes me sick, and that makes me do thaI, 
and reasons of either past experience, or very initial experiences wilh 
chemoprophylaxis, and they just abandon it. So, it's a mixture, a mixture of reasons, 
bui I think "can't be arsed" or "too expensive" they are the two common ones (SCI) 
Do people ever mention the cost of chemoprophylaxis as being a reason why they 
haven't taken it? 
Uh, yes I have, um, I mean some people, you know, would, particularly with some of 
the antimalarials that are appropriate, you know, Malarone for example, which I 
think is quite, quite costly. I mean if you take a family of, you know, three or four 
you know, and yourself taking a, if you're therefor two months, um, you know, the 
cost is, is quite significant, and I think that's, most, and so most people do mention 
the reason why they haven't taken it is, is cost, and whether that's, whether that's the 
reason why they're selecting, you know, ineffective drugs, you know chloroquine, 
proguanil, because it's cheaper, and, and you can get it, maybe, and I'm not clear 
whether why that's the reason why people are goingfor, you know, cheaper options, 
because they think ok, this is going to cost us less ifwere goingfor x number of 
months (SC2) 
And you think that the cost is a big problem? 
Well, anything that, yeah, anything that stops you, I mean, if you did pay for it, it's 
bloody expensive 
It is 
So that, and if you ... you know, no one's gonna pay that are they? It's 80, 100 quid or 
something like that for a course, so, you know. Forget about it. 
But do the patients actually say, "Well, it was expensive?" 
Yeah, people have said to me, yeah, there's cost involved 
Many of them, or •.. ? 
Yeah. A few (SC3) 
This respondent was not aware that malaria chemoprophylaxis could be purchased on an 
NHS prescription in the area in which he worked. 
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7.7.3 Strategies to manage the cost of chemoprophylaxis 
None of the VFRs mentioned strategies that they would use to manage the cost of 
chemoprophylaxis. 
Practice nurses described a range of strategies which were taken by their patients to 
make the cost more manageable. For example, practice nurses reported that on 
occasion, the purchase of chemoprophylaxis was prioritised by their VFR travellers to 
mothers and/or children only, with fathers deciding to buy drugs upon arrival in Nigeria 
or Ghana. This prioritisation within families was linked to perceptions of men as being 
physically stronger and so able to withstand malaria infections. Other strategies adopted 
included asking practice nurses for the names of the drugs recommended, with the aim 
of buying a cheaper version in Nigeria or Ghana or changing the initial prescription for 
a cheaper regimen, in particular from AP to mefloquine. Some might choose to 
purchase chloroquine. 
Nurses expressed frustration that they had put much effort into educating themselves 
about chemoprophylaxis, only for it not to be purchased by some VFRs because of the 
cost. A few stated they had better job satisfaction working in more affluent areas where 
patients were more "compliant". Strategies they employed to persuade VFRs to take 
chemoprophylaxis included not telling travellers the likely cost of the prescription at the 
pre-travel interview but hoping that it would be purchased once the commitment to buy 
it had been made; encouraging patients to buy a few tablets in the UK to provide 
protection upon arrival in the malarious area, even if the rest was purchased abroad; 
issuing FP 1 Os for children, but not for adults in non-subsidised areas, particularly if it 
was felt that the child would not otherwise be given anti-malarials; advising patients to 
compare prices in different pharmacies; reinforcing the risk of acquiring malaria whilst 
travelling to a malarious country. 
One community pharmacist, like some practice nurses, would recommend to customers 
that they restrict their purchase of chemoprophylaxis in the UK to that needed during 
the fIrst days of as stay in Nigeria or Ghana, and suggested that they then buy a cheaper 
alternative from a reputable pharmacy. 
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7.7.4 Adherence to chemoprophylaxis 
Of the eight VFRs who always took chemoprophylaxis on the most recent trip, seven 
were still taking it at the time post-travel contact was made. However, one was 
experiencing symptoms which she attributed to side effects from the chemoprophylaxis, 
and at the time of the email correspondence carried out with me upon her return, was 
intending to visit her GP to get it changed. 
VFR3, who had appeared to be committed to taking chemoprophylaxis before travel had 
described how the families of professional clients of his had travelled from Nigeria to 
the UK to be treated for malaria, to emphasise how he recognised malaria as being a 
serious disease. Despite this, on his return to the UK, he reported that he had not had 
enough time to visit the privately-funded travel clinic where he had intended to 
purchase his chemoprophylaxis a few days before travel. He had borrowed some from a 
friend who was travelling with him, and used this whilst abroad. He had intended to 
purchase chemoprophylaxis to finish the course upon return to the UK, but again, had 
not had time. He reported that on previous trips he had never finished a course of 
malaria chemoprophylaxis. 
Those three who intended to use it on their most recent trip, but took it intermittently on 
previous trips reported that on this most recent visit, they had completed the course. 
One however said that on previous trips she had not done so consistently. 
Many practice nurses felt certain that VFRs did not finish the course of 
chemoprophylaxis prescribed and some of their patients confirmed this to them during 
subsequent pre-travel health consultations. They reported that some admitted on 
attending for pre-travel health advice that they had some tablets left over from a 
previous trip, but others were reluctant to admit that they had not finished the course, 
even then they returned with malaria. Some practice nurses felt that adherence to 
mefloquine was particularly problematic, as when patients returned from their trip 
symptom-free, they felt no need to fmish the course, which would still take several 
weeks to complete. One Ghanaian-born practice nurse considered the purchase and 
failure to adhere to the prescribed course as a ritual regularly undertaken by VFRs. 
Although pre-travel health advice was routinely sought, once relaxed and enjoying 
themselves on holiday, she described how they regularly neglected to finish it. 
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Only one hospital consultant mentioned lack of adherence to anti-malarials as being a 
reason why he thought VFRs might contract malaria, and, as mentioned by the practice 
nurse referred to above, felt that they might forget to take chemoprophylaxis when they 
were in a holiday mood. 
7.8 Discussion 
The data from the interviews with the VFRs and patients in this study suggest that their 
major health concerns when they went to visit friends or relatives in Nigeria or Ghana 
were associated with risks that they had commonly encountered on previous trips, for 
example gastro-intestinal problems or malaria, or risks that were perceived to be 
particularly hazardous with an unclear outcome, such as road traffic accidents and 
typhoid fever. Reports from the Health Protection Agency suggest that there is a high 
incidence of gastrointestinal illness amongst VFRs (Health Protection Agency, 2007a). 
Concerns about contracting gastrointestinal illnesses were also found in the study by 
Leonard and VanLandingham referred to in section 3.5.2 (Leonard and 
VanLandingham, 2001). 
These data suggest that the participants were not only concerned about the risks that 
they perceived to be the most hazardous (as suggested by Slovic 2002) but also with the 
risks that they considered might most likely occur, and which were not life-threatening. 
Furthermore, few VFRs and one patient believed that they had not suffered from 
malaria before, and as such, malaria was a disease that had already been experienced 
and survived. That is, it was a risk, but one with known consequences. Many studies in 
endemic areas in Nigeria and Ghana have found that these perceptions of malaria are 
commonly found among local populations, that is, that malaria may be a serious illness 
among children but is generally perceived to be a mild febrile illness that, if not 
avoidable, is often treatable in the home (McCombie, 2002, Adongo et aI., 2005) 
Whilst the fmdings of Bazaz and colleagues (Bazaz et aI., 2010) described in section 
2.5.1 show that travel health information provided with airline tickets is not routine, 
this thesis suggests that for these participants at least, it was not a useful way of 
providing information. Few respondents read it, and those who did felt it was not 
applicable to them. 
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In common with other studies carried out among the African Diaspora (Leonard and 
VanLandingham, 2001, Pistone et aI., 2007, Schilthuis et aI., 2007), all VFRs and 
patients involved in this study knew that malaria was transmitted by the bite of a 
mosquito. They were also aware that when they made trips to visit friends and relatives 
in Nigeria and Ghana they were visiting a malaria endemic country putting them at risk 
from contracting the disease. This was also a finding from previous studies (Scolari et 
aI., 2002, Pistone et aI., 2007, Schilthuis et aI., 2007). Furthermore, the health 
professionals and community pharmacists were all conscious of the fact that it was not a 
lack of knowledge of the likelihood of contracting malaria that put VFRs at risk and 
influenced their adoption of appropriate preventive behaviours. 
VFRs and patients understood the differences in the risk of transmission between urban 
and rural areas of Nigeria and Ghana. They were also aware of how a lack of adequate 
vector breeding site management, even in urban areas, could increase their risk of being 
bitten. However, despite the fact that most mentioned that they took some form of 
action to avoid being bitten by mosquitoes, the perception was that this was inevitable. 
This was also a finding from the study carried out by Leonard and VanLandingham 
(Leonard and VanLandingham, 2001). Some of the older VFRs and patients appeared 
to be surprised by the breakdown in local environmental control measures witnessed on 
their most recent trip, suggesting that they were unaware of how local or national 
environmental health policies, or the priority given to their implementation within their 
country of birth, may change over time. 
With respect to mosquito avoidance methods, most VFRs reported that they adopted the 
established methods used by their hosts, emphasising their wish to fit in with families' 
customs. None ofthe participants reported using 'traditional' methods such as the 
burning of herbs to avoid being bitten by mosquitoes, as described in three studies 
carried out in Nigeria and Ghana (Ahorlu et aI., 1997, Agyepong and Manderson, 1999, 
Adedotun et aI., 2010), but rather reported that they relied on more modem methods 
such as the use of an air conditioner, window screening, house spraying with 
insecticides and nightly spraying of individual rooms with an aerosol insecticide. 
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Some VFRs who had affinned before travel that household sprays were routinely used 
by their families reported upon return that they were not. This discrepancy between 
intentions and actual behaviours with respect to mosquito avoidance methods was also 
noted in the study of French VFRs who were visiting friends and relatives (Pistone et 
aI., 2007). In some cases, in the research carried out for this thesis, the reason given for 
not using sprays was simply because there were no mosquitoes. Without knowledge of 
local transmission rates, it is not possible to comment on this, but it is possible that the 
prevalence of mosquitoes is decreasing, as suggested by Behrens and colleagues 
(Behrens et aI., 2008), and discussed in section 1.3. Other factors however, such as 
returning home late, were also given as a reason by one patient to explain why a room 
spray was not used, suggesting that intentions were not always easy to carry out. 
Whilst the HPA malaria prevention guidelines recommend the use of bed nets when 
window and door nets are not available (Health Protection Agency, 2007b), the negative 
attitude towards them by VFRs and patients was striking. One of the principal reasons 
given by VFRs and patients for not using bed nets was similar to one reason found to 
deter people in studies of bed net use carried out in Nigeria and Ghana, namely that they 
exacerbate the discomfort of an already hot and stuffy atmosphere (Agyepong and 
Manderson, 1999). In several instances, VFRs and patients drew on childhood 
memories of sleeping under bed nets and these experiences infonned their current 
opinions. Furthennore, it was clear that many of the participants perceived that more 
convenient ways were now available to control the environment. These perceptions 
were reinforced by a desire to fit in with the local nonns of their hosts, for whom bed 
nets were a necessity only for children who needed additional protection. This finding 
echoes those studies which found that children are often given priority because of their 
particular susceptibility to malaria (Agyepong and Manderson, 1999, Adedotun et aI., 
2010) 
The findings about perceptions of the seriousness of malaria are in agreement with other 
studies among VFRs, and illustrate the many factors that contribute to decisions about 
the use of preventive behaviours (Leonard and Vanlandingham, 2001, Morgan and 
Figueroa-Munoz, 2005, Pistone et aI., 2007, Schilthuis et aI., 2007). However, the data 
from this thesis also suggest that peer pressure, the desire to 'fit in' with local nonns, 
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and perceptions that the destinations to be visited are still 'home' may also playa role in 
the decision making of some VFRs. 
The concept of belonging (remaining a 'Ghanaian" or 'Nigerian' despite being resident 
in the UK) also appeared to playa small, but perhaps important, role in decisions 
relating to chemoprophylaxis. That is, a few of the VFRs suggested that the need to 
take chemoprophylaxis marked them out as different to the friends and relatives that 
they would be visiting, and this might be a factor to be taken into account when 
deciding whether or not to initiate chemoprophylaxis. 
In contrast to many other preventive measures (e.g., the use of house screening, house 
spraying, repellents) the use of chemoprophylaxis in endemic countries is rare. Perhaps 
not surprisingly, therefore, while knowledge of the value of physical protection against 
mosquitoes was common amongst VFRs there was much less awareness of options 
available for drugs, and VFRs relied for their information on the expertise of practice 
nurses. 
In line with the findings from other studies (Leonard and VanLandingham, 200 I , 
Schilthuis et aI., 2007), the cost of chemoprophylaxis was cited as a deterrent to its use 
by some respondents in all groups. However, although some of the respondents were 
very vocal in the discussion of this topic, overall the data suggest that the cost of 
chemoprophylaxis was not a decisive factor for all in their decision making. On the 
other hand, for a few of the VFRs who were resident in non LSL areas, decisions 
around where to access drugs for chemoprophylaxis (either through the UK health 
sector, or in Nigeria or Ghana) do appear to have been influenced by the differences in 
cost of drugs between these countries. 
The data presented in this chapter suggest that the majority of the participants in this 
study were well aware of the risks of contracting malaria and of most of the measures 
that could be used to prevent them from contracting the disease. it is also clear however 
from this small sample that there are a range of social, cultural, environmental, 
economic and structural factors that affect their ability and willingness to seek pre-travel 
health advice and adopt the preventive behaviours suggested including: the 
destination(s) to be visited; knowledge of malaria transmission; beliefs about the 
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seriousness of malaria; previous experience of preventive measures in the destination 
that they will be visiting; previous experiences of malaria; perceptions of their 
relationship to the people and places that they will be visiting; the cost of 
chemoprophylaxis. The following chapter provides a more detailed analysis of the 
factors that might contribute to the ability ofVFRs to access chemoprophylaxis before 
travel. 
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Chapter eight: processes surrounding the seeking 
and provision of pre-travel health advice. 
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This chapter explores in more detail the process of seeking and providing pre-travel 
health advice. It describes the sources of information available to practice nurses and 
community pharmacists. The problems mentioned by GPs and practice nurses 
connected with the operation of a pre-travel health advice clinic are also discussed. The 
issues surrounding access to pre-travel health advice are described, and in particular the 
problems associated with travelling at short notice. The chapter finishes by describing 
some relevant information with respect to patient-nurse interactions in the travel health 
clinic. 
8.1 Perceptions 
8.1.1 Nurses' perceptions of VFRs who attend travel health clinics 
Nurses reported that some of the VFRs attending pre-travel clinics were travelling for 
the first time while others had travelled previously. They described three types of 
Nigerian and Ghanaian travellers who sought pre-travel advice. The first group 
consisted of those who were travelling back to visit friends and relatives with their 
children during the summer, winter or Easter holidays. Trips were taken typically for 
two to six weeks, depending on the time available to them. Not all family members 
would necessarily travel together, and this was thought to be associated with the 
expenses involved. The second group consisted of those travelling for births, marriages, 
and funerals. These trips were often shorter. The third group consisted of those who 
might own accommodation in Nigeria or Ghana, who spent more time in these countries 
and travelled for up to three months or more at anyone time. 
Nurses reported that they rarely questioned VFRs in detail about the areas of a country 
they would be visiting on their next trip, but they believed that most VFRs were 
travelling to urban areas. 
Women would typically be responsible for bringing children to the travel clinic; men 
would come alone. One possible reason was assumed to be because men had to fit in an 
appointment around their work schedule. Another was that childcare was traditionally 
the role of women. 
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8.1.2 Community pharmacists' perceptions of VFRs who used pharmacies for 
pre-travel health advice 
Community pharmacists stated that some VFRs tried to use their services for the 
purchase of chemoprophylaxis. Whilst some respondents were not able to estimate how 
many VFRs did this, estimates made by others ranged from one customer each month to 
about 12 a month in the summer, when more people travel. Community pharmacists 
emphasised that they had limited time available to talk to their customers, and some of 
their understanding about the characteristics of VFRs was based on their assumptions. 
They believed that most VFRs had travelled to Nigeria or Ghana previously, although 
some were fIrst time travellers. The average duration of travel for VFRs as estimated by 
community phannacists was between three and six weeks, although two felt that many 
would be travelling for between two and up to six months. Most VFRs were thought to 
be travelling to urban areas, but in a similar way to practice nurses, community 
pharmacists did not possess a detailed knowledge of the geography of these countries. 
Four pharmacists thought that there was no difference in the number of men compared 
to women who used their services for pre-travel advice, whilst three felt that more men 
than women would do this. One felt this might reflect the desire of some men to follow 
the practice common in Nigeria or Ghana of using local pharmacies for the purchase of 
malaria drugs. 
8.2 Sources of Information 
8.2.1 Sources of information for travel health nurses 
The nurses interviewed considered the most reliable source of information to be the 
website Travax (Health Protection Scotland, 2011) (see section 2.5.3). This was the 
most popular system used. The advantages of this system, as explained by practice 
nurses, were that it allowed them to show patients maps of the areas being visited, and 
point out the likelihood of acquiring malaria in these. Up-dates were continuously made 
by the website providers, which reassured practice nurses that they were receiving 
current advice. Using just one source of information was most convenient for the 
majority of the nurses interviewed. Another source of information mentioned was the 
HPA's malaria prevention guidelines (Health Protection Agency, 2007b). 
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Practice nurses explained that some travel scenarios presented to them were 
complicated, for example the correct regimen to offer pregnant women. In these cases, 
the expertise of GPs was sometimes called upon. 
8.2.2 Sources of information and the role of community pharmacists 
All community pharmacists reported that they used information provided by the 
National Pharmacy Association for information they might need regarding 
chemoprophylaxis. Other sources of information were MIMS, or the British National 
Formulary, both drug prescribing databases. The focus of their role was to ensure that 
the dosage of drugs prescribed was appropriate, for example that children had not been 
prescribed with an adult dose. As was the case for practice nurses, there were no 
problems for community pharmacists to get access to accurate up-to-date information. 
Although community pharmacists reported that GPs sometimes incorrectly prescribed 
chloroquine, the majority of prescriptions were suitable for the area being visited. One 
community pharmacist said that patients occasionally told him that they had been 
directed by the practice nurse to purchase chemoprophylaxis from him, despite the area 
being visited by the traveller requiring the use of prescription-only drugs. 
8.3 Pre-travel Advice 
8.3.1 Operation of travel health clinics 
A range of three to eight weeks was suggested by practice nurses as being an 
appropriate time before travel that travellers should seek health advice. 
Consultations with travellers typically lasted between 15 and 20 minutes although some 
practice nurses reported that they allocated double that if the patient was travelling for 
the first time. For families who came to the clinic together, separate consultations were 
carried out for each patient to ensure that advice was tailored to their needs. In some 
practices, the time allocated for consultations was set by the GP, and often judged by 
nurses as being inadequate, particularly when additional time was needed to persuade 
VFRs to take anti-malarials. 
Practice nurses who gave pre-travel advice may have been keen to portray their 
practices in a wholly professional light. In addition, those GPs who recommended to me 
which nurse in their practice might be interviewed may have selected those whom they 
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judged were most experienced, personable, and able to highlight the professionalism in 
the practice. The information collected during the practice nurse interviews did suggest 
a high level of commitment to providing high quality pre-travel service. For example, 
in some practices where nurses were allowed flexibility in planning the services they 
operated, efforts were made to arrange clinics at times convenient for patients, including 
one practice which offered a service on one evening a week until 8pm. Others had set 
up systems where an initial telephone consultation was made with the patient, with a 
subsequent appointment arranged if necessary, thus saving themselves and patients 
time. Some were disappointed when GPs had changed clinics to times which practice 
nurses felt patients would find it more difficult to attend. On the other hand, travel 
health clinics were operating within GP practices that were described by GPs and 
practice nurses as being extremely pressured by their workload, not only with requests 
for pre-travel advice, but in all respects. As such, both GPs and practice nurses reported 
that some patients found it difficult to get an appointment at a time convenient to them. 
At the time of the interview, the travel health service had been suspended for the last six 
weeks in one practice to enable practice nurses to prioritise other work. This practice 
was in a deprived area of South London, but those seeking pre-travel advice were 
directed to privately-operated (ie non-NHS) travel clinics for which they would be 
obliged to pay for a consultation. In this practice the priority, as described by the OP 
interviewed, seemed to be on providing services which attracted payment through the 
QOF system (see section 2.5.1), if key performance indicators were met. Other practice 
nurses described how GPs were starting to consider the cost-effectiveness of offering 
travel services, as the provision of travel health advice was not included in these 
performance indicators. 
8.3.2 Access to pre-travel health advice 
Discussions about access to health care included both factors associated with GP 
registration, and the availability of appointments to obtain pre-travel health advice. 
One VFR who did not plan to get pre-travel health advice based his decision partly on 
the fact that he was not registered with a GP, and found it difficult to find one who was 
accepting new patient registrations. He had stayed no longer than one year at the same 
address in the last eight years, and explained that as soon as he registered with a GP, he 
moved again. However, access to primary care was not the only factor in his decision 
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making about malaria protection, as he felt able to manage any symptoms of malaria 
should they occur. 
All other VFRs and patients interviewed were registered with a GP. 
Community pharmacists stated that difficulties with GP practices accepting new patient 
registrations were an uncommon reason for their Nigerian and Ghanaian customers to 
seek pre-travel health advice from them. One felt that where this might occur, it would 
be because they were keen to avoid contact with Government agencies. 
With respect to the issue of seeking a timely pre-travel health appointment, few VFRs 
interviewed reported problems. However, this may have been uncomfortable for some 
to express in front of someone who may have been seen as representing the health 
service, ifit were thought that any complaints might be relayed back to the GP. 
However, two of the six patients interviewed did complain vociferously about their 
inability to obtain chemoprophylaxis before travelling. It was possible that they may 
have been keen to deflect any possible criticism surrounding their own personal 
responsibility with respect to protecting themselves against malaria before travel. Even 
so, for one of these two patients, his desire to share his frustration and annoyance, 
coupled with his wish to assert that malaria chemoprophylaxis should be available at 
short notice, were the reasons he agreed to be interviewed. The personal circumstances 
they describe are interesting as they illustrate the range of factors which influence 
decision making. The first patient, whilst describing himself as perhaps complacent, and 
acknowledging he had left it too late to book an appointment for pre-travel advice, had 
medical problems which had restricted his mobility for three weeks. This, together with 
the need to buy many presents for his host and family had prevented him accessing pre-
travel advice until the day of his travel. As he described it, he had forgotten the most 
important thing, his own health. On attending the GP surgery he was directed to a 
privately-funded British Airways Travel Clinic, which was too far away for him to 
attend, and which he was disinclined to visit because he felt it unjust that the local free 
service was not available to him. Although he went to a local pharmacist who was a 
personal friend of his to try to buy AP, he was unable to do so because of its status as a 
prescription-only drug. 
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The second patient, who had decided with four days' notice to go to Nigeria to care for 
his sick mother, reported that although he obtained an appointment with his GP, he was 
unable to get any chemoprophylaxis. He did not explain clearly why this was so, but 
described that he was directed to visit a pharmacist instead. On attending the 
pharmacist, he found the queue to be too long and decided not to wait. His decision to 
travel without prophylaxis was also influenced by his opinion of himself as being a 
physically fit man able to withstand any illness he thought likely to afflict him. 
Practice nurses stated that whilst many travellers, including VFRs, sought pre-travel 
advice in time for appropriate vaccinations and malaria chemoprophylaxis to be 
prescribed, some only attempted to do so a few days before travel. This last-minute 
attendance was frustrating for several of the practice nurses interviewed. However, very 
few reported that they asked patients why they left it so late, assuming that it was 
because the patients could not be bothered. Others however, acknowledged that some 
patients would be at work and so unable to take time off to attend the GP surgery, or 
might be arranging other aspects of their trip. One older practice nurse explained that in 
her experience many 'late attenders' were travelling to funerals at short notice, and 
related that some had very sad stories to tell. She gave the impression that having the 
time to talk to patients enabled her to view them as individuals, and as she described it, 
she had "learned to listen". Other nurses though, were obviously operating within 
particular time constraints and because of this, their priorities were to ensure that 
travellers were given as much protection as possible. They gave the impression that they 
did not consider it their role to initiate discussions about the reasons for delay. 
Community pharmacists stated that VFRs who accessed their services would seek pre-
travel advice from them between one or two days and a month before travel, with the 
average estimated to be about a week or two. 
Although four of the patients decided to travel less than a week before their departure, 
consultants did not mention travelling at short notice without time to access pre-travel 
health advice as a common reason why VFRs acquired malaria. 
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8.4 Practice nurse and VFR interactions 
Many of the VFRs participating in this study considered themselves to have accurate 
knowledge about malaria transmission, and from their experiences, to be familiar with 
managing malaria. By contrast, the experience of many practice nurses was of VFRs 
typically being passive recipients of health advice during pre-travel consultations, both 
with respect to malaria and for other pre-travel health issues. The nurses reported that 
although some travellers who were VFRs requested protection against specific diseases 
including malaria, typhoid and cholera, more commonly, VFRs stated that they were 
travelling and asked for advice 
Nurses acknowledged that their role was to impart pre-travel health advice. There was 
an assumption by one nurse in particular that the provision of correct knowledge would 
be all that was required to ensure that patients would protect themselves against malaria, 
and she expressed surprise when told the number of infections due to this disease in the 
PCT in which she worked. Many nurses explained that there was little time available to 
become involved in more in-depth discussions with travellers and it seemed that some 
nurses felt under pressure to "tick all the boxes" to prove that they had provided all the 
infOImation patients might need. 
The difference in ethnicity between some practice nurses and VFRs seemed to 
occasionally instil a feeling of awkwardness among a few of the practice nurses. For 
instance, one nurse of Caucasian ethnicity, described how she had taken the trouble to 
provide information to some other Caucasian travellers about bednets, as she had sought 
out this information recently for her son. However, she admitted that she did not always 
give the same advice to those of African origin, and was unsure if they would follow the 
advice given. Another nurse of Caucasian ethnicity described how the expression on the 
faces of some African patients "glazed over" when they were receiving advice about 
mosquito avoidance measures, and it was felt certain that it would not be followed. 
Although there were few examples of racial prejudice, one community pharmacist 
insinuated that VFRs were taking advantage of the NHS by accessing quantities of 
drugs for relatives resident in Nigeria or Ghana, and described how patients might 
"twist the arm" of the doctor to persuade him or her to give them more than the limits 
imposed by UK regulations. She described how the "natives of Africa" do not worry 
218 
about what medicine they get compared to British people, who she believed, may have 
read about the side effects of drugs in the press. 
Being of African origin did not in itself act as a guarantee against stereotyping. For 
example, one Ghanaian community pharmacist was surprised at someone of African 
ethnic origin wanting to buy a bed net. Another GP (of Sri-Lankan descent) cautioned 
against stereotyping one entire community, and alluded to a change in attitudes to risk 
over time by some of his Nigerian patients, some of who he felt were coming forward 
more frequently to access pre-travel advice than previously. 
8.5 Discussion 
Access to knowledge about chemoprophylaxis was not a problem for practice nurses or 
community pharmacists. Instead, the most significant issues discussed in this chapter 
were access to pre-travel health advice, particularly when travelling at short notice. 
With respect to the operation of pre-travel health clinics, some practice nurses appeared 
to have more autonomy than others in deciding the times when they ran. Where this was 
the case, travel clinics were organised broadly in line with the recommendations 
suggested by Chiodini (Chiodini, 2005) which were described in section 2.5.3, 
demonstrating that nurses were aware of the benefits of providing flexible clinic times. 
On the other hand, others appeared to be operating within a system which they 
perceived as inadequate, but over which they had little control. Then again, whilst GPs 
appeared to have more influence over the running of pre-travel health clinics, they were 
also working within their own constraints and the demands and opportunities of QOF, 
the quality and outcomes framework outlined in section 2.5.1, through which GPs are 
financially rewarded for reaching certain targets, and which do not include the provision 
of travel health. Despite the concerns of practice nurses and GPs about some patients 
having poor access to pre-travel health services, the majority ofVFRs who intended to 
seek pre-travel health advice did not report this as being a problem for them, 
In section 2.5.2, it was noted that there was no consensus amongst healthcare providers 
about the amount of time before travelling in which travellers should access pre-travel 
health advice. Similarly, there was no consistency to the time considered appropriate by 
practice nurses who took part in this research. Even so, whilst guidelines on the amount 
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of time before which travel advice is sought may be appropriate for those who make 
journeys which are planned well in advance, these will not be useful for those travelling 
at short notice. Although practice nurses considered this latter group to be a particular 
problem for them, there does not appear to have been any research carried out to 
investigate the extent to which this results in VFRs returning to the UK with malaria. 
The feelings of awkwardness between ethnicities when they occurred were perhaps 
because nurses recognised that patients did not appear to listen to the advice given about 
mosquito avoidance methods in particular. Interestingly, although many VFRs appeared 
in the interviews to assert their expertise with respect to malaria, many practice nurses 
noted that they were passive recipients of health care, appearing to rely on the expertise 
of the nurses for chemoprophylaxis advice in particular. One explanation for this may 
be that VFR travellers are less knowledgeable about the options available to them with 
respect to chemoprophylaxis, compared to other methods of malaria control. 
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Chapter nine: the diagnosis and treatment of 
imported malaria. 
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In the introduction to this thesis prompt diagnosis and treatment of malaria was 
described as being one of the four components of the "ABeD" of malaria control in the 
UK. The aims of this chapter are to explore attitudes towards malaria treatment in 
Nigeria and Ghana and in the UK, and describe the actions taken by patients and by 
clinicians to manage individuals when symptoms present. Barriers which may result in 
a delay in prompt diagnosis and treatment are also discussed. 
9.1 Diagnosis and treatment of malaria in Nigeria or Ghana 
VFRs were asked what action they would take if they developed symptoms which they 
thought might be malaria when they were in Nigeria or Ghana. The plan most 
commonly described was that if symptoms were similar to those previously 
experienced, they would monitor their own condition for 24-48 hours. Twelve of the 20 
respondents said that, following the initial monitoring period, if they were still sick, 
they planned to treat themselves. Of these, 11 said that they would purchase drugs for 
self-treatment from a community pharmacist, and one said she would double her dose of 
the antibiotic doxycycline, the chemoprophylactic drug she always took. If symptoms 
persisted after self-treatment was tried, they would seek medical advice. The eight 
others would not treat themselves, but would seek medical advice if they had not 
recovered within 24/48 hours. 
Four VFRs had relatives with medical expertise in Nigeria or Ghana and they would 
take advantage of this source of advice, whether they planned to treat themselves or not. 
The advantages of obtaining a medical opinion to discover the aetiology of an illness, 
compared to self-treatment based on clinical symptoms were noted by one. Another 
compared the two medical systems in the UK. and Ghana in the context of explaining 
why the use of community pharmacists for the purchase of malaria treatment, which he 
too described as the social norm, might not be recommended: 
It's one thing I've noticed about our people back home, if they are sick. instead of 
them going to the hospital for a doctor, a qualified doctor to examine them, they 
don't do that, they just go to the chemist 
Do they? 
It's something I have warned my mum about that, not to do that, whenever you feel 
like you're sick, you go to the hospital, and make sure that the doctor examine her. 
to find out the causes of it 
Okay 
Because it 's not good to go to walk out to the chemist and buy a tablet or whatever 
and take it,jor a headache, you don't even know the root of the headache, and you 
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go and buy a tablet. and take it. it's not good, let Ihe doctor prescribe you the 
tablets or the medicine that you need (VFR2). 
Although not questioned about their knowledge of the WHO recommendation that 
malaria should only be treated after being parasitiologically confirmed, no VFR or 
patient made any reference to this as being the current policy in these countries. 
Drugs mentioned that could be used for treatment of malaria included chloroquine, SP 
and artemisinin. One explained that the three SP tablets he had previously taken when 
he developed malaria symptoms now acted only to "suppress the virus". His increase in 
physical build made it necessary now to take a five day course. 
The risk of buying sub-standard drugs from community pharmacists in Nigeria and 
Ghana was recognised by many VFRs, but not considered as a serious danger to them. 
Strategies planned to overcome the risk of purchasing sub-standard drugs included 
taking advantage of their own knowledge of local pharmacies from where they believed 
they could purchase effective drugs, or asking friends and relatives to purchase drugs 
from local reputable pharmacists. 
Only one VFR specifically mentioned fmancial reasons why advice might not be sought 
from a medically trained doctor in Nigeria. He had previously explained vividly his 
poverty-stricken childhood in Nigeria in a way which marked him out in my mind from 
some of the other respondents. He voiced his feelings as follows: 
... and I mean to check you, you have to pay money, some of them don 'I have money 
to pay, they say ok, let me go to the chemist and buy tablet and drink. you know. So 
that one contribute to a lot of deaths, sudden deaths. So people does not, the 
Government does not pay attention on them. There's no free medicament or all 
these things at all. It makes people to manage themselves in certain things that they 
are not supposed to manage, you know. You know what I mean (Pt 5) 
One VFR said he would avoid buying any drugs anywhere in Africa because he felt 
pharmacists were more interested in profit, rather than patient care. Another voiced her 
more general distrust: 
But you would go to a hospital? 
I would rather go to, yeah 
Why's that then? 
I like to see a doctor, you know 
Do you? 
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Yeah. (Laughter) 
You don't trust the chemist or ... ? 
It's Africa you know, I have to take a little bit precaution, you know. Yeah. They are 
good you know, but I prefer to see a doctor (VFR 7) 
Three VFRs had personal previous experience of treating suspected malaria when 
abroad and had been to a local pharmacist for advice and treatment. One of these three 
had previously also sought professional health advice to exclude concerns about typhoid 
fever. One VFR found she was infected with malaria on her most recent trip, as a result 
of following her usual routine of being tested before leaving Nigeria. This was the 
second year in succession that she had acquired malaria as a VFR. She had not taken 
any anti-malarials, which she insisted was predominately due to her laziness. However, 
until taking part in the interview, she was unaware that she may have less immunity to 
malaria than in previous years, and described that in Nigeria it had not been a disease 
that had seriously affected her. On this most recent trip, she purchased an artemisinin-
based treatment, but then decided not to take it, but to purchase SP. The following 
extract illustrates the conflicting factors which affected her decision making, namely the 
low parasitaemia associated with the infection, the gradual development of more serious 
symptoms and her concerns about the side effect of drugs. The latter appeared to be the 
decisive factor for her: 
I always do the blood test to see whether it's malaria or not. And then I'll buy the 
tablet. And then (laughs) but I don't think, I was, you know, I wasn'l that ill for me 
to start, Ihis one plus malaria, I don't, I was actually ... if you, I was actually, 
actually feeling very very ill when I came back, and they said, "Oh, go to the GP, 
what ifit's malaria, and "/ know". And why I didn't take the Fansidar is because 
the people started saying, "Oh, it's very nice, but it gives such a headache, you 
can ... the side effects is headache, even from where I bought it. I said, "So what is 
the point now. I don't .. what type of headache?" He said, "Oh, it's a very bad 
headache, but it's very good". That is, it will cure this, but it gives headache, I said 
ok, I'm not taking it 
So you haven't taken anything other than paracetamol? 
No. Ok. Paracetamol and ibuprofen, and paracetamol and ibuprofen 
Do you think you'd better get it checked out? 
No, no no. I'm well now (VFRlS) 
Eight of the 10 GPs said that patients had tried some form of self-treatment for malaria 
before visiting their surgery but were unaware where these would have been purchased. 
Some GPs noted requests were sometimes made by VFRs for confirmatory tests to 
check if their self-treatment of malaria had been successful. Others told their GPs that 
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they had treated themselves for malaria whilst abroad and it was left to the GP's 
judgement to decide whether to have the patient tested again. 
Two of the three consultants reported that patients would have typically tried some self-
treatment purchased in Nigeria or Ghana before presenting, typically SP or quinine. 
Proguanil was a drug often mentioned to the paediatric consultant as a drug they had 
used to treat their children, though it was not known if this was for attempted prevention 
or treatment. None believed that their patients would be aware that chloroquine may no 
longer be effective. 
9.2 Diagnosis and treatment of malaria in the UK 
The actions ofVFR18, who found she was infected with malaria before her return to the 
UK, have already been described above. For the patients interviewed, symptoms of 
uncomplicated malaria were initially attributed by one as being caused by influenza, and 
another by stress or post travel fatigue. The others speculated that they might have 
contracted malaria. 
All initially tried some form of symptom relief, including paracetamol, aspirin, and 
Ibuprofen. Two also took SP as advised by friends, before seeking medical advice. One 
patient also drank two bottles of Schweppes tonic water, as recommended by his wife. 
He did this on the understanding that it contained quinine and had been used previously 
by his wife's family in Ghana as a malaria treatment. 
Upon arrival in hospital, all expected to be admitted, except for one who had not alerted 
friends and relatives that he might not be available to them. 
The events between the onset of symptoms and being admitted to hospital for each 
patient was as follows and show the range of actions that may be taken: 
• Pt 1: began to feel ill three days after returning to the UK, considered that the 
symptoms he was feeling might be caused by malaria, and went that day to A&E 
where he was admitted. This was the second time he had returned with malaria, 
the first time was after visiting Sierra Leone, his country of birth. 
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• Pt 2: was ill for three days on return to the UK and thought he had influenza. He 
contacted the local out of hours GP service, described the symptoms, mentioned 
recent travel to Ghana and was prescribed an analgesic. His daughter called an 
ambulance later that day as his symptoms worsened. The ambulance paramedics 
realised that he may have malaria, and took him to hospital where he was 
admitted. 
• Pt 3: presented at his GP after he felt ill for five days. He himself did not suspect 
malaria. He worked in a hospital and had in the meantime reported his illness to 
his manager, was diagnosed with "the fever" and given an analgesic. The GP 
suspected malaria. He was sent to A&E for blood tests, and was admitted. 
• Pt 4: bought chloroquine and proguanil from a pharmacy upon returning to the 
UK and started taking it. This was not because he felt ill, but because he had 
failed to take these, the tablets he took as a matter of course when visiting 
Nigeria. He started to feel ill about eight days after returning to the UK. He 
went to his GP three days later. He was sent to the hospital for a blood test as the 
doctor suspected malaria, and was waiting to return to his GP the next day for 
the results when he became so unwell that he went to A&E. He thought he had 
had malaria before as a VFR after returning to Nigeria from Japan. He did not 
suspect malaria on this most recent occasion, because he believed in the 
effectiveness of the chloroquine and proguanil he had purchased. 
• Pt 5: went to his GP the day following the onset of symptoms which started five 
days after his arrival in the UK. He suspected he had malaria. He was given 
various tests, including one for malaria. The result was negative. He was given 
SP by a friend. This did not work, and two weeks later he returned to his G P 
when he felt very ill. A second test also proved negative. His GP then referred 
him for an appointment at HTD the following morning, where he was diagnosed 
with malaria and admitted. 
• Pt 6: decided to go to HTD the second day after arriving back in the UK. He had 
begun to feel ill during the return flight from Lagos, suspected malaria, and was 
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given SP by a friend when he arrived in the UK. He made his decision to visit 
HTD as he had been referred there previously. This was the fourth time he had 
acquired malaria when visiting as a VFR. 
9.2.1 The diagnosis of malaria by GPs 
GPs would consider malaria when a patient presented with an unexplained fever or 
influenza-type symptoms and/or reported that they had recently travelled to a malarious 
country. Although GPs reported that some VFRs volunteered information about recent 
travel to them, this was not routine and eight of the ten said that they asked about this as 
a matter of course. Another GP said that he had a heightened awareness of malaria 
during the month of September, the time of year when most suspected cases were seen, 
and the tenth would consider malaria as a possible diagnosis if patients told him they 
had been abroad. The number of patients seen by the GPs who were subsequently 
diagnosed with malaria varied, with an annual range of 0-10 patients. 
GPs explained that they had a low threshold for testing, explaining that it is better to 
"over-test" than to "under-test". None appeared to be particularly concerned by the 
possibility oflegal action if they made a mistake, instead, pride in their own clinical 
practice, together with an awareness of the possible consequences for the patient ofa 
mis-diagnosis, appeared to account for the overriding concern amongst GPs not to miss 
a case of malaria. It should be noted that several of the GPs had been employed in this 
role for a number of years, and as such, may have had considerable experience in 
considering malaria as part of a differential diagnosis. In addition, two were trainers of 
other GPs, suggesting they had high levels of expertise. 
Although very few had personally treated cases of severe malaria, the details of cases 
seen by other GPs in the UK where undiagnosed malaria had resulted in severe illness 
or death were described by a few, and provided a forceful reminder to them to always 
consider malaria. As an example, one GP described a case of severe malaria that had 
occurred when he had been called to see a young boy who had previously visited his GP 
surgery and whose parents had subsequently requested a home visit: 
And why have they left it so long then, or had it just deteriorated very rapidly? 
Yes, I didn't get the impression of people leaving it too long, um, but I got the 
impression that my visit was crucial, and also that slight free-floating anxiety that 
so many of us GPs have. The, if I missed this, what might have happened tomorrow, 
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thank goodness I thought malaria was a possibility, arranged the blood test, got thaI 
person into hospital today, thank goodness I did that home visit, and didn', just say, 
not that I would, take another aspirin and call me in the morning if you're not hefter. 
and of course I wouldn't do that, but it's a constant reminder why. the importance (~l 
not taking that glib approach. And one person I remember vividly was a very 
atypical presentation. A two, three year old boy who just had diarrhoea and 
vomiting. So many people have diarrhoea and vomiting aged two to three. and wel/. 
it's just joining nursery isn't it? What is it? And luckily I asked about fever, once 
he'd got a fever, "oh, dear, it's bad diarrhoea and vomiting then". I couldn't give a 
figure, but a large proportion of diarrhoea and vomiting a/so have a fever hut 
suddenly I pricked up my ears at that point, and mum wasn't bothered at all ahO/JI 
the fever, she was just worried about, she just felt for her little hoy, who was 
vomiting all over the place, and I homed in on the fever, and said, "So he's got a 
fever, have you been abroad recently, still thinking not necessarily malaria. it could 
be another tropical illness, and she said about the trip, and, actually, the hoy hadn'l 
had malaria syrup and I sent that boy straight in and it wasfalciparum malaria. and 
I remember feeling lucky, feeling they were lucky, that I was lucky, that that was II 
close shave (OP3) 
Upon suspicion of malaria all OPs said that they would either take a blood sample. and 
send it urgently to the local hospital to be tested. or would ask the patient to attend the 
hospital phlebotomy service immediately. They would request laboratory results to be 
communicated to them the same day. However, some OPs acknowledged that this 
service is very busy and the waiting time for a patient to get a blood test can be 
prolonged. 
One hospital used for referrals by three of the GPs interviewed had a policy of 
outpatient care for malaria patients who were diagnosed with uncomplicated falciparum 
malaria, whilst in other geographical areas, such patients were admitted. Thus, if 
diagnosed, patients would either be asked to come to the surgery for a prescription. or 
be referred to hospital for admission, depending on the protocols followed by the local 
hospital. 
One OP said that they would start treating patients with chloroquine before the result 
was known and then discuss his decision with hospital microbiologists upon 
confirmation of the diagnosis. The practice of commencing treatment before a diagnosis 
was known had been carried out by another OP when he previously worked under the 
supervision of an African doctor, but he now considered this to be "cavalier". 
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Consultants estimated that only between 10-20% of the patients who presented at A&E 
would have initially sought care from their GP, and one expressed satisfaction that 
patients attended his Department so that their treatment could be started promptly if 
necessary. One hospital consultant cited occasions when delays in a correct diagnosis 
had occurred as a result ofGPs not considering it as a possible cause of their patient's 
illness. However, the more frequently mentioned concern of consultants was of 
problems for patients in gaining access to GP services and they explained that patients 
might wait up to a week for a GP appointment. Even those who could access GP 
services after only 24 hours, hospital consultants indicated, might be unwilling to do so. 
Although not common, community phannacists stated that VFRs might attempt to 
purchase malaria treatments from them. The drug most typically sought was SP. One 
pharmacist explained that some patients become irate on learning that they could not 
issue this. All referred potential cases of malaria to their GP or to hospital. 
9.2.2 Consultants' perceptions of VFRs attending A&E 
Two of the hospital consultants estimated that they saw about 200 patients with 
suspected malaria each year. The one who treated children stated that when he 
previously worked in a secondary, rather than tertiary care setting, there would be one 
or two possible cases a week seen during the peak season of August to September. 
Approximately 80% to 95% of patients they saw who had suspected malaria were of 
African origin. The majority were thought to be of Nigerian descent, although the 
precise number was difficult for hospital consultants to quantify. 
Two believed that there were more cases in the summer and winter months, though the 
third did not notice any increase in cases at these times. All three suspected that 
although many patients visited both urban and rural areas, most cases were acquired 
when visiting the latter. However, one, himself of Nigerian origin, observed that 
detailed information on the exact location of areas visited could be difficult to obtain 
from patients. 
The paediatric consultant estimated that a common duration of travel was two to three 
months, whilst the other two believed that patients had travelled for between three or 
four weeks. Those VFRs who worked in the UK. were thought to travel less frequently 
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than those with business interests in Nigeria or Ghana. The latter might travel four or 
five times each year. Less frequent travel was associated with being employed in the 
UK, or because of financial constraints. 
9.2.3 Diagnosis and treatment of patients in the A&E setting 
For those adult patients who presented to A&E, the waiting time to see a doctor, either 
for those who were referred by their GP or who self-referred, depended on the severity 
ofthe patient's symptoms. As many patients had what were judged to be mild 
symptoms at presentation, the typical waiting time could be between two and four 
hours. As was reported by GPs, not all patients volunteered the information that they 
had been to Nigeria or Ghana. However, the majority of patients did share with the 
consultant their thought that their illness, or that in a child, might be due to malaria. In 
the paediatric setting, patients would be seen more quickly, with a diagnosis made, and 
treatment started within four to five hours. 
No patient had mentioned sickle-cell disorder or G6PD to consultants. 
It was rare for two of the consultants who treated adults to see patients with severe 
malaria, though the paediatric consultant did more regularly see such cases, as they 
would be referred to his tertiary referral unit. 
Estimates were given of between 20% of 40% of patients tested who were confirmed to 
have malaria. SCI reported that approximately 30% may discharge themselves once 
their diagnosis was known, and also observed that others were only eager for a 
diagnosis of typhoid fever, which they considered to be a more serious illness, to be 
discounted before choosing to leave. Those who did would be given quinine and 
contacted a few weeks later to confirm that they had recovered. He wondered if this 
method of care might become a policy adopted by his hospital in the future. 
The paediatric consultant noted that self-discharge was rare, although a few families did 
not recognise the need for their child to be admitted. However, child protection laws 
were in place to prevent children being discharged without treatment. The third 
consultant worked in a hospital where a policy of treating most malaria as outpatients 
was in place, and so this issue did not arise. 
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9.3 "Fever" and malaria 
To find out the extent to which the term "fever" was used synonymously with 
"malaria", respondents were asked if these words might be used interchangeably. Some 
VFRs appeared to wonder why the question was being asked. For them, fever was 
simply a rise in temperature and was one symptom of malaria. However, one 
immediately explained that these words were previously used interchangeably in 
Nigeria or Ghana as there was no specific word to describe malaria in African 
languages. Another described that for the "lay mind" , the words would still be used 
interchangeably in this way. Symptoms experienced, she explained, might be described 
as fever until or if, a laboratory diagnosis was made, and only if parasites found, 
identified as malaria. 
GPs and community pharmacists were also asked this question, and many replied in a 
similar way to the majority ofVFRs in describing fever as a symptom of malaria. 
However, a few, for example a Ghanaian-born community pharmacist, also described an 
interchanging of these words. 
9.4 The attribution of convulsions to malaria 
There was a certain apprehension amongst a few VFRs and patients when the question 
of what might cause convulsions was raised in the interview, and in these cases the 
topic was not pursued. The attribution of convulsions to physical causes including 
malaria was recognised by many VFRs. At the same time, some acknowledged a 
difference between their own understanding and that held by some in Nigeria and 
Ghana about the aetiology of convulsions. Amongst their friends and relatives who 
lived in rural areas of these countries, or who were less well educated, VFRs and 
patients explained, convulsions might be attributed to supernatural causes. 
A few VFRs and patients also suggested reasons other than malaria why people might 
convulse. A hot climate was one alternative reason given, justified for one by the 
experience of seeing many children suffer convulsions in the much hotter climate of 
Ghana, but never in the UK. Although she herself believed that convulsions were 
caused by malaria, another VFR said that she would follow the custom in Ghana that a 
child with convulsions should only be carried by a man. Another VFR described with 
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pride the ability of his mother to cure children with convulsions with ointments 
throughout his childhood in Nigeria. 
One patient, a pastor, felt that convulsions had a spiritual cause and explained that he 
would pray for a person who began to convulse. His rationale was based on his 
childhood experiences, when his brother was the only member of the family who 
experienced convulsions as a child. This stopped when he became older and the 
implication was that he had been cured by the power of prayer. Another patient, also a 
pastor, described the differences in beliefs about convulsions between Nigeria and the 
UK as follows: 
And if someone had convulsions, what would you anribute that to? Would you 
have any ideas about that? Like a kid 
Convulsions in my society, is more spiritual. 
Is it? 
That's how we regard it. You know, because they think a child is innocent. Um, fi>r a 
child to be in that position, uh, I would say, you know, most of them attribute it to 
spiritual, you know, these things. But I think, because they are not aware (~lthe 
medical side, they've come to embrace it, and they live with it. So I remember during 
my childhood, when anything comes, it is, you know, you, you, you solve it the 
traditional way, and not the medical way, you see? 
Here, amongst your community here, would they see it the same way? 
I don't think so. I don't think so, you see, because, to me, this country is an open 
society. And if anything happens, now, children, who go to play class, to school, and 
so on and so forth, so if for a matter of, let's say days, they are not found 
For a maner oj? 
They are not found, you know, in these places, people become suspicious, and they 
can easily report you, you know. Even those of us, to me, I would say who are 
enlightened, if I happened to see anything of the sort, there's no way I would 
condone any other way than hospital, see your 
GP, or quickly, take, you know, the child to these things. But I can assure you, some 
of us, I can't give you exact ... still think it's more spiritual than ... "(Pt2) 
This suggestion that these beliefs may be current amongst some Nigerian and Ghanaian 
residents in the UK was reinforced by another patient who, after the interview had 
concluded, explained that his wife was upset until he was diagnosed with malaria, as 
she believed that he may have been jinxed in Nigeria, when he first developed 
symptoms. He observed that there were many aspects of life in the UK-based Nigerian 
community that I could not understand. 
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9.5 Perceptions of VFRs and patients to treatment in the UK settina 
In contrast to the reported care taken to diagnose and refer patients promptly, described 
by the GPs and hospital consultants interviewed, some VFRs made unfavourable 
comparisons of the way diagnosis and treatment is managed in the UK compared to 
Nigeria and Ghana. For example one VFR was concerned that doctors in the UK may 
assume any illness in a returning traveller to be malaria, and so not consider other 
causes, whilst another felt that it may be difficult for GPs in the UK to recognise the 
symptoms of malaria. The concerns of the latter were also voiced by another four VFRs 
who had either been treated for malaria themselves or how had witnessed hospital care 
for friends and relatives in the UK. They cited delays in diagnosis, on occasion 
necessitating transfer to another hospital where clinicians had more expertise, as well as 
inappropriate treatment being given. The most extreme example of mistrust of UK-
based doctors was expressed by one VFR who had been begged by a friend to smuggle 
SP to him in hospital, as he feared he would die if he continued to take the treatment 
prescribed. According to this respondent, if malaria patients were transferred from 
Nigeria to the UK, several deaths would result. Similarly a VFR from Ghana claimed 
that patients could die from malaria in the UK, but not in Ghana. 
No GP or consultant was aware that patients had these concerns, or at least did not raise 
these issues in the interviews. In fact by contrast to the VFRs, for their part, all three 
consultants suggested that some Nigerian and Ghanaian patients felt that the care given 
in the UK to malaria patients was disproportionate to the threat. However, one also felt 
that some people were becoming more aware of the reasons for this: 
I don't think they, the sort of anxiety we have as clinicians about falciparum in 
particular, patients don't get it. You're going on about it, they're just laughing at 
you, basically 
And have there been any changes over time, or has it always been the case that 
people don't see it as being a serious disease? 
I suspect that some of our campaigns, you know, the posters and things are 
beginning to get people to think a bit, some of them have sort of come to terms with 
the fact that they are not quite as immune as they used to be when they lived their 
other life out there. I've heard that from one or two people in the last year. 
So it's beginning to get through? 
The message is beginning to get through, but it will take a while before the majority 
get the message (SC 1) 
The second factor which led to feelings of mistrust of the UK-health system and claims 
of incompetence was the fear of being placed in isolation in hospital when diagnosed 
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with malaria. This was not a subject for inclusion in the initial topic guide, but was 
raised by some study participants. One VFR said this had happened to a relative, whilst 
another had worked in a hospital where she described this as having been the policy. 
Two others said that they had heard of its occurrence. One of these, who had previously 
experienced malaria symptoms when on holiday in the UK described how, until her 
condition necessitated hospital care, her family had tried to treat her themselves because 
of concerns that her illness would be treated like some "scary disease". 
The perceived policy of isolation of malaria patients was described by these YFRs as 
having been implemented because indigenous UK-based clinicians did not understand 
that malaria was not directly transmissible. The reaction of the VFRs was incredulity 
and bewilderment that what is an easily managed illness in Nigeria or Ghana is dealt 
with in the UK in this unnecessary way. 
Three of the six patients also had concerns about being isolated. One thought that it was 
only because his parasitaemia level was low that he was kept with other patients when 
he was admitted. In common with the VFR described above, one described how he was 
encouraged by a friend to treat himself in order to avoid being isolated upon admission 
to hospital in the UK: 
Yeah, so how do your friends and relatives over here feel about that? 
Uh, they think it's a joke. Because when I phone my friend in that, in the flighl. my 
friend is telling me to come down the aircraft and get treatment over there before I 
fly back. I said I'd rather gel back here and treat myself. He said but they're gonna 
quarantine youfor about a week, I said, I don 'I care, as long as I gel well. yeah 
So it's commonly accepted that people think you're gonna get treated like that? 
Yeah. 
So do your friends normally take tablets before they travel? 
A lot of them do 
They do? 
Yeah, a lot of them do (Pt6) 
The other VFR said that as a result of his treatment he would be happy to assure friends 
that the rumours prevalent in the community about being isolated when presenting with 
malaria were incorrect. 
None of the hospital consultants had a policy in place of isolating malaria patients, and 
one had a policy of outpatient treatment for the majority of malaria cases. He believed 
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that patients were aware of this when they attended. Of the two others, one understood 
the fear amongst patients of being isolated: 
And so with their children, would they bring themselves in more quickly if they 
suspect something or would it be pretty much ... ? 
I think in my view, not quickly enough. Maybe in their judgement they think they 
bring them in quickly, but, the attitude generally is ok, /, you know, / look 
precautions, whether they are the right precaution or not, um, this kid took their 
medicine, whether that be the right medicine or not, and they'refine, we're fine. 
they're probably fine, um, without any kind of thoughts around how semi-immune 
they might be, relative to their children, and they kind of sit on them a lillie hit. in 
my view. Sit on them a little bit. They still bring them relatively quickly. hut not until 
the symptoms have persisted for a good couple of days in the typical scenario 
Why do you think that is? 
Difficult to tell, but you can't help but think it's due, it's linked to their own view 
about how malaria might be treated, or is treated. Many of them express concern or 
anxiety about being urn, isolated if they were shown to ... 
That came up in the conference (a conference which we had both attended) didn'l 
it? And they're worried on behalf of their children as well? 
They're worried on behalf of their children. And that anxiety sort of plays on their 
mind and about their children, which is probably why occasionally when the kids 
present they tend to be slightly sicker (SCI). 
The paediatric consultant did not think a fear of their children being isolated was a 
concern of parents. However, he described some embarrassment on the part of families 
when their children's diagnosis of malaria was discussed in earshot of other patients, 
and believed that there was a certain stigma felt by some African families around 
malaria. Whilst he described this as minimal when compared to that which may be 
associated with a diagnosis of HIV or TB in some African families, he wondered if it 
was because of parents' knowledge ofa high mortality associated with malaria in 
African countries, as he was unable to think of other reasons for this. 
9.6 Discussion 
There has been little previous research carried out to investigate how Nigerian and 
Ghanaian VFRs view malaria treatment in non-malaria-endemic countries. In the 
literature review described in chapter two, this was only investigated in any detail in the 
study by Leonard and VanLandingham (Leonard and VanLandingham, 2001). Thus, 
there was little opportunity to compare the findings from this thesis with other research. 
On the other hand, comparisons could be made with research carried out in Nigeria and 
Ghana about malaria treatment, and here there were similarities with respect to the 
common use of self-treatment using drugs purchased in a local pharmacy (Ahorlu et aI., 
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1997, Onwujekwe et aI., 2005b, Buabeng et aI., 2007). The answers given to the 
questions about planned action if malaria symptoms were acquired in Nigeria or Ghana 
did however reveal a recognition by some VFRs of the limitations surrounding self-
treatment of malaria in these countries. Many VFRs appeared to adopt a pragmatic 
approach to this, taking advantage of any local expertise as well as the fast and easy 
access to drugs purchased from pharmacists in Nigeria or Ghana, whilst being prepared 
to seek more formal medical treatment in these countries if it became necessary. 
The depiction by VFRs in particular of malaria treatment in Nigeria and Ghana as being 
quick and easy to obtain, despite its limitations, contrasted with the perceptions that 
some had with respect to malaria treatment in the UK. The perceived incompetence of 
non-African clinicians, possibly leading to mis-diagnosis and hence delayed treatment 
voiced by some respondents was also a finding made by Leonard and VanLandingham 
(Leonard and VanLandingham, 2001). Whilst many of the clinicians interviewed for 
this thesis appeared to be competent in their patient care, there was some indication that 
clinical guidelines might not always be followed. 
In section 7.2, it was noted that some VFRs were keen to stress during the interview that 
malaria is not directly transmissible and it was surmised that this was emphasised in 
case my own knowledge might not be correct. A lack of understanding about why 
patients might be isolated was another example of misunderstanding about the skills of 
non-African clinicians, and reported previously by Leonard and VanLandingham 
(Leonard and VanLandingham, 2001). 
Although many VFRs had asserted that they were able to recognise the symptoms of 
malaria, two of the patients interviewed did not, when infected, attribute their symptoms 
to this disease. On the other hand, those patients who did recognise that they might have 
malaria sought treatment promptly and this was in line with the opinion voiced by many 
VFRs that prompt treatment of malaria was recognised as being of fundamental 
importance to avoid a serious outcome. 
None of the patients described their symptoms as mild, and although only discussed 
briefly in the research carried out by Morgan and Figueroa-Munoz and Leonard and 
VanLandingham, in these studies, of the few who mentioned this, their experiences 
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were of malaria being a debilitating illness (Leonard and VanLandingham, 200 I, 
Morgan and Figueroa-Munoz, 2005). 
In section 3.8.1a, the use of the word fever to equate with a clinical diagnosis of malaria 
was described as common in Nigeria and Ghana. The results in this thesis found that 
for some Nigerians and Ghanaians living in London, fever was also considered to be 
synonymous with malaria. This was a similar finding to that reported by Morgan and 
Figueroa-Muiioz, (Morgan and Figueroa-Munoz, 2005) where UK participants of 
African ethnicity asked if there was a difference between the words fever and malaria. 
The extent to which this perception is held and whether it may cause confusion when 
patients of Nigerian and Ghanaian ethnicity seek medical advice for presumed malaria 
when in the UK is unclear. 
No previous studies carried out in European countries or the USA have investigated 
whether, in the malaria context, convulsions may be attributed to malaria by VFRs, or 
alternatively are perceived to have a supernatural cause. Beliefs in spiritual causes of 
malaria were described by VFR respondents as originating from Nigeria and Ghana 
rather than from the UK, and as reported in chapter two, the linking of convulsions to 
spiritual influences was also a finding from some studies carried out in these countries 
(McCombie, 2002, Williams and Jones, 2004, Onwujekwe et aI., 2005a, Adongo et al., 
2005). The fmding that supernatural causes may be thought to be responsible for 
convulsions illustrates how parallel aetiologies may be considered by some VFRs when 
understanding this phenomenon. However, some VFRs differentiated between beliefs 
about malaria commonly held by their friends and relatives in Nigeria and Ghana, many 
who lived in urban areas and who believed that convulsions could be caused by physical 
illnesses including malaria, and those views held by others who were judged to be less 
well educated. 
In the experience of the participants of this study, there were few structural barriers to 
prompt treatment seeking from the NHS in the UK. Unlike the finding from the study 
by Leonard and Vanlandingham (Leonard and Vanlandingham, 2001), which was 
conducted among VFRs in America, the participants in this study did not express any 
concerns about the cost of treatment, presumably because treatment is free for those 
who attend NHS hospitals. GPs described waiting times for blood tests to be long. Few 
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of the VFRs had personal experience of using NHS services for the treatment of 
malaria, but of those who did, neither they nor any of the patients mentioned that they 
were delayed in getting treated, nor complained of long waits in phlebotomy clinics. In 
addition, while hospital consultants considered that access to GPs was a problem for 
VFRs suffering from malaria and could cause delays in receiving adequate treatment, 
for the patients and VFRs interviewed for this thesis, there was no evidence that this 
was a particular problem. The data also suggest that alternative sources of treatment 
were rarely sought, as the community pharmacists reported that very few customers 
attempted to purchase malaria treatments from them. However, taking a larger sample 
of interviews with community pharmacists may have identified more examples of this. 
The results presented in this chapter build on the results from the previous two chapters 
showing that as the VFRs move from the UK to Nigeria or Ghana and back, they are 
moving between contrasting cultural and social systems of which the health systems are 
an integral part. In the UK, health professionals are perceived to have access to expert 
knowledge, to be the guardians of public health and in practice they control access to 
drugs and other treatments. As a consequence, if a VFR becomes ill on their return to 
the UK their treatment choices are limited, but their access to appropriate biomedical 
treatment is not constrained by structural factors. By contrast, in Nigeria and Ghana 
health professionals may be perceived to possess expert knowledge, but they are not the 
only source of drugs or other treatments and structural factors. 
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Chapter ten: conclusions 
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The aim of this research was to explore the reasons for the burden of imported malaria 
in the Nigerian and Ghanaian communities living in London. It was driven by the 
concern that despite it being preventable, imported malaria is a common travel-related 
illness that primarily affects one particular group: those visiting friends and relatives in 
West African countries. Little previous work had been undertaken to understand why 
this might be so. 
The epidemiological analysis described in chapter five updated previous analyses which 
had covered the period 1987 to 2006 (Smith et aI., 2008), by providing data for 2007 
and 2008. The calculation of ethnicity rates using two epidemiological methods 
(cumulative incidence and incidence rates) confirmed that those most at risk of reported 
malaria remain those categorised by the MRL as being "of African ethnicity", and 
showed the large difference in incidence rates in this group compared to those in two 
other ethnic groups. The thesis also provided for the first time an epidemiological 
analysis of the group most at risk of imported malaria in the UK: namely Africans living 
in London who had acquired falciparum malaria whilst visiting friends and relatives 
abroad. This was carried out for the period 2004-2008. There were two findings which 
were of particular interest. One concerned the higher number of reports of those who 
did not take chemoprophylaxis in areas where malaria was subisdised compared to other 
areas, and this, in combination with the results of the qualitative research, provide new 
information which should be taken into consideration in future efforts to reduce the 
incidence of malaria in the Nigerian and Ghanaian communities. This is discussed in 
section 10.1. The second concerned the heterogeneity within the sample. The diversity 
of beliefs and experiences amongst these communities was also a finding from the 
qualitative analysis, and had not been previously identified in previous research. The 
implications of this are discussed in section 10.2. 
Some of the fmdings from the qualitative study included in this thesis have been 
described previously by other researchers. Examples include a perception amongst some 
VFRs of a continuing immunity to malaria, and the extent to which they are aware of 
how malaria is transmitted. As very little primary research has been carried out into the 
issue of imported malaria in African VFRs, the replication of these results is valuable in 
itself. However, this is the first time that the perspective of health care providers and 
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community pharmacists has also been included in research carried out in a UK setting, 
and this provided useful evidence to show that in many respects, individuals from these 
groups were aware of why VFRs believed themselves to be at risk. It also provided an 
opportunity for them to identify operational barriers to the provision of effective malaria 
prevention and treatment. 
The thesis also provided new insights to explain the reasons for the burden of imported 
malaria in the Nigerian and Ghanaian communities in London and introduced a novel 
conceptual framework to explain the reasons for the burden of imported malaria in the 
UK. In this chapter, more detail is provided about this framework, incorporating the 
new insights gained from the qualitative findings. These were: 
• introducing new information about the social, structural and physical 
environment in the UK; namely an understanding of the challenges facing the 
providers of pre-travel health services in London and the operational barriers to 
effective malaria diagnosis and treatment in a UK setting. 
• identifying and exploring more fully than has been previously described those 
factors that may be relevant to the individual VFR. One of these, the adequacy 
of mosquito avoidance advice, has been not previously described in detail by 
other researchers. Two others have not been previously identified. One is the 
importance given by VFRs to the beliefs of other family members about malaria, 
and the second is information about attitudes of VFRs towards the diagnosis and 
treatment in a UK setting. 
These issues are discussed between sections 10.2.1 and 1 0.2.2a of this chapter. Four 
examples are then provided of how the conceptual framework can be used to explain the 
burden of imported malaria in Nigerian and Ghanaian VFRs. 
The next section of this chapter discusses three of the theoretical issues that arose 
during the writing of the thesis are described, and the conceptual framework is used to 
explore these. These issues are: whether malaria could be prevented within non-endemic 
countries by the removal of structural barriers, or whether this is unlikely, given the 
broad range of factors which impact on the burden of disease; what constitutes an 
241 
appropriate definition of"VFR" and in particular. whether ethnicity should he im:luded 
in this definition; whether risk could be considered as a social construct, as proposed hy 
Douglas and Wildavsky (Douglas and Wildavsky, 1982). The chapter concludes by 
describing the limitations of the thesis, and offering some final thoughts. 
Before beginning the discussion of these issues, it should be emphasised that that the 
qualitative methodology used in this research means that these results cannot he 
extrapolated to a wider population. Instead, as described in section 4.2, the choice of 
this methodology was to allow an in-depth exploration of the reasons that explain the 
incidence of imported malaria in the Nigerian and Ghanaian communities in London 
who visit friends and relatives abroad. These findings need to be tested using 
quantitative methodology to assess their validity. and the following sections should be 
read with this caveat in mind. 
10.1 Cost of malaria chemoprophylaxis. 
As stated in section 2.5.4, the decision made in LSL areas not to implement a 
Government policy making travellers responsible for the full cost of malaria 
chemoprophylaxis was taken because of fears that the already high incidence of 
imported malaria in LSL areas would increase. Furthennore, after the policy was 
implemented, concerns were raised by medical professionals in other parts of the UK 
that the number of cases would rise (Badrinath et aI., 1998, Evans. 1996, Hollyoak. 
1995, Hossain, 2008). The cost of chemoprophylaxis has been previously identified as a 
barrier to it use in three previous research studies (Leonard and VanLandingham, 2001. 
Morgan and Figueroa-Munoz, 2005, Schilthuis et al.. 2007). Results of the qualitative 
analysis shown in section 7.2 suggested that the cost of malaria chemoprophylaxis does 
prohibit its use for some VFRs, and some healthcare professionals believed it presented 
a major barrier. Therefore the epidemiological analysis described in section 5.2.7. which 
showed that there were more reports of VFRs who did not take chemoprophylaxis in 
LSL areas compared to other areas of London is surprising. However. the thesis 
provided other insights which might explain this finding. 
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10.1.1 Non-adherence 
Firstly, non-adherence to chemoprophylaxis by some travellers, whether it is subsidised 
or not, should be considered. If this is found to be a signi ficant issue. then subsidising 
chemoprophylaxis will not have the intended impact on reducing the incidence of 
imported malaria. Previous research has indicated that some VFRs might leave unused 
chemoprophylaxis for host friends and family in malarious countries. rather than 
completing the course themselves, or that alternatively, practical reasons such as a 
dislike of its taste, or forgetfulness might lead people not finishing the course (Morgan 
and Figueroa-Munoz, 2005, Pistone et aI., 2007). The poor quality of information 
recorded by clinicians on the MRL report forms, in particular the finding by Phillps-
Howard that 24% of those who had recorded on this form had not actually done so 
(Phillips-Howard et aI., 1990b), must also be considered when interpreting data from 
this source. 
Findings from the qualitative analysis showed that adherence was good amongst the 
small number of VFR participants (n=8) who started chemoprophylaxis. There was no 
unanimity of opinion between healthcare professionals about whether adherence to 
chemoprophylaxis was a significant issue amongst VFRs more widely. Further research 
is justified to explore the extent to which adherence to chemoprophylaxis impacts on the 
incidence of malaria. This would also provide the opportunity to explore the most 
suitable regimens for different travellers. One new insight from the interviews with 
practice nurses was that it was particularly difficult for some travellers to adhere to 
specific regimens. For example some preferred drugs they could take weekly, whilst 
others preferred chemoprophylaxis which could be started just before travel and 
finished shortly afterwards. Nurses suggested that once VFRs were comfortable with a 
particular regimen, they would be more likely to ask for the same prescription for future 
visits, suggesting that they found adherence manageable. This new research would be 
particularly timely as the policy of subsidising malaria chemoprophylaxis in LSL areas 
has recently changed, with AP only being prescribed if all other anti-malarials are 
contraindicated (Health Protection Agency, 2012). If a majority of those who take 
mefloquine are found to be more likely not to complete the prescribed course for 
example, this may not lessen the burden of imported malaria. Thus, any financial 
savings that could be anticipated from this policy change would be limited. 
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10.1.2 Lack of awareness of the LSL policy 
A lack of awareness amongst some residents of LSL that malaria chemoprophylaxis is 
subsidised should also be considered. Of the three clinicians interviewed, one, who 
worked in an LSL hospital, and so was in a position to impart this infonnation to more 
than one hundred patients each year, was not aware that the policy existed. The 
decision to implement the policy was in part a political decision, taken with the backing 
ofa local MP, Simon Hughes (Liz Hunt, 1996). From my experience of working for the 
Health Protection Agency, I can confinn that at until at least February 2011, no 
campaigns were undertaken to infonn the population of LSL that malaria 
chemoprophylaxis is subsidised, and this may be for fear of it being revoked by the 
UK's Department of Health. Whatever the reasons may be for not communicating this 
message, one possible consequence may be that some travellers in LSL might not 
consider purchasing malaria chemoprophylaxis as they mistakenly believe the cost to be 
prohibitive, or not to represent good value for money, given the alternatives available to 
them. An unawareness of the policy, considered in the context of the relatively large 
Nigerian and Ghanaian communities in at least two boroughs in the LSL area (see 
section 49.2) could mean that the volume of individuals travelling without prophylaxis 
(as indicated by the quantitative analysis) from these areas is higher than in many other 
London boroughs. 
10.1.3 Volume of travellers from LSL areas 
Another possible explanation for the higher incidence of imported malaria in African 
VFRS travelling without chemoprophylaxis in LSL areas is that the volume of 
individuals seeking pre-travel health advice may put a strain on the services that provide 
these. This, in combination with other pressures on primary care services, as described 
by many GPs may mean that travel health services are given a lower priority. This may 
result in more travellers in LSL areas compared to other boroughs being unable to 
access chemoprophylaxis. Practice nurses from all areas described their services as 
being over-stretched, but more research would be valuable to detennine if pre-travel 
health services in areas with relatively high proportions of people travelling to 
falciparum malaria-endemic countries are adequate. 
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10.1.4 The relative importance of the cost of chemoprophylaxis compared to 
other factors 
The qualitative analysis provided evidence that the cost of chemoprophylaxis was not 
considered by some when making decisions about whether to use it. For others, it was 
not the sole factor determining its use, or was only one of a number of other factors that 
were taken into consideration. Thus, another reason to explain why the incidence of 
malaria was higher in LSL areas than others, despite the policy of subsidising 
chemoprophylaxis, was that the cost of these drugs is not a key determinant of its usc. 
Instead, the decision an individual makes may be influenced by a complex interaction of 
factors. Therefore, implementing a policy that only seeks to impact on one of these is 
unlikely to be successful. 
This introduces the second new contribution of this thesis; that is the development of a 
conceptual framework which explains the factors VFRs take into account when making 
decisions about malaria control. 
10.2 Conceptual framework 
An outline of a conceptual framework was introduced in chapter four. This is re-
introduced in figure 10.2.1, with data gathered from the interviews providing more 
details. 
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Social, structural and physical environment: UK 
Malaria perceived of as a life-threatening disease 
Access to pre-travel health advice and treatment through healthcare 
rofessionals 
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Social, structural and physical envi.fonment: Nigeria/Ghana 
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possible 
Figure 10.2.1 Conceptual framework re\isited 
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It is important to note that not all factors shown in the oval shape in the framework are 
taken into consideration by each VFR in decision making about imported malaria. 
Instead, the particular combination of knowledge, circumstances and perceptions of the 
individual VFR determine which are considered. Furthermore, different individual-
level factors impact on one another. One example from the qualitative interviews to 
illustrate this is ofVFRI6, whose decision about malaria prevention was influenced 
partly by personal biological factors, the attitudes of family members, and the cost of 
chemoprophylaxis. Furthermore, no one specific factor in the conceptual framework is 
of more relevance than another. These assertions are based on a conclusion drawn from 
both the quantitative and qualitative research that the Nigerian and Ghanaian 
communities in London are heterogeneous in nature. An example concerns the month of 
travel. The quantitative analysis in section 5.3 showed that although some patterns were 
apparent, with many travelling in the summer holidays, there was some variation. The 
results of the qualitative analysis described how some of those travelling in the summer 
holidays may be taking trips planned well in advance, including the uptake of pre-travel 
health advice several weeks before travel and uptake and adherence to 
chemoprophylaxis. Others who take well-planned trips at these times travel without this. 
For those who take trips at other times of the year and who may plan these only at short 
notice, operational barriers may be significant for some, but not for others. 
The conceptual framework is not meant to describe a static context, but one which 
changes over time. These changes occur both with respect to the structural, social and 
physical environments, and also in the factors which the individual considers to be 
important. One examples of the former is the evolving resistance to SP and chloroquine, 
whilst another is the increasing urbanisation in Nigeria and Ghana which may reduce 
the prevalence of anopheles mosquitoes in the local environment. In the UK context, 
examples of changes are health promotion campaigns which may raise the awareness of 
some VFRs about the risk of imported malaria or the temporary closure of pre-travel 
health clinics, which prevents access to NHS-funded travel health services. Examples of 
factors relevant to the individual include the loss of acquired immunity, which may 
make symptoms more serious than previously experienced or a change in the frequency 
of travel. Repeated infection-free trips may lower the perception of the risk of acquiring 
imported malaria in future visits. 
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The social, structural and physical environment relevant to malaria control in Nigeria 
and Ghana was described in chapters one and two. The new findings of the qualitative 
part of this thesis focus on issues related to the social structural and physical 
environment in the UK with respect to malaria prevention and treatment, and to 
individual level factors. These are discussed in the following sections, with 
recommendations made about further work or interventions that could be undertaken. 
Some of the recommendations focus on providing up-dated advice to VFRs about 
effective prevention and diagnosis and treatment of malaria which are relevant to them 
in their unique situation, as members of a Diaspora. This is not an endorsement of 
psychological models of service uptake, discussed in section 4.1. Rather, it is in 
response to evidence from the thesis which suggests that tensions exist about who holds 
expert knowledge about malaria (VFRs, many of whom claim to have personal 
experience of managing the disease, or clinicians, who may have less personal 
experience but more up-to-date theoretical knowledge). However, although I believe 
that the provision of correct information is important, I do not assert that this is the only 
intervention undertaken. Indeed, given the complexity and interaction of the factors 
shown in the conceptual framework and the heterogeneity within the Nigerian and 
Ghanaian communities, it is worth emphasising that one of the main conclusions that 
can be drawn from this thesis is that it is not likely that implementing one intervention 
will be successful. Instead, multi-level interventions would need to be put in place. The 
related question of whether interventions carried out in one country alone are sufficient 
to prevent imported malaria is discussed in section 10.3. 
10.2.1 The social. structural and phYSical environment in the UK 
10.2.1 a The operation of pre-travel health clinics 
The thesis results revealed some difficulties experienced by health care professionals in 
operating travel health clinics. One issue was related to the pressure under which these 
services were operating, given the other priorities under QOF arrangements, and the 
non-inclusion of pre-travel health advice in these. One solution adopted by a GP 
practice was to direct travellers to privately-funded travel health clinics during times 
they were not able to offer services. Evidence from the thesis suggests that many VFRs 
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consider the financial costs involved in their healthcare. To persuade them to opt for the 
UK system, the easy and free accessibility of pre-travel health advice should be ensured. 
Without this, I argue, some may choose to continue to follow the established method of 
malaria control in Nigeria or Ghana, with a focus on treatment for an illness presumed 
to be malaria. Instead, an evaluation of the operation of local pre-travel health services 
is called for, to ensure that travellers are able to access free travel health advice at a 
surgery close to their area of residence. Local, rather than national policies are justified, 
as geographical areas with large migrant communities may need to offer a different 
range of services to other areas. 
Another issue relating to the operation of pre-travel health clinics was concerned with 
timely attendance by travellers. Malaria is only one of several diseases that may be 
discussed in consultations. There may be a need to vaccinate travellers against other 
diseases such as typhoid and hepatitis A, and these vaccines do not offer immediate 
protection after being administered. Therefore, one priority for travel health services 
must be to encourage attendance well before travel wherever possible. There is however 
a need for consistency about the time before travel in which pre-travel health advice is 
sought, and clear communication made with patients about this. An assessment of the 
time before travel that health advice is sought could be made by a small working group 
of nurses, who could disseminate recommendations to colleagues. 
Although information giving the time before travel that appointments should be made 
was available in some GP practices visited for this research, it was not always 
advertised. Furthermore, such advice is only read by those who attend GP practices. 
Other sites where such information may be provided include community pharmacists, 
libraries and in local newspapers. One possible implication of promoting the use of pre-
travel health advice may be to increase the volume of travellers who access these. Given 
the difficulties already experienced by some practices in providing these services, a 
means of addressing this issue would need to be in place before advertising them 
widely. 
10.2.1 b Accessibility of travel health advice when travelling at short notice 
The evidence from practice nurses was that travel at short notice may be more common 
amongst VFRs than in other groups of travellers, particularly given the need to attend 
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family-related events such as funerals. It has only been previously mentioned as an 
issue affecting the accessibility of travel health services for VFRs in one published 
study in the UK (Morgan and Figueroa-Munoz, 2005). This thesis identified the 
provision of pre-travel health advice at short notice to be one of the main difficulties 
experienced by the majority of practice nurses, and was also raised as an issue by 
community pharmacists. Two of the six patients interviewed also described their 
inability to access chemoprophylaxis at short notice as being the reason they travelled 
without it, although one acknowledged that he had not prioritised the need to visit a 
travel clinic. As noted in section 8.5, more research would be useful to gain an accurate 
estimate of the proportion of malaria cases in the UK which can be attributed to 
difficulties in accessing pre-travel health advice shortly before travel. 
Given the acknowledged constraints on the operation of travel health clinics described 
above, if further research identifies access to pre-travel health advice at short notice to 
be a barrier to its use, providing sufficient appointment times for individuals who seek 
health advice shortly before travelling is likely to be difficult. One option may be to set 
up in peTs with large migrant populations one or two well-advertised and resourced 
travel health clinics, with extended opening hours to provide this service. Providing two 
or three trained community pharmacists who are able to prescribe and administer 
chemoprophylaxis in each borough may be another or additional option. Whilst this 
solution would only prevent malaria, and not travel-related vaccine-preventable 
diseases, it may be a pragmatic means of helping to reduce the incidence of imported 
malaria in areas of high incidence. This would also be a means by which the providers 
of local healthcare services in these areas could demonstrate an understanding of the 
needs experienced by some members of their local migrant communities who may need 
to travel at short notice. Of course, the cost of chemoprophylaxis may be a disincentive 
for some VFRS, even if they are able to access it at short notice. The recent policy 
change in LSL areas described in section 10.1.1 would have to be re-considered for 
these travellers, as the only drug which can be started shortly before travel should not 
now be prescribed unless other drugs are contraindicated. Amending this policy to 
provide this drug on a subsidised basis for one particular group of travellers (those 
travelling at short notice) may have the unintended consequence of encouraging more 
travellers to only access pre-travel health advice shortly before travel. This highlights 
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the complex nature of the issue of imported malaria and the interventions that can be 
taken to reduce the incidence. 
10.2.2 Factors relevant to malaria control at the individual level 
1 0.2.2a Adequacy of mosquito avoidance advice 
Although the avoidance of mosquito bites is one of the four WHO recommendations for 
the prevention of imported malaria, only two studies have previously investigated this. 
One used a standardised questionnaire (Pistone et aI., 2007), a study method that does 
not allow for in-depth discussions with respondents. The other only commented briefly 
on this issue (Leonard and Vanlandingham, 2001). This thesis explored for the first 
time the factors which VFRs consider when deciding how to protect themselves against 
mosquito bites when in Nigeria or Ghana, the constraints associated with these and the 
operational difficulties associated with providing this aspect of pre-travel health advice. 
The results revealed concerns by both VFRs and practice nurses about the provision of 
advice about protection against malaria bites. Together, these uncertainties may result in 
this issue being given little attention. Difficulties mentioned by nurses included the 
occasional awkwardness caused by ethnic differences between the individual nurse and 
the traveller, the need felt by some nurses to "tick all the boxes" to prove they had 
communicated the risk, thus precluding the opportunities for a relaxed discussion, and 
the time constraints that may prevent comprehensive pre-travel health advice being 
given. The unwillingness of many VFRs to listen to the advice of travel clinic nurses 
about the risk of being bitten by mosquitoes is perhaps an example of the general lack 
of confidence of some VFRs in British healthcare professionals vis a vis malaria 
control, compared to their own familiarity, gained from the experience of living in a 
malaria-endemic area. Indeed, in the questions asked about mosquito control in the 
interviews, many VFRs and patients displayed knowledge about the local environment 
in which they would be staying, and may justifiably feel that travel health nurses do not 
have this. None of the VFRs stated they would seek pre-travel health advice in order to 
learn about effective methods of mosquito control. Instead, the intention of seeking pre-
travel health advice, amongst those who chose to do so, was to obtain a prescription for 
chemoprophylaxis. The skills of the practice nurse, as appeared to be perceived by 
many VFRs, were in prescribing this appropriately. 
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Although seeming not to pay heed to the advice given by travel clinic nurses, many 
VFRS however acknowledged that they did face difficulties in protecting themselves 
against mosquito bites, as described in section 7.5.3. Personal bednets, which would 
help to overcome at least some of these problems were however almost universally 
unpopular for VFRs and patients. This thesis produced new evidence to show the extent 
of this dislike, and the reasons underlying this. 
Nevertheless, mosquito avoidance is important. As noted in section 2.3.1, the efficacy 
of malaria chemoprophylaxis is estimated to be is 90%. Thus it cannot be fully relied 
upon to prevent malaria. Aside from the lack of adherence to chemoprophylaxis by 
those who do choose to take it, it appears (from the epidemiological analysis in section 
5.2.7), that many VFRs who contract falciparum malaria whilst visiting friends and 
relatives in Sub-Saharan African countries travel without it. This means for some there 
is almost a total reliance on protection against mosquito bites to prevent malaria. Given 
the constraints on GP practice-led travel health services, and that this method of 
imparting pre-travel health advice only reaches one section of the community (those 
who access pre-travel health services), other ways to communicate these messages 
about effective ways of preventing mosquito bites should be considered by UK-based 
imported malaria strategists. The findings from this thesis suggest that this information 
needs to be tailored in a way which acknowledges the expertise and experience of 
VFRs. Without this, suggestions about the most effective method for providing this 
information are unlikely to be successful. This is because from the evidence from those 
interviewed for this research, many VFRs do not consider such information to be 
targeted at them. This was particularly noticeable with respect to the discussions with 
travellers about the usefulness of pre-travel health advice issued on travel tickets. One 
option might be for practice nurses with an interest in travel health to work together 
with African community groups to determine the type of information that would be 
useful to them, and how it should be presented. For example, this might include sharing 
information about successful measures taken by other VFRs to protect themselves from 
being bitten by mosquitoes, and promoting the use of skin creams when sitting outside 
in the evening, a practice that appeared to be used by few VFRs. The best methods for 
disseminating this information to target communities could also be discussed in such 
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collaborations. A start to such work has already been undertaken (Health Protection 
Agency, 2009), and the opportunity to work together with healthcare professionals was 
received positively by the African community groups involved. 
10.2.2b The influence of family and friends on VFRs 
That some VFR respondents reported pressure by their family or friends not to use 
chemoprophylaxis was another significant new finding from this research. There were 
two different ways in which this could potentially impact on the decision to use it: one 
by dissuading VFRs from purchasing it in the UK before travel, the other by 
discouraging them from adherence to planned malaria prevention measures in Nigeria 
or Ghana. Only a few VFRs mentioned that the views of friends and relatives affected 
their decision making, and its importance would need to be evaluated in future research 
studies. The VFR (VFR12) who appeared to be the most influenced by peer pressure in 
the UK and in Nigeria was amongst the youngest of respondents, and it may be that 
those who are older, and/or travelling with children to whom they have a responsibility, 
may be less likely to be influenced by friends and family. The connection made by 
some younger African migrants living in London between cultural identity and the use 
of chemoprophylaxis, as described by this VFR, was interesting as it suggests a wish by 
some migrants to maintain established ways of managing this disease. The results also 
indicate an unawareness by some friends and relatives in Nigeria and Ghana of the 
changing risk for VFRs once they leave a malarious country, and/or an unwillingness to 
accept these. It should be remembered however, that although made fun of by her father 
for taking chemoprophylaxis, VFR12 was persuaded to take it by her mother; showing 
how even within one family, pressures to use chemoprophylaxis can be contradictory. 
More details of the specific factors which may influence host family's attitudes were 
also described by some VFRs in comments made about other aspects of malaria 
prevention. For example, with respect to the use of mosquito control measures, VFRI 
described how hosts' wealth and personal travel experiences may make them more 
likely to encourage protection against mosquito bites by their guests, compared to those 
who are less well educated and/or those living in rural areas. The interview with 
VFR18 meanwhile showed how the personal perceptions of individual VFRs (which for 
this respondent included a vehement dislike of chemoprophylaxis, an unawareness of 
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her possible loss of immunity and confidence in self-treatment) may make them 
resistant to the encouragement of friends and family. Others, such as YFR16, who 
believed his host family would "snigger" at their guests for taking chemoprophylaxis, 
was himself ambivalent about their use (see section 7.7.2). Much of the previous 
research about YFR's knowledge, attitudes and beliefs towards malaria has focused on 
exploring their own perceptions. These new findings suggest that the attitudes of family 
and friends and the interplay between them and the traveller may also be significant to 
some extent. If this is the case, then it presents an added complexity for travel health 
nurses in the discussions that are held with YFRs about travel health risks. It also 
provides more evidence for the assertion that imported malaria cannot be controlled 
solely by reducing barriers that are present in the UK (see section 1.4), such as 
improving access to pre-travel health advice. 
10.2.2c Diagnosis and treatment of malaria 
The only study to have previously investigated these issues was conducted in the USA, 
and only included Nigerian migrants. Whilst there were some similarities in the findings 
between the two studies (distrust of non-African clinicians and a fear of being isolated 
upon admission to hospital), there were also some new insights about the diagnosis and 
treatment of malaria that were explored in this thesis. 
In some ways, the discussions with YFR and patient respondents about the diagnosis 
and treatment of malaria revealed similar findings to those described in section 10.2.2a 
which considered mosquito control methods: a belief held by some that previous 
experiences of the disease provides expertise to manage future situations. With respect 
to mosquito prevention measures, this sometimes failed YFRs and patients for reasons 
over which many felt they had little control, such as local environmental factors. With 
respect to the diagnosis of malaria on the other hand, many of the VFRs and patients 
perceived themselves as confident in their own ability to diagnose malaria from clinical 
symptoms (a skill some believed to have been acquired from previous experience and 
which some believed they had in contrast to non-African clinicians). This thesis 
provided examples of how in practice, these failed. Similarly, although many believed 
they were knowledgeable about the appropriate treatment for malaria, and confident in 
their ability to treat themselves, in the interviews carried out, few were aware of parasite 
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resistance to chloroquine and SP. The consequences of not being up to date with current 
effective malaria treatments were clear from the experiences of some YFRs described in 
the interviews. 
Clinicians are thus faced with the challenge of providing new information to YFRs 
about the diagnosis and treatment of malaria in a way which acknowledges the expertise 
and previous experience that many YFRs have. For example, this might consist of 
summarising research about parasite resistance to SP and chloroquine in a way which 
can be easily communicated by VFRs. With respect to malaria diagnosis, clinicians 
could share their experiences of where self-diagnosis was not successful. Collaboration 
between clinicians and VFRs who are willing to engage with them may be one valuable 
method of circulating this to the wider African community. All of the patients 
interviewed were grateful for their care, and one, a pastor, was keen to disseminate the 
message that the fear of isolation was unfounded. Taking advantage of the goodwill of 
such individuals would be useful to overcome the mistrust and suspicion that appears to 
be held by some VFRs. 
The thesis also provided evidence of a changing perspective among some YFRs with 
respect to diagnosis. Some were keen to take advantage of the facilities that are freely 
available in the UK, even if it entailed a wait of four hours or more, to exclude malaria 
as a possible diagnosis. According to one clinician, a growing number of YFRs are 
becoming aware of their gradual loss of immunity and that as a consequence of this, the 
symptoms experienced in future episodes of malaria may be more severe than 
previously. This gradual adaptation to the changing reality for some YFRS provides 
another opportunity for clinicians to engage with VFRs, and this could be done either 
opportunistically, and/or by engagement in local workshops or conferences. 
However, these messages, whether disseminated by clinicians and/or community 
members are unlikely to be successful if mis-diagnoses and delayed treatment by UK-
clinicians continue to be experienced by VFRs, as the evidence from this thesis suggests 
that anecdotes of these experiences are likely to be shared within the local Nigerian and 
Ghanaian communities. Thus, these problems must be dealt with effectively in order to 
increase the confidence of VFRs in non-African clinicians, and this presents another 
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challenge for clinicians. As with other issues discussed in this chapter, it also 
exemplifies the multi-faceted approach which must be taken to reduce the incidence of 
imported malaria in London, if it is to be successful. 
10.2.2d Examples of VFR decision making about malaria using the 
conceptual framework 
Four examples are provided in this section to show how the conceptual framework can 
be used to explain how VFRs may become infected with malaria. 
The first is of a student, travelling back to Nigeria to visit his parents. He had no 
intention of seeking pre-travel health advice in the UK, because he believed he could 
recognise the symptoms of malaria, as he had previously successfully treated himself 
for an illness which he had presumed to be malaria. Although encouraged to take 
chemoprophylaxis by some of his UK-based Nigerian friends, he feared they would 
contain chloroquine, against which he had had a severe reaction in the past. A friends 
persuaded him to do visit his OP practice, and he did so a week before he left. He was 
told that AP, the only drug that could be taken shortly before travel was no longer 
available for the price of a NHS prescription, but he could purchase it at a British 
Airways travel clinic. He thought the cost of this service to be unjust and did not 
purchase it. 
He planned to stay in his parent's house in Lagos throughout his visit. He was aware of 
the mosquito control measures in their home, and intended to protect himself from 
mosquito bites by covering his body in the evenings when he was outside. However, he 
had to make an unexpected trip to a rural area of Nigeria to visit his grandmother. Just 
before leaving Nigeria, he developed symptoms suggestive of malaria and purchased SP 
from a community pharmacist. This was the usual method he used to treat himself. It 
was ineffective and he attended A&E two days after arrival in the UK, where he was 
confirmed to have malaria. 
A female VFR was travelling to Nigeria with her children. She made this trip every two 
years, and planned it carefully. She visited her local OP practice in Lambeth for pre-
travel health advice and obtained subisdised malaria chemoprophylaxis. She took care 
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to protect herself and her children from mosquito bites for the first two weeks of her 
trip. Her parents criticised her for what seemed to them to be an over-reaction to the risk 
of malaria when she applied creams to her children's skin, and made them cover their 
anns and legs in the evening. The children themselves were also reluctant to do this. 
They also disliked taking the weekly dose of mefloquine. Despite this, she enforced 
these measures. After she arrived back in the UK, she did not insist on them finishing 
the course because they had no symptoms of malaria. One child developed malaria-type 
symptoms, which were initially mis-diagnosed by her GP. The child received a 
laboratory-diagnosis of malaria upon admittance to hospital. 
A VFR travelled with his wife and children to Ghana for the first time in several years. 
They sought pre-travel health advice, but were unable to afford the cost of the 
chemoprophylaxis they were prescribed. Instead, they decided to purchase it for the 
children only. The husband had sickle-cell trait, and felt as such, he was not susceptible 
to malaria. The wife felt she had some immunity to malaria. Although she remembered 
experiencing severe symptoms in her childhood, as an adult, the symptoms she had 
acquired, and which she had assumed to be malaria were mild and easily treated. 
Ghanaian-born friends living in the UK advised them to purchase malaria treatment for 
themselves before returning to the UK. Despite attempting to protect themselves from 
malaria bites, they were unprepared for the number of mosquitoes in the area in which 
they stayed. As they did not have malaria symptoms before they left Ghana, and had 
little spare time, they did not purchase the treatment they intended. The wife contracted 
malaria. 
A VFR had travelled annually for the last five years without taking chemoprophylaxis 
before leaving the UK on any of these visits. The nature of his employment meant that 
he always had to travel at short notice. He had become aware through cases publicised 
in the UK media that he was more at risk of malaria than he had previously thought, and 
for the first time decided to seek pre-travel health advice. He tried to make an 
appointment at his GP travel clinic, but was told none were available at short notice. His 
attempt to purchase chemoprophylaxis from a community phannacist was unsuccessful. 
His Accra-based hosts had recently moved, and were in the process of renovating their 
new property, but had not yet replaced the old window and door screens which had 
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holes in. He acquired malaria shortly before leaving Accra. He was reluctant to attend 
hospital in London, because he had heard rumours that he would be isolated. However, 
after his health deteriorated, he was admitted. 
10.2.2e Summary of the conceptual framework 
The conceptual framework presented in this thesis is the first time that such a 
framework has been constructed for imported malaria. This needs to be tested in other 
contexts to examine its validity. One example might be New Zealand residents of 
Pacific Island ethnicities visiting the Solomon Islands, Vanuatu or Papua New Guinea 
as VFRs. Another example where it could be tested is for second generation migrants. A 
third example is its validity with respect to other common travel-related diseases, such 
as typhoid. The relevance of the framework with respect to how VFRs manage new and 
emerging infections, which may perhaps become more prevalent as a result of climate 
change, is also deserving of further research. 
10.3 Other theoretical issues discussed in the thesis 
The next section deals with the three theoretical questions raised in this thesis, and uses 
the conceptual framework shown in figure 10.2.1 to answer these. 
The first question was whether diseases such as imported malaria could be prevented 
within non-endemic countries by the removal of structural barriers, or whether this is 
unlikely, given the broad range of factors which impact on the burden of disease. As 
shown in the conceptual framework, it is clear that there were structural barriers which 
may have contributed to the decision not to seek prevention against malaria. However, 
as has been demonstrated throughout the thesis, there is considerable heterogeneity 
within the Nigerian and Ghanaian communities. Thus, no single structural barrier is 
likely to be a problem for all respondents. For example, for some, the cost of 
chemoprophylaxis may not be a deterrent, but problems with accessing travel health 
advice at short notice may prevent them from taking chemoprophylaxis. For others, 
none of the structural barriers revealed in this thesis may be relevant to their decision 
making. Therefore, it is unlikely that even where a particular structural factor was a 
deterrent, would its removal result in a significant decrease in the incidence of imported 
malaria. Nonetheless, I argue that it is worthwhile making interventions in countries 
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where imported malaria occurs to reduce the Public Health burden of this disease and 
the impact of infection on the individual. . 
The remaining question is whether interventions carried out in the UK alone could 
prevent imported malaria. The evidence from this thesis was that some VFRs were 
content to follow the established way of managing malaria in Nigeria or Ghana. 
Furthermore, the finding that the attitudes of friends and relatives influence the 
behaviours of UK-based VFRs suggests that imported malaria cannot be eliminated 
solely by focusing on reducing barriers in the UK. On the other hand, as asserted in 
section 10.2, the contexts in which VFRs make decisions are not static, but change over 
time. Thus, the importance given to the beliefs of family friends and members for 
example, may become less relevant. However, I believe that this question cannot be 
answered until all new interventions undertaken in the UK as suggested in this chapter 
are implemented and evaluated. Further research could then take place to determine the 
reasons why individuals did not adopt a policy of prevention rather than treatment of 
malaria and the extent to which these were influenced by factors not directly in the 
control of UK-based health professionals. 
The second issue raised in the thesis was concerned with what constitutes an appropriate 
definition of "VFR" and in particular, whether ethnicity should be included in this 
definition. As shown in the conceptual framework, one factor which impacted on 
decisions made about malaria control was related to the importance of following 
societal and cultural norms in Nigeria and Ghana. Nearly all VFRs and patients' 
decision making was influenced to some extent by these factors. Health care providers 
and community pharmacists also voiced these issues as being a contributory factor to 
decision making by their patients and customers respectively. Clearly, there were 
individual differences in the extent to which ethnicity was a contributory factor, and the 
importance of understanding these individual differences were cited by Matteelli and 
colleagues (Matteelli et aI., 2010). However, it could justifiably be argued on the 
evidence presented and shown in the conceptual framework that ethnicity is an 
important component associated with the term "VFR". Of course, this work is restricted 
to one disease area, and it would be useful to discover to what extent ethnicity is 
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important with respect to decision making about other travel-related infectious diseases, 
such as typhoid. 
The third issue, how risk is assessed by individuals, was an important theme which 
arose throughout the research. It was identified initially in the literature review in 
chapter two, with respect to the perceived potential and personal risks associated with 
contracting malaria, and in each of the three qualitative results chapters there were many 
examples of risk assessment being made by VFRs. In section 3.9, the issue was raised 
of whether risk could be considered as a social construct, as proposed by Douglas and 
Wildavsky (Douglas and Wildavsky, 1982). Again, the conceptual framework shown in 
figure 9.2.1 helps to address this issue. 
Of the three inter-related components with respect to risk put forward in this theory, the 
first was "private, subjective perception". As shown in the conceptual framework, 
subjective perceptions influenced some decisions that individuals made about the risk of 
malaria. One example was how previous experiences of malaria contributed to the 
decision to use chemoprophylaxis on future trips. Another was the dislike of taking 
tablets, which was a relevant issue for some. 
The second component was the importance of accurate knowledge in order to be able to 
assess risk. The patient and VFR respondents demonstrated clearly the benefits of 
holding correct knowledge, as they understood why avoiding mosquito bites is 
necessary to reduce the risk of acquiring malaria when visiting a malarious country. The 
information presented in chapter two also showed how insufficient knowledge can lead 
to difficulties in assessing risk. This was with respect to the time required for immunity 
to malaria to be lost, which was unclear for VFRs but also for malaria experts. 
The third component of Douglas and Wildavsky's theory was that following societal 
norms enables individuals to deal with the otherwise unmanageable amount of 
information they are faced with when assessing risk. Although no respondent 
specifically indicated that their decision making was a result of their inability to process 
or manage large amounts of, or conflicting information, there was evidence in the 
responses given by respondents of the following of social norms by some VFRs. 
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Examples include the choice of those mosquito avoidance measures which were 
common amongst friends and relatives in Nigeria and Ghana, and the use of community 
pharmacists in Nigeria and Ghana to purchase treatment for malaria. 
Douglas and Wildavsky claim further that the prevailing social environment puts 
constraints on the individual with respect to the choices they make about risk. This was 
overtly expressed by some respondents, with respect to their perception that they were 
at a greater risk of malaria than their host families in Nigeria and Ghana. This was seen 
to lead to some instances of peer pressure when they visited their families in these 
countries and adopted practices with respect to protection against malaria that would not 
be followed in these countries. In the UK context also, the social environment imposed 
risks, for example some did not understand that the common view held in the UK that 
malaria is potentially a fatal disease. The unique situation of VFRs, as shown in the 
conceptual framework is that they are at the interface of two social environments, each 
of which is taken into consideration when making decisions about managing malaria. 
The results of the research carried out for this thesis and presented in the conceptual 
framework show that not only the social environment, but also the structural and 
physical environment are valid, and the failure by Douglas and W ildavsky to include 
these is perhaps a limitation of their theory. 
10.4 Limitations 
The limitations associated with each research methods (epidemiological analysis and 
qualitative research) have been described within the thesis. To summarise, with respect 
to the epidemiological analysis, these were broadly related to issues of data quality of 
both numerator and denominator, for example, the MRL reporting form may be not 
fully completed, or there may be inaccuracies in the information provided by clinicians 
completing the forms. 
The MRL dataset includes reports of laboratory-confIrmed malaria. The findings from 
the study carried out by Ladhani and colleagues showed that there may be individuals 
with mild symptoms of malaria who are never tested (Ladhani et aI., 2003). Thus, the 
MRL data may only reflect a sub-set of the true number of those infected, and risk 
factors for those with more mild symptoms may differ. Without the availability of a 
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dedicated plasmodia screening programme for those who return to the UK after visiting 
malarious endemic countries, including the collection of risk factors for these 
individuals, there is little that could be done to overcome this, but the results of the 
epidemiological analysis should be borne with this limitation in mind. 
The use of mid-year population estimates to measure incidence rates is not an accurate 
measure, as not all members of the community may travel, and some may travel more 
than once in any given year. The use of an alternative denominator, IPS data from the 
ONS, provided a useful alternative, but more detailed categorisation, relating to age, and 
sex, which would have enabled a more thorough analysis to be undertaken. 
One of the main limitations of the qualitative study was its small-scale nature, which 
comprised only 56 respondents. Only a limited number of individuals were invited to 
attend, and others may have provided different perspectives. In addition, those 
individuals who were invited to participate but declined to do so may have provided 
different information to those who did agree to be interviewed. Having said this, similar 
themes were raised by participants in each respondent group, and it appeared that 
saturation point was reached for VFRs, GPs, practice nurses and community 
pharmacists by the end of data collection. Difficulties with recruitment of hospital 
consultants and patients precluded more being interviewed, but it is accepted that it 
would have been useful to increase recruitment to these groups. It was acknowledged 
throughout the thesis that the results of the qualitative study need to be tested using 
quantitative research methods to examine the extent to which they can be extrapolated 
to a wider population. 
Given the small scale of the qualitative study, in the analysis, the findings from both 
Nigerians and Ghanaian respondents were included together. Although the 
epidemiological analysis showed that both groups are disproportionately affected by 
imported malaria, many factors, such as the structural, social and physical environment 
between these countries may differ considerably. More detailed research would be 
needed to explore this. 
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In the qualitative research, one patient explained that there were some factors which, as 
a non-Nigerian I could not understand. Thus, the difference in ethnicity between myself 
and the respondents may have introduced a certain reticence or bias in the responses that 
they gave. The result of this would be a failure to include all relevant factors in the 
analysis. This is accepted as a being a limitation. However, as noted in section 6.6.1, 
many African respondents took on the role of experts in the interviews, and some of the 
information provided to me, may not have been imparted to someone they judged to be 
already familiar with the issues discussed. 
One of the most significant limitations of the qualitative research was that with the 
exception of one respondent, all VFRs and patients were born in either Nigeria or 
Ghana. Thus, the views of second generation migrants were not included. The results of 
the qualitative analysis should be considered in the light of this limitation. 
10.5 Final thoughts 
The reasons for the burden of imported malaria in the UK amongst the Nigerian and 
Ghanaian community are complex. Attempting to forecast future incidence trends will 
require consideration of a variety of factors and their interactions. It is worth repeating 
Bradley's 1989 comment, first quoted in the introduction to this thesis, that unexpected 
and relatively unpredictable events may determine the course of imported malaria, and 
making predictions about its future incidence is fraught with danger (Bradley, 1989). 
One issue that will affect future trends is the extent to which structural factors in the UK 
continue to present a barrier to accessing chemoprophylaxis in particular, and this in 
turn reflects the level of commitment of the UK Government to a policy of health 
prevention rather than to treatment for common travel-related diseases. Without a 
concerted policy to ensure that measures are put in place to help VFRs protect 
themselves against malaria, some may continue to follow the established method of 
malaria control in Nigeria and Ghana, with a focus on treatment for an illness presumed 
to be malaria. In addition, the distrust held amongst some VFRs about the skills of non-
African clinicians must be overcome in order that their recommendations are accepted. 
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However, the use of these established methods will also be affected by the extent to 
which VFRs recognise that the risk to themselves is not the same as when they were 
resident in Nigeria or Ghana, that a focus on prevention rather than treatment is 
preferable, and that there are limitations to the ways in which malaria is diagnosed and 
treated in Nigeria and Ghana. It has been shown in this thesis that there is some 
evidence of this changing perspective, and focused, appropriate health promotion 
campaigns could help to ensure this continues. 
Environmental changes within Nigeria and Ghana, for example caused by increasing 
urbanisation, may also affect future trends in malaria incidence. Whilst this may 
decrease incidence, paradoxically, a level of complacency amongst VFRs with respect 
to the perceived risk of contracting malaria when in a malarious country may result. 
This would mean that fewer efforts at protection are made, and that cases continue, or 
even perhaps increase. 
Another issue influencing future trends in imported malaria will be the success or 
failure of the current efforts to eliminate malaria in Nigeria and Ghana. The acceptance 
and affordability of one change in policy, namely that introduced by the WHO in 20 I 0 
that all cases should be parasitiologically-diagnosed and treated with ACTs (World 
Health Organisation, 2010) may be an indicator of the extent to which elimination 
efforts are practical. It will be interesting to evaluate whether this policy change is 
recognised by VFRs, and in particular to determine if they are aware of and follow these 
recommendations themselves when they are visiting Nigeria and Ghana. 
In writing this thesis, it has been difficult at times to envisage that imported malaria 
could be controlled, given the wide-ranging factors which contribute to the burden of 
this disease. Nevertheless, it is worth remembering that malaria is preventable, and that 
it has already been eliminated in a number of malaria-endemic countries (Tatem et aI., 
20 I 0). Thus, whatever health policies are considered and implemented should be 
undertaken with confidence that a reduction in the incidence of imported malaria in the 
Nigerian and Ghanaian communities living in London can be achieved. 
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Appendix 1 - MRL Report Form 
Iyour R .. f"r@nc. No. 
Family nam<!: 
All other names: 
Hom" post cod,,: 
Add",ss in U.K: 
Oat .. of birth: 
HEALTH PROTECTION AGENCY 
MALARIA REFERENCE LABORATORY 
PATIENT REPORT FORM 
In Confidence 
Date --~---I---
Primary Ca ... Trust: .. 1------_________ ..., 
__ 1_- 1 __ 
"0"---- Sex : ... I F 
Country of birth: ______ _ Country of usual residenoe: _______________ _ 
Ethnicity: (m~rk onel 
J White British 
J Oth .... White background 
J Black African 
J Black Caribbean 
J Other Black background 
J Indian Sub-Continent 
~ Sou1t>-East Asian 
] Other Asian background 
!J Mixed ethnicity 
J Other (please specify) 
Reason for trawl:emar1< on", 
[ New Entrant to UK 
C Visiling family in co..-.try 01 origin 
[ UK citizen living abroad 
[ Civilian seala;' crew 
[ Bt~ish anned forces 
Q BuY\es!OlProfessional travel 
[ Foreign student studying in UK 
[ Holiday travel to malarious country 
[ Foreign visitor I whit! in UK 
o Children visiting parents living abroad 
o Other (please specify}, ____ _ 
Malw prophyluis tak.n:emark as rol.nntl 
o NONE 
o t.\efloquine (Lan am) 
o t.\alarone 
o Doxycycline 
o Chloroquine CNivaquineiAvioclor) 
o Progtlanil CPaludrine) 
o UIlknown 
O Olher __ 
Prophytaxis taIc"n regularly? Y , N 
Continued on Il!!um for _ .. ks 
0 ..... of onset of illnI!ss: __ '___ '___ Date of s1arting lreatment ___ ,___ ,__ 
Date of arrival in UK from malarious country: __ , ___ , __ 
Ouration of stay abroad : _________ _ 
For India. please specify 
areas visited 
Country rles) where infection acquired : __________________________ _ 
G.P. Ham<! & Addn!'Ss : 
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Hame & Contact Details 
of person completing this fonn if not 
theG.P. 
Please complete other side -
aboraloryl Hospital \Ml~re diagnosis maeSe: 
Date of diagnosis: ___ 1 ___ 1 ___ Dat~ of sampl~ : ___ 1 ___ ' __ -
..... thod of diagnosis : o Blood film 0 Antigen t~st o Clinocal 
pleas~ specify 
S~cies of malanal paras~: 
0 P.fsiaparun 0 P.ovale 
0 P.vivs .• 0 Species unknown 
0 P.malariae 0 No ma~ria parasit~s found 
Was patil!f'lt treated as an o outpatient 0 inpatio!nt Was this patJent admitted to rrull-lOU? Y I N 
DLnition of stay 111 hOiprtal days. 
PrelPlan!? Y I N ---/40 
Outcome of illness: Recovery 0 Death 0 Unknown 0 
Any other information relevan! to this case; 
MALARIA IS A NOTIFIABLE DISEASE- PLEASE FILL IN A STATUTORY NOTIFICATION FORM 
AND FORWARD TO THE CCDC . 
Please return this form to: MALARIA LAB. USE ONLY 
HPA Malaria Refe,en.,.. Laboratory 
London School of Hygi,me & Tropical Medicine 
K.eppel Street (Gower Streetl 
London WC1E 7HT 
Tel no: surveillance 020 7927 2435 
bboratOf)' 020 7927 2427 
fax 020 7&37 0248 
I Hlldlng _1_ . .,.... Indicate ___ 10 wflOIII 
rwulla ........ d be MIll 
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Appendix 2 - Topic Guides 
VFRs 
Country and area being visited/area just visited 
Length of time spent planning the trip 
Where ticket purchased and whether any health advice was noticed 
Health concerns when travelling 
Potential risk of acquiring malaria in the country being visited 
Planned/actual use of mosquito avoidance measures 
Perceptions of malaria as a serious disease 
Personal susceptibility to malaria including sickle-cell and G6PD 
Previous experience of malaria 
Potential fatal consequences of contracting malaria (for VFRs 16-20) 
Beliefs about immunity to malaria 
Perceived differences between Nigerians/Ghanaians and friends and family in the UK 
with respect to the seriousness of malaria 
Use of chemoprophylaxis 
Choice of chemoprophylaxis 
Cost of chemoprophylaxis 
Access to pre-travel healthcare 
Plans for dealing with any symptoms in Nigeria or Ghana, and on return to the UK 
Perceived reasons why malaria was contracted, description of symptoms, actions after 
initiation of symptoms (if relevant) 
F ever and malaria 
Convulsions and malaria 
Perceptions of UK health services for the treatment of malaria 
Knowledge about malaria transmission 
Date of birth 
PCT of residence 
Country of birth and subsequent migration 
Number of years resident in the UK 
Areas within Nigeria or Ghana visited, frequency of travel, duration of visits 
Number of people travelling on most recent trip 
Borough of residence 
Occupation 
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Patients 
When became ill 
Symptoms 
Initial actions 
How malaria was diagnosed 
Where treated 
Perceptions of where malaria may have been acquired 
Country and area just visited 
Length of time spent planning the trip 
Where ticket purchased and whether any health advice was noticed 
Health concerns when travelling 
Potential risk of acquiring malaria in the country being visited 
Use of mosquito avoidance measures 
Perceptions of malaria as a serious disease 
Personal susceptibility to malaria including sickle-cell and G6PD 
Previous experience of malaria 
Beliefs about immunity to malaria 
Perceived differences between Nigerians/Ghanaians and friends and family in the UK 
with respect to the seriousness of malaria 
Use of chemoprophylaxis 
Choice of chemoprophylaxis 
Cost of chemoprophylaxis 
Access to pre-travel healthcare 
Plans for dealing with any symptoms in Nigeria or Ghana, and on return to the UK 
Fever and malaria 
Convulsions and malaria 
Perceptions of UK health services for the treatment of malaria 
Knowledge about malaria transmission 
Date of birth 
peT of residence 
Country of birth and subsequent migration 
Number of years resident in the UK 
Areas within Nigeria or Ghana visited, frequency of travel, duration of visits 
Number of people travelling on most recent trip 
Borough of residence 
Occupation 
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GPs 
Length of time employed as a GP 
Seasonality of VFR presentation with symptoms 
Symptoms which would make malaria be considered as part of a differential diagnosis 
Estimate of number of patients seen with suspected malaria 
Self-treatment ofVFRs before seeing GP 
Recent travel asked/volunteered by patients with malaria-type symptoms 
Actions upon presentation of malaria symptoms 
Estimate of number suspected subsequently found to be infected with malaria 
Fever and malaria 
Experience of cases of severe malaria 
Cost of chemoprophylaxis 
Exploration and evaluation of: 
VFR perceptions of a potential risk of acquiring malaria 
VFR perceptions of a personal risk of acquiring malaria 
VFR perceptions of their susceptibility to malaria 
VFR perceptions of malaria as a serious disease 
VFR perceptions of their immunity to malaria 
VFR knowledge of how malaria is transmitted 
Operation of travel health clinics 
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Practice nurses 
Length of time employed as a practice nurse 
Sex 
Duration of travel 
Seasonality 
Urban or rural areas visited 
First time or regular VFR travellers 
Length of time before travel pre-travel health advice sought 
Health concerns of travellers 
Initiation of discussion about health advice 
Sickle celV G6PD 
Chloroquine resistance 
Choice of chemoprophylaxis 
Plans for bite avoidance measures including bed nets 
Cost of chemoprophylaxis 
Adherence to chemoprophylaxis 
Sources and sufficiency of infonnation to issue VFRs pre-travel health advice 
Operation of travel health clinics 
Exploration and evaluation of: 
VFR perceptions of a potential risk of acquiring malaria 
VFR perceptions of a personal risk of acquiring malaria 
VFR perceptions of their susceptibility to malaria 
VFR perceptions of malaria as a serious disease 
VFR perceptions of their immunity to malaria 
VFR knowledge of how malaria is transmitted 
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Community pharmacists 
Length of time employed as a phannacist 
Number of customers seeking pre-travel health advice 
Sex 
Duration of travel 
Seasonality 
Urban or rural areas visited 
First time or regular VFR travellers 
Length of time before travel pre-travel health advice sought 
Health concerns of travellers 
Purchase of chloroquine by VFRs 
Purchase of mosquito avoidance measures, including bednets 
Cost of chemoprophylaxis 
Appropriateness of the prescription for the area being visited and dosage 
Subsidising of chemoprophylaxis 
Sources and sufficiency of information to check appropriateness of prescriptions 
How often updated 
Perceptions of why VFRs might use community pharmacists to seek per-travel health 
advice 
Requests for malaria treatment 
Actions upon presentation of a customer with suspected malaria 
Fever and malaria 
Exploration and evaluation of: 
VFR perceptions of a potential risk of acquiring malaria 
VFR perceptions of a personal risk of acquiring malaria 
VFR perceptions of their susceptibility to malaria 
VFR perceptions of malaria as a serious disease 
VFR perceptions of their immunity to malaria 
VFR knowledge of how malaria is transmitted 
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Hospital consultants 
Length of time working as a hospital consultant 
Duration of travel 
Seasonality of VFRs presenting with malaria symptoms 
Urban or rural areas visited 
First time or regular VFR travellers 
Presentation at GP surgery before attending A&E 
Estimate of number of patients seen 
Waiting times in A&E 
Presenting symptoms 
Sickle-celllG6PD 
Self-treatment before presentation 
VFR knowledge of chloroquine resistance 
Number of patients confirmed with malaria 
Number of patients presenting with severe malaria 
Isolation of patients with suspected malaria 
Cost of chemoprophylaxis 
Use of mosquito bite avoidance measures including bednets 
Exploration and evaluation of: 
VFR perceptions of a potential risk of acquiring malaria 
VFR perceptions of a personal risk of acquiring malaria 
VFR perceptions of their susceptibility to malaria 
VFR perceptions of malaria as a serious disease 
VFR perceptions of their immunity to malaria 
VFR knowledge of how malaria is transmitted 
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Appendix 3 - Ethical Approval 
3a - The following is the transcript of email correspondence between me and 
NRES, asking if ethical approval is required for interviewing staff employed by the 
NBS 
Thank you. 
The following reply has been provided by Hilary Tulloch, Business 
Support Coordinator. 
Your study does not fall within our remit because it does not involves 
the categories listed in 3.1 ofGAfREC. 
I hope this helps. 
Regards 
Queries Line 
National Research Ethics Service (NRES) 
National Patient Safety Agency 
2nd Floor, Block A 
50 Eastboume Terrace 
London W2 6LG 
-----Original Message-----
From: Penny Neave [mailto:Penny.Neave@lshtm.ac.uk] 
Sent: 31 August 2007 11: 10 
To: Queries 
Subject: RE: Ethical approval for my PhD research 
in reply to your request, please fmd below my research proposal. 
NB: this has already been granted ethical approval by the London School 
of Hygiene's ethic's committee 
The aim of the project is to explore the 'perceptions of illness risk 
associated with visiting friends and relatives in Africa among the 
African population living in London and their malaria prevention and 
treatment behaviours.' 
Both quantitative and qualitative methods will be used 
Quantitative analysis includes secondary analysis of Malaria Reference 
Laboratory data including cases of malaria from 2001 to 2006. Analysis 
of more recent yearly data will be undertaken when available. 
All qualitative work will be undertaken in the areas of London with high 
numbers of African residents. 
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It will take the fonn of case studies, including 
1. Semi-structured interviews with Africans aged over 16 about to 
travel to Africa and their families, (separate interviews with each) 
both before and after travel 
Recruitment will take place through: 
a) written requests for participation through contacts with members of 
churches with large African congregations, with a subsequent use of a 
"snowball effect" whereby those recruited would be asked for other 
potential participants 
b) requests through primary, secondary schools, and technical colleges 
This would include a letter to the Headteacher IPrincipal explaining the 
reasons for the study and requesting a short interview to further 
discuss the issues. A letter would then be written to parents of African 
children within the school explaining the project and asking for 
potential participants to contact the Principal Investigator. 
The preparation of a lesson plan on malaria at an appropriate level that 
can be used by teachers would be offered by the Principal Investigator 
to all schools contacted to ensure that some educational benefit was 
included. 
2. semi-structured interviews with GPs, practice nurses, community 
phannacists and A&E consultants in areas of London with high African 
population 
These will be identified through infonnation obtained through Primary 
Care Trusts and the Royal Pharmaceutical Society. Letters will be 
written to potential participants describing the study, with follow-up 
telephone conversations to arrange interviews if agreed 
About 20 interviews with families are planned, together with 15 
interviews in total with GPs, practice nurses, community pharmacists and 
A&E consultants 
»> "Queries" <Queries@nationalres.org.uk> 08/30/07 4:58 PM »> 
Thank you. 
The following reply has been provided by Jo Downing, Infonnation Officer 
Thank you for your query. So that we might further consider your query, 
please email an A4 summary (one side only) outlining your proposal to 
Queries Line. For ease of reference please include your request in the 
covering email. 
I look forward to hearing from you. 
Regards 
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Queries Line 
National Research Ethics Service (NRES) 
National Patient Safety Agency 
Website: www.nres.npsa.nhs.uk 
Ref: 021/00 
Sent: 30 August 2007 14:52 
To: Queries 
Subject: Ethical approval for my PhD research 
I wonder if you could advise please. 
I have got ethical approval from the London School of Hygiene and 
Tropical Medicine for my PhD research. I will be carrying this out with 
various groups including 1) members of the public, not patients 2) 
community pharmacists 3) GPs/practice nurses/A&E consultants. It will 
involve interviews with individuals and families. 
Can you advise me whether I also need ethical approval from you please? 
Hope you can help, and look forward to hearing from you 
Best wishes 
Penny Neave 
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3b: NRES approval (their reference H0706/6) for interviewing patients at King ' s 
College Hospital 
'~l:kj 
Health Research Authority 
Ms P Neave 
PhD studen 
London School of Hygiene and Tropical Medicine 
cia Malaria Reference Laboratory 
London School of Hygiene and Tropical Medicine 
Keppel Street, WC1 E 7HT 
06 March 2009 
Dear Ms Neave 
Riverside Research Ethics Committee 
Room 4WI 2. 4th Floor West 
Olaring Cross os.pi 
Fur am P ace Road 
London W O 8RF 
Tf!lepnone : 02 884e 7282 
Fa.csimir~ : 0208846 7280 
Full title of study: Perceptions of illness risk associated with visiting 
friends and relatives in Africa among the African 
population living in London and their malaria prevention 
and treatment behaviours 
REC reference number: 09/H0706/6 
Thank you for your letter of 23 February 2009, responding to the Committee's request for 
further information on the above research and submitting revised documentation. 
The further information has been considered on behalf of the Committee by the Chair. 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
Ethical review of research sites 
The Committee has deSignated this study as exempt from site-specific assessmen (SSA). 
The favourable opinion for the study applies to all sites involved in the research. There is no 
requirement for other Local Research Ethics Committees to be informed or SSA to be 
carried out at each site. 
Conditions of the favourable opinion 
The favourable opinion is subject to the follOwing conditions being met prior to the start of 
the study. 
Management permission or approval must be oI)tained from each host organisation prior to 
the start of the study at the site concerned. 
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Managemen permission at NHS si es ("R&D approval") should be obtained from the 
relevant Cdre organisation(s) in accordance 'Nith NHS research governance arrangements. 
Guidance on applying for NHS pemlission is available in the Integrated Research 
Application System or at http://www.rdforum.nhs.uk. 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
Document Version Date 
Clarification of sponsor's e-mail 
Appli:cation AB/1 4428612 12 December 2008 
Key Collaborator 1 01 November 2006 
Supervisor's CV 1 01 November 2006 
Participant Consent Form 1 01 November 2008 
Protocol 28 November 2008 
Investigator CV 
Parti cipant Information Sheei 3 01 February 2009 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangemen s for 
Research Ethics Committees (July 2001) and complies fu lly with the Standard Operating 
ProceOures for Research Ethics Committees in the UK_ 
After ethical review 
Now that you have completed the appliCdtion process please visit the National Research 
Ethics Website> After Review 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you Wish to make your views 
known please use the feeaback form available on the website. 
The attached document "After ethical review -9uidance for researchers" gives detaileO 
guidance on reporting requirements for studies With a favourable opinion, including: 
• Notifying substantial amendments 
• Progress and safety reports 
• Notifying the end of the study 
The NRES website also provides guidance on these topiCS, which is updated in the light of 
changes in reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk. 
I09fH0706l6 Please quote this number on all correspondence 
With the Committee's best Wishes for the success of this project 
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Yours sincerely 
Sabita Uthaya 
Chair 
Email: atul.patel @.>,impertal.nhs.uk 
Enclosures: • After ethical review - guidance for researchers" 
Copy to: Dr Ron Behrens 
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3c - NRES approval for interviewing patients at HTD (amendment to application 
number H0706/6) . 
Ms P NQave 
PhD student 
LDndon School of Hygilln9 and Trq>ical Mlldicin9 
do Malaria R9 f9191lOQ 1.JIbor81 ory 
LDndon School of Hygilln9 and Trq>ical Mlldicin9 
1l4Ipp91 Strll91 
WCtE7HT 
Riverside ReM.rch Ethic. Commitllle 
Ao<n ~11 2. £111 Aou W.1 
CtI.-.g Clo •• HoopIII' 
Full ... PalI .OI Rood 
London Wu RF 
T &t: 020 3311 7282 
Fax: 020 3311 72«) 
Study title: Perception. of line .. rI •• aaod.t.d wllh v.kln<;! trt.ndl 
.nd ... !.IIIw. In Afrlcll .mong It. African population 
Iwlng In London Wld tt.lr malar. prev.ntlon.nd 
tra.tITIent behllVlour. 
REC ,,",.nc.: OlrH0701i16 
Amendnwnt Runber: 1 
AmenclrMnt dlllI: 12 NowmMr 200Il 
ethical opinion 
The! mllmbers ofth9 CommtIeG taking part in the! rvviGw gavQ a lavourab» IIIhicaJ q>lnbn 
d the! amendment on till basis descrll9d in the! notlc$ of amendment firm and I~rtlng 
OOcumentali()O. 
Approved document. 
The! docum9nts rvvi9*K1 and apprCMld a \hQ meG OIl WQrv : 
~ VenIIan D_ 
Pa1dp.fI1lnfonnaDon &.et , 01 ~20011 
Pr<*>COl 8 (Exduding AA>-ndic 1) OI~2OOII 
Nob 01 &.b-" ArMnd .... fI1 {non-CTIMP.j 1 12 NcN._ 2000 
... mbershlp of the COI'IWTIlttH 
Th9 mllmbers ofth9 Commlte9 who look part In I he! rvvi9w ar9 IisWd on the! allacillXl 
stI9Ql. 
R&D Ipproll.1 
All invostigltoo and RISIIaroh oolaborators n th9 NHS should notify th9 R&D oIfioo lor \hQ 
IlIkw ant NHS carD organisation ofti. , arnQnctnQnt and chIIdo; whIIthe!r h &ICIcIs R&D 
approval ofth9 _rdl. 
SlatAHMnt 0' compIlIInce 
The CammitlQ& is oonstitu\Qd In aooordanoe with the Govemanoo Arrangllm«rts for 
R9searoh Elhics Comminges (.iJIy 20(1) and oomplills Iully with tile SlandBrd ~lBting 
PrOO9<iJrgs lor R_oh Ethics CommlttCl9s in \hQ lK 
Yours SinOllrvly 
Atull>llill 
CornmIltN Co-ordinator 
E-mail: atul.p8IAl@imperial.nhs.,* 
EndosurfIB: 
Q)py to: 
LIst of II&'IlIIS .nd {Xat96S1ons at msmbflfs who rook pIfi In /tie 
rQII/f/JIf 
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3d: Permission from King ' s College Hospital R&D Department to carry out intervi ews 
with patients 
lJiucUNml' oJ 
RESEARCH & 
DEl' ELO PW EN T 
Ms Penny Neave 
Research Student 
London School of H)'~ne and Tropical Medicine 
London 
WC IE 7 HT 
9 Jul)' 2009 
KH/WF 
run Research & [)r1'eJopmenl A!)J)rol'al 
R&D: KCH632 
Tille: Perceptions of illness ri, k a'iSociated wilh I'isiling fri ends and relalhes in Africa amon!! 
the frican populalion liI'ing in London :uxltheir malaria preve ntion and lreatmenl 
behaviours 
REC: 09fH0706l6 
Dear Ms Neave 
Thank you for submitting )'our research project to the R&D DepW'tment, The project has now been 
:lpproved by the Trust. Ple:lse quote the R&D registration number noted above in 3D)' 
communications witb the R&D DepW'tment re ~arding your project 
Condilions or Approl'al: 
• The Principal Investigator mUSI notify R&D or the .lctu:tl stan and end rute of the projec t. 
• The Principal Investigator is responsible for ensurin~ that D.lta Protection Principles are 
oh!lerved throughout the course of the project :lnd adhere to relevant Trust policies. 
• The agreed protocol must be followed. R&D must be notified of .lny changes to tbe protocol 
prior to implemenUtioo, 
• The Principal Investigator and research team must have .lpproprillte substant.ive or honorary 
contracts with t.he Trust 1be Princip.'l1 Investi ~ator is respoosible for ensuring that the team 
is covered. including new staff recruited to the stud),. 
• If your study is a DJedicirul clinical trial all DJembers of !.he rese:trcb team mu st have 
completed GCP, Pharmacov'igilance and Trial Master File lTaining - ple:tse COnt3ct 
scott. vezina@kcl. ac. uk if training ex' annual upd.ltes are reqUired. 
• Please submit a copy of the progress report 00 tbe anniversary of the Ethi cs favourable 
opinion (sent vi ll the CI) 
Trust approval for the researcb is subject to the research being undertaken in line with the 
Dep.mment of Health's Research Governance fraDlework, and Trust policies re latjn~ to Research 
Govenunre. 
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The Research Governance Framework and details of you and your researchers responsibilities within 
this framework can be found on the Depa.rtment of Health's website at: 
http://w,,,,w. dh. !lOy. u klenlPu bli cationsandstati sticsIPubl icatiom"JPu b licati onsPol i cvA n dO II i dancelDH 
4108962 
If appropriate it is recommended thai pm regi . tu \\ ilh Ihe urn' lll ontrlllled Trial. 
we bsile: http"/liSITtn pri:/ 
In line with the Research GOVe/1l.'l.nre Framework, your project may be randomly selected for 
monitoring for compliance against the standards set out in the framework. For informJtion, the 
Trust's process for the monita-jng of projects and the associated guidance is a\'.!libble from the 
Trust's intranet or on request from the R&D Department. You will be notified by the R&D 
Dep:1rtment if and when your project has been selected 3S part of the monitoring process. No action 
is needed until thaI time. 
Many thanks for regist.ering. your research project 
Yours sin re rei)' 
Wendv Fisher 
Rese~ch and Development Mamp:er (non-commercial ) 
Research and Development Dep:trtment 
Kings CoUe~ Hospital NHS Trust 
First Flooc Jennie Lee House. 34l..o\'e Walk 
London SES SAD 
R& DRegislration @kdulhs. uk 
CC: TUDye i..a.9:l}'e, Consuttant and Clinical l.9ad , Emgrgency Department. " First Floor, Denmark Wi~ , KCH 
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3e -pennission from Joint UCLH/UCLIRoyal free Biomedical Research Unit to carry 
out interviews with patients at HTDI 
University College London Hospitals 'rt:kj 
NHS Foundation Trust 
Joint UCLHlUCURoyalFree Biomedical Research (R&D) Unit 
OffIce Location: Postal Add,...a: 
1" Roor Maple House Ro&eo.heim Wing, Ground Floor 
25 Grafton Way 
LoOOon WC1E 60B 
149 Tottenham Court Road 
London W1T roN 
22112rlO1 0 
Ms Penny Neave 
HTD 
Dear Ms Neave, 
Project 10: 1010194 (Please quote In all correspondence) 
09/t-«>70616 REC Ref: 
Trtle: Peroeptions of llneBs risk associated with visitng friends and relatives In Africa 
among the African population living In London and their malaria prevention and 
treatment behaviours 
Thank)lOO for registering the above study (non-tMP) with Ihe UClIUClHIRF Joint Biomedical 
Research Unit (UCLH Site). I am pleased to inform you that your study (non-IMP) now has local 
R&D approval \0 proceed and recruit parti~ants at Universi ty Colege London Hospitals NHS 
FOll"ldation Trust 
As ChieffPrincipaJ nvestigator you are required to ensure that your atudy/dlnlcal trial (non-IMP) Is 
conduct8d In ecoordance with the Departmenl of Healh's Researttl Governance Framework for 
Health and Social Care (2nd edltioo 2005) and that aU members of the research team are aware 
of their responsibDities under the FrameWOf1(. 
Please no. that you are also required: 
To comply with the Data Protection Act, Caldloott Principles and Trust Information 
Govemance Policy. 
To ensure all reaea.rc:hers taking pert In this study have ~-to-date and appropriate 
honorary contracts. 
To ensure that a signed and dated copy of the consent form Is kept In the studyttrial file 
and a copy also given to the partlclpanl 
To maintain an investigator file 10 store allstudyltrial documentation to be made available 
foraud • . 
Where applicable to acknowledge NIHRlCBRC funding and support and collaboration with 
the BioStatistics Grol4J. 
tf appflcable to the methodology and conduct of the proposed study: 
There Is a legal obligation 10 ablde by the Medicines for Human Use (Clnlcal Trials) 
Regulations 2004 and subsequent amendl1l8Ot$ as wen 8S any other applicable 
regulations. 
Medical Devices research regulated by the MH RA should be COMJcted in accordance to 
the Device Regulations. 
TISSue research must be conducl8d n accordance 10 the Human TIssue Act 2004 and the 
Codes of Practice Issued by the. Human T1s&Ue Authority, with speclal retevance to Code 9 
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Research. Where tissue is used for human application please ensure that you abide by the 
Human Tissue (Quality and Safety for Human Appi cation) Regulations 2007. 
This R&D approval is conditional upon you complying with all requinlments of the Research 
Ethics Committee notice of favourable opinion (dated) and notifying the UCUUClH/RF 
Biomedical Research Unit of the following as they arise: 
Serious Adverse Events & untoward research incidents 
Amendments (including a request to extend the study/cHnlcal trial (oon-IMP)) 
Anoosl Progress Repons 
Any change In staff, their duties and their tine on the studyllrial 
End of 01' suspension of srudylbial noOOcation 
Planned audits by the Sponsor 
Publications 
Please do not hesitate to contact 8 member of the team with regards to assistance and guidance 
for yoor research. 
Yours sincerely 
ff f ·D'/ 
Professor Monty Mythen 
Oirector of Research and Development 
UCUUCLHlRoyal Free Biomedical Research Unit 
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Appendix 4 - Recruitment of VFRs, GPs and practice nurses 
4a - VFRs 
VFR1 
Workshop on VFR 2, 4, 5,7 
HIV, TB and (via two different 
malaria participants) 
VFR 3, 12 
African community (via two different 
group 1 group members) 
I African commun;ty I group 2 ~ VFR 11 
VFR 9, 10,16 I Work colleague 1 I J VFR 6, 8, 13 (via VFR 6) I I J 
Work colleague 2 ~ VFR 18 
Workshop on J VFR 20 I infectious -, diseases 
Request in 
Lambeth J VFR 15 J PCT newsletter I 
Malaria , VFR 14 , VFR 17,19 
Conference 
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4b - GPs 
Direct 
-c::J request from 
researcher 
Colleague ! GP2.GP4! 
-! 
GP7 
1 
1 ~ (via GP2) 
Colleague 
1 GP3.GP5 1 
-I 
GP8 GP9 
1 
2 ~ (via GP 5) 
-0 Colleague 3 
University 
-c::J Slaff member 
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4c - Practice Nurses 
c::J • c:J 
c::J ~ C:J 
c::J ~ c:J 
c::J ~ c:J 
c::J ~ c:J 
c:J ~ c:J 
c:J ~ c:J 
c:J ~ C:J I Work 
colleague 
~ I PN9, PN10 I 
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Appendix 5: Country where P. falciparum was acquired (2004-2008) 
Country Year 
2004 2005 2006 2007 2008 Total 
Nigeria 147 162 186 162 166 823 
Ghana 52 81 43 63 46 285 
Sierra Leone 27 24 27 11 29 118 
Uganda 17 24 19 21 13 94 
Ivory Coast 5 9 11 9 6 40 
Cameroon 5 6 4 3 3 21 
Gambia 5 3 2 1 3 14 
Kenya 2 3 5 2 13 
Congo 5 3 2 0 11 
Sudan 2 1 2 3 3 11 
Angola 1 0 2 2 6 
Malawi 3 2 0 0 0 5 
Guinea 0 2 1 5 
Liberia 0 0 3 0 4 
Togo 0 0 2 0 2 4 
Burkina F aso 0 2 0 0 3 
Zambia 0 0 3 0 0 3 
Benin 0 0 0 2 
Guinea Bissau 0 0 0 2 
Rwanda 0 0 0 2 
Somalia 0 0 1 0 2 
Tanzania 0 0 0 2 
Central African Republic 0 0 0 0 
Democratic Republic of Congo 0 0 0 0 
Equatorial Guinea 0 0 0 0 
Ethiopia 1 0 0 0 0 
Gabon 0 0 0 0 
Mozambique 0 0 0 0 
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Appendix 6: Period of qualitative data collection 
2007 2008 2009 2010 2011 
Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 
VFR1 x 
VFR2 x 
VFR3 x 
VFR4 x 
VFR5 x 
VFR6 x 
VFR7 x 
VFR8 x 
VFR9 x 
VFR10 x 
VFR11 x 
VFR12 x 
VFR13 x 
VFR14 x 
VFR15 x 
VFR16 x 
VFR17 x 
VFR18 x 
VFR19 x 
VFR20 x 
CP1 x 
CP2 x 
CP3 x 
CP4 x 
CP5 x 
CP6 x 
CP7 x 
GP1 x 
GP2 x 
GP3 x 
GP4 x 
GP5 x 
GP6 x 
GP7 x 
GP8 x 
GP9 x 
GP10 x 
PN1 x 
PN2 x 
PN3 x 
PN4 x 
PN5 x 
PN6 x 
PN7 x 
PNS x 
PNS x 
PN10 x 
HC1 x 
HC2 x 
HC3 x 
P1 x 
P2 x 
P3 x 
P4 x 
P5 x 
P6 x 
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Appendix 7: Location of VFR interview (before or after travel) and method 
by which second interview carried out (where appropriate), and location of 
patient interviews. 
Before After Location of first Method of 2na 
travel travel interview interview 
VFRI y Y Work office of In person 
participant 
VFR2* y N Participant's nla 
home 
VFR3 y Y Private club Phone call 
suggested by 
participant 
VFR4 y Y Participant's Phone call 
home 
VFR5 y Y Participant's Phone call 
home 
VFR6 y Y Participant's Email 
home 
VFR7 y Y Participant's Phone call 
home 
VFR8* y N Work office of nla 
participant 
VFR9 y Y Participant's Phone call 
home 
VFRIO y Y Cafe Phone call 
VFRII y Y Participant's Phone call 
home 
VFRl2 N Y Private room in nla 
PCT offices 
VFR13* y N Bar nla 
VFRl4 y Y Work office of Email 
_partic~ant 
VFR15 y Y Private room in Email 
peT offices 
VFR16 N Y Bar nla 
VFR17 N Y Cafe nla 
VFR18 N Y Work office of nla 
participant 
VFRl9 N Y Cafe nla 
VFR20 N Y Cafe nla 
*lost to follow up 
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Patient number Location of interview 
P1 Cafe 
P2 Participant's home 
P3 Participant's home 
P4 Participant's home 
P5 Participant's parked car 
P6 Bar 
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Appendix 8: VFRs demographic details; sex; occupation; country born 
and countries of residence before immigration to UK 
VFR Age Sex Occupation Country Countries of residence 
range born before 
immigration to UK 
I 40-50 M Policy officer in France Mauritania at age of five. 
Government Organisation also Senegal and Cote 
d'Ivoire as student. United 
States, France. NiKeria 
2 50-60 M Cleaner Ghana Ghana 
3 30-40 M Lawyer/motivational speaker UK Nigeria at age seven for 
nineLears 
4 40-50 M Cleaner Ghana Ghana 
5 50-60 F Healthcare assistant Ghana Ghana 
6 30-40 M MSc student in health-related UK Nigeria at three years of age 
subject for 22..2'.ears 
7 40-50 F Cleaner Ghana Ghana 
8 50-60 M Computer Executive UK Nigeria at two years of age 
for 22 years 
9 40-50 M Events organiser Nigeria Nigeria 
Italy at 24 years of age, for 
17 years 
10 20-30 M MSc student in non health- Nigeria Nigeria 
related subject 
11 60-70 F Nurse Nigeria Nigeria 
12 20-30 F Student (non-health related Ghana Ghana 
su~ec!l 
13 30-40 M Student (non-health related Nigeria Nigeria 
SUbject) 
14 40-50 F Nurse specialising in Ghana Ghana 
infectious diseases 
15 40-50 F Commissioner of NHS UK UK 
services not including 
malaria 
16 30-40 M Management consultant UK Nigeria at five years of age 
for 16 years 
USA and Ghana 
17 40-50 F Hairdresser (part-time Ghana Ghana 
student) 
18 40-50 F Nurse (specialising in an Nigeria Nigeria 
infectious disease other than 
malaria) 
19 30-40 F Housewife (part-time Ghana Ghana 
student) 
20 20-30 F Volunteer in charity and Nigeria Nigeria 
graduate student (non-health 
related subject) 
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Appendix 9: VFRs: years of residence in UK; travel details and use of chemoprophylaxis 
VFR Number of years Current frequency of Country (area) Duration Number of Use of chemoprophylaxis 
resident in UK at travel to Nigeria/Ghana being/just visited of travel travellers 
time of interview (weeks) (relationship to 
interviewee) 
I 10 Once or twice a year Nigeria (Lagos) 2 I No 
Ghana (Accra) 
2 22 Once eveI)' year Ghana Kumasi) 3 3 (wife and son) Intended to, but lost to follow-up 
3 14 Once previously Ghana (Accra, Kibi, 3 1 Intended to, but did not use it on his 
Swedru, Scintrex, most recent trip. Had used it on one 
Cape Coast) previous trip to a malarious country 
4 22 Twice. First time six years Ghana (Kumasi) 4 2 (wife) Intermittent previously, taken for 
ago and once since then. this trip 
5 30 Every two years Ghana (Accra, 6 1 Yes 
Kumasi) 
6 4 Every year Nigeria (Enugu, los, 4 2 (a friend) No 
Bauchi, Kano, 
Lagos, Port 
Harcourt, Wari) 
7 19 Every two years Ghana (Kumasi, 7 3 (wife and Yes 
Accra) daughter) 
8 25 Once or twice a year Nigeria (Ikeja-near 3~ 6 (wife, children and Provided contradictory information, 
Lagos) other relatives) and lost to follow-up 
9 2 Four years since last visit, Nigeria (Lagos, 4 1 Yes 
but previously once or Inugu, Port 
twice a year (for business) Harcourt) 
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VFR Number of years Current frequency of Country (area) Duration Number of Use of chemoprophylaxis 
resident in UK at travel to Nigeria/Ghana being/just visited of travel travellers 
time of interview (weeks) (relationship to 
interviewee) 
10 8 months 1st time visiting since Nigeria (Lagos, 2 1 No 
coming to UK Enugu,Port 
Harcourt, Ahuja) 
11 35 Every year Nigeria (Lagos, 4 1 Yes 
Ogwashi-Uku) 
12 9 Every year Ghana (Accra, 4 1 Intermittent 
Takoradi) 
13 30 Twice or three times a year Nigeria (Lagos) 1 1 Intermittent previously and lost to 
follow-up 
14 19 Every year Ghana (Prestea) 2Y2 1 Yes 
, 
15 Since birth Visited twice with gaps of Accra 2 6 (siblings, nephews Yes I 
10 years between and nieces 
16 16 Initially "infrequent travel", Abuja, Enugu 2 3 (wife and child Intermittent on previous trips, used 
I now "virtually every year" on this trip 
17 20 Once every two years Ghana (Accra, 5 4 (three children Yes 
K wuhu Abetisi 
18 16 Once every year Nigeria (Wari 3 1 No 
19 13 Once every two years Ghana (Elmina 5 3 (two children Yes 
20 1 'l2 1 S1 time visiting since Nigeria (Lagos 2 1 No 
coming to UK 
---
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Appendix 10: Patients: demographic details; occupation; residency; travel-related details and use of chemoprophylaxis 
ID Age Sex PCTof Occupation Country No of years Country Frequency of Number of Use of chemoprophylaxis 
residence born resident in UK visited travel travellers 
I 40- M Southwark Teacher of Sierra 22 Nigeria First time since One No 
50 and autistic Leone 2003 
Bromley children 
2 60- M Lambeth Maths teacher Ghana 24 Ghana Once every two One (but joined No 
70 and part-time years by two family 
pastor members later 
in the trip) 
3 50- M Southwark Hospital Nigeria 32 (also Germany Nigeria Once or twice a One No 
60 technician and for two years, year 
part-time Norway five 
~astor years) 
4 40- M Southwark Nurse in Nigeria 20 (also lived in Nigeria Last year six times One Intended to use pharmacist-
50 mental Japan for 18 and "frequently" purchased drugs bought in I 
healthcare months after before then since the UK which he stockpiles I 
leaving Nigeria) finishing studies in Nigeria, but they were 
not there when he got 
there. 
Usually uses this 
5 40- M Newham Caretaker Nigeria 2 (but resident 17 Nigeria First time since One No 
50 years in Germany 2002 
after leaving 
Nigeria). 
6 40- M Croydon Businessman Nigeria 26 Nigeria Several times a One Intermittent, not on current 
50 (auto-trade) year currently, trip 
Upon arrival to 
UK yearly visits 
then gaps of three 
to four years 
-- ---
-
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Appendix 11: GPs: sex, ethnicity, practice details and number of years employed as a GP 
Ethnicity No. GPs NoofPNS 
in in practice* 
GP Sex practice* 
1 M Caucasian 1-4 1-4 
2 M Caucasian 10-14 5-9 
3 M Caucasian 10-14 1-4 
4 M Caucasian 5-9 1-4 
5 M Caucasian 5-9 1-4 
6 F Afro- 1-4 1-4 
Caribbean 
7 F Caucasian 5-9 1-4 
8 M Caucasian 1-4 1-4 
9 M Caucasian 10-14 1-4 
10 F Indian 5-9 1-4 
Sub-
Continent 
- --
*infonnation taken from Practice profile on internet 
**infonnation taken from LHO website 
Number of patients % of patients of 
registered with "Black African" 
practice* ethnicity** 
5000-9999 15-19 
15000-19999 15-19 
10000-14999 15-19 
5000-9999 10-19 
10000-14999 5-9 
5000-9999 15-19 
5000-9999 5-9 
5000-9999 20-24 
5000-9999 10-14 
15000-19999 15-19 
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peT Number of 
years 
working as a 
GP 
Lambeth 20-24 
Greenwich 20-24 
Lambeth 20-24 
Greenwich 20-24 
Lambeth 20-24 
Southwark 10-14 
I 
Greenwich 10-14 
Lambeth 25-29 
Lambeth 20-24 
Greenwich 1-4 
--
Appendix 12: practice nurses: sex, ethnicity, practice details and number of years working as a practice nurse 
Practice Sex Ethnicity NoofGPs 
nurse in 
practice* 
1 F Afro-Caribbean 1-4 
2 F Caucasian 10-14 
3 F Caucasian 5-9 
4 F Caucasian 5-9 
5 F Caucasian 1-4 
6 F Black-Caribbean 10-14 
7 F Black-Caribbean 10-14 
8 F Caucasian 5-9 
9 F ISC 5-9 
10 F Black African 1-4 
*infonnation taken from Practice profile on internet 
**infonnation taken from LHO website 
No ofPNs 
in 
practice* 
1-4 
5-9 
1-4 
1-4 
1-4 
1-4 
1-4 
1-4 
1-4 
1-4 
Number of % of patients peT Number of years working 
patients of "Black As a practice nurse 
registered African" 
with ethnicity** 
practice** 
5000-9999 15-19 Lambeth 5-9 
15000-19999 15-19 Greenwich 5-9 
5000-9999 15-19 Greenwich 15-19 
5000-9999 10-14 Greenwich 25-29 
5000-9999 5-9 Lambeth 5-9 
5000-9999 15-19 Lambeth 1-4 
10000-14999 5-9 Lambeth 10-14 
15000-19999 20-24 Greenwich 10-14 
5000-9999 10-14 Lambeth 10-14 
<5000 5-9 Greenwich 5-9 
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Appendix 13: Community pharmacists: sex, ethnicity, location of 
employment and number of years working as a community pharmacist 
Pharmacis Se Ethnicity peT Number of years working as a 
t x pharmacist 
1 F Caucasia Lambet 5-9 
n h 
2 F African Lambet 5-9 
h 
3 M Asian Lambet 15-19 
h 
4 M Afro- Newha 25-29 
Caribbea m 
n 
5 M Asian Lambet 10-14 
h 
6 M Asian Newha 1-4 
m 
7 M Asian Newha 10-14 
m 
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